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SUMMARY
The objectives were to investigate the relationship between lung cancers and 
to determine the effects of micro-environmental and genetic manipulation on 
regulation of phenotypic expression.
A small cell lung carcinoma (SCLC) cell line, NCI-H69 was selected as a 
model for the study of heterogeneity. Two adherent sublines (H69V and H69VZ) 
have been isolated, and characterized, for species and lineage confirmation, and for 
expression of neuroendocrine markers. They have also been characterized for their 
growth, morphological properties, and invasiveness in vitro, radiation- and chemo- 
sensitivity. The cell lines have also been investigated for tumorigenicity, invasion 
and metastases formation in vivo. The cell lines were also investigated for c-mvc 
expression by immunostaining.
Significant morphological differences have been found in culture, between the 
parental and the derivative lines. While the parental line grew as densely packed 
free floating cellular aggregates, the sublines grew as a monolayer of epithelioid 
cells. Both the derivative lines either expressed very low levels or did not express 
neuroendocrine cell markers including L-dopa-decarboxylase, creatine kinase-BB 
isoenzyme, bombesin-like immunore activity, neuron specific enolase, and 
neurosecretory type granules, compared to the parental line. All the lines stained 
positively for epithelial markers. Karyotypic analysis of the derivative lines showed 
features of SCLC. Differences have also been observed in their growth 
characteristics, both in vitro and in vivo. The growth rates of both the derivative 
lines are faster than the parental line, with doubling times closer to non-small cell 
lung carcinoma (NSCLC) cell lines. In vitro invasion studies of the cell lines showed 
early, single cell invasion in the parental cells, while solitary invasion was absent in 
both the derivative lines. Both the parental and the derivative lines were 
tumorigenic in nude mice. The parental line was both invasive locally, and formed 
multiple metastatic lesions in visceral organs, while local invasion was not found in 
either of the derivative lines, and they were non-metastatic. Xenograft histology of 
all the lines revealed an anaplastic, pleomorphic and rather large cell type tumours. 
However, the derivative lines showed focal spindle cell morphology, and spaces filled 
with an amorphous material, which was alcianophilic, and some of the cells 
contained glycogen. These features were not found in the parental line. Therefore,
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it seems likely that H69 cell line contains cells of both small and non-small cell like 
phenotypes, suggesting a common origin for these two cell types. Further studies 
showed that H69 clones were able to give rise to a heterogeneous cell population 
similar to the parental line. These data suggest a common origin for both derivative 
and parental lines.
Having established that phenotypic changes can occur spontaneously in H69 
cells, they were also investigated further to establish whether similar phenotypic 
changes could be induced in these cells by micro-environmental manipulation. The 
cells were exposed to different chemical inducers, and investigated for various 
parameters as above. The specific aim was to see whether malignant cells still 
respond to changes in microenvironment, and if they do, whether it was possible to 
alter the malignant behaviour of cells by micro-environmental manipulation.
Cells treated with hexamethylene bisacitamide (HMBA), dibutyryl cyclic 
adenosine monophosphate (dbcAMP), and sodium butyrate (Na-But) showed 
cytostatic effects on cell growth in culture, changes in culture morphology, inhibition 
of invasion in vitro, decrease in final tumour volume in vivo, changes in tumour 
histology, and reduction in expression of some neuroendocrine markers e.g L-dopa 
decarboxylase, suggesting that the H69 cell phenotype can be regulated be micro­
environmental alterations.
A NSCLC cell line (WIL) derived from an adenocarcinoma of lung was 
selected for the study of phenotypic expression in this group of lung cancer, caused 
by varying the micro-environmental influences. Growth of cells in conventional 
monolayer, with and without stromal interactions, was compared with the growth in 
a histotypic tissue culture model and xenografts in vivo. The malignant cells grown 
in optimum conditions (histotypic culture) also were exposed to various chemical 
agents, and effects on morphology both at light and electronmicroscopic level, and 
on the production of mucin-like glycoproteins, and immunohistochemical markers 
were analyzed. Cells grown on collagen in histotypic culture showed increased 
production of mucin-like glycoproteins and formation of surface microvilli, and 
intracellular mucin-like inclusions. Effects in histotypic culture were similar to in 
vivo growth of cells as xenografts in nude mice.
For the study of the effects of oncogene transfection on lung epithelial cells, 
the MvlLu cell line derived from mink lung, was transfected with human c-mvc. and 
normal and activated Ha-ras. oncogenes individually. The parental and the three
derivative lines were characterized following transfection. Though the MvlLu line 
was already immortalized, it is contact inhibited, has a very low cloning efficiency in 
suspension and low tumorigenic potential, and shows a normal response to serum 
and growth factors. Several parameters were selected to evaluate the effects of 
oncogene transfection on the induction of the malignant phenotype. These included 
a high saturation density, a high growth fraction at saturation density, serum and 
anchorage independent growth, response to cytotoxic drugs, plasminogen activator 
activity, invasiveness in vitro, tumorigenicity, invasiveness, and metastasis in vivo. 
were also characterized morphologically, immunohistochemically, and for their 
growth characteristics both in vitro and in vivo. Morphology of transfected cells was 
altered, with a more spindle shaped morphology compared to the epithelioid 
morphology of the parental cell line. Transfection with each oncogene had increased 
the growth rate of the transfectants in vitro, increased their plating efficiency in 
monolayer, and in suspension, and reduced their serum dependence. Growth in vivo 
as xenografts was also increased. While a very few tumours were formed from the 
parental line and after a prolonged lag period, the transfected lines produced 
tumours with 100% efficiency, and a short lag period. There was no significant 
increase in PA activity as a result of transfection, and the invasion of the lines in 
vitro in organotypic culture was broadly similar. There was no significant effect on 
the response of cells to cytotoxic drugs following transfection. A gradual rise in the 
expression of the malignancy associated phenotype was observed where c-mvc 
exhibited slight differences from the parental line, while transfection with Ha-ras 
produced more pronounced differences from the parental line, and in general the 
effects of activated Ha-ras were more aggressive and extreme, with the highest 
growth rates, plating efficiencies, clonogenicity in soft agar, and shortest lag periods 
and doubling times in vivo. This showed that enhanced expression of the malignant 
phenotype in a continuous cell line of epithelial origin could result from a single 
activated gene.
CHAPTER ONE
GENERAL INTRODUCTION
This Chapter provides an overview of the literature on the subject of human lung 
cancer, with emphasis on the changing phenotypes, and also on the molecular 
aspects of the disease with special reference to oncogene involvement.
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1.1 HUMAN LUNG CANCER
This is the commonest primary neoplasm, and is one of the major causes 
of death throughout the world. Over 90% of lung cancer patients will die of the 
disease. In the beginning of the century it was quite infrequent, but it has since 
become the commonest fatal cancer in men, and second leading cause of cancer 
deaths in women age 35-74 years; the incidence in women is rising mainly due 
to increased smoking. The male to female ratio is 3:1. The incidence of lung 
cancer is increasing, and it is the second major cause of death in the United 
Kingdom after cardiovascular disease [HMSO, 1985].
Scotland has the highest incidence of lung cancer in the world. The 
overall 5 years survival rate remains between 8-12%. At present only 20% of 
patients with lung cancer have evidence of localized disease at the time of 
diagnosis. Like other cancers the incidence increases with age, but has been 
reported in young men in their thirties. The commonest known causative agent 
is smoking, while other causes are airborne carcinogens, industrial pollutants, 
atmospheric radiation, occupational factors, genetic susceptibility, diet, viruses, 
and various chemical carcinogens. Early spread via both lymphatics and blood 
is common; direct spread to thoracic and abdominal organs is also common in 
late stages.
Most classifications, including the latest one proposed by the World Health 
Organization [WHO, 1982], divide lung cancers into four major histological types: 
small cell carcinoma, squamous cell carcinoma, adenocarcinoma, and large cell 
carcinoma, plus other subtypes and relatively uncommon forms. However, for 
various biological [Gazdar et al., 1983; Gazdar, 1984; 1986], pathological 
[Matthews et al., 1973], clinical and therapeutic [Ihde, 1984] reasons, lung cancers 
are often divided into two major subdivisions: small cell lung carcinoma (SCLC), 
accounting for about 25% of all lung cancers, and the remaining 75%, collectively 
referred to as non-small cell lung carcinomas (NSCLC) including; squamous cell 
carcinoma 40%, adenocarcinoma 20%, and large cell carcinoma 15%). The 
clinician has been concerned mainly with this classification, because of different 
treatment modalities, and response to therapy. Recent advances in the concepts 
of lung cancer biology, diagnosis, and staging and therapy, suggest an emerging 
clinical role for sub-classification of NSCLC.
SCLC has characteristic histological features. The tumour appears highly 
cellular with scanty stroma. Histologically, three types of SCLC have been 
recognised. (1) Oat cell carcinoma composed of uniform small cells, generally 
larger than lymphocytes, with dense round or oval nuclei, diffuse chromatin and
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inconspicuous nucleoli, and very sparse cytoplasm. (2) Intermediate cell type, 
composed of small cells with nuclear characteristics similar to the oat cell, but 
with more abundant cytoplasm. (3) Combined oat cell carcinomas with a definite 
component of oat cell carcinoma combined with squamous and/or 
adenocarcinoma.
SCLC has also been classified as a unique clinicopathological entity for 
several clinical and therapeutic reasons, such as a high tumour cell growth 
fraction, early potential for metastatic spread, and sensitivity to both radiotherapy 
and chemotherapy, in comparison to NSCLC. In patients with limited disease, 
an overall response rate of 80% following combination chemotherapy has been 
attained, with a complete remission rate approaching 50%. In spite of this 
dramatic response to induction chemotherapy, the median survival is only about 
15 months, and 2 years survival about 10-20% largely due to subsequent relapse 
with tumour resistant to chemotherapy.
While the basic classification of lung cancer has not changed significantly 
over the course of last several years, the histological criteria have undergone a 
considerable evolution, mainly by input from biological studies, in both SCLC and 
NSCLC. New advances in technology such as in molecular biology and 
immunohistochemistry have aided the subtyping of some tumours, and have also 
helped in delineating the accurate typing of lung tumours. The application of 
clinical protocols directed to specific subtypes of lung cancer will extend these 
studies further.
1.1.1 COMPONENTS OF NORMAL AIRWAYS EPITHELIUM
The normal tracheobronchial epithelium is composed of basal cells, 
intermediate cells, ciliated cells, and mucous cells [Breeze and Wheeldon, 1977]. 
There are also other rare cells such as Kultschitzky-like cells (K-cells, small 
granule cells, neuroendocrine cells), and brush cells. The basal, intermediate, 
and mucous cells are capable of division [McDowell et al., 1978]. Two types of 
epithelial cells line the bronchiole. The ciliated and the Clara cells (non- 
ciliated). Mucous cells develop following injurious stimuli in the latter. There 
are no basal cells. The Clara cells act as the reserve cell, and differentiate into 
ciliated and mucous cell [Evans et al., 1978]. The alveoli and the alveolar ducts 
are lined by type I and II pneumocytes, the latter is the precursor of type I.
In the human adult respiratory tract mucosa the neoroepithelial (NE) cells 
are found to have special topographic organization. Two well identified 
components of the system are : 1) the solitary NE-cells, 2) and neuroepithelial
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bodies (NEB). Both components have been found extending from trachea to 
alveolar ducts, being most numerous at bronchiolar level [Lauweryns & Peuskens, 
1972; Cutz et al., 1974; Hage, 1974; Stahlman et al., 1985]. The solitary NE- 
cells are in the majority, located close to the basement membrane, with long 
dendrite like cytoplasmic processes containing neurosecretory granules. They are 
scattered throughout the entire length of the tracheobronchial mucosa, and 
constitute approximately 1-2% of bronchial epithelial cells. The structures now 
referred to as neuroepithelial bodies (NEB) were described as innervated clusters 
(knotchen) by Feyrter [1938; 1954] and Froehlich [1949]. They consist of 4-12 
cells, which are non-ciliated with clear to slightly eosinophilic cytoplasm. In 
correctly oriented sections these cells extend from the bronchial basal lamina to 
its lumen. NEB have been described only in the intrapulmonary bronchial 
mucosa in human lungs, and have been observed in bronchial, bronchiolar, and 
alveolar lining epithelium especially at bronchial bifurcations [Cutz et al., 1974; 
1978; 1975; Lauweryns et al., 1972]. Both the NE-cells and the NE-bodies show 
characteristic neurosecretory granules [Cutz & Conen, 1972; Hage, 1973].
The origin of the NE-cell system of lung is controversial. According to the 
latest hypothesis by Pearse & Takor [1979], the diffuse neuroendocrine system 
(DNES) is divided into three segments of related, but, distinct embryogenesis, 
including neural crest derivatives, derivatives of neural tube and ridge, and the 
derivatives of "neuroendocrine programmed" cells of embryonal ectoblast or 
epiblast (definitive endoderm precursors). It is possible that cells derived from 
all three embryonic layers may share a common neuroendocrine programme that 
enables them to synthesize and variably utilize biogenic amines and peptides 
common to the nervous and endocrine systems through closely linked systems or 
a similar responsiveness to common stimuli [Gould et al., 1983]. Pearse [1977] 
has also suggested a central and peripheral division of DNES, where lung and 
gastroenteropancreatic axis have been included in the latter category, with a 
possible origin from embryonal ectoblast.
The functional relationship of NE-cells and NEB is not clear. NE-cells 
are thought to have an endocrine or paracrine (regulatory) function, whereas 
NEB are considered analogous to peripheral chemoreceptors.
1.1.2 ORIGIN OF LUNG CANCER
The origin of lung cancers, especially their relationship to normal cell 
types, is mostly controversial, because of the lack of readily accessible material 
for the detailed study of sequential development of neoplasia. It is generally
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accepted now however, that all have a common stem cell origin.
1.1.2.1 Small Cell Lung Carcinoma
SCLC and bronchial carcinoid are thought to arise from or are related 
to bronchial NE-cell [Cutz et al., 1981; Gazdar et al., 1981]. The endocrine 
behaviour of SCLC [Pearse, 1969; Greco and Oldham, 1979] and the production 
of biologically active polypeptide hormones such as adrenocorticotropic hormone 
(ACTH), anti-diuretic hormone (ADH), calcitonin, the expression of NE related 
enzymes (e.g., dopa decarboxylase) and the presence of dense core granules 
(DCG) are in support of this theory. A neural origin was suggested by findings 
of Tischler et al. [1977] who have shown that certain functions present in neural 
cells such as the ability to generate short duration electrical action potentials, 
could be demonstrated in a number of normal and neoplastic NE-cells, including 
cultured SCLC. Bell and Seetharam [1979] have shown that certain antigens of 
neural origin were expressed by SCLC as opposed to other types of human lung 
cancers.
However, over the past decade an emerging body of data from both 
clinical and laboratory studies have challenged the validity of the theory for a 
separate cell of origin of SCLC. An increasing number of biochemical studies 
have revealed that various polypeptide hormones are indeed found in each of the 
histological types of lung cancer, and are not restricted to SCLC as it was thought 
before. Bayline et al. [1980], have observed dopa decarboxylase (DDC) activity 
from surgical and autopsy material of all types of lung cancers. Gazdar et al. 
[1988] have found DDC in 12% of NSCLC cell lines such as adenocarcinoma 
and large cell carcinoma although the DDC activity was much lower in NSCLC 
compared to SCLC specimens. Similarly, other hormones and peptides such as 
bombesin/gastrin releasing peptide, once thought to be the key NE-cell marker, 
have also been found in about 17% of NSCLC from surgical and autopsy 
material [Yamaguchi et al., 1983]. It has been well known to pathologists for 
many years, that the same patient may present with disease that shows SCLC 
histology in combination with the morphologic characteristics of other lung 
cancers [Yesner, 1978]. In a series of clinical studies Abeloff et al. [1979] have 
shown that patients diagnosed as SCLC on biopsy material showed that 12% had 
NSCLC, 15% had mixed small cell-large cell histology at autopsy. These changes 
in SCLC phenotype suggested a link between different lung cancer types. 
Bonikos and Bensch [1977] have proposed that if the tendency for this tumour 
to express NE-cell like properties is interpreted as evidence that the tumour 
originates from NE-cells, which are scattered in sparse number, then the
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incidence of SCLC might be predicted to be much lower.
These data have led the investigators to revive the older, Unitarian theory 
of histogenesis. Several new studies, and some of the previous data indicate a 
relationship among the major forms of lung cancer including SCLC, and 
suggested a common embryological origin.
1.1.2.2 Non-Small Cell Lung Carcinomas
NSCLC represents a group of tumours with distinct but overlapping 
histological features, clinical course, and biological behaviour. Their response to 
therapy, other than surgical excision, is limited and they cannot be cured once 
they have disseminated outside the thoracic cavity.
Squamous cell carcinoma is assumed to take origin from the foci of 
atypical squamous metaplasia in respiratory epithelium, maybe from basal cells. 
Metaplastic squamous cells can develop from mucous cells [McDowell et al., 
1978]. However, it is not clear whether they arise directly from multipotential 
basal cells or from more differentiated cells. Adenocarcinomas are thought to 
arise from basal and/or mucous cells. Dermer [1981] has demonstrated from the 
cellular distribution of glycoproteins after in vitro labelling that adenocarcinomas 
arise from a cell type committed to differentiate into ciliated epithelium. 
Bronchiolo-alveolar carcinomas arise from bronchiolar or alveolar epithelium, 
from type II pneumocytes or their precursors, or from Clara cells or the mucous 
cells that have developed from Clara cells. Typically, these tumours form acinar 
structures, surface microvilli, mucin production, and other epithelial features on 
ultramicroscopy.
Large cell carcinomas are the tumours of basal and/or mucous cell origin 
that have developed beyond the basal cells stage but lack sufficient glandular or 
squamous differentiation to be classified into these categories. Horie and Ohta 
[1981] have shown that large cell carcinomas have ultrastructural features of both 
squamous and adenocarcinoma. They may also even express features of 
endocrine tumours [McDowell et al., 1981], and it has been suggested that this 
group may represent a potential stem cell.
1.1.3 THE INTERRELATIONSHIP OF LUNG CANCERS
Overwhelming evidence exists for a common origin of all the mucosal 
cells of bronchial epithelium, and the tumours derived from them [Yesner, 1978; 
Gazdar et al., 1981]. The main evidence comes from the study of embryonic 
derivation of bronchopulmonary tract [Andrew, 1976; Fountaine & LeDauarin, 
1977]. According to this theory a stem cell undergoes progressive differentiation,
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through morphologically undifferentiated intermediate stages committed to 
specific pathways of differentiation. The fully differentiated cells are end stage 
cells, and therefore, incapable of further division [Gazdar et al., 1981]. A 
committed precursor cell may differentiate along more than one pathway 
depending on environmental conditions (e.g carcinogens, viral infections) and may 
even switch from one pathway to another, probably due to genetic alterations (e.g 
oncogenic activation, suppression of anti-oncogene). Pulmonary NE-cells with 
amine precursor uptake and decarboxylation (APUD) cell properties may be one 
type of differentiation. It is possible that APUD-cell properties develop in this 
cell with the onset of endocrine differentiation or else these properties develop 
in all intermediate cells, and are then selectively retained only in endocrine cells 
[Baylin and Mendelson, 1981].
Transforming events occur in undifferentiated cells, since fully 
differentiated cells are not capable of replication. The differentiation status of 
the transformant may depend on the level of differentiation at which 
transformation occurs. According to this concept SCLC are regarded as partly 
differentiated along the endocrine pathway. Large cell carcinoma may represent 
the stem cells or undifferentiated tumour. This explains the presence of tumours 
having more than one morphological component, and also the APUD-cell 
markers in NSCLC. These cell types may represent intermediate stages in the 
spectrum of lung cancer.
The tumour cell population is propagated by a core of undifferentiated 
stem cells capable of a large number or infinite divisions, some of the progeny 
differentiate, while others remain relatively undifferentiated, and maintain the 
stem cell pool [Figure 1.1]. The stem cell fraction in a tumour may appear 
morphologically different. It has been demonstrated that most SCLC cultures 
contain a very small percentage of large cells [Gazdar et al., 1981] which may be 
stem cells. According to this theory, a changing tumour morphology can be 
explained by progressive failure of the stem cells to undergo differentiation. 
Depending on the severity of differentiation failure, a pure small cell or mixed 
small cell-large cell tumour or pure NSCLC may be found in an originally SCLC 
with a very small stem cell population.
The stem cell theory can also explain the co-existence of SCLC with other 
histological types of lung cancer such as squamous and adenocarcinoma. If all 
lung cancers arise from a single stem cell, conversion from one differentiated cell 
type to another can occur, by maturation down one particular pathway, resulting 
in either a pure squamous, adeno or SCLC or even a mixed population of SCLC
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Figure 1.1:- Common stem cell theory of the origin of the cells of the respiratory 
mucosa (a), and lung cancers (b).
with any of other lung cancer types. The stem cell concept of lung cancer has 
also been supported by data derived from clonogenic assays which indicate that 
only a small percentage of SCLC (1-5%) is capable of giving rise to progressively 
growing colonies, but that many cells are capable of limited replication [Carney 
et a l 1980]. In addition, in mixed small cell-large cell tumours, cell kinetic 
studies indicate greater thymidine uptake by the large cell components, suggesting 
a greater replicating ability of the latter.
The cells of carcinoid tumours resemble the K-cells of the bronchus. 
Small cell carcinomas are poorly differentiated with some features of K-cells, but 
more often resemble bronchial basal cells. It seems most likely that the cell of 
origin of SCLC is the basal cell [Sidhu, 1979]. It may be the case that carcinoid 
arise from cells already on the pathway of differentiation toward K-cells. This 
also explains the epidemiological divergence of SCLC and carcinoid of lung. 
Therefore, it appears that perhaps only the basal cell is susceptible to the 
influence that results in an increased incidence of SCLC; cells more differentiated 
toward K-cell may be less susceptible, explaining why carcinoid have not 
increased with the rising incidence of SCLC.
1.1.4 BIOLOGY OF LUNG CANCER IN  VITRO
1.1.4.1 Small Cell Lung Cancer Cell Lines
It has been possible now to establish cell lines with over 70% success, due 
to the use of defined media [Gazdar et al,. 1980; 1981; Carney et al., 1981]. 
Once established, cell lines express characteristic properties [Table 1.1]. They 
have a relatively prolonged cell population doubling time which decreases with 
increasing passage number, suggesting a selective process or adaptation to the 
culture environment. They form colonies in semi-solid media with a low 
efficiency (1-5%) and form tumours in athymic nude mouse with a characteristic 
SCLC morphology.
SCLC cells grow in culture either as free floating aggregates or as a 
partially attached monolayer. In the latter cases, it has been found that as cell 
density increases, large clumps of cells detach from the surface of the monolayer 
and float to grow in suspension [Pettengill et al., 1980]. Depending upon the 
morphological appearances of the cultures, SCLC cell lines have been classified 
into four types by Carney et al. [1985]. Type 1 cells lines grow as spherical 
aggregates of floating cells with frequent central necrosis in large sized 
aggregates. Type 2 cell lines grow as floating cellular aggregates with irregular 
outlines, packed tightly as in type 1, but without central necrosis. Type 3 cell
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Table 1.1:- Biological properties of lung cancer cell lines.
Characteristic
SCLC
Classic Variant
NSCLC
Morphology FFA FFA/monolayer epithelioid
Substrate adhesion absent absent present
Tumorigenicity + + +
Ploidy aneuploid aneuploid aneuploid
CFE + + + + + +
Histology SCLC SCLC NSCLC
Doubling time long short short
DCG +
DDC +
BLI/GRP + + _
BLI receptors +
_ _
NSE + + +
CKBB + + + + -
Neurotensin + +
Peptide hormones + + + /_ ■'_
EGF receptors _ _ +
Chromosome 3p del + +
IF cytokeratin cytokeratin cytokeratin
RS sensitive resistant resistant
CS sensitive resistant resistant
c-mvc + + + _
N-mvc + /_ + /_ —
L-mvc + /_ - -
FFA, free floating aggregates; CSF, colony forming efficiency; DCG, dense core 
granules; DDC, dopa decarboxylase; NSE, neuron specific enolase; BLI/GRP, 
bombesin like immunoreactivity/gastrin releasing peptide; CKBB, creatine kinase 
isoenzyme-BB; IF, intermediate filaments; RS, radiation sensitivity; CS, 
chemosensitivity.
lines grow as a combination of loosely adherent cells and floating small irregular 
aggregates. Type 4 cell lines grow attached to the substrate like monolayer 
cultures.
Depending on their morphological, and biochemical properties SCLC cell 
lines have been further classified into two major groups, classic and variant 
[Carney et al., 1985; Gazdar et al., 1985]. Classic SCLC cell lines exhibit type 1 
or 2 morphology in culture, show intermediate cell type histology in xenografts, 
express elevated levels of dopa-decarboxylase (DDC), bombesin-like 
immunoreactivity (BLI), neuron specific enolase (NSE), and creatine kinase BB 
isoenzyme (CKBB). The variant SCLC cell lines lack DDC, and BLI but 
continue to express NSE, and CKBB, and exhibit type 3 or 4 morphology. The 
variant SCLC cell lines have been further divided into 1) biochemical variant 
lines which have typical SCLC morphology, intermediate cell type histology in 
xenografts, and characteristic SCLC growth properties, but with variable 
biochemical profiles, and 2) morphological variant SCLC cell lines which have 
variant morphology, biochemical profiles, altered growth characteristics, exhibit 
a histological appearance in xenografts of undifferentiated large cell carcinoma, 
and show amplification of c-mvc oncogene. A transitional class of SCLC cell 
line has also been proposed characterized by mixed classic-variant characters, 
and there have been speculations as to whether this class represents an 
intermediate state between pure classic and pure variant groups. This model 
would represent a transition from SCLC to NSCLC phenotype.
Many clinical specimens and established cell lines of SCLC form tumours 
when inoculated subcutaneously into nude mice, and tumours can be transplanted 
with 100% take, and established as continuous cell lines in culture [Sorenson et 
al., 1981; Gazdar et al., 1981]. Some lung tumour cells have shown differentiation 
when grown in the mouse [Giovanella et al., 1974]. In general the more poorly 
differentiated tumours were those that grew best in the nude mice. In general, 
xenografts retain the morphological characteristics of the parental tumours at 
light and electron microscopic level, but some features may be lost due to 
selection as an increased rate of proliferation with serial passage of tumour in 
animals. Tumours have also been found to express biological markers, which are 
found in the serum of the animal bearing the tumour. Studies have shown a 
good correlation between the response of xenografts to cytotoxic drugs and the 
patient’s tumour [Shorthouse et al., 1980].
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1.1.4.2 Non-Small Cell Lung Cancer Cell Lines
NSCLC cell lines can be readily established from approximately 40% of 
all specimens obtained [Brower et al., 1986], and can be more readily established 
from metastatic lesions compared to primary lesions. Once established as 
permanent cell lines, they can be characterised for different parameters [Table 
1.1]. These cells retain the morphology of the original tumour type. They form 
tumours in athymic nude mice, and colonies in soft agarose, with relatively more 
frequency compared to SCLC cell lines.
1.1.4.3 Molecular Genetics of Lung Cancer
Many cancers have now been associated with specific chromosomal 
abnormalities e.g retinoblastoma [Cavenee et al., 1983], Wilms tumour [Fearon 
et al., 1984], leukaemia [Nowell and Hungeford, 1980; Deklein et al., 1982], and 
Burkitt’s lymphoma [Taub et al., 1982]. Molecular analysis of these lesions has 
resolved different potential mechanisms by which these specific chromosomal 
abnormalities may play a role in the development of the transformed phenotype.
Various genetic changes have been described in lung cancer cells. These 
include point mutations, chromosomal rearrangements, deletions, and gene 
amplifications. The target genes include dominantly acting cellular oncogenes, 
onco-suppressor genes, and genes for growth factors and their receptors, 
especially autocrine growth factors. These studies, therefore, suggest that lung 
cancer can be regarded as a genetic disease, and the products of these altered 
genes and their biochemical pathways involved are the potential targets for new 
therapeutic strategies.
Various genetic abnormalities in SCLC have been reported by Whang- 
Peng et al., [1982]. A modal chromosome number ranging from 40 to 90 has 
been observed in SCLC cell lines. Many cell lines have been found to be 
hypodiploid, hyperdiploid, or tetraploid. Other chromosomal abnormalities 
include the absence of chromosomes 13 and 15, aberrations of chromosomes 
1,2,9,10, 14, and X. Another characteristic abnormality is the deletion in the 
short arm of the third chromosome 3p 14-23. This abnormality is found in over 
90% of SCLC, and about 25% of NSCLC [Brauch et al., 1987]. It has been 
proposed that such a deletion may uncover an otherwise recessive mutation 
residing on the cytogenetically normal chromosome 3, since such mechanisms 
have been suggested for retinoblastoma (13q24) [Benedict et al., 1983], and 
Wilms tumour ( lip )  [Orkin et al., 1984], and the genes inactivated by these 
chromosomal changes are proposed to be anti-oncogenes. Abnormal expression 
of various proto-oncogenes have been found in lung cancer cells [see Table 1.2].
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Amplification of mvc oncogenes has been found in SCLC. It has been 
shown that SCLC morphological variant cell lines express high levels of c-mvc 
oncogene. Amplified c-mvc mRNA has been found in the variant compared to 
classic cell lines [Little et al., 1983; Gazdar et al., 1985; Nau et a l, 1985; 1986]. 
Other members of the mvc family of genes have also been found in association 
with SCLC.
1.1 A A Growth Factors and Lung Cancer
Lung cancers, like many other tumours, synthesize and secrete a number 
of growth regulatory factors. Several growth factors have been identified, which 
are synthesized and secreted by lung cancer cell lines [Sporn & Todaro, 1980]. 
Moody et al. [1981] have shown that SCLC cell expresses high levels of 
intracellular bombesin. Others have shown that bombesin and its related peptide 
GRP are potent mitogens for normal lung epithelial cells [Willey et al., 1984], 
and in SCLC [Carney et al., 1987]. Cuttitta et al. [1985] have shown that the 
growth of SCLC tumours both in vitro and in vivo is inhibited by a monoclonal 
antibody 2AII which binds to the C-terminal portion of bombesin, and inhibits 
binding of bombesin to its receptor. Macauley et al. [1987] have shown other 
growth factors such as insulin-like growth factor 1 (IGF-1) to be secreted by 
SCLC cells and to be a potent mitogen for these cells. This may explain the 
relative ease with which SCLC may be grown in low serum or serum free 
medium.
Studies of NSCLC cell lines have also shown that these tumours secrete 
and respond to growth factors [Betsholtz et al., 1987]. Gamou et al. [1987] and 
Siegfried [1987] have shown an increased expression of epidermal growth factor 
(EGF) receptors in NSCLC in contrast to SCLC tumours, and in some cases 
modulation of the receptors or alteration of binding of EG F to the receptor by 
monoclonal antibody can inhibit both in vitro and in vivo growth of tumour cells.
1.1.4.5 Expression of Marker Proteins in Lung Cancer
The ability of many pulmonary tumours to produce and secrete hormones 
and other substances has been used as a tumour marker. Many of these markers 
are measured in blood, or other body fluids, and still others may only be present 
within the tumour tissue. Tumour may be associated with humoral markers that 
are not released by the tumour tissue per se, but result from a secondary effect 
of the malignancy on some other tissues. The tumour markers or products 
include hormones, hormone precursors, placental and fetal proteins, and enzymes 
[Minna et al, 1982]. Various clinical applications of these markers have been 
suggested such as early detection, diagnosis of undifferentiated SCLC tumours
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[Baylin et al., 1980; Marangos et al ., 1982], clinical staging of lung cancers 
[Minna et al., 1982; Gazdar et al., 1981; Carney et al., 1982], and monitoring 
response to therapy [Minna et al, 1982; Carney et a l, 1982].
However there is no definite marker for screening for the presence of lung cancer 
[Minna et a l, 1982],
A variety of markers are produced by all lung cancers, but the 
concentrations have usually been found to be significantly higher in patients with 
SCLC than in patients with NSCLC. These include ACTH, which is mainly 
produced by SCLC, but also by NSCLC tumours, lipotropin [Odell et a l, 1979], 
calcitonin [Silva et al, 1976; 1979], human chorionic gonadotropic (HCG) 
[Tashjian & Weintraub, 1973], carcinoembryonic antigen (CEA) [Sculier et al, 
1985].
Elevated expression of neuroendocrine markers has been reported in 
NSCLC. Berger et a l  [1981] have shown elevated expression of L-dopa 
decarboxylase, and NSE in up to 20% of NSCLC tumours, and Ariyoshi et a l 
[1986] have found elevated serum levels of NSE in up to 15% of patients with 
NSCLC. These NSCLC tumours with neuroendocrine properties have been 
shown to be more sensitive to cytotoxic therapy like SCLC [Mulshine et a l, 1987], 
In a prospective trial preliminary data suggest that endocrine NSCLC are more 
chemosensitive than non-endocrine NSCLC tumours. Therefore, these data 
suggest that elevation of the expression of endocrine properties in primary lung 
cancer may be of prognostic value and may aid in selection of appropriate 
therapy in such patients.
1.1.4.6 Chemosensitivity of Lung Cancer
In vitro tests of chemosensitivity and radiosensitivity have been carried out 
both on fresh specimens and cell lines of lung cancer. Carney et a l  [1985] have 
shown a good correlation between in vitro chemosensitivity testing and predicted 
in vivo resistance in the majority of cases, and predicted in vivo sensitivity in up 
to 60% of cases. However, due to the low cloning of fresh specimens of lung 
cancer, the results of tests for specific cytotoxic agents are limited to a small 
number in fresh specimens. Therefore, the use of cell lines for chemosensitivity 
testing is another alternative, and has many advantages, when compared to fresh 
specimens. Using established cell lines of both SCLC and NSCLC it has been 
shown that many retain a similar pattern of in vitro chemosensitivity to that of 
fresh biopsy specimens [Carney et al, 1983]. Although the results and the pattern 
of chemosensitivity may vary in different culture conditions, the overall data 
suggest that such cell lines can be used to predict in vivo responses [Carney et al,
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1985], and to evaluate drug resistance mechanisms [Shoemaker et al., 1983], 
They may also be used for screening new drugs in clinical trials [Carney et al., 
1985], and for the investigation of correlations between marker expression and 
other aspects of the phenotype, such as drug resistance and sensitivity [Johnson 
et al., 1987; Twentyman et al., 1986].
1.2 CARCINOGENESIS
Carcinogenesis is a multistage process. The evidence comes from 
epidemiological studies in man [Armitage and Doll, 1957], biochemical [Farber,
1984] and histopathological [Foulds, 1954] analysis of tumours in vitro and in vivo, 
the studies of experimental cancer induction in animals using chemicals, 
irradiation and viruses [Spandidos, 1986], and in vitro cell transformation assays 
[Spandidos and Siminovitch, 1978]. The process of carcinogenesis can be divided 
into three distinct stages: initiation, promotion and progression.
The first stage of tumour formation is initiated by a carcinogenic agent 
that can be a chemical carcinogen, oncogenic virus, radiation, replication error, 
or other unknown factors. This step is an absolute requirement which results in 
irreversible mutational events in the cellular genome. Initiation is a very rapid 
process which may result following a single application of a carcinogen. It has 
been shown that some chemical carcinogens induce activation of the ras gene by 
point mutation. Balmain et al. [1984] have demonstrated activation of ras gene 
in chemically induced benign skin papillomas in mouse. Wiseman et al. [1986] 
have shown mutational activation of the c-Ha-ras proto-oncogene in chemically 
induced mouse hepatomas. It is possible that a point mutation in the ras gene 
confers a selective growth advantage on these cells, which in time undergo 
phenotypic diversification, with subsequent malignant transformation. Point 
mutations in the ras oncogene have also been demonstrated in lymphomas 
following X-ray exposure [Guerrero et al., 1984]. In vitro transformation assays 
have shown that over-expression of a single mutated ras oncogene was sufficient 
to transform primary rodent cells [Spandidos and Wilkie, 1984] and early 
passaged rodent cells [Wyllie et al., 1987]. The c-mvc gene has been found as an 
initiator of carcinogenesis, in transgenic mice [Stewart et a l, 1984].
The application of carcinogen does not lead to the immediate formation 
of a tumour, but rather there is a series of changes following tumour initiation 
caused by carcinogen. The initiated cells may persist for a considerable time, 
until they are acted upon by promoting agents. Tumour promotion may be
facilitated by carcinogen or by other substances called tumour promoters, which 
do not themselves produce tumours. They also stimulate tumour formation in the 
initiated cells, and interfere with the differentiation process. The exact role of 
tumour promoters remains unknown [Parker and Ullrich, 1986].
The third and clinically most significant stage is the progression of the 
benign tumour to malignant tumour. This stage is characterized by both 
phenotypic and genotypic changes in the tumour cells. The tumour cells acquire 
malignant phenotypes such as invasion and metastasis. Tumour progression is 
also associated with various genetic alterations such as aneuploidy, double minute 
chromosomes, homogeneously staining regions in chromosomes, chromosomal 
rearrangements, deletions, mutations, amplifications of specific genes, and 
increased DNA content of cells.
It is established that cancer is a result of defective regulation of cell 
growth and differentiation. Regulatory processes which control the events during 
a normal cell division are deranged in cancer cells [Campisi et al., 1986]. The 
study of cell cycle events shows that a major regulatory control occurs in 
G 1-phase just prior to the entry of cells into S-phase (restriction point) [Pardee, 
et al., 1978]. Data strongly suggest that a normal cell needs to make a critical 
amount of an unstable protein (e.g p68) in order to pass the restriction point 
[Campisi & Pardee, 1984]. It was found that various transformed cells behave 
as if this protein is stabilized or made in excess suggesting that greater availability 
of this or similar proteins may permit the escape of cells from growth control, 
and this may be under oncogenic control. Synthesis of these proteins requires the 
presence of growth factors, and is blocked by protein synthesis inhibitors [Campisi 
et a l , 1984; Zetterberg & Larsson, 1985]. It has been shown that ras oncogene(s) 
is activated during 6 hours pre DNA synthesis period [Campisi & Pardee, 1984], 
and similar results have been shown in other cases [Mulcahay et al., 1985], 
suggesting a possible oncogenic involvement in this process.
1.3 INVASION AND METASTASIS
Alteration of growth properties and uncontrolled proliferation is a primary 
but not a critical step as such during tumour progression, since neoplastic growth 
is seen in benign tumours. Proliferation only produces benign tumours, invasion 
and metastasis are the characteristics of the malignant phenotype. As a rule a 
benign tumour grows but neither invades nor metastasizes. A benign tumour may 
remain benign or may become malignant [Foulds 1969, Balmain 1985].
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Although tumour growth and proliferation are associated with invasion 
there is ample evidence that invasion is not dependent on cell proliferation in 
vitro [Mareel et al., 1982, Thorgeirsson et al., 1984] and in vivo [Disttelmans et al.,
1985]. Drugs such as 5-Fluorouracil (5-FU) that completely inhibited cell 
proliferation [Bracke et al., 1984, Storme et al., 1985] did not block invasion.
A three step hypothesis has been proposed for the sequences of events 
during tumour cell invasion: 1) adhesion, 2) matrix hydrolysis, 3) and tumour cell 
motility or locomotion. A continuous invasion of the matrix takes place by cyclic 
repetition of these three steps, and all the processes are taking place at the same 
time.
Certain molecules mediate communications between metastatic cells and 
their milieu. This is essential for tumour cell detachment from the primary 
tumour mass, its transportation through matrices, and re-attachment at metastatic 
sites. These matrix and cell surface molecules can be divided into tumour and 
stromal components. The tumour cell surface contains receptor molecules, which 
are thought to be essential for homotypic and heterotypic adhesions. Tumour cell 
adhesion with matrix may be mediated by specific glycoproteins such as laminin, 
fibronectin, vitronectin, integrins, and tenacin on the cell surface [Alberts et al., 
1989]. Homotypic adhesion is necessary for tumour cells to break in lumps or 
aggregates and to survive the long journey in the blood or lymphatic channels, 
and also to help their arrest in capillary wall. Heterotypic adhesion is essential 
for tumour cell-stromal interactions at different levels of invasion and at 
metastatic site. Homotypic adhesion is reduced, but heterotypic adhesion may 
be increased in metastatic tumour cells.
Malignant cells have been shown to express various types of proteolytic 
enzymes which facilitate invasion and dissemination of tumour cells by matrix 
degradation. These include various collagenases [Thorgeirsson et al., 1985], 
cathepsins [Sloane et al., 1981], and plasminogen activators [Liotta et al., 1981]. 
It has been proposed that when a normal cell or benign tumour cell attaches to 
the extra-cellular matrix (ECM) it may respond by shifting into a resting or 
differentiated state, but not a malignant cell [Liotta & Schiffmann, 1988]. Many 
of these hydrolytic enzymes are cell surface associated, and may require contacts 
with matrix for lysis to occur. Many of the proteases are secreted in proenzyme 
form and therefore require activation. The localization of degradative enzymes 
at the cell surface suggests a spatial organization which may be essential for 
activation and directional movements.
Cell movements and locomotion have a fundamental role in cancer
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spread. Two types of molecular mechanisms have been described for the 
regulation of locomotive behaviour of cancer cells. Chemokinetic movements are 
thought to be under influence of autocrine motility factors (AMF) secreted by 
tumour cells, while directional movements are due to chemotactic factors.
Invasive cells also possess the ability to deform and squeeze through 
narrow spaces like blood cells, and deformability may facilitate their entry into 
intercellular spaces and between endothelial cells on the blood and lymphatic 
vessels. This property may be due to altered cytoskeleton. Alterations in actin 
polymerization and vinculin phosphorylation and interaction with transmembrane 
proteins and other similar mechanisms may be involved.
There are also alterations in cell-cell interactions, both at primary tumour 
site and at metastatic site. Loss of spatial control results from abnormal cell 
interactions and altered recognition, leading to a loss of orientation, which may 
be due to loss of specific sites for cell or matrix recognition.
The growth of vasculature in tumour is another important factor in tumour 
growth and progression. Tumour angiogenesis factors (TAFs) are produced by 
the tumour, and stimulate migration and proliferation of endothelial cells in the 
tumour mass.
Although, invasion is an essential step for metastasis [Hart, 1984], all 
invasive tumours are not necessarily metastatic. Primary brain tumours are highly 
invasive, but they do not metastasize, likewise the basal cell carcinoma of skin 
[Dvoretzv et al, 1978].
The formation of metastatic tumour is a multi-step process. The first steps 
are as in invasion; motility and detachment from primary tumour site, invasion 
of basement membrane and subsequent infiltration of vascular channels and 
dissemination. Once in the circulation, adhesion to vascular endothelium is 
essential, and this may be facilitated by mechanical entrapment or injury to the 
endothelial lining. Tumour cells then penetrate the endothelium, due to their 
deformability facilitated by proteolytic enzyme secretion, or by specific surface 
receptor mechanisms. The extravasated cells then penetrate the secondary tissue, 
followed by tumour growth at the secondary site. Not all of the tumour cells that 
reach the new organ site are capable of forming tumour. The "seed" has to be 
able to respond to the "soil", according to "seed and soil" hypothesis, proposed by 
Paget [1889] that cancer cells, like plant seeds, may travel in different directions, 
but can only grow if they fall on soil favourable for their growth. Organ specific 
metastasis has been well documented both in clinical and experimental studies. 
Both the adhesion and invasion may be facilitated at different fronts by specific
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affinity factors. A growth factor has been isolated from lung which stimulates 
melanoma cells which readily form lung metastases. It is possible that metastatic 
cells may become responsive to the growth factors by switching on the gene that 
codes the receptors for it. They have also shown that an increase in EGF 
receptors on human gastric carcinoma was associated with progressive disease in 
vivo, and a significant correlation was found between the depth of tumour cells 
invasion into gastric wall and EGF receptors on the tumour cells. Therefore, the 
growth of the tumour cells in a specific organ microenvironment could be 
facilitated by the production of organ specific growth factors generated 
subsequent to organ damage, which in turn is followed by repair process.
1.4 HETEROGENEITY IN MALIGNANT TUMOURS
Tumour cell heterogeneity is a well established phenomenon [Fidler et al., 
1978; Fidler and Hart, 1982]. Such heterogeneity includes variations in 
morphology, antigenicity, karyotype, enzymatic profiles, drug resistance, growth 
characteristics, biochemical, and immunological properties, invasion and 
metastatic potential. It is now generally accepted that tumour heterogeneity is 
a manifestation of tumour progression [Heppner, 1984], by a dynamic 
combination of variant cell generation and selection of those best fitted to 
survival.
It is well recognised that both naturally occurring and induced neoplasms 
generally develop from a single transformed cell [Reddy and Fialkow, 1983]. 
Tumour progression probably starts when tumour cells diversify in their unique 
microenvironments, and the variants with altered phenotypes arise in the tumour 
cell population. The cellular variant generation seems to be a stochastic, highly 
disordered, and multidirectional process, which involves both genetic and 
epigenetic changes. To survive and grow in a competitive environment, such a 
variant must have some selective growth and other advantages over other cells 
[Nicolson et al., 1984; Nowell, 1986]. Several factors [Table 1.2] such as genetic 
instability of transformed cells [Bishop, 1987; Nicolson, 1987], microenvironmental 
influences [Sutherland, 1988] and other interactions [Heppner et al., 1983; 
Nicolson, 1987] play an important role in variant generation changing a 
homogeneous cell population to a heterogeneous one. Then gradually with time, 
evolution of more stable variants may result in the eventual dominance of a 
particular subpopulation of tumour cells with more advanced malignant 
characteristics [Nicolson, 1984]. However, changes within tumours do not always
19
Table 1.2:- Factors influencing cell phenotype.
I. INTRACELLULAR
(A). Nuclear events
1. Chromosomal alterations (e.g breakage, translocation).
2. DNA alterations (e.g mutations, deletions).
(B) Cytoplasmic Events
1. Cytosol alterations (e.g second messengers, metabolites).
2. Cytoskeleton alterations (e.g membrane interactions).
3. Post-transcriptional (e.g mRNA processing, post-translational).
II. EXTRACELLULAR
(A). Cell-Cell Interactions (e.g cell junctions, cell contacts).
(B). Cell-Matrix Interactions (e.g matrix receptors, cell shape changes).
(C). Cell-Factor Interactions (e.g hormones, growth factors).
(D). Iatrogenic Effects (e.g radiation- and chemo-therapy).
result in progression of tumour cells to more malignant phenotypes and rarely 
may also result in tumour regression [Nicolson, 1984].
Genotypic variations within tumour cell populations have been 
demonstrated by molecular and karyotypic analyses. A variety of different 
genetic alterations have been found in malignant cells such as aneuploidy, 
translocation, homogeneously staining regions, double minute chromosomes, 
mutations, deletions, and amplifications. More recent molecular studies have 
shown that these genetic rearrangements and changes can result in expression or 
suppression of genetic sequences involved in generation of malignant phenotypes. 
These sequences are oncogenes [Bishop, 1987], tumour-suppressor genes [Todaro, 
1986; Spandidos and Anderson., 1989], and a recessive gene associated with 
cancer predisposition [Knudson, 1986]. Cancer has myriad causes, but probably 
all work through a final common path of activation or suppression of these 
genetic sequences.
Most, if not all, malignancy-related gene products are also associated with 
normal developmental processes, suggesting that virtually all of the cellular 
characteristics of malignant neoplasms may also be encoded by normal genes. 
The quantitative changes in gene expression are also evident from the 
reappearance of fetal characteristics and gene products in malignant cells. It is 
possible that the genes that regulate embryonic cellular growth and differentiation 
may be intimately linked in the genome, and their quantitative variations in 
expression may explain expression of embryonic characteristics in malignant 
phenotype. Tumour progression is therefore, characterized mainly by 
quantitative, not qualitative, changes in gene expression, and the role of 
qualitative changes, such as genotypic alterations, might be to circumvent normal 
growth and differentiation controls and accentuate developmental heterogeneity 
leading to quantitative differences in gene expression among tumour cells. This 
explains the dynamic phenotypic shift seen in malignant cells population, an event 
that occurs much too quickly to be explained by genotypic changes in a minor cell 
subpopulation.
In addition to the genetic factors, the phenotypic stabilities in tumour 
cells are largely determined also by microenvironment [Nicolson, 1984]. 
Genotypic instability and selection alone cannot explain the rapid rates of tumour 
cell phenotypic variation that are observed in vitro and in vivo, since these are 
orders of magnitude lower than the rate of variant generation. It is important to 
recognize that phenotypic variability in cellular population is a normal cell 
attribute that is essential for tissue adaptability, however in malignant tumour it
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may be accentuated beyond that required for normal tissue adaptation. Slight 
differences in tumour microenvironment may generate events that lead to local 
differences within the tumour. These include differences in cell-cell and cell- 
stromal interactions within the tumour, soluble inducers, nutrients, growth factors, 
hormones, enzymes, oxygen, and other different tumour regulators. These factors 
may play important roles in destabilizing tumour cells, and determining their 
susceptibility to genetic and epigenetic alterations.
1.5 CELL MICROENVIRONMENT AND PHENOTYPIC REGULATION
1.5.1 Mechanism of Differentiation Control
The differentiated state is achieved by interactions between parenchymal 
and mesenchymal elements in a tissue, both during embryogenesis and in adult 
life. Different germ layers of the embryo interact to give rise to differentiated 
tissues. Primitive endoderm differentiates into various visceral organs by 
interacting with the mesoderm in which it proliferates, e.g, lung buds arise from 
foregut primordium, and start proliferating in somatic mesenchyme. As 
developing bronchial ducts ramify, epithelium is induced by mesenchyme to form 
alveolar morphology, while mesenchyme is induced to form elastic tissues in lung 
substance [Taderera, 1967], suggesting a bilateral stimulatory effect of interacting 
tissues in order to give rise to the differentiated phenotype of each.
The phenomenon of tissue interaction is also found in adult tissues for the 
regulation and maintenance of normal structural and functional integrity. In the 
beginning it was assumed that the particular phenotypes of the cells in different 
tissues were established in embryonic life and that they would subsequently 
"breed true" as observed for instance during transplantation of full thickness skin 
[Billingham and Silver, 1968]. However, now it is established that both 
morphological and functional properties of various adult tissues are the outcome 
of interactions with their micro-environment, and they are of a similar nature as 
in their embryonic counterparts. Degeneration of taste buds following their nerve 
resection [Zalewski, 1969], maintenance of epidermal organization in combination 
with dermis [Billingham and Silver 1968], hair and nail formation [Oliver, 1967], 
amphibian limb regeneration only in presence of nerve supply [Singer, 1965], are 
just a few of the examples where tissue interactions have been found essential for 
the maintenance of a tissue.
It has been proposed that at least in vitro there could be four major
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parameters for the regulation of differentiation [Freshney, 1985; 1987].
1.5.1.1 Cell-Cell Interaction
Cellular interactions can be heterologous or homologous. Heterologous 
cell interaction is probably responsible for initiation and promotion of 
differentiation. The exchange of information may occur at the cell surface by 
paracrine signals [Roberts et al., 1988] or by cell surface molecules or receptors 
[Simon-Assmann et al., 1988]. Homologous cell interactions occur at high cell 
density probably involving gap junctional communications, which probably 
harmonizes the expression of differentiation within one cell population [Pitts et 
al., 1988]. These interactions have been found both during embryogenesis and 
in adult life, and are often lost in malignant tumours.
1.5.1.2 Cell-Matrix Interaction
Matrix, mainly comprised of glycoproteins and proteoglycans, forms a 
complex within each tissue around each cell. It has been shown that matrix 
regulates gene expression [Bissell, 1988]. Degradation of matrix in malignant 
cells would suggest that either they are less dependent on extra-cellular matrix 
for growth, or less able to interact with it due to loss of specific receptors or 
surface molecules, or they produce endogenous matrix components essential for 
their growth. Collagen is a major component of extra-cellular matrix in vivo and 
it has been used as substrate for cultured cells in different studies dealing with 
morphology [Chambard et al., 1981; 1982], migration [Greenberg & Hay, 1982], 
and differentiation [Bissel etai., 1981; Kleinman et al., 1981]. Collagen occurs in 
four forms: collagen type I, II, III, and IV [Bornstein and Sage, 1980]. Collagen 
used as a substrate in culture work is in the form of either a thin film of dried 
collagen, or a hydrated collagen gel usually consisting of type I found in acid 
extract of rat tail.
1.5.1.3 Polarity and Cell Shape
Orientation in space, and the shape of the cell are important determinants 
of the differentiated phenotype. It has been shown that full maturation of 
hepatocytes growing on collagen gel required release of the gel from the bottom 
of the dish [Ben-Ze’ev et al., 1988]. Similarly, thyroid epithelial cells showed 
polarity and expression of differentiated phenotype, when allowed to grow in a 
filter well assembly [Chambard et al., 1981]. In malignant cells there is 
disorganization with loss of inter-cellular and cell-matrix interactions, and 
polarity. Therefore, re-establishment of matrix and cell relationships with 
restoration of polarity may restore a state more responsive to other inducers of 
differentiation in malignant cells.
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1.5.1.4 Soluble Factors
Various soluble factors have been described as inducers of differentiation. 
These include endocrine hormones such as hydrocortisone, dexamethasone 
[Steffen et al., 1988] paracrine factors such as transforming growth factor- £ 
[Goustin et al., 1986], fibroblast pneumocyte factor [Post & Smith, 1984] and, 
vitamins such as retinoic acid [Davies et al., 1988] and inorganic ions. Different 
physiological and non-physiological inducers have been found to induce 
differentiation in different cell types (see below).
1.5.2 Specificity of Interactions
It has been found that these interactions are not just the result of some 
general kind of response, rather they are very specific. The epidermis of mouse 
embryo skin undergoes male urogenital gland morphogenesis when implanted in 
embryonic mesenchyme of the urogenital sinus and seminal vesicle, suggesting 
a tissue specification for interaction [Cunha, 1972]. Mouse bladder epithelium 
was induced by embryonic mesenchyme of the urogenital sinus and seminal 
vesicle to differentiate into male urogenital gland phenotype [Cunha et al., 1983], 
suggesting a specification of these cells to respond to inductive influences of 
embryonic microenvironment. Tissue specificity was also shown by Neubauer et 
al. [1983], in similar studies where expression of prostatic markers was associated 
with differentiation of epithelial cells in urogenital sinus mesenchyme. The 
patterns of differentiation expressed by guinea pig epidermis depend on 
topographic location of the dermis upon which it is grafted [Billingham and 
Silver, 1968]. Mullerian epithelium forms the lining epithelium of oviducts, 
uterus, cervix, and vagina. The differences are attributed to regional variation 
in the inductive properties of the urogenital stroma [Cunha, 1975; 1976]. The 
adult mouse salivary gland epithelium can undergo branching development when 
combined with fetal salivary mesenchyme in vitro [Auerbach, 1964], and adult 
vaginal and uterine epithelium respond to fetal mesenchyme [Cunha, 1976]. It 
has been shown that the capacity for embryogenic morphogenesis persists in the 
adult mammary epithelium, when epithelial cells make direct contact with 
syngeneic embryonic mesenchyme from mammary rudiments, while mammary 
epithelial cells failed to respond to mesenchyme of lung, pancreatic and 
nephrogenic origin [Sakakura et al., 1976; 1979], suggesting a specificity for a 
particular tissue in maintenance of differentiated functions.
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1.5.3 State of Interactions in Malignant Tissues
It has been observed that many factors contribute in creating a micro­
environment deficient in interactions in a malignant tissue. There is loss of inter­
cellular communication, and contact inhibition. It may be due to changes in cell 
surface glycopeptides [Hynes, 1976; Sherbert et al., 1982], or altered sialation of 
cell surface glycoproteins [Van Beck et al., 1973], increased proteolytic activity 
of tumour cells [Unkless et al., 1974], or mediated by stroma [Gross et al., 1983]. 
All these factors collectively lead to an uncontrolled cell that has lost its 
orientation, and response to normal control mechanisms.
1.5.4 Induction of Differentiation in Malignant Cells.
In different studies it has been shown that cell interactions can induce or 
restore a differentiated phenotype in malignant tumours. Teratocarcinoma cells 
were induced to differentiate when implanted into blastocyst, but only when 
placed in contact with trophoblast, suggesting a specificity of interaction [Martin, 
1975; Mintz and Illmensee, 1975]. Neuroblastoma cells (C1300) were induced to 
differentiate by implanting at the stage of neural tube development [Pierce, 1984], 
suggesting that induction depends on the spatial and temporal inductive 
environment. When B-16 mouse melanoma cells were implanted into the limb 
buds of 14 days old mouse embryos [Pierce, 1984], melanogenesis was initiated 
and differentiation and inhibition of proliferation were observed, suggesting that 
malignant processes can be reversed, but only when the cells are placed in the 
proper micro-environment.
Attempts have also been made to re-establish cellular orientation by 
stromal interaction. Malignant cells have been co-cultured with stromal cells 
from both embryonic and adult tissue. De Coss et al. [1973] have shown 
induction of differentiation in breast carcinoma, following co-culture with 
embryonic stroma. Cracker and Vernier [1972] have shown differentiation in 
congenital nephroma of infancy in organ culture, suggesting that tumour cells can 
be reorientated by stromal interactions. Such interactions are mediated at least 
in some systems by diffusible factors. Induction of surfactant production by 
hydrocortisone treated stroma has been reported both in normal and malignant 
lung tissues [Post & Smith, 1984; Speirs & Freshney, 1989].
Therefore, it is possible that tumour cells may retain the ability to 
differentiate, if they are induced in appropriate conditions, either in vitro or in 
vivo. Induction of differentiation has been proposed as a potential mode of 
cancer treatment [Spremulli and Dexter, 1984; Freshney, 1985].
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1.5.5 Markers of Differentiation and Malignancy
Before studying differentiation or malignancy, it is important to define the 
marker properties, which will allow these phenotypes to be recognized. Different 
parameters can be used as markers. They can be functional such as enzymes, e.g 
DDC, NSE, peptides such as BLI, morphological features, lineage specific 
proteins e.g cytokeratins for epithelium, and protein products e.g mucin for 
glandular differentiation. Similarly loss of these differentiation associated 
properties or expression of malignancy associated properties can also be used as 
criteria for malignancy such as loss of anchorage dependence, serum 
independence, tumorigenicity, invasion and metastasis. Expression of at least two 
such properties can be regarded as a change in phenotype.
1.5.6 Chemical Inducers
1.5.6.1 Hexamethylene Bisacetamide
Hexamethylene bisacetamide (HMBA), a compound structurally related 
to N-methylformamide, and dimethyl sulfoxide, is the most potent inducer of 
differentiation in this group of compounds. In vitro studies have shown that 
HMBA induces differentiation in a number of murine and human leukaemic and 
solid tumour cell lines including Friend murine erythroleukaemia [Reuben et al., 
1980], human HL-60 promyelocytic leukaemia [Collins et al., 1980], glioblastoma 
[Reiss et al., 1986], mouse neuroblastoma [Kloog et al., 1983], rat hepatoma 
[Hughes et al., 1982], and embryonal carcinoma [Speers et al., 1979]. In vivo 
studies have shown that rats treated with HMBA after receiving the carcinogen 
methylnitrosourea developed fewer mammary tumours with a delay in onset 
compared with untreated animals [NCI-Clinical Brochure, 1984]. HMBA has also 
been used in phase-1 clinical trials [Egorin et al., 1987].
The mechanism of action of HMBA as an inducer of differentiation 
remains unknown. Studies of the structure-activity relationships of various polar- 
planar compounds have demonstrated that the activity is derived from the Lewis 
base character of the CH3-CO-NH moiety [Matsuo et al., 1984], and that the 
optimal number of carbon atoms between the functional polar group is five or 
six for maximum differentiating activity [Reuben et al., 1978].
A polar planar compound must be flexible to penetrate the cell membrane 
for the induction of differentiation [Marks and Rifkind, 1978]. Cellular uptake 
of HMBA seems to be essential for its actions, since HMBA linked to glutathione 
is inactive [Gabrilove, 1986]. HMBA has also been shown to modulate ion 
transport [Kennedy and Lever, 1985], and has also been shown to be associated
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with the membrane fraction of the cell [Reuben, 1979]. Studies on cellular 
uptake, metabolism, and intracellular distribution of HMBA have demonstrated 
that the compound was taken up by the cell, and an intracellular concentration 
equal to the extracelluar concentration was achieved by 6-8 hours of exposure 
[Reuben et al., 1980], and uptake continued for up to 20-24 hours, but with no 
further increase in the intracellular concentration of undegraded compound. 
Commitment to differentiation is both time and concentration dependent, and it 
takes at least 10 hours after equilibration, before differentiation is detected. 
Murine erythroleukaemia cells cultured with HMBA exhibited a prolongation 
of the Gl-phase [Terada et al., 1977], and a slight increase in intracellular cAMP 
[Gazitt et al., 1978]. However, the significance of these phenomena remain 
unknown. It has been shown that HMBA must be present during DNA synthesis 
(S-phase) for induction of erythroid differentiation [Levy et al., 1975].
HMBA also induces certain changes in intra-cellular polyamines, which in 
turn have been shown to be associated with the differentiation processes of the 
cell [Meilhoc et al., 1986]. Catabolites of HMBA (N-acetyl -1, 6-diaminohexane 
and 1-, 6-diaminohexane) may be responsible for direct changes in polyamine 
synthesis in murine erythroleukaemia cells [Meilhoc et al., 1986] and HL-60 cells 
[Egorin et al., 1988]. In vivo studies have also shown similar metabolites of 
HMBA [Egorin et al., 1988]. The enzymes responsible for HMBA catabolism, 
such as deacetylase, are involved in acetylation of histone in nuclear chromatin. 
There is a possibility that HMBA may inhibit histone deacetylation and thereby 
keep the histone in a hyperacetylated state which in turn might be responsible for 
gene transcription necessary for differentiation.
1.5.6.2 Sodium Butyrate
Butyric acid, a short chain 4-carbon chain fatty acid, occurs naturally in the 
body and is formed also by the hydrolysis of ethyl-butyrate. It has been shown 
to have an anti-leukaemic effect in vivo, when given to a patient with acute 
myeloid leukaemia [Novogrodsky et al., 1983]. It produces a variety of effects on 
mammalian cells in culture depending on the cell type. It has been shown that 
addition of millimolar concentrations of the compound to actively proliferating 
cells generally leads to 1) inhibition of DNA synthesis by arrest of the treated 
cells in G1 stage of cell cycle [Wintersberger et a l, 1983, 2) modulation of gene 
expression [Andrews and Adamson, 1987], 3) induction of terminal differentiation 
[Prasad & Sinha, 1976; Philippe et al., 1987], 4) alteration in cell morphology and 
composition of membranes [Fishman et al., 1974], 5) changes in activities of 
enzymes, and modulation of protein synthesis [Prasad and Sinha, 1976], 6)
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increase in histone acetylation [Candido et al., 1978], 7) increase in chromatin 
decondensation [Fallon and Cox, 1981], 8) DNA hypomethylation in certain cell 
types [Christman et al., 1980].
While it is well recognized that sodium butyrate causes growth arrest in 
treated cells in culture, the exact mechanism(s) by which it exerts these effects 
is not known. G1 is generally thought to be the major regulatory stage of the 
mammalian cell cycle [Prescott, 1987]. It is this stage which is modulated by 
conditions which affect growth [Pledger et al., 1978], and cells cease to 
proliferate [Pardee et al., 1978]. One approach commonly used to study the 
regulation of mammalian cell growth involved the investigation of the means by 
which various anti-proliferative agents bring about growth arrest in G l. Sodium 
butyrate induced arrest does not result from a generalized mechanism, which 
non-specifically shuts down the expression of growth associated genes, but rather 
occurs via a more specific mechanism which leads to the reduction in the 
expression of certain genes, while inducing the expression of others. This involves 
inhibition of histone deacetylase, leading to hyperacetylation of chromatin 
associated histone, causing gene expression [Toscani et al., 1988]. Collectively 
these data suggest that many of the effects of sodium butyrate occur as a 
consequence of changes in patterns of gene expression.
1.5.6.3 Cyclic Adenosine Monophosphate.
Alteration of synthesis of cyclic adenosine monophosphate (cAMP) 
induced by external ligands act as membrane-generated signals changing the 
course of many intra-cellular processes. It has been shown to alter phenotypes 
in a variety of normal cells [Haddox et al., 1980; Hackett et al., 1987], 
transformed cells [Tagliaferri et al., 1988], and tumour cell lines [Guiffre et al.,
1988]. It has been suggested that the altered morphology of transformed cells 
may be associated with a decreased level of cAMP. Low concentrations and 
decreased activity of adenylate cyclase have been found in a variety of 
transformed cell lines [Willingham, 1976].
Cyclic nucleotide dependent protein kinase activity present in the 
membranes of normal chick fibroblasts, was lost following transformation of these 
cells with Rous sarcoma virus [Brantan et al., 1978]. However, the reverse 
transformation or differentiation effects of cAMP are not universal, since other 
studies have shown that cells transformed with SV-40 virus expressed cytoplasmic 
cAMP dependent kinase that was not found in parental 3T3 cells [Gharret et al., 
1976]. Similar findings have been reported by Somers et al. [1977] using a 
normal rat kidney cell line transformed with a temperature sensitive mutant of
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mouse sarcoma virus. These findings suggest that although expression of 
transformed phenotypes are associated with loss of protein kinase activity, it is 
not always negatively correlated with the intra-cellular levels of cAMP. Although, 
cyclic AMP levels seem to modulate phenotypic expressions, the exact mechanism 
is unknown.
1.5.6.4 Dexamethasone
Dexamethasone (Dex) is a synthetic analogue of naturally occurring 
glucocorticoids. Dex has been shown to inhibit growth of human NSCLC cells 
[Jones et al., 1978], human glioma [Freshney et al., 1980], human breast [Osborne 
et al., 1979], prostate [Smith et al., 1985], and smooth muscle [Syms et al., 1984], 
and various tumour cell lines. A significant reduction of growth inhibition was 
observed following addition of growth factors [Smith et al., 1985; Syms et al., 
1984], suggesting that dex and growth factors have antagonistic effects, on 
different cells. Glucocorticoids have also been reported to either potentiate 
[Linebaugh and Rillema, 1977], or antagonize [Osborne et al., 1979], insulin- 
stimulated macromolecular synthesis in human breast carcinoma cell lines. 
Growth inhibitory effects of glucocorticoids have been found to be decreased by 
EG F or TGF in different cell lines [Smith et al., 1985], although, the mechanism 
is not clearly understood. Dex potentiates anti-proliferative effects of interferon 
in human cancers, and has been shown to induce differentiation in human lung 
and brain malignancies in vitro [Freshney, 1985].
Glucocorticoids elicit an array of physiological responses in target tissues 
and cultured cells, including regulation of cellular growth and modulation of gene 
expression [Rousseau, 1984]. They alter cells by passive diffusion and act via 
specific receptors. The first step in glucocorticoid action is reversible, 
noncovalent, high affinity binding to its intra-cellular receptors and translocation 
to nucleus. Subsequently the receptor hormone complex undergoes some 
conformational changes, followed by activation of receptor during which it 
acquires the capacity to interact with chromatin , where it occupies receptor sites 
composed of DNA and non-histone nuclear proteins [Rousseau, 1984].
The extensive use of glucocorticoids in various therapeutic regimens is 
largely due to their anti-inflammatory, immunosuppressive, and anti-allergic 
properties. Their catabolic effects generally result in an inhibition of cellular 
growth, which might also induce cellular lysis. It appears that glucocorticoids act 
directly at the level of regulatory mechanisms for cellular proliferation. Two 
opposite effects have been shown: firstly an inhibitory effect on various cell types, 
and secondly a stimulatory effect for a limited number of other cell types.
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There is evidence for more than one mechanism of action of 
glucocorticoids [Keller et al., 1982]. In addition to mechanisms in which receptors 
are involved, there is also a strong inhibitory effect at high concentration, 
probably the consequence of several metabolic inhibitions e.g carbohydrates, 
proteins which result in decrease cellular activity [Hainque et al., 1987].
1.5.6.5 Retinoic Acid
Vitamin A and its analogues (retinoids) inhibit proliferation and suppress 
the transformed phenotype of many tumour cells in vitro. Vitamin A is essential 
for normal in vivo development, reproductive capacity, vision, and maintenance 
of several epithelial tissues [Kim & Wolf, 1974]. Retinoids have also been shown 
to regulate differentiation in different cell types in vitro, including malignant 
melanoma [Lotan et aL, 1978], teratocarcinoma cells [Piet et al., 1987], myeloid 
leukaemia cells [Olsson et al., 1982] and different other cell types. The effects 
of retinoids have also been shown in differentiation of normal respiratory 
epithelium in vitro [Jetten & Smits, 1985; Jetten et al., 1986]. It is essential for 
the differentiation and maintenance of normal respiratory mucociliary epithelium. 
In vitamin A deficiency mucus secreting epithelia such as that of the respiratory 
tract develop foci of atrophy and keratinizing squamous epithelium and a 
decrease in number of goblet cells [Bonanni, 1973]. It has been suggested that 
specific binding proteins mediate the translocation of retinoid to the nucleus 
where they interact with the chromatin and modify gene expression [Jetten and 
Smits, 1985]. Several studies have also shown a relationship between retinoic 
acid, cyclic AMP, and cyclic AMP protein kinase activity in some cells [Fontana 
et al., 1986].
1.5.6.6 Transforming Growth Factor- p
Transforming growth factor, type-/? (TGF-/?) is a peptide factor produced 
by a variety of cells, which can either stimulate or inhibit cell proliferation, and 
differentiation. The role of TGF-/? in neoplastic transformation is unknown. As 
most cells release TGF-/? in an inactive form and also have receptors for TGF- 
p, it has been suggested that at least part of the regulation of its actions is at the 
post-receptor level or at the level of precursor activation. TGF- p is primarily a 
growth inhibitor and not a classic growth factor [Moses et al., 1978]. It stimulates 
growth only in fibroblastic cells, and it has been shown that the stimulatory effect 
of TGF- p is mediated through induction of c-sis and autocrine stimulation by a 
PDGF-like growth factor [Leof et al., 1986]. Therefore, either autocrine 
stimulation by endogenous TGF-/? in fibroblastic cells or the loss of the inhibitory
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effects of TGF- p in other cells, may lead to an increased proliferative potential 
and thereby contribute to the induction of neoplastic phenotype.
1.6 ONCOGENES AND MALIGNANT TRANSFORMATION
An oncogene is a gene that encodes a protein that contributes to the 
malignant transformation of the transfected cell [Huebner and Todaro, 1969]. 
Oncogenes are derived from normal cellular genes, expressed in an altered form.
1.6.1 Oncogenes in Human Malignancies
Following the discovery of proto-oncogenes, it has been found that a 
number of altered or overexpressed proto-oncogenes are involved in the genesis 
of human tumours. Table [1.3] lists genetic lesions that are found at reasonable 
frequency (varying from 20 to 100%) in these tumours [Varmus, 1984]. 
Amplification of the myc gene family has been described in SCLC. L-mvc proto­
oncogene amplification has been found both in primary as well as in relapsed 
SCLC [Johnson et al., 1987], and in another study a 20-fold amplification was 
found in SCLC [Chan et al., 1986]. L-mvc has been mapped to chromosome 1 
[Nau et al., 1985]. Abnormal expression of mvc and ras has also been found in 
human colorectal tumours.
The ras oncogene expression has been found in bladder cancer [Tabin et 
al., 1982; Reddy et al., 1982]. Ha-ras oncogene activation, and c-mvc 
amplification [Escot et al., 1986] have been reported in breast cancer.
Three classes of genes have been described which are involved directly in 
carcinogenesis [Spandidos, 1986]. The first class is comprised of oncogenes, 
originally identified by transduction with retroviruses and subsequently by DNA 
mediated gene transfer [Bishop, 1987]. Oncogenes act dominantly at the cellular 
level and can convert normal cells to transformed or malignant cells. This is the 
best studied group and around forty such genes have been directly identified and 
isolated [see Tables 1.2 & 1.3]. The first human cellular oncogene was cloned 
in 1982 from T24 bladder carcinoma cells, and was found to be homologous to 
the viral Ha-ras oncogene [Tabin et al., 1982; Reddy et al., 1982],
The second class of genes is comprised of a diverse group of genes whose 
expression inhibits the cancer phenotype. The existence of these genes was first 
noticed from studies of cancer associated with heritable single gene traits 
[Rnudson, 1986]. In some cases deletion or inactivation of both alleles have been 
found in association with tumour formation [Knudson, 1983]. Various descriptive
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Table 1.3:- Examples of proto-oncogenes and associated human malignancies.
Proto-oncogene Neoplasm Lesion
c-mvc
L-mvc
c-ras
c-abl
c-erbB
Burkitt’s lymphoma Translocation
SCLC
Ca of breast 
SCLC
Neuroblastoma
Diverse
CML
Amplification
Amplification
Amplification
Amplification
Point mutation
Translocation
Squamous cell Ca Amplification 
Glioblastoma Amplification
SCLC: small cell lung carcinoma. CML: chronic myelogenous leukaemia. Ca: 
carcinoma.
terms have been used in literature such as anti-oncogenes [Knudson, 1983], 
tumour-suppressor genes [Stanbridge, 1986], ortho-, plato-, or emero-genes 
[Todaro, 1986], onco-suppressor genes [Spandidos and Anderson, 1989]. There 
is substantial evidence to suggest that malignant transformation may be inhibited 
by expression of proto-oncogenes and their deletion may release oncogene 
expression [Spandidos and Wilkie, 1988]. These genes have been found to inhibit 
the malignancy-related phenotypes in different studies such as morphological 
transformation, tumorigenicity and metastasis. They have been associated with 
the predisposition to dominantly inherited disorders such as retinoblastoma [Lee 
et al., 1987].
A third class of genes is associated with predisposition to cancer in patients 
with recessively inherited disorders such as ataxia telangiectasia, Bloom’s 
syndrome, and Fanconi’s anaemia. The patients with these disorders have defects 
in DNA repair, which indirectly results in increased incidence of malignancy 
[Knudson, 1986]. One such gene has been identified and cloned, the human 
excision repair gene ERCC-1 [Van Duin et al., 1986].
1.6.2 Origin of Oncogenes
Viruses have been associated with the development of both human and the 
animal tumours [Bishop, 1985; Varmus, 1986]. Analysis of the genome of 
oncogenic viruses has revealed that viruses capable of transformation have lost 
their replicative gene (pol) and in their place are new nucleic acid sequences 
termed v-onc which confer malignant potential. The transduction hypothesis 
states that the viral oncogenes were derived from cellular genes that had been 
"hijacked" by the virus earlier in evolution. These cellular genes have been called 
proto-oncogenes. Recombination between retroviruses and the cellular genome 
can implant cellular genes into the viral genome, and in this new setting the 
cellular genes may become oncogenic. These observations have implied that 
normal cellular DNA contains genes which when transplanted or transducted into 
retrovirus become cancer causing genes. Over 50 of such virus isolates have been 
found to have this property [Table 1.4], and over 20 have been characterized.
1.6.3 Activation of Proto-oncogenes
There are several mechanisms by which a proto-oncogene may be 
activated to a functional oncogene. A single point mutation in a proto-oncogene 
can give rise to a functional oncogene resulting in an amino acid substitution in 
the gene product that can alter the biological behaviour of the normal cell. An
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Table 1.4;- Examples of viral oncogenes, their cellular counterparts and 
associated human malignancies.
Viral oncogene Cellular Oncogene Human Tumour
v-ras c-ras (Ha & Ki)
v-mvc c-mvc
L-mvc
N-mvc
v-erbB c-erbBl
c-erbB2
v-erbA c-erbA
v-sis c-sis
v-abl c-abl
Bladder carcinoma 
Colorectal adenocarcinoma 
Ovarian adenocarcinoma
Prostate carcinoma 
Breast carcinoma 
Lung carcinoma 
Neuroblastoma
Brain tumour 
Breast cancer
Breast carcinoma 
Brain tumour
Chronic myeloid leukaemia
example is the activation of ras. proto-oncogenes by point mutations at codon 12, 
13, and 61 [Tabin et al., 1982; Reddy et al., 1982]. The amplification of a proto­
oncogene may also lead to overexpression of gene products, and malignant 
transformation [Varmus, 1984; 1986]. The c-mvc oncogene amplification has 
been found in leukaemia [Collins and Groudine, 1982], and in SCLC where it has 
been associated with aggressive clinical behaviour [Little et al., 1983]. N-mvc 
amplification has been found in metastatic neuroblastoma [Schwab et al., 1983]. 
The transduction of a cellular sequence (proto-oncogene) into the viral genome 
may lead to its activation [Varmus, 1984]. Proto-oncogene activation may also 
result from insertional mutagenesis, when a retroviral promoter integrates 
adjacent to the proto-oncogene [Varmus, 1986]. More recently, it has been 
proposed that inactivation of a constitutive suppressor or anti-oncogene may also 
lead to activation of proto-oncogene [Knudson, 1985; Spandidos and Anderson,
1989]. Various chromosomal abnormalities have been related to the activation 
of proto-oncogene into active oncogene. Translocation and break points have 
been demonstrated in different human malignancies, Philadelphia chromosome 
9; 22 translocation in chronic myelogenous leukaemia, and chromosome 8; 2, 14, 
22 translocation in Burkitt’s lymphoma possibly involving mvc oncogene. 
Malignant cells have also been found to contain homogeneously staining regions 
(HSRs) and double minutes chromosomes (DMs), which are thought to be the 
result of gene amplification.
1.6.4 Oncogene Product
In a normal cell the expression of a proto-oncogene product is well 
controlled and appears to play a role in the growth and development of the 
organism. The oncogene codes for protein product which can be a growth factor, 
a growth factor receptor, membrane associated and/or cytoplasmic protein 
kinases, or GTP binding proteins and nuclear proteins [Figure 1.2]. The sj^ _ 
oncogene has been recognized as being homologous to the gene for the p -  
chain of platelet derived growth factor (PDGF) [Waterfield et al., 1983]. A 
number of transmembrane receptors have protein kinase activity, including 
epidermal growth factor receptor (EGFR), platelet derived growth factor receptor 
(PDGFR), insulin-like growth factor 1 receptor and colony stimulating factor-1 
(CSF-1). The protein product of v-erb-B is homologous to EGFR and the 
product of vfms is homologous to the CSF-1 receptor. The protein products of 
v-erb-B. v-fms. and c-fos are undoubtedly concerned with growth control. A 
number of different oncogenes have been found to have protein kinase activity
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such as abl, fes, fms, erb-B. and ras. ras gene product p21 is a GTP binding 
protein with GTPase activity. Its submembranous position and the ability to 
stimulate adenylate cyclase, suggests that it may act as an intermediate between 
a receptor on the cell surface and adenylate cyclase in the signal transduction 
pathway. A group of oncogenes including mvc. mvb. fos. and p53 encode a group 
of related oncoproteins, which share the properties of nuclear localization, and 
binding to nuclear matrix or DNA. Several members of this group have been 
implicated in control of gene transcription [Alitalo et al., 1987] and cell 
proliferation [Makino et al., 1984], self renewal control [Greenberg & Ziff, 1984] 
and differentiation control [Pfieffer-Ohlsson et a l, 1984; Stewart et a l, 1984].
1.6.5 THE ras FAMILY OF ONCOGENES
To date three members of the ras gene family have been identified in the 
mammalian genome. They have been designated Harvey (Ha), Kirsten (Ki) and 
N-ras. They encode highly related proteins generically known as p21 with 
molecular weight of 21,000 and 189 amino acid residues [Barbacid, 1987]. The 
ras gene can become activated and acquire transforming properties by 
quantitative (amplification) and qualitative (mutation) mechanisms. The latter are 
more frequent.
Mutations have been identified directly from analysis of tumour DNA with 
molecular cloning and sequencing of genes, and by this method all mutations 
occurring in the naturally occurring tumours have been found in the codons for 
amino acids 12, 13, and 61 where either glycine or glutamine has been replaced 
by any other amino acid. A second approach was the molecular cloning of 
normal ras genes, their in vitro mutagenesis, and analysis for transforming 
potentials in NIH 3T3 focus forming assay. Using chemical carcinogens it was 
found that in addition to the codons found in naturally occurring tumours or 
tumour cell lines codons 59 or 63 are also potential targets for mutations 
[Vousden et al., 1986]. Others [Sigal et al., 1986; Walter et al., 1986] have shown 
that some mutations in codon 116, 119 can also activate ras genes in vitro. 
Various deletion mutations have also been shown to have transforming activity 
such as deletion of non-coding regions [Chipperfield et al., 1985].
The involvement of ras genes in human cancers is not limited to their 
activation by point mutations. It is likely that the expression of abnormally high 
levels of normal ras products may also contribute to malignancy. This could be 
possible by perturbation of their regulatory sequences [Westaway et al., 1986] or 
by gene amplification. The overall ras gene amplification in human neoplasia is
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estimated to be not higher than 1% [Pulciani et al., 1985]. Enhanced expression 
or amplification of ms oncogene can be obtained by the insertion of a strong 
promoter or enhancer in the vicinity of the ras gene [Westaway et al., 1986; 
Mckay et al., 1986]. Linkage of normal ras gene to retroviral regulatory elements 
(LTR) results in malignant transformation of NIH 3T3 cells [Chang et al., 1982; 
Mckay et al., 1986]. Similar results have been shown by amplification of normal 
genes brought about by integration of multiple copies of a DNA clone of the 
normal human ms gene [Pulciani et al., 1985] or by deletion of the first (non­
coding) exon [Cichutek and Duesberg, 1986]. These cells invariably show 30- to 
100-fold higher levels of ras expression than either their normal counterparts or 
cells transformed by ras oncogenes activated by single point mutations [Chang et 
al., 1982; Pulciani et al., 1985; Mckay et al., 1986;]. Spandidos and Wilkie [1984] 
have shown enhanced expression when ras genes were surrounded by both SV40 
and Moloney virus LTR enhancers, and this has been used in the present 
constructs (see below, Chapter five).
1.6.5.1 Mechanism of Action
The resemblance of the ras protein to the G-proteins controlling adenylate 
cyclase has suggested that normal p21 ras proteins are involved in the signal 
transduction [Gilman, 1984]. According to the currently accepted model [Figure 
1.3], the ras proteins exist in equilibrium between an active and an inactive state. 
Most of ras. proteins in a normal cell at rest would exist in their inactive state 
which is characterized by conformation that allows binding to GDP. They remain 
in this inactive state until they receive a stimulus resulting in the change of GDP 
to GTP followed by a conformational change of the ms protein to its active state. 
Activated ms protein would then interact with the effector molecules. Once the 
signal transduction has taken place, they would immediately become inactivated 
by their intrinsic GTPase activity thereby returning the ms. protein to the inactive 
GDP-bound state. According to this model mutations that confer transforming 
properties to ms genes must reverse the normal equilibrium between the active 
and the inactive forms. Stabilization of ras proteins in their active state would 
cause a continuous flow of signal transduction, which would result in malignant 
transformation. Theoretically, this state can be achieved by: 1) mutations that 
inhibit the intrinsic GTPase activity of ras proteins. Normally the activated state 
is terminated by hydrolysis of bound GTP to GDP due to the intrinsic GTPase 
activity. A loss of GTPase activity would result in a constitutively activated ras 
protein, most likely due to transforming mutations in codons 12,13 or 61. Sweet 
et al. [1984] have shown that the inhibition of GTPase activity is the preferred
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Figure 1.3:- Model for the mechanism of action of normal and transforming ras 
proteins: signal transmission from growth factor to adenyl cyclase through p21 and 
growth factor receptor [modified from Barbacid, 1979; Thomas & Waxman, 1988].
mechanism of activation of oncogenic ms proteins as illustrated in Figure [1.3 a], 
2) by increasing the exchange rate between GDP and GTP [Figure 1.3 b], 3) by 
inducing an active conformational change that does not require binding of 
guanine nucleotide. It has been found that for the mutations in codon 59, 116, 
and 119 both GDP and GTP still bind to the ras protein, but this binding is less 
stable [Lacal and Aaronson, 1986]. Since the intracellular concentration of GTP 
is 10 times higher than that of GDP therefore, GTP will be bound more 
frequently than GDP and thus the protein will be mostly in its active 
configuration [Figure 1.3 c].
It is proposed that highly overexpressed levels of normal ras. proteins as 
a result of gene amplification may produce enough molecules in their GTP- 
bound active state to induce malignant transformation, without affecting the 
equilibrium between inactive and active forms, which is the characteristic of the 
normal ras proteins.
1.6.5.2 Transforming Properties in vitro
In addition to their involvement in human cancer and in vivo transforming 
properties, the ms oncogenes have been extensively studied for their transforming 
properties in vitro assays. Cellular ras genes induce morphological and growth 
transformation in established rodent cell lines in a dominant manner [Barbacid, 
1985], suggesting a role in malignant transformation. Shih et al. [1979] have 
shown that ras oncogenes are involved not only in the initiation, but also in the 
maintenance of the transformed phenotype suggesting a possibility of their 
continued expression in transformation. Winter and Perucho, [1986] have shown 
that the level of ms oncogene expression appears to regulate or modulate their 
transforming potency when used to induce reversible transformation of normal 
rat fibroblasts. In other studies [Land et al., 1983] cellular ms genes could not 
transform rat primary embryo cells alone, but required the cooperation of nuclear 
oncogenes such as c-mvc [Schwab et al., 1985], suggesting that a single oncogene 
may not be sufficient to cause transformation. However, Spandidos and Wilkie 
[1984] have shown that Ha-ras oncogene can transform rat embryo cells if the 
surrounding cells are eliminated by selection system, suggesting that the linkage 
of ras oncogenes to transcriptional enhancers increases the percentage of cells 
that become transformed under these conditions. Similar results have been 
shown by Dotto et al., [1985] and Pozzatti et al., [1986], suggesting that normal 
cells can inhibit transformed phenotypes of ras transfected cells, and this 
inhibitory effect can be partly overcome by treating the ras containing primary 
embryo cells with tumour promoters or other selection systems.
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Evaluation of the neoplastic properties of ms oncogenes in cells other than 
cultured fibroblasts has been limited because of the difficulty in transfecting non- 
fibroblastic cells. However, the use of retroviruses carrying ras oncogenes has 
circumvented this problem to some extent. Yoakum et al. [1985] have shown that 
the transfection of normal human bronchial epithelial cells by ms oncogenes from 
DNA clone of Harvey-MSV, yielded clones of transformed cells. Others have 
been able to transform human epidermal keratinocytes [Rhim et al., 1985] and 
embryonic kidney cells [Pater and Pater, 1986] with ras containing retroviruses, 
but with prior acquisition of independent life span. The ras oncogenes have also 
been found to cause additional neoplastic change to cell lines derived from 
human tumours [Kasid et al., 1985], such as tumorigenesis, invasion, and 
metastasis, suggesting a multistep process of carcinogenesis, and involvement of 
carcinogens (oncogenes) at different stages.
1.6.5.3 Nature of Normal and Activated ras.
It is important to know whether activated and/or normal ras genes are 
dominant or recessive. It has been shown that human tumours contain an 
activated ras allele in addition to a corresponding normal ras allele, and either 
the normal allele has been lost or the mutated allele has been amplified, and that 
during tumour progression the ratio between the normal and the activated allele 
can shift towards the mutated allele [Mckay et al., 1986; Bos et al., 1987]. 
However, it has been shown by others [Tabin and Weinburg, 1985] that the 
normal ras allele even at an increased level of expression had no effects on the 
transforming capacity of the mutant allele. Theillet et al., [1986] and Fearon et 
al. [1985] have shown in several different tumours that one of the Ha-ms alleles 
was deleted suggesting suppression of normal ms genes might have a role in a 
tumour development. The loss of a normal allele in cells carrying ras oncogenes 
has been observed by others also [Santos et al., 1984]. These observations suggest 
that the deletion of the Ha-ras allele coincides with the locus of another gene 
located in the proximity of the Ha-ras gene. Possible candidates are the tumour- 
suppressor genes, which when present can suppress the oncogenic phenotype. 
Suppressor genes have been located on chromosome 11 in some of the cell fusion 
studies [Saxon et al., 1986], suggesting that if the ras gene was located close to a 
tumour-suppressor gene it could be deleted simultaneously, such as in Wilms 
tumour.
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1.6.5.4 The ras Expression: Early or Late Event
Expression of ras proto-oncogenes or oncogenes in various stages of 
carcinogenesis, have suggested their involvement at different stages of disease. 
The ras expression has been shown in early, intermediate, and late stages of 
carcinogenesis. Malignant transformation of early passage rat cells with a single 
oncogene, the T24 Ha-ras 1 has been shown by Pozzati et al. [1986]. Spandidos 
and Wilkie [1984] have shown that when linked to transcriptional enhancers, the 
mutant T24 Ha-ras 1 gene induces the complete malignant transformation of early 
passage rodents including Chinese and Syrian hamsters and rat. These results 
suggest that the ras gene may be involved in carcinogenesis at early stages of 
tumour initiation. Yoakum et al. [1985] have shown that transfection of human 
early passage bronchial epithelial cells by a recombinant plasmid carrying the 
viral Ha-ras. oncogene caused immortalization and malignant conversion of these 
cells. In vivo studies have shown similar results. Balmain et al. [1984] have 
shown that chemically induced papillomas of mouse skin contain a transforming 
cellular Ha-ras gene as evident from elevated transcript levels in these tumours, 
suggesting an early involvement of ras in carcinogenesis. Elevated ras transcripts 
have been found in several human tumours such as pre-malignant and malignant 
tumours of the colorectum [Spandidos and Kerr, 1984], tumours of head and neck 
region [Spandidos et al., 1985], malignant tumours of human breast [Spandidos 
and Agnantis, 1984], suggesting that ras activation may be early event in 
carcinogenesis in vivo. Williams et al. [1985] have shown expression of ras p21 
protein by immunocytochemical methods, using monoclonal antibody to p21 
protein in various tumours of colorectum and experimental models. These 
findings have suggested that ras may be involved in tumour initiation.
There is enough evidence for the involvement of ras genes in the 
intermediate stages of carcinogenesis such as focus formation anchorage 
independence, and tumorigenic conversion of immortalized cells, and also in 
clinical tumour specimens. Malignant transformation of early passage rodent 
fibroblasts by a single ras gene have been shown by Spandidos and Wilkie [1984], 
and in colorectal tumours [Spandidos and Kerr, 1984]. Recent evidence suggests 
that ras oncogene may also be involved in the late stages of carcinogenesis. This 
has been demonstrated in rodent fibroblasts transfected with ras oncogene 
[Spandidos and Wilkie, 1984], and in hamster cells [Spandidos and Siminovitch, 
1978], and in primary rat embryo cell after ras transfection [Pozzati et al., 1986], 
in human lymphoma [Vousden and Marshall, 1984], and in human teratoma cells 
[Tainsky et al., 1984]. Vousden et al. [1986] have shown enhancement of
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spontaneous metastasis of mouse carcinoma cells transfected with activated H a­
ms oncogene, suggesting an involvement of ras also in the late stages of the 
malignancy. Albino et al. [1984] have shown various metastatic clones of human 
melanoma expressing ras oncogene. Thorgeirsson et al. [1985] have shown that 
NIH3T3 cells transfected with human tumour DNA containing activating ras 
oncogene expresses metastatic phenotype in nude mice. These data suggest that 
ras oncogenes are involved in addition to early stages, in the late stages of the 
malignant progression, such as invasion and metastasis.
Thus on the one hand activated ms genes have been shown to convert 
immortalized cells or benign tumours into malignant tumours or malignant 
tumours into tumours with metastatic capacity, on the other hand activated ras 
genes have been found in pre-malignant cells or benign tumours. These 
observations suggest that ras may be involved in tumour initiation and 
maintenance.
1.6.5.5 The ras. Oncogene and Metastasis
The ability of ras oncogenes to induce the metastatic phenotype is not 
fully established. Both in vitro and in vivo studies have shown that some ras 
containing tumours are metastatic, but others are not. It has been shown that 
NIH 3T3 and primary rat embryo cells transfected with ras oncogene formed 
metastatic foci in lung when injected subcutaneously in nude mice [Pozzatti et 
al., 1986; Thorgeirrsson et al., 1985], suggesting a possible role of ras oncogene 
in metastatic progression of the tumour. Bradley et al. [1986] have observed 
metastatic nodules only when ras transfected 3T3 cells were injected 
intravenously, suggesting that the route of injection may also be important in the 
metastatic growth, and that all ras expressing cells are not necessarily metastatic. 
In a comparative study, Muschel et al. [1985] used different mouse cell lines 
transfected with the ras oncogene. NIH 3T3 cells were metastatic but C127 cells 
were non-metastatic. These studies have suggested that the induction of the 
metastatic phenotype is not an intrinsic property of ras oncogenes, but may 
depend upon the cell type and other factors. Studies on human tumours both 
from primary and metastatic sites have shown a similar incidence of ms oncogene 
expression. Therefore, it may be that ms is not directly involved in the metastatic 
process, but provides better growth potential to the cells which indirectly may 
give them a better chance to form metastases, and this may vary among different 
cell types and target tissues.
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1.6.6 THE mvc FAMILY OF ONCOGENES
To date a number of related genes have been included in the ever 
expanding family of mvc genes. These are characterized by the presence of 
conserved myc homology regions, of highly conserved amino acid sequences of 
c-mvc protein, nuclear targeting of gene products, and DNA binding capacity. 
The mvc family consists of three well characterized members, c-mvc [Varmus,
1984], N-mvc [Schwab et al., 1983], L-mvc [Zimmerman et al., 1986], and newly 
found oncogenes such as R-mvc. U-mvc. one pseudogene and functional activity 
of at least one other gene P-mvc has also been described. The v-mvc genes were 
first identified and characterized as transforming genes from several different 
strains of avian retroviruses [Coffin et al., 1981]. Like the discovery of many 
other proto-oncogenes, an attempt to discover a cellular counterpart of this viral 
sequence has led to the discovery of the first member of this family, the c-mvc 
gene. The human c-mvc gene has three exons with the coding regions located on 
exon 2 and 3 [Watt et al., 1983]. The remainder of the gene is untranslated, 
encoding a transcript with large 5, and 3, untranslated regions [Stanton et 
al., 1984].
1.6.6.1 The mvc in Growth and Differentiation
The mvc gene displays a distinct pattern of expression during normal 
growth and development. The c-mvc expression has been observed in cells 
progressing from a resting state to a dividing state [Makino et al., 1984]. It is 
thought that mvc is involved in cellular proliferation and differentiation, and that 
when activated, it can induce cellular proliferation and block differentiation. The 
level of mvc gene expression decreased rapidly in tumour systems induced to 
differentiate in vitro following treatment with agents such as DMSO, sodium 
butyrate, retinoic acid [Lachman and Skoultchi, [1984], and reappeared later in 
a cell cycle restricted manner [Lachman et al., 1985]. In another study Grosso 
and Pitot [1985] have demonstrated that c-mvc expression was abruptly repressed 
when susceptible murine tumour cell lines were induced to differentiate by a 
variety of inducing agents such as retinoic acid and sodium butyrate. The c-mvc 
has also been shown to inhibit DMSO induced differentiation in mouse 
erythroleukaemia cells [Dmitrovsky et al., 1986]. It may be involved during 
differentiation in human cells as c-mvc mRNA copy number shows a peak at 4- 
5 weeks in developing placenta [Pfeiffer-Ohlsson et al., 1984], and a peak during 
spermatogenesis, with stem cells and mature sperms showing very low levels 
[Stewart et al., 1984]. These observations suggest that c-mvc gene might be 
associated with the process of cellular proliferation prior to differentiation.
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1.6.62, The c-mvc and Malignant Transformation
Deregulated expression of c-mvc gene in many different tumours, its 
enhanced expression during cell division, and a reduced expression in 
differentiated cells, suggest that the aberrant expression of c-mvc can contribute 
to the development of neoplastic transformation in different tumour types by 
influencing the rate of cellular proliferation [Varmus, 1984; Bishop, 1985]. 
Amplification of c-mvc has been found in various human cancers and tumour cell 
lines, including leukaemia [Collins and Groudine. 1982], colonic tumours [Alitalo 
et aL, 1983; Stewart et al., 1986], and both NSCLC [Yokato et al., 1988], SCLC 
[Wong et al., 1986], and SCLC cell lines in culture [Little et al., 1983; Nau et al.,
1985]. Several human epithelial tumours express c-mvc p62 protein at a level 
higher than in the adjacent normal tissue, such as testicular and colonic tumours 
[Sikora et al., 1987] and breast tumours [Spandidos, 1987], suggesting that mvc 
oncogene expression is associated with human malignancy.
Activated c-mvc gene has been found to be implicated in immortalization, 
transformation, and tumour progression depending upon the model used. The 
c-mvc is expressed in virtually all cells in their proliferative phase. It seems most 
likely that the same biochemical activity and targets promote tumour cell growth, 
whereas the cell background determines how this activity is going to be 
manifested. It has been shown that when linked to a transcriptional enhancer the 
c-mvc proto-oncogene induced immortalization of early passage rodent fibroblast 
cells [Mongueau et al. 1984]. The mvc transfection can trigger tumorigenic 
conversion of immortalized cells [Spandidos, 1985]. It has also been shown that 
c-mvc gene converted a non-tumorigenic cell line to tumorigenic [Keath et al., 
1984], and induced metastatic properties in tumorigenic cells [Wyllie et a l, 1987]. 
Moguneau et al. [1984], and Kelekar & Cole. [1986] have shown that the c-mvc 
transfection of normal fibroblasts could induce immortalization and 
tumorigenicity in nude mice.
The early studies with the mvc oncogene utilized the acute oncogenic 
avian retrovirus (MC29) containing the cellular mvc gene. They have been 
demonstrated in different lymphomas e.g., feline lymphomas [Mullins et al., 1984].
The study of transgenic mouse strains with abnormal c-mvc expression has 
demonstrated a variety of tumours including testicular, breast, lymphoid and mast 
cell origin [Leder et al., 1986; Adams et al., 1985], hepatocellular carcinoma 
[Messing et al., 1985], and pancreatic carcinoma [Hanhan, 1985].
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1.6.6.3 Regulation of c-mvc Expression
The expression of c-mvc in many cell types, both normal and malignant, 
has suggested that it is in a pathway present in most cells. Observations of the 
quantitative differences in the levels of c-mvc mRNA expression in normal and 
tumour tissue have suggested that the regulatory mechanisms might be operating 
at both transcriptional and post-transcriptional levels. At the transcriptional level 
a mitogenic stimulus to quiescent fibroblasts leads to a transient rise in C-mvc 
expression [Kelly et al., 1983], suggesting an association between c-mvc expression 
and entry of cells into cell cycle (Go to G l). Land et al. [1983] have shown that 
the increased transcription rate observed during the initial stage of mitogenic 
stimulation was not sufficient to account for the 40-fold increase in the c-mvc 
mRNA level, suggesting a post-transcriptional control responsible for the 
remainder of the increase in mRNA level. In further studies it has been 
demonstrated that the c-mvc mRNA level can be modulated in the absence of 
any changes in the transcription rate of the gene [Knight et al., 1985]. Teratoma 
cells induced to differentiate, and lymphoma cells treated with interferon therapy 
suppressed their c-mvc mRNA level at least by 20-fold without any change in the 
rate of mRNA synthesis [Dani et al., 1985].
These findings therefore, suggest that the primary mode of c-mvc mRNA 
regulation in the transition from quiescent to proliferating cells or vice versa is 
post-transcriptional. Nevertheless, transcriptional control of c-mvc may be 
important at certain stages of cellular differentiation. Post-transcriptional 
modulation of c-mvc mRNA level may result either from altered mRNA 
transportation from nucleus to cytoplasm or its stability. It has also been shown 
that the amount of c-mvc protein p62 correlates directly with the mRNA level, 
and that the protein half life does not change with the cell growth rate [Persson 
et al., 1985] suggesting that an increased level of mvc transcription in tumour 
cells may be due to the deregulation of the negative feedback inhibition between 
the mvc product and the mvc gene.
The c-mvc protein, a 439 amino acid sequence, has been isolated and 
characterized from human cell lines. It is a nuclear phosphoprotein with a 
molecular weight of 62 kD [Ramsey et al., 1984]. The turnover of both the c- 
mvc protein and its mRNA is rapid with half lives in order of 20 to 30 minutes 
in exponentially growing cells [Hann et al., 1985]. However, protein species with 
longer half lives have also been described [Persson et al., 1985]. It has been 
shown that the synthesis and half-life of the c-mvc protein are constant 
throughout the cell cycle in normal and transformed avian and human cell lines
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growing in log phase in culture [Hann et al., 1985].
1.6.6.4 Activation of c-mvc Oncogene
Unlike the ms oncogenes which are activated as a result of mutations 
within the protein coding regions, no amino acid changes have been found in the 
c-mvc activation. Different mechanisms are involved in the activation of the c- 
myc proto-oncogene, such as proviral insertion, chromosomal translocation, and 
gene amplification. Hayward et al. [1981] were first to demonstrate that avian 
leukosis virus was integrated into the c-mvc locus in viral induced B-cell 
lymphomas. A general model has been described by Varmus [1984] that 
retroviral insertion activates cellular genes by enhancer insertion which elevates 
transcription from the normal c-mvc promoters. The c-mvc gene was found to 
be located at the chromosomal translocation breakpoints in Burkitt’s lymphoma 
and in murine plasmacytoma [Adams et al., 1985; Erikson et al., 1983]. 
Amplification of the gene has been found in large cell variant of small cell lung 
cancer [Little et al., 1983; Nau et al, 1985; 1986]. Proto-oncogene amplification 
in tumour cell line was first described in the c-mvc gene locus [Collins and 
Groudine, 1982; Alitelo et a l, 1983]. It has been shown in HL-60 that c-mvc 
gene is not deregulated and can be suppressed by inducers of differentiation 
[Westin et a l, 1982], suggesting that amplification would promote tumour 
progression by rapid growth and proliferation.
1.6.6.5 The mvc Expression: Early or Late Event
There is some evidence for the involvement of mvc in early, intermediate, 
and late stages of the carcinogenesis both in vitro and in vivo. The mvc 
oncogenes have been shown to cause immortalization of early passage fibroblasts 
in culture [Land et al, 1983; Mougueau et al., 1984]. The mvc has also been 
shown to cause tumorigenic conversion of mammalian fibroblasts [Vennstram et 
al, 1984; Kelekar and Cole, 1986]. The involvement of mvc has also been shown 
in late stages of human lung carcinoma [Little et al., 1983], and in human 
neuroblastoma [Schwab et a l, 1984], therefore, suggesting that the expression of 
mvc oncogene may be significant in tumour initiation and maintenance.
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1.7 RATIONALE FOR THE WORK PRESENTED IN THIS THESIS
Heterogeneity and phenotypic changes have been well documented in 
human lung cancer, but relatively little is known about the nature and the 
regulatory control mechanisms underlying these phenotypic drifts.
The tumour cell phenotype can be modulated by several different factors 
[see Table 1.2]. The most important are genetic and microenvironmental. The 
microenvironment of the tumour is determined by the matrix synthesized by both 
normal and tumour cells, as well as host stromal components secreted by 
fibroblasts and other normal cells present in the surroundings. It has been shown 
that the manipulation of extracelluar matrix and stroma can lead to alterations 
in gene expression and cell phenotype [Lee et al., 1985]. The differing influences 
of extra-cellular elements synthesized by parenchyma cells, endothelial cells, 
mesothelial cell, fibroblasts, and other host cells may be important in modulating 
state of differentiation in tumours [Nicolson, 1984]. Although malignant cells 
have altered response to extracelluar matrix and stroma, they can still be partly 
or differentially responsive to microenvironmental influences [Freshney, 1987]. 
Therefore, the tumour cell microenvironment is extremely significant in 
modulating phenotypic expressions of cells, probably by modulation of gene 
expression.
This thesis describes the development and characterization of models for 
the study of phenotypic shifts in lung cancer. Three model systems have been 
utilized in this study including: SCLC, NSCLC, and normal and oncogene 
transfected (transformed) lung epithelial cells. A SCLC cell line NCI-H69 was 
selected as a model because of its heterogeneous properties both in term of 
morphology and drug resistance. The initial studies were performed to 
investigate whether spontaneous phenotypic changes can take place in this model 
[Chapter three-A]. It was possible to isolate two sublines of H69 with different 
morphologies. H69 with its two derivative lines provided a very useful model for 
the study of heterogeneity, interrelationship, and origin of lung cancers. The 
studies were designed to ask specifically whether SCLC can change to NSCLC, 
by comparative studies of the SCLC (parental), the NSCLC, and the derivative 
lines.
Having established that phenotypic shifts can occur in H69 cells 
spontaneously, and that H69 cells may represent a stem cell population, studies 
were extended further [Chapter three-B] to investigate the effects of 
microenvironmental manipulation (i.e using phenotypic inducers) on tumour cell
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phenotypic expressions. These studies investigated how malignant cell can alter 
its phenotype in response to chemical stimuli.
The effects of extracellular matrix and stromal interactions on malignant 
phenotype were also investigated in a NSCLC cell line [Chapter four]. These 
studies examined the phenotypic changes in a cell line derived from an 
adenocarcinoma of lung. Assuming that tumour cells often acquire a quasi- 
embryonic phenotype, fetal fibroblasts were selected for stromal interaction 
studies. Studies were also designed to see if other factors for expression of 
differentiation associated properties were important for induction of 
differentiation in these cells, such as polarity, and spatial orientation. The cells 
were allowed to grow in a histotypic culture, and then investigated for features 
associated with differentiation and malignancy. The effects of three dimentional 
culture on tumour cell (WIL) phenotype were compared to conventional 
monolayer culture on plastic substrate.
Studies were also performed to elucidate the effects of of genotypic 
manipulation on the phenotypic expression of the cell [Chapter five]. An 
immortalized lung epithelial cell line MvlLu transfected with human c-mvc and 
normal and activated Ha-ras oncogenes individually, provided a model to confirm 
the proposed hypothesis, that phenotypic changes are controlled by these specific 
genes. This model was characterized for a variety of different malignancy and 
differentiation associated characteristics both in vitro and in vivo, in order to 
determine a shift in transfected cell phenotype compared to untransfected 
parental cells. It has been found that both normal and activated ras and c-mvc 
could exert malignancy associated changes in transfected cells. Therefore, in 
addition to spontaneous phenotypic changes, both genotypic and 
microenvironmental factors were investigated for their possible roles in regulation 
of normal and malignant cell phenotype in vitro and in vivo.
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1.8 THESIS LAYOUT
This thesis comprises seven Chapters. Chapter one introduces the 
background related to the work performed in this thesis. Chapter two outlines 
the general methodology adapted in these studies, which is applicable to whole 
thesis. Chapters three-A, three-B, four, and five together form the main body of 
the practical work and the data derived from it, each Chapter is self-contained 
with its own introduction, methods and materials, results and discussion. Chapter 
three concentrates on phenotypic changes in SCLC models. Spontaneous 
phenotypic changes in a SCLC, H69, are investigated in Chapter three-A, while 
Chapter three-B deals with the induced changes in H69. Chapter four presents 
a short account of phenotypic studies in a NSCLC model, with special emphasis 
on microenvironmental influences. It is also divided into three sections, the first 
deals with studies in conventional monolayer culture, while the second highlights 
the effects of three dimensional culture on cell phenotype and last section of this 
Chapter describes the effects of in vivo growth on malignant cell phenotype. 
Transfection of normal (immortalized) lung epithelial cells with human oncogenes 
and the effects of transfection on cellular phenotype are detailed in Chapter five, 
which is again divided into five sections, each concentrating on a specific aspect 
of phenotypic change. Chapter six gives a brief account of the overall findings 
of the thesis as a whole, drawing conclusions with possible implications, further 
experiments, and future prospects.
The contents are provided in the beginning of each chapter. The location 
of figures, plates and tables is indicated by the preceding page in the text. 
Methods applicable to more than one chapter are described in General Methods, 
and methods specific to a particular chapter are described in the appropriate 
chapters.
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CHAPTER TWO
GENERAL METHODS
The main purpose of this chapter is to describe the experimental methods in 
general which have been used in more than one chapter in this thesis. Methods 
specific to a particular chapter will be described in the appropriate chapters in 
the individual "Materials and Methods" section.
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2.1 TISSUE CULTURE
2.1.1 Aseptic Techniques
All the experimental work involving tissue culture was conducted under 
strict aseptic conditions, in microbiological safety cabinets class-II (M.A.T Ltd., 
UK), with vertical laminar air flow. All the equipment, glassware etc., was 
sterilized by dry heat at 160 °C for a minimum of one hour. All heat stable 
solutions were sterilized by autoclaving at 120 °C, and 15 p.s.i. (2 bar), for 20 min 
(dry materials) or 40 minutes (wet materials).
2.1.2 Maintenance of Cell Lines
The cell lines growing as adherent monolayer cultures were maintained in 
tissue culture grade plastic flasks (NUNC, 25 cm2, 75 cm2, 150 cm2). Cells were 
grown in 1:1 v/v Hams F10, and Dulbeccos Modified Eagles Medium 
F10:DMEM (Gibco, Paisley, Scotland) or RPMI1640 medium (Northumbria 
Biological Ltd; NBL) supplemented with 10% foetal bovine serum FBS (NBL or 
Gibco) with 8 mM sodium bicarbonate (Gibco), and a 98% air and 2% C 0 2 gas 
phase. Cells were fed with fresh medium as indicated by the fall in pH. 
Confluent or near confluent cultures were passaged weekly, using 0.25% trypsin 
in 1 mM EDTA, in phosphate buffered saline (PBS, Gibco). It was called PET- 
solution. PET was removed after 30 sec and then incubated at 37 °C for 5 min 
and disaggregated by pipetting. The cells were then resuspended in fresh 
medium, and transferred into a sterile 30 ml plastic universal container (Sterilin, 
Middlesex). The cell number was determined using an electronic counter 
(Coulter, Luton, Beds.). Cell viability was confirmed by dye exclusion with 0.1% 
trypan blue, and also by tetrazolium [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl- 
tetrazolium bromide or (MTT)] dye reduction. Subcultures were set up in sterile 
flasks with lxlO4 to 1x10s cells per ml, in 25 ml fresh medium in 75 cm2 flasks. 
Cell cultures were replaced with fresh stocks from freezer every three months 
approximately.
SCLC cell lines growing in suspension were maintained in RPMI1640 
medium containing 10% FBS. 1 to 3 xlO6 cells were seeded in 25 cm2 flasks 
(Falcon) in 5 ml fresh medium, and passaged by a 1:10 split in late log phase. 
Cultures were fed before being split by allowing the cells to sediment and 
replacing three quarters of the spent medium.
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2.1.3 Cell Freezing, Thawing and Storage
A cell suspension (l-5xl06 cells/ml) in culture medium containing 10% 
dimethyl sulphoxide (DMSO), analar grade (BDH) was frozen, with an 
approximate cooling rate of 1 °C per minute, by placing the ampoules in an 
insulated box, in the -70 °C freezer, and subsequently transferring the ampoules 
to liquid nitrogen for storage. Tumour pieces were also stored by the same 
method.
Cells were thawed in water at 35 °C for 5 min, transferred to small flasks 
(NUNC, 25 cm2), and culture medium added slowly to avoid osmotic shock. 
The DMSO containing medium was replaced with fresh medium as soon as 
possible, usually within 6 to 12 hours of plating the cells in the flask in monolayer 
cultures, when cells had got attached to the substrate. Medium with preservative 
was removed from the non-adherent cells by centrifuging at 200g for 3 min and 
resuspending in fresh medium.
2.1.4 Mycoplasma Testing
Cell cultures fixed with 25% acetic acid in methanol were screened for 
mycoplasma contamination by staining with the fluorescent DNA stain Hoechst 
33258 (Sigma), at 0.5 /ig/ml for 15 min, at room temperature [Chen, 1977]. The 
detection of the extra-cellular DNA by fluorescence microscopy was indicative of 
the presence of mycoplasma in the culture.
2.1.5 Estimation of Cell Growth Rate
The growth characteristics of each cell line used in this work were 
determined in the beginning, to optimize the maintenance conditions. Cells were 
seeded in 24 well plates at low cell concentrations in their respective growth 
media. The cells were then allowed to attach and grow for 24 to 72 hours, 
depending upon the particular cell type. Thereafter, the cells in triplicate wells 
were counted daily, and the rest fed with fresh medium, until the cell growth 
reached a plateau, usually 8 to 12 days after seeding, depending on the cell line 
used. Growth curves were constructed by plotting the cell concentration on a log 
scale, against time in days on a linear scale. The doubling time was determined 
at mid log phase and the saturation density at plateau.
2.1.6 Morphological Observations
Morphological observations were performed on live cultures by phase 
contrast microscope, and on Giemsa stained fixed cultures by light microscopy.
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2.2 INVASION ASSAY IN  VITRO
Embryonic chick heart fragment-tumour cell confrontation assay has been 
adapted from Mareel et al. [1979; 1987] and Mareel [1983]. A schematic outline 
of different steps of the assay is given in Figure [2.1].
2.2.1 Formation of Monolayer Fragments or Suspension Cellular Aggregates
Approximately 0.2 mm mechanically detached fragments of monolayer 
culture or cell aggregates in suspension cultures were selected under the 
stereomicroscope using fine dissection needles, to get a suitable rounded up mass 
of cells for confrontation with the heart fragment.
2.2.2 Preparation of Embryonic Chick Heart Fragments
Fresh heart fragments were dissected from a 9 day old embryonic chick 
as described by Mareel et al (1979). Briefly chick heart ventricles were cut into 
0.3-0.4 mm blocks (50 to 100), and cultured in 2 ml MEM (Eagle’s minimum 
essential medium, Flow Labs. Ltd. Irvine) with 5% fetal bovine serum (Gibco, 
Biocult) on a gyratory shaker at 70 r.p.m., in 50 ml siliconized, tightly stoppered 
Erlenmeyer flasks at 37 °C for 2 to 3 days. During this period heart fragments 
formed well circumscribed spheroids consisting of a central core of myoblasts and 
fibroblasts, and surrounded by a well defined layer of extracellular matrix. These 
rounded fragments were termed pre-cultured embryonic heart fragments (PHF). 
For confrontation assays PHF with a mean diameter of 0.5 mm were selected, 
since previously it has been found that only small size fragments could maintain 
their morphology for up to 10 days in culture, without central necrosis and 
deterioration. Routine observation of PHF was carried out under a dissecting 
phase contrast stereomicroscope. A normal and healthy growing fragment 
appeared reddish and with evenly rounded edge.
2.2.3 Co-Culture of Heart Fragments and Test Cells
PHF were placed on a dish with 0.4% semisolid agar medium. All 
medium was removed carefully and PHF were placed in a circular array with a 
central space reserved for a fragment or aggregate of potentially invasive test 
cells. PHF and test cells were confronted, making sure that no medium was left 
on top of the agar, otherwise there could be a risk of fragments being moved 
apart by the movement of any fluid left on the agar surface. About 12 
confrontations were made per dish.
Test cells were placed in close contact with PHF and the attachment was
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Figure 2.1:- Schematic representation of the organ culture assay for in vitro 
invasion.
In this assay test cells are co-cultured with normal tissue fragments followed by 
sequential evaluation of invasion using various histological techniques [Mareel et al., 
1979; 1987].
assessed during first 24 hours, under the microscope, and later on by histology of 
the confronted tissue. Each confronting pair was subsequently transferred to a 
5 mm Erlenmeyer flask containing 2 ml culture medium, and shaken at 120 rpm 
on a gyratory shaker, at 37 °C, perfused with 5% C 0 2 in air.
2.2.4 Tissue Processing and Staining
Living co-cultures were examined and photographed daily, at 1,2, 4, 7, and 
10 day, and at least 3 confronting pairs were examined at each time point. They 
were fixed in Bouin-Hollande solution, embedded in paraffin wax, and 1 and 6 
fim thick complete serial sections were cut, and stained with haematoxylin and 
eosin (H&E), which was usually sufficient to differentiate tumour cells from chick 
heart tissue. Confirmation was achieved using an indirect immunoperoxidase 
technique with a polyclonal rabbit anti-chick primary antibody as described by 
Mareel et al. [1981]. Specific antibodies were also used to confirm the identity 
of the tumour tissue in the confronting co-cultures. These are described in 
appropriate experiments.
2.2.5 Analysis of Invasion
Invasion activity in this assay was based on the occupation of the normal 
tissue (PHF) by test cells. Therefore with a three dimensional confrontation 
assay system the invasive ability had to be deduced from the histological sections 
of the confronting tissue fixed in situ. after various time intervals. Analysis of 
occupation and degradation or replacement of normal tissue by tumour tissue 
was mandatory to grade the degree of invasion. Interaction of the confronting 
tumour cells with the heart fragments was classified according to the grading 
system described by Bracke et al. [1984]. Invasion of the test cells or tissues into 
the heart fragment in a confronting assay was divided into five grades according 
to this semi-quantitative grading or scoring system.
Grade 0 :- Serial sections of complete co-cultures showed no tumour (test) cells. 
The causes could be 1) test cells non-adherent to PHF, 2) failure to attach for 
technical reasons, 3) maladaptation of the cells in new culture conditions, and 
4) non-invasive cells.
Grade I :- The confronting cells were found at the periphery of the outer 
fibroblast layer of the heart fragment, so that cells surrounded the PHF. Grade 
I confrontation was interpreted as modelling the natural situation of epithelial
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(tumour cells), and stromal (fibroblast layer of PHF) confrontation in vivo.
Grade II:- Type II co-cultures were usually seen when two normal tissue were 
brought together so that they either fused at the site of attachment (Ha) or one 
of the confronting partners surrounded the other (lib). Ha indicated that the 
cells were occupying the outer fibroblast layer or had formed a cap at the pole 
of attachment or had surrounded the heart fragment. Grade lib indicated that 
the cardiac muscles had surrounded the nodule of confronting cells with a 
minimal area of contact (circular in section), [Mareel et al.. 1983].
Grade III:- Test cells or tissue had replaced less than one half of the heart 
fragment.
Grade IV:- Test cells or tissue had replaced more than one half of the heart 
fragment.
Grades III & IV fulfilled the criteria for invasiveness [Mareel et al.. 1982, 
1983]. Invading tumour cells could easily be identified in confronted cultures 
because of their distinct morphological and antigenic characteristics. The number 
of cells on surface and with in each fragment was assessed and the percentage of 
PHF invaded by test cells was determined.
2.3 CYTOTOXICITY ASSAYS
Two types of assays were used. Microtitration or MTT assay for quick 
screening of many samples, and clonogenic assay for more detailed analysis of 
cell survival. The methods for MTT assay were adapted from Plumb et al. [1989], 
established within the Department of Medical Oncology. The assay is based on 
observations made by Mosmann [1983], Cole [1986], and Carmichael et al. [1987].
2.3.1 Monolayer Cloning
Exponentially growing cell cultures were treated with a range of drug 
concentrations in 25 cm2 flasks (Nunc, Gibco), for a given period of time (1-3 
days), the drug being replaced daily. The cultures were then trypsinized and a 
single cell suspension was obtained. Each cell suspension was diluted to the final 
concentration in growth medium, to give required cell number per ml by 
determining the number of cells in the control flasks.
Cells were plated out in 60 mm sterile petri dishes (Nunc) in 5 ml culture
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medium, incubated for 2-3 weeks at 37 °C, 98% air, 2% C 0 2, in a humidified 
incubator. When discrete colonies were formed the medium was decanted, and 
the dishes washed with PBS, fixed in graded alcohol and stained with 1% crystal 
violet.
Colonies were counted both manually and with the help of an automatic 
colony counter [Artek Counter, Modal 1980]. Plating efficiency (PE) was 
calculated according to following formula:
number of colonies formed
Plating Efficiency = _________________________________  X 100
number of cells seeded
and the surviving fraction was calculated as below:
mean colony number of tests
Surviving Fraction = __________________________________
mean colony number of control
The surviving fraction was plotted against drug concentration as 
percentage of control. The IC50 and IC90 were then determined as the drug 
concentrations required to inhibit colony formation by 50% or 90% respectively 
of untreated control.
2.3.2 Microtitration Assay
The assay is based on the selective ability of living but not dead cells to 
reduce a yellow tetrazolium salt [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl- 
tetrazolium bromide or (MTT)] to a purple formazan product, which may be 
measured spectrophotometrically. The viable cell number per well is directly 
proportional to the absorbance at 570 nm.
The assay can be divided into four parts: 1) an initial growth phase, 2) 
period of drug exposure, 3) recovery period, and 4) MTT assay.
Slightly different protocols were employed for adherent and non-adherent 
cell lines. For adherent cultures a total of 200 /il of the cell suspension at a 
concentration designed not to reach plateau by the end of the assay were added 
to all but two outer columns of triplicate 96-well micro titration plates (Linbro). 
The outer columns received 200 /il of culture medium only, and were used as 
blank.
Cells were incubated at 37 °C in an atmosphere of 2% C 0 2 in air, and
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allowed to attach and proliferate for 2 to 3 days. Medium was then removed 
from the exponentially growing cultures and replaced with 200 (A of fresh culture 
medium containing drug or solvent control, and six to eight drug concentrations 
were used with six replicates at each.
For drug exposure time longer than 24 hours, fresh drug was added every 
24 hours in 200 /il fresh medium. Thereafter, drug containing medium was 
removed and plates fed daily with 200 /il fresh medium. The recovery period 
was determined for each cell line, depending on growth rate of the cell line, to 
allow approximately 2-3 cell population doublings, but not reaching plateau.
On the last day of the assay, cells were fed as usual with 200 /il per well 
fresh medium, containing HEPES buffer (10 mM) (Gibco), followed by the 
addition of 50 /il per well MTT (Sigma) solution (see below). Plates were then 
incubated in the dark (wrapped in aluminium foil) at 37 °C for 4 hours. Medium 
containing the non-reduced MTT was removed from the wells and the formazan 
crystals were dissolved in 200 /il DMSO per well. To each well were added 25 
/il glycine buffer (BDH). Sorensen’s Glycine Buffer: 0.1 M glycine + 0.1 M 
NaCl, pH 10.5. All formazan present was as a single species with an absorbance 
maximum at 570 nm single wavelength, using a microtitration ELISA plate reader 
(Bio-Rad, Model 2550 ELA Reader, Watford, Herts, U.S.A.), interfaced with an 
Amstrad PC 1512 computer.
The optimum MTT concentration for a particular cell line was determined 
by plating a constant cell number per well and incubating with different 
concentrations of MTT, and the concentration which gave the maximum 
absorbance without cytotoxicity selected.
All non-adherent cells were treated as above except as follows: Cells were 
plated in 96-well plates (round bottomed wells, Nunclon) in 100 /il culture 
medium at 2x final cell concentration. Drug was added on the same day (100 /il 
of a 2x final concentration). Plates were centrifuged at 200g for 10 min, to pellet 
the cells before adding drug and subsequent feeding.
A graph was plotted for absorbance (Mean +_ SEM) on a linear scale 
against drug concentration on a log scale. The amount of drug required to give 
a 50% reduction in absorbance at the end of the assay was calculated as IC50. 
As a linear relationship can be demonstrated between absorbance and cell 
number, it was assumed that a 50% reduction in absorbance implied a 50% 
reduction in viable cell number, although confirmation of this was not attempted 
in each assay.
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2.4 CLONOGENIC ASSAYS
2.4.1 Soft Agar Clonogenic Assay
A modification of the double layer soft agar petri-dish clonogenic assay 
was used.
One ml of cell suspension in 0.3% agar was pipetted on a pre-formed 1% 
agar under-layer. The final cell concentration varied among different cell lines, 
but was between 103-104 cells per dish. Following application of the cell layer 
to the dishes, they were transferred to refrigerator at 4 °C for 5 min, then to 
room temperature for 10 min, to allow proper and uniform gel formation. 
Thereafter plates were incubated at 37 °C, in 98% air, 2% C 0 2, in a humid 
incubator. On the following day, the dishes were checked for the presence of a 
single cell suspension. Plates with cellular aggregates were not included. One 
ml of growth medium was added on top of the agar in each dish on the next day. 
Colony formation was examined at least twice a week, using an inverted phase 
contrast light microscope. Colonies consisting of more than 50 cells could be 
identified after 3-4 weeks.
MTT was used for staining to identify viable clones. The use of 
metabolizable dyes in conjunction with soft agar cell culture has been described 
previously [Alley and Lieber, 1984]. Briefly, stock MTT was prepared fresh at 
concentration of 5 mg/ml PBS. The optimal staining of colonies was achieved 
by applying 1 ml of MTT solution to the surface of each culture, followed by 
reincubation at 37 °C for at least 4 hours. Viable colonies of approximately 50 
cells could be counted easily.
For standardization, selected colonies were isolated and teased apart to 
confirm the number of cells in a given-sized colony, both by phase contrast 
microscopic examination and following Giemsa staining.
2.4.2 Monolayer Clonogenic Assay
As in cytotoxicity assays, except that drug was not included in the protocol.
2.5 CELL LINE CHARACTERISATION
The species of origin of cell lines was confirmed by chromosome analysis 
and cross contamination excluded by isoenzyme analysis.
2.5.1 Lactate Dehydrogenase Isoenzymes Analysis
Lactate dehydrogenase (LDH) isoenzymes were separated by 
electrophoresis on an agarose gel. The area of enzyme activity was then
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visualized histochemically, according to the following reactions.
LDH
L[ + ] Lactate + N A D ---------------» Pyruvate + NADH
NADH + PMS ---------------> NAD + PMS-H
PMS-H + TNBT ---------------» PMS + TNBT-Formazan
The TNBT formazan which is coloured and insoluble, localizes in the 
electrophoretic zones of LDH activity.
NAD: Nicotinamide adenine dinucleotide.
NADH: Nicotinamide adenine dinucleotide, reduced.
PMS: Phenazine methosulfate.
TNBT: Tetranitroblue tetrazolium.
The assay can be divided into five parts: 1) preparation of the cell extract, 
2) electrophoresis, 3) staining, 4) scanning, 5) and analysis.
For preparation of the cell extract, exponentially growing cell cultures were 
harvested by trypsinization to give approximately lxlO7 cells. The cells were 
washed three times by centrifugation in 10 ml 0.9% NaCl pH 7.1, containing 
6.6x10*^ EDTA (saline-EDTA). The cell pellet was resuspended in 1 ml saline- 
EDTA solution, and lysed by freezing and thawing rapidly at least three times 
in liquid nitrogen or a dry ice-alcohol bath and a water bath at 37 °C. The lysate 
was then dispensed into Eppendorf tubes, and clarified by centrifugation at 8700g 
in a Microfuge B (MSE) for 5 min. The supernatant was collected and stored 
at -70 °C for subsequent assay.
Agarose gel (Corning Universal Electrophoresis Films) was equilibrated 
in LDH-Electrophoresis Buffer solution (50 mM tris, 12 mM citrate, 25 mM 
barbital) (Sigma) for 1 hour prior to electrophoresis. Gel was removed from 
the equilibrium solution and excess buffer was drained off. The area containing 
sample application wells was blotted gently using a filter paper, and two 1/il 
aliquots of freshly thawed sample extract were applied to each application well. 
Separate disposable sample tips (Corning Medical Co.) were used for each 
sample. After absorption of the second aliquot of the sample, the loaded gel was 
placed in the electrophoresis cell cassette holder, with agarose side facing down, 
and run at 90 V (120 V/cm) for 30 min.
For staining the gel was removed from the electrophoresis cell, trimmed
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to approximate size and stained in the chromogen at 37 °C, in the dark for 30 
min. The gel was then soaked in 200 ml of methanol acetic acid solution for 30 
min, followed by another wash in 200 ml of distilled water for 30 min, and then 
dried in an incubator at 60-70 °C to give a transparent film, which was scanned 
on a densitometer, but usually it was possible to evaluate the patterns visually 
[see below, Plate 3A.2]. A sample of human LDH supplied with the Kit was 
used as a standard.
Results were recorded both in terms of the number and intensity of bands, 
and with reference to the distance of migration from the origin, compared to 
standard. Typical banding patterns for each cell line were also compared to the 
standard zymograms [Macy, 1978].
2.5.2 Chromosome Analysis
Adapted from Rothvels and Siminovitch [1958], Worton and Duff [1979] 
and Freshney [1987].
Cells in mid log phase of growth were exposed to colcemid (0.1 /iM) for 
four hours, at 37 °C. Medium was replaced with hypotonic solution (0.04 M KC1, 
0.025 M sodium citrate) for 20 min. Non-adherent cells were treated in 
suspension while adherent cells were collected by shake-off and pipetting. This 
procedure was useful to obtain maximum number of cells in metaphase. The 
cells were then spun at lOOg for 3 min, fixed in ice cold acetic-ethanol (1 part 
glacial acetic acid + 3 parts ethanol) slowly with constant mixing on a vortex, and 
then centrifuged again at lOOg for 3 min. The supernatant was discarded. The 
pellet was buzzed on a vortex mixer, and then fresh fixative was added, slowly 
with continuous mixing. This procedure was repeated three times. Finally the 
pellet was buzzed in 0.5 ml fixative to give the final dispersed cell suspension. 
Approximately 50 1^ was then dropped onto a clean, cold glass slide and blown 
slightly. The preparations were air dried and examined under the microscope for 
optimal spread, and processed for G-banding.
The chromosome number was counted per spread for a minimum of 20- 
30 spreads, and the results presented as a histogram. The status of ploidy was 
defined i.e aneuploid, diploid, near diploid if countable, and polyploid if high and 
uncountable. Any other aberrations such as deletions, losses, were also recorded.
2.5.3 Chromosome Banding
Slides were incubated in 2x SSC (saline sodium citrate : equal volumes of 
sodium chloride (17.63 g/L) and sodium citrate (8.82 g/L), at 60 °C for 2 hours.
58
They were then rinsed in saline and in distilled water, and dehydrated in graded 
alcohols (50%, 70%, 90%, 100%), 2 min in each, and allowed to dry. Slides 
were then treated with trypsin solution (1% trypsin in saline); test slides were 
used to determ ine optimum timing. Slides were rinsed in saline, and stained in 
1 part Leishman to 3 parts buffer (G urr’s buffer tablets were dissolved in water 
and adjusted to pH 6.8, according to manufacturers instructions) for 3 min. 
Slides were subsequently rinsed in buffer and allowed to dry. Completely dried 
slides were used to examine under bright field, oil-emersion objectives without 
a coverslip. Finally the slides were soaked in xylol for 15 min and mounted. 
(Chromosome banding was done by Dr Elizabeth Boyd at Yorkhill Yospital, 
Glasgow).
2.6 BIOCHEM ICAL AND RADIOIMMUNOASSAYS
2.6.1 Bombesin Radioimmunoassay
Radioimmunoassay (RIA), for bombesin-like immunoreactivity (BLI), was 
adapted from Moody et a I., [1983]: Cuttitta et al., [1985]; and Bepler et al.. [1987]. 
BLI was measured both in cellular as well as in secreted fractions of the tumour 
cells in culture. Exponentially growing cultures were harvested by centrifugation 
at 200g for 10 min. Medium was retained for the assessment of secreted BLI. 
For the m easurem ent of the intracellular bombesin content, the cells were 
washed twice in PBS. and the cell pellet was resuspended in 1 ml of acetic acid 
(2 M) (BDII), boiled in a water bath for 15 min, and homogenized. A fraction 
was saved for protein estimation. The remainder of the homogenate was clarified 
by centrifugation at lO.OOOg for 15 min. The supernatant was frozen, lyophilized, 
and stored below -70 °C until assayed.
For the assessment of secreted BLI, trasvlol (Aprotinin, Sigma) 500 KIU; 
kallikrein inhibitor unit) per ml was added to the medium in which the cells were 
grown, immediately prior to centrifugation at 760g for 15 min. Acetic acid was 
added to the supernatant to give a final concentration of 2 M. The acidified 
samples were then vortexed, frozen, lyophilized, and stored below -70 °C.
Lyophilized extracts of the test samples were resuspended in 1 ml PBS, 
supplemented with bovine scrum albumin (BSA), 0.25% w/v. The amount of 
BLI in the test samples was assayed by a commercial double antibody RIA Kit 
(Incstar Co. Ltd.), following the m anufacturer’s instructions. Briefly, BLI-RIA 
involved simultaneous addition of unknown sample (unlabelled bombesin), 
rabbit-anti-bombesin (specific primary antibody), and 125I-BN (labelled specific 
antigen), followed bv an overnight (16-20 hours) incubation at 4°C. During this
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incubation BN in the unknown samples competed with the labelled-bombesin for 
the common antibody binding sites.
A pre-precipitated carrier, secondary antibody, and polyethylene glycol 
(goat-anti-rabbit precipitating complex, GAR-PPT) were then added 
simultaneously, and incubated for 20 min at 25 °C. The precipitated antigen- 
antibody complex was then separated by centrifugation at 760g, and decanted. 
The radioactivity in the precipitate was counted using a gamma scintillation 
counter (Nuclear Enterprices, NE1600), for 4 min, and the amount of BLI in the 
unknown sample calculated from a standard curve included in each test.
Using the standard curve, the BLI equivalent of the cell homogenate 
peptide was determined and expressed as pg BLI per mg total cellular protein in 
the homogenate. The results were the mean of triplicate determinations, with 
duplicate counts for each determination.
2.6.2 Neuron-Specific Enolase Radioimmunoassay
Cell cultures in late log growth phase were harvested and centrifuged at 
200g for 5 min. The cell pellet was washed twice in PBS, then resuspended in
2.5 volumes of Tris-phosphate buffer (20 mM) containing M gS04 (2 mM), and 
lysed by freezing and thawing three times, using Drikold-methanol and a water 
bath at 37 °C. Having confirmed that the lysis was complete, a fraction of the 
lysate was saved for protein estimation, and stored frozen below -70 °C. The 
remaining lysate was centrifuged at 100,000g for 1 hour in an ultracentrifuge 
(Model L5-50, Beckman & Co., U.S.A.), in a Ti 50 rotor. The supernatant was 
stored frozen below -20 °C until assayed.
For the measurement of secreted NSE, medium from exponentially 
growing cells was collected, centrifuged, and the supernatant frozen immediately, 
and stored at -20 °C prior to assay.
NSE was measured using the Pharmacia NSE-RIA test (Pharmacia 
Diagnostic AB, Uppsala, Sweden) as described by Cooper et al. [1985]. The 
Pharmacia NSE-RIA test is a double antibody RIA. Briefly NSE in the sample 
(test or standard) competes with a fixed amount of 125I-labelled NSE for the 
binding sites of the specific antibody (rabbit IgG). The antibody is available only 
in limited amount. Bound and free NSE were separated using a second antibody 
(sheep anti-rabbit IgG), covalently bound to sepharose particles. After addition 
of decanting suspension i.e, sepharose antibody derivatives (sepharose-anti-rabbit 
IgG raised in sheep), the mixture was incubated for 30 min at room temperature, 
and centrifuged at 1500g for 10 min. The supernatant with free NSE was then
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separated from the sepharose pellet, containing the bound NSE, by decanting for 
5 min. The radioactivity in the pellet was then determined using a gamma 
counter as above. The radioactivity in the sample is inversely proportional to 
the quantity of NSE.
Each sample was assayed in triplicate and total cellular protein determined 
for each replicate. Computer calculations were performed using the WHO 
Immunoassay Processing Program (version 5.1) software. Assays were repeated 
at least twice to get reproducible results. NSE values are expressed as ng 
NSE/mg cellular protein.
2.6.3 Creatine Kinase Assay
To determine total creatine kinase (CK) activity the cell cultures were 
harvested in late log phase, and centrifuged at 200g for 5 min. The cell pellet 
was washed three times with ice cold PBS, and finally resuspended in 1 ml borate 
buffer (Borax 0.025 M + KH2P 0 4 0.05 M, pH 7.6). The cell suspension was 
lysed as before by freezing and thawing 3 times. Complete cell disruption was 
confirmed by trypan blue test. The lysate was mixed thoroughly and aliquots 
were saved for protein estimation for each sample. The remainder of the lysate 
was centrifuged at 8000g for 5 min. The supernatant was saved, and stored 
frozen below -70 °C until assayed.
Total CK activity in the test sample was determined using a commercial 
Kit (Sigma Co. Ltd.) following the manufacturer’s instructions. Briefly, the 
fraction of test sample for CK analysis was added to CK reagent preincubated at 
30 °C, mixed by inversion, and placed again at 30 °C for sufficient time (4-5 min) 
to get a linear trace at 340 nm against water as a reference, in a 
spectrophotometer (Gilford 250). The rate of reaction was then determined from 
the trace. The rate of change in absorbance was proportional to formation of 
NADH. The enzyme activity was expressed as units per milligram cellular 
protein, where one unit was defined as the amount of enzyme which produced 
one //mol of NADH per min under the conditions of the assay.
The CK isoenzymes were analyzed electrophoretically, according to 
manufacturer’s instructions (Coming Diagnostic Ltd). The isoenzymes were 
separated by electrophoresis for 20 min in a preformed 1% w/v agarose gel film 
at 9 v/cm, loaded in a cassette electrophoresis cell containing 3-(N-morpholino)- 
2-hydroxypropane sulfonic acid (MOPSO) buffer (0.05 M, pH 7.8). Following 
electrophoresis the film was overlaid with CK substrate solution (MES buffer, pH 
6.2). The film was incubated at 37 °C for 20 min in the dark. During this period
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of incubation NADH was formed. Following incubation, the agarose film was 
dried and visualized under UV light at 340 nm. NADH produced was quantified 
using a scanning fluorimeter (Helena) at an excitation wavelength: 365 nm, and 
emission wavelength: 460 nm, against a human CK standard.
CK-1 (CK-BB) was the fastest migrating fraction; CK-2 (CK-MB) migrated 
in the position of an alpha-2 globulin, and CK-3 (CK-MM) remained at the site 
of application in the mid gamma globulin position. The percentage of each 
isoenzyme was calculated from total CK activity. For quantitative results the 
percentage of each isoenzyme was multiplied by total CK activity to get 
isoenzyme concentration in IU/mg protein.
2.6.4 DOPA Decarboxylase Assay
The assay was adapted from Laduron and Belpaire [1968]; Fonnum [1969]; 
Emson et al. [1974], and modified by Murray [1989].
DOPA decarboxylase (DDC) in the presence of pyridoxal 5-phosphate 
converts L-DOPA to dopamine, with loss of carbon dioxide. The enzyme activity 
can be estimated by the rate of formation of 3H-dopamine from L-3H-DOPA. 
Radioactive dopamine (product) is separated from unchanged L-DOPA by 
heptane-3-one extraction in the presence of tetraphenylboron. The amount of 
product formed is directly proportional to the enzyme activity.
The extraction method was same as for CK assay. The incubation mixture 
for enzyme reaction was prepared as below, omitting pyridoxal 5’phosphate.
Borate buffer Borax (0.025 M) + KH2P04 (0.05 M, pH 7.6), (BDH)
pyridoxal 5’phosphate 100 /iM (Sigma)
Nialamide 125 /iM (Sigma)
EDTA 1.5 mM (BDH)
L-DOPA 1200 /iM (Sigma)
(L-/3-3,4- dihydroxyphenylalanine)
3H-L-DOPA 30 /iCi/ml (20-40 Ci/mmol)
(Dihydroxyphenylalanine L-3,4-[ring-2,5,6-3H] (Du Pont)
Reaction mixture (45 /A) was aliquotted into 15 ml glass stoppered
centrifuge tubes, and incubated at 37 °C for 5 min. The cell extract (200 /il) was 
added to 100 /il of pyridoxal 5-phosphate (1200 /iM), and vortexed. To start the 
reaction, 15 /il of this mixture was added to the appropriate tubes containing
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reaction mixture. Samples were incubated at 37 °C for 1 hour. The reaction was 
stopped by adding 5 ml ice cold sodium phosphate buffer (10 mM, pH 6.5), and 
samples transferred to ice.
Dopamine was separated from unchanged L-DOPA by liquid cation 
exchange with sodium tetraphenylboron according to the method of Fonnum 
[1969]. One ml of heptane-3-one (BDH) containing 25 mg sodium 
tetraphenylboron (BDH) was added to each sample tube. Samples were mixed 
gently by inversion for 1 min. Subsequently the two phases were separated by 
centrifugation at 1500g for 5 mins at 4 °C. The aqueous phase was removed, 
using a Pasteur pipette, and discarded. The organic phase was washed again with 
2 ml of sodium phosphate buffer (10 mM, pH 7.4), containing 1 mg 
tetraphenylboron. The samples were centrifuged at 1500g for 5 min at 4 °C. 
Finally a 0.5 ml aliquot was removed from the organic phase and 10 ml of 
Ecoscint [National Diagnostic, Sumerville, NJ, U.S.A] were added. The 
radioactivity in the sample was counted for 10 min, using a scintillation counter 
(Packard).
For determination of the extraction efficiencies, percentage recoveries of 
both 3H-dopamine (5-15 Ci/mmol) (Amersham UK) and 3H-DOPA were 
calculated for each assay. The values range from 50-75% in case of 3H-
dopamine, and less than 1% percent in case of 3H-DOPA.
Controls included were a reagent blank (incubation mixture without 
enzyme) and a sample blank (enzyme added at the end of the incubation). The 
blank values were subtracted from the sample values to account for non-specific 
or non-enzymatic decarboxylation of DOPA. The results were expressed as 
/ilU/mg cellular protein, where one *JU was defined as one u^mol of substrate 
converted into the product per minute under the conditions of the assay.
2.6.5 Protein Assay
The cellular protein was solubilised in 0.3 N NaOH (BDH) prior to 
protein assay. Samples were stored at -20 °C for subsequent assay. The 
estimation of total cell protein was carried out according to the method of Lowry 
et a l  [1951].
2.7 ANIMAL EXPERIMENTS
Nude mice ( M F - l / N u N u / O L A C / H S D )  were produced in sterile isolators 
by mating heterozygous (Nu/ + ) females with homozygous (Nu/Nu) males, or
purchased from Olac (Bicester, Oxon). The mice were housed in sterile
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transparent MTI polycarbonate cages in vertical Bassair laminar flow hoods, and 
sterile grade 18 wood chips were used as bedding. The surrounding temperature 
was maintained at 27 °C, with a humidity of 40-60%. A cycle of 12 hrs light and 
12 hrs dark was provided. Pre-sterilized food Special Diet Services (SDS) No. 
3, (Essex) and drinking water were freely available.
2.7.1 Tumour Growth and Maintenance
Studies were performed on both the primary (implant) and the secondary 
(transplant) tumours in nude mice.
The primary xenografts were generated by injecting a minimum lxlO6 
cells subcutaneously into the caudal flank of each animal. Following inoculation 
mice were examined twice weekly and tumour growth and condition of animals 
recorded.
Growing tumours were maintained in nude mice as stocks by serial 
passage in a laminar flow hood at intervals of 4-6 weeks. A tumour bearing 
mouse was killed by cervical dislocation. Tumour was removed, obvious fat, 
connective tissue, or necrotic tissue was separated. Usually the outer rim of the 
tumour contained the healthy viable tissue, which was carefully dissected out, and 
divided into small pieces. The tumour fragments were then used either for serial 
passage (2x2 mm) or stored frozen in liquid nitrogen at -196 °C. For tumour 
transplantation, animals were anaesthetized, by intraperitoneal injection of 0.1 ml 
anaesthetic; 1 part Hypnorm, (Janssen Pharmaceutical Ltd., Oxford), to 1 part of 
Hypnovel (Roche Products Ltd., England), diluted in sterile distilled water at 1:2 
dilution. Alternatively ether by inhalation was used as anaesthetic.
Animals were assigned to experimental groups in a random manner. A 
group of 4-6 animals was prepared by placing them with their dorsal surfaces 
facing upwards. With a small surgical incision, a hole (4-5 mm) was made in the 
skin of the right flank. The scissor tip was inserted subcutaneously, and widened 
slightly to open the incision. Using fine tipped forceps, a piece of tissue was 
inserted into the wound, well away from the site of the incision. The wound was 
then closed with sterile autoclips. The animals were then placed in sterile cages 
in the laminar flow hood, and allowed to recover. Clips were removed once the 
wound had healed.
2.7.2 Analysis of Tumour Growth
The tumour take was defined as formation of a tumour which grew after 
implantation and could be serially passaged.
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The latent period was defined as the time between inoculation and the 
appearance of a palpable tumour at the site of injection, measuring approximately 
> 3x3 mm. This was confirmed histologically.
The tumour take rate was defined as the number of successful implants 
or transplants, expressed as the percentage of the total number of the implants 
or transplants.
The volume was calculated from the two diameters of the tumour, on the 
assumption that the tumour was ellipsoid in shape, from the following 
mathematical expression [Fergusson et al.. 1986].
V = 7r x Dd2/6
Where V = Tumour volume in mm3 
7i -  3.14
D = largest diameter across the tumour 
d = smallest diameter across the tumour
Tumour doubling time, and growth rate were also determined for each 
tumour. The growth rate of subcutaneously implanted tumours decays from 
exponential with increasing volume and is designated as Gompertzian [Poulsen 
et al.. 1982]. Tumour doubling times were therefore estimated during the early 
growth phase approximating to exponential and later when the rate had 
decreased. Actual time of measurement depended on individual curves and is 
described later. The tumour doubling time was calculated by slight modifications 
in the methods adapted by Steel et al. [1983]. The tumour volume was plotted 
against time scale, and the tumour doubling time was determined by interpolation 
on a semilogarithmic plot, and from the formula given below. The growth rate 
was assessed from tumour doubling time.
Dt = T/D n
Where
Vi = tumour volume (mm3) at any given time Ti
Vf = tumour volume (mm3) after time Tf
V = change in volume between Vi and Vf
T = time between Ti and Tf in days
Dn = number of doublings in tumour volume (V), in time (T).
Dt = tumour doubling time in days
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Tumours were also evaluated for total duration of observation i.e interval 
between inoculation and death of animal, minimum tumour bearing period i.e 
duration of observation minus latency period. Any gross lesions e.g ulceration 
were also recorded.
2.8 HISTOLOGICAL METHODS
Tissues were fixed in 10% neutral buffered formalin (NBF), or Bouin’s 
fixative, and embedded in paraffin wax. Sections 4 fim thick were cut, and 
processed for haematoxylin & eosin, periodic acid-Schiff alcian blue, and 
immunohistochemical staining [Figure 2.2].
Where appropriate, fresh tissue was snap frozen in liquid nitrogen and 
stored below -70 °C. Frozen sections, 3 ^m thick were cut onto slides coated 
with 3-aminopropyl triethoxysilane (Sigma Co. Ltd.), and air dried overnight. 
These were fixed in acetone for 10 min, and air dried before staining.
Cell suspensions in PBS were centrifuged onto silane coated glass slides. 
The cytospin preparations were fixed in methanol, acetone, or 10% NBF, and 
processed for immunohistochemistry.
Cells suspensions in a plasma clot or 2% agar were fixed and processed 
for paraffin sections. Plasma was replaced by agar for immunohistochemical 
staining. Cells were also grown on glass coverslips, Lab-Tek slides (Miles 
Scientific, USA).
2.9 IMMUNOHISTOCHEMICAL TECHNIQUES
Immunohistochemical staining was performed using the indirect 
immunoperoxidase, peroxidase anti-peroxidase (PAP) [Sternberger, 1979], avidin- 
biotin complex (ABC) [Hsu, 1981; Guesdon et aL  1979], or indirect immuno- 
alkaline phosphatase (AP) techniques [Cardell et al., 1984],
Controls for all techniques included omission of primary antibody, 
substitution of non-immune rabbit serum or an inappropriate antibody, or 
monoclonal control as appropriate, and where possible incubation of the sections 
with antibody preincubated with excess antigen. Known positive controls were 
used to establish optimal dilutions in all antibodies, and an appropriate positive 
control was included in each run.
2.9.1 Indirect Immunoperoxidase
For paraffin sections, appropriate numbers of test and control sections 
were cut, and brought to water through graded alcohols. Endogenous peroxidase
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Figure 2.2:- Schematic representation of working ^
strategies for histopathological studies.
activity was blocked by incubating the slides in a solution of 0.5% hydrogen 
peroxide and 0.2% hydrochloric acid in methanol, for 30 min. Slides were rinsed 
briefly in water, and then in tris-saline. Sections were trypsinized as appropriate, 
using a solution containing 0.1% trypsin, and 0.1% CaCl2 in tris buffer pH 7.8 at 
37 °C for 10 min, then washed in two changes of tris-saline, 5 min each wash. 
Sections were incubated with non-immune serum, from the species supplying the 
second antibody at a dilution of 1:5 in tris buffer for 15 min. This step was 
omitted in the case of monoclonal antibodies. The primary antibody was applied 
at standard established dilutions, usually for 30 min in case of polyclonal and 2 
hours with monoclonal antibodies. Slides were rinsed three times in tris-saline, 
5 min each. Horseradish peroxidase (HRP)-conjugated secondary antibody was 
then applied for 30 min and the slides washed in tris-saline for three changes of 
5 min each. The colour reaction was developed using diaminobenzidine 
tetrahydrochloride dihydrate (DAB) solution for 10 min. Slides were 
counterstained in haematoxylin, dehydrated, and mounted.
For frozen sections tumour was removed immediately after sacrificing the 
animal. Tissue blocks, 3x3 mm, were embedded in OCT (Miles Scientific, USA) 
snap frozen in liquid nitrogen, and stored below -169 °C until sectioned. Four 
micron thick sections were mounted on slides coated with silane, air dried 
overnight, and fixed in acetone for 10 min at room temperature. They were 
rehydrated in water then in tris-saline and processed as above.
For cytology, monolayer whole mounts and cytospin preparations were 
fixed in methanol at 4 °C for 20 min, 1% paraformaldehyde or in acetone for 10 
min at room temperature, and rehydrated before staining as above.
2.9.2 Peroxidase-Anti-peroxidase
Steps for the PAP technique were as for indirect immunoperoxidase until 
the application of the unconjugated secondary antibody which was applied for 30 
min. Then peroxidase-antiperoxidase complex (Dakopatts) was applied at 
appropriate dilutions in tris-buffer for 30 min.
2.9.3 Avidin-Biotin Complex
As indirect immunoperoxidase until the application of the secondary 
antibody. Biotinylated antibody was applied for 30 min, and avidin-biotin 
peroxidase complex; ABC Kit (Vector Labs.) for 45 min. Mouse ABC Kit was 
used for monoclonal antibodies, and rabbit ABC kit for polyclonal antibodies.
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2.9.4 Immuno-Alkaline Phosphatase
An indirect AP technique was applied. The sections were processed as for 
indirect immunoperoxidase until the application of the secondary antibody. An 
AP-conjugated antibody was applied at 1:20 dilution for 45 min. Freshly 
prepared substrate solution-A was applied for 20 min to develop a red coloured 
end product. Cryostat sections were incubated in substrate solution-A containing 
1 mM levamisole (Sigma) to inhibit endogenous alkaline phosphatase. Slides 
were washed twice in distilled water, counterstained lightly with haematoxylin 
without differentiating in acid alcohol, dehydrated rapidly, and water mounted in 
glycerine gelly.
2.10 ELECTRON MICROSCOPY
2.10.1 Transmission Electron Microscopy
Material for transmission electron microscopy (TEM) was obtained either 
from cell cultures or from the xenografts. Tissue was fixed in 4% glutaraldehyde, 
postfixed in 1% osmium tetroxide, and embedded in epoxy resin. At least two 
blocks were selected from each specimen. Semithin sections were cut and used 
to locate the areas for ultrathin sections. Silver/gold sections were cut on an 
Ultratome-III at a thickness of 500-700 °A, mounted on copper grids, and stained 
in 2% uranyl acetate and lead citrate. The grids were scanned on a Philips E.M 
301 transmission electron microscope, at 80 Kv. Electron micrographs were made 
using either Kodak plates (type EM-5, Kodak electron microscope cut films, 
6.5x9 cm) or Ilford plates (Ilford technical films, 6.5x9 cm). Prints were made 
using Ilfospeed paper grade 1-5.
2.10.2 Scanning Electron Microscopy
The specimens were fixed as described above, and processed according to 
the standard schedule. The critical point dried specimen was mounted on 
mounting copper stubs in carbon mounting medium (carbon conducting cement), 
and air dried, spatter coated with gold particles in an atmosphere of argon 
(polaron), and an SEM coater unit (E5000M, BIO-RAD, Polaron Division). All 
specimens were examined using a Jeol 1200 EX TEM-SCAN, at 60 KV gun 
potential. Electron micrographs were made on Kodak 35 mm roll films. Prints 
were made as above.
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2.11 PHOTOGRAPHY
Growing cell cultures were photographed under phase contrast on 
Ektachrome 160 ISO tungston film. Fixed cultures were photographed using a 
Polyvar microscope [Reichart] with a 35 mm camera attachment on Ektachrome 
35 mm ASA 160 film.
2.12 STATISTICAL METHODS
In experiments where the structure was simple (i.e there was no blocking 
factor such as varying times of analysis) non-parametric tests were used. For 
multiple group comparisons the Kruskal-Wallis test was adopted. A level of 
P<0.05 was considered significant. In the event of significance, two group 
comparisons were carried out using the Mann-Whitney U-test and the Bonferoni 
adjustment. Differences were considered significant at P < 0.05/n, where n = 
number of pairwise comparisons. If the Kruskal-Wallis test indicated a difference 
but none was evident using the Bonferoni adjustment, then the root significant 
pairwise comparison was used.
In experiments with more complex structure, analysis of variance was 
applied. Where appropriate, data were transformed before analyses. Two group 
comparison were carried out using the two independent sample t-test. The 
Bonferoni method of multiple comparison was again applied. Significant levels 
were as above. Computations were undertaken using a statistical package (Systat 
version 4.0).
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CHAPTER THREE 
(A)
ESTABLISHMENT AND CHARACTERIZATION OF A MODEL FOR 
THE STUDY OF SPONTANEOUS PHENOTYPIC TRANSITIONS IN 
HUMAN SMALL CELL LUNG CARCINOMA.
This chapter deals with the origin, heterogeneity, and interrelationship of lung 
cancers. A SCLC cell line and two NSCLC-like derivative cell lines were used to 
analyze phenotypic characteristics relevant to the transition from SCLC to NSCLC. 
The data suggest a common origin for both types of lung cancer.
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3A.1 INTRODUCTION
SCLC is a clinicopathological distinct entity of pulmonary carcinoma, 
characterised by more rapid tumour cell proliferation [Straus, 1974], early metastatic 
potential [Matthews et al., 1973], and greater response to both chemotherapy and 
radiation therapy [Cohen, 1975]. It also has characteristic morphological [Cohen & 
Matthews, 1978], biochemical [Baylin et al., 1980], ultrastructural [Hattori et al., 
1972], and cytogenetic [Whang-Peng et al., 1982] markers. Although this apparent 
distinction suggests a separate histogenesis of SCLC, a significant number of SCLC 
cases appear to be admixed with or convert to other histological types of lung cancer 
during the course of disease [Gazdar et al., 1981; Minna et al., 1982;].
Heterogeneity in lung cancer particularly in SCLC is well recognised. The 
classic histological description of SCLC by Azzopardi [1959] identified tubular 
structures, squamous nests, rosette formation, giant cells, and mucin secretion. The 
presence of foci of squamous carcinoma or adenocarcinoma in SCLC are well 
recognised entities by the WHO classification of lung cancer [1982]. Patients 
presenting with mixed histology have a significantly worse prognosis, compared to 
pure SCLC [Radice et al., 1982]. Histological changes in SCLC are frequently 
observed after drug treatment. In a clinical study of patients diagnosed as SCLC on 
biopsy material, Abeloff et al. [1979] showed that at postmortem 12% had non­
small cell and 15% had mixed small cell-large cell histology. Minna et al. [1981] 
have shown that approximately 35% patients who died of SCLC show mixed 
histology at postmortem, and these patients are less responsive to chemotherapy. 
Goodwin & Baylin, [1982] have shown that the transition from small cell to non­
small cell phenotype is associated with resistance to radiation therapy.
SCLC derived cell lines sometimes show a similar transition in vitro [Gazdar 
et a l, 1981; Goodwin & Baylin, 1982; Bepler et al., 1987] and in SCLC xenografts 
in athymic nude mice [Goodwin et al., 1983]. This phenotypic conversion in SCLC 
in vitro is accompanied by a change to NSCLC-like morphology and loss or reduction 
of neuroendocrine cell markers. SCLC cell lines with NSCLC-like properties have 
been classified by some investigators as variant cell lines [Carney et al., 1985; Gazdar 
et a l, 1985]. There is also clear evidence that some of the neuroendocrine and 
cytogenetic markers are also expressed by NSCLC. Significant levels of L-dopa 
decarboxylase activity have been detected in other types of lung cancer [Baylin et al.,
12
1980; Gazdar et al., 1988], bombesin-like immunoreactivity has been found in about 
17% of NSCLC [Yamaguchi et al., 1983], and 3p deletion, a lesion previously 
thought to be SCLC specific, is now also found in about 25% of NSCLC [Brauch et 
al., 1987]. Immunohistochemical studies utilizing specific monoclonal antibodies 
have shown that most of the antigens are expressed by all types of lung cancer. 
Waibel et al. [1987] have shown that common antigens are expressed by SCLC and 
other lung cancer type (e.g. LAM-2). MOC-1 a monoclonal antibody raised against 
a human SCLC cell line was found to react with all major histological types of lung 
cancer including SCLC, adenocarcinoma, and in mixed adeno-squamous tumours [de 
Leij et al., 1985]. Others [Olsson et al., 1984] have shown phenotypic heterogeneity 
in clones of human lung cancer cell lines.
The origin of SCLC is uncertain. Initially it was considered to be an 
undifferentiated tumour associated with a variety of paraneoplastic syndromes caused 
by ectopic hormone secretion. Later on in late 1960s, recognition of neurosecretory 
granules in these tumours [Bensch et al., 1968; Hattori et al., 1968] led to a new 
concept that different forms of lung cancer originate from different specialised 
normal cells, and according to this hypothesis SCLC was thought to arise from the 
normal neuroendocrine or APUD (Kulchitski) cells of the lung [Bonikos & Bensch, 
1977], which were originally supposed to be neural crest origin [Pearse & Takor, 
1979]. However, more recent observations (above paragraph) have led to the 
common stem cell theory of lung carcinoma histogenesis [Gazdar et al., 1981]. 
According to this theory all lung cells arise from a common stem cell of endodermal 
origin and different histological tumour types represent different routes of malignant 
differentiation regulated by the nature of the genetic lesion(s) and the effects of 
cellular microenvironment.
Although these phenotypic conversions in lung cancer may have significant 
implications for prognosis and response to therapy of lung cancer, the mechanism 
of phenotypic changes in SCLC is as yet unknown. This is in part due to lack of 
readily available material for the study of sequential changes in the development of 
tumours in natural host, and also due to the fact that relevant in vitro models have 
not been developed. The present study is an attempt to develop an in vitro model 
for the study of phenotypic transition in SCLC in vivo. A classic SCLC cell line 
(H69) and its two derivative cell lines (H69V & H69VZ) have been used as a 
model, because of the potential relevance to clinical progression of lung cancer. The
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parental cell line was originally established from a pleural effusion of a patient with 
relapsed SCLC [Gazdar et al., 1980], and characterised as a classic SCLC cell line 
with typical morphological and biochemical profiles [Carney et al, 1985; Gazdar et 
al, 1985]. However, drug resistant variant cells have been reported in this cell line 
[Twentyman et al., 1986; Mirski et al., 1987]. Heterogeneity in culture morphology 
of the cell line is often found with some cell sticking to the substrate having 
epithelioid morphology, while the bulk of cells grew in suspension. Characterization 
of these phenotypic shifts from SCLC cells (H69) to NSCLC-like cells (H69V & 
H69VZ) in vitro probably will better reflect the clinical behaviour of lung cancer 
progression.
Specific objectives were: 1). To exclude cross-contamination and confirm a 
common origin of the parental and the derivative line, by cytogenetic analysis, 
isoenzyme studies, study of H69 clones, antigenic marker expression, and 
ultrastructural features. 2). Characterization of the derivative cell lines, and 
comparison with SCLC (parental) and NSCLC cell lines, for growth, morphology, 
NE-cell marker expression, invasion, metastasis both in vitro and in vivo, and for 
response to chemotherapy, radiotherapy and oncogene expression.
3A.2 MATERIALS AND METHODS
3A2.1 Cell Lines
Cell lines used in this Chapter belonged to three groups [Table 3A.1]: (1) the 
SCLC cell line NCI-H69; (2) derivative cell lines of the SCLC cell line; (3) and 
NSCLC cell lines. The SCLC cell line H69 was originally derived from a male 
patient who had previously received multidrug therapy including adriamycin. It was 
obtained at passage number 33, from Dr Desmond Carney, NCI, Bethesda, Md. It 
grew in suspension, forming tight cellular aggregates. The cell stocks were stored 
frozen, and all experimental work on this line was conducted between passage 33- 
45 in culture. Two adherent sublines (H69V and H69VZ) were derived from H69 
cell line in culture (see below). Two NSCLC cell lines (WIL and A549) were also 
included for comparison. The WIL cell line obtained from ICR, Sutton, was derived 
from an adenocarcinoma of lung, and grew as monolayer of epithelioid cells (see 
Chapter 5). Cell line A549 derived originally from human pulmonary 
adenocarcinoma [Giard et al, 1972] grew as monolayer.
74
Table 3A.1:- Cell lines.
Cell line Source Tissue of origin
'NCI-H69 NCI Bethesda Human SCLC
2MOG-H69V Med. Oncol. Glasgow NCI-H69
2MOG-H69VZ Med. Oncol. Glasgow NCI-H69
3w il Haddow Labs. Sutton Human lung adenoca.
4A549 ATTC, Maryland Human alveolar cell 
carcinoma
1 Carney et al., [1985]. 2 Khan et al., [1990]. 3 Unpublished. 4 Giard et al., 
[1972].
3A2.2 Cytotoxic Drugs
Adriamycin [Farmitalia], and vincristine [Sigma] were used in this study. 
Stock solutions of the drugs in distilled water were stored frozen at -20 °C. Drugs 
were diluted in complete culture medium before use. For longer duration of 
treatment fresh drug was used after every 24 hours.
3A2.3 Isolation of Adherent Sublines of H69
The parental cell line H69 was grown in 175 cm2 flasks (Falcon) for 3 weeks, 
by which time cells had formed large sized aggregates which settled down on to the 
substrate. Subsequently, cells from the aggregate grew out as adherent cells. Once 
the monolayer was formed, cells in suspension were removed, and the adherent cells 
were washed, and re-incubated to form a complete monolayer, which was then 
trypsinized and subcultured at 105 cell/ml in 75 cm2 flasks. Cultures were passaged 
weekly, and mass cultures were derived after 8-10 passages for frozen stock. Two 
adherent lines (H69V and H69VZ) have been derived from the parental cell line 
H69 by this technique at different occasions.
3A.2.4 Isolation and Expansion of H69 Clones
A single cell suspension was cloned in agar. Growing colonies were isolated, 
dispersed mechanically, and plated in 24-well plates containing 2 ml RPMI1640 
containing 10% FBS. These cells were expanded in culture, stored and used to get 
mass cultures for isolation of monolayer cells.
3A.2.5 Radiation Sensitivity Assay
Cell cultures were prepared in 96 well plates, as for the MTT assay. 
Exponentially growing cultures were irradiated using a Mobaltran Cobalt-60 gamma 
unit, operating at a dose rate of 140 cGy per minute, at room temperature, and with 
a source-axis distance of 80 cm, using full built-up and backscatter. Following 
radiation cells were fed with fresh medium, for at least three cell doublings.
3A^.6 Other Methods
The details of primary antibodies used in immunohistochemical methods are 
shown in Table 3A.2. Other methods employed in this Chapter have been described 
in General Methods.
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3A.3 RESULTS
3A.3.1 Establishment of Model
The H69 cell line consists of an apparently homogeneous cell population 
[see below, Plate 3A.4]. However, in a dense culture, a few cells adhere to the 
substrate and grow out to form monolayer [Plate 3A.1]. Two adherent sublines 
(H69V and H69VZ) have been isolated from the H69 cell line.
3A.3.2 Confirmation of The Origin of Cell Lines
LDH isoenzymes and chromosome analyses confirmed the human origin of 
the cell lines. Both the parental and the sublines showed human specific lactate 
dehydrogenase isoenzyme profiles [Plate 3A.2; Figure 3A.1]. The cell lines were 
aneuploid and heteroploid with similar modal chromosome numbers as shown in 
Figure [3A.2].
Karyotypic analysis of derivative lines carried out by Dr Stephen Merry in 
association with the Dept of Medical Genetics Yorkhill Hospital and Dr Jeffery 
Trent showed that the H69V cell line did in fact contain many of the identifiable 
markers which had previously been found in H69, including IP deletion, a marker 
involving 10P, and llq , and a translocation 9:19 [Plate 3A.3].
3A.3.3 Lineage Identification
Various markers including cytokeratin (CAM5.2) expression, ultrastructural 
features such as desmosomes, and intermediate filaments, and an epithelial 
morphology in monolayer culture were consistent with an epithelial origin of both 
parental and the derivative cell lines (see below).
3A.3.4 Morphological Characterization In Vitro 
Culture Morphology
The parental line grew as tightly packed floating cellular aggregates, spherical 
as well as irregular in outline, amorphous, and without central necrosis [Plate 3A.4a]. 
Individual cells appeared small and rounded, with clear cytoplasm, and small nuclei. 
The sublines grew as a monolayer of multipolar epithelioid cells, with a clear 
amorphous cellular outline. Individual cells appeared larger in size, with large 
clearer cytoplasm and a small granular nuclear zone with indistinct outline and small
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Plate 3A.1 .-Derivation of adherent cells from NCI-H69 non-adherent cell line.
H69 cells after 4 weeks in culture, showing large sized aggregates, both rounded 
(above) and irregular (below) shaped, attached to the bottom of the flask. Adherent 
cells are seen growing out from the H69 aggregate, forming a monolayer of cells, 
different from the parental line (X 20 objective, phase-contrast, bar=  100 /an).
Plate 3A.2Electrophoretic fractionation of lactate dehydrogenase isoenzyme profile 
from the cell lines of different species.
All human cell lines (H69, H69VZ, WIL, EWLU) show five distinct lactate 
dehydrogenase (LDH) isoenzyme bands corresponding to the human standard (S) 
Mink (Mvl, M l, N l) and mouse (STO) cell lines show LDH isoenzyme bands at 
different levels, compared either to the standard or the human cell lines. Numbers 
1-5 refer to the LDH isoenzyme bands present in the human LDH standard. Arrow 
indicates the site of sample application. All samples were electrophoresed and 
stained as outlined in General Methods.
Figure 3A. Is- Electrophoretic scan of the lactate dehydrogenase isoenzymes.
The scan shows the typical pattern of five human LDH isoenzymes with total LDH 
activity within normal range. [Sigma].
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Figure 3A.2:- Histiogram showing distribution of chromosomes in H69, H69Y, and 
H69VZ cell lines.
Exponentially growing cells were incubated with colcemid for 4 hours, exposed to 
hypotonic solution for 30 min, and metaphases collected, fixed and spread on slides 
by drop technique. Air dried, Giemsa stained preparations were examined under oil 
immersion lens x 100. Chromosome number was determined from at least 20 
spread. All cell lines are aneuploid with chromosome number ranging from 35 to 
70.
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Plate 3A.3:- Karyotype of H69V cell with 60 chromosomes.
G-banded karyotype of H69V cells showing lp  deletion, a marker involving 
lOp and l lq , a translocation 9:19, and other lesions, found in SCLC [from Dr 
Stephen Merry].
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Plate 3A.4:- Culture morphology of H69, H69V, and H69VZ cell lines.
(a) Morphology of H69 cells growing in RPMI 1640 medium as free floating cellular 
aggregates with amorphous outline, and showing two types of aggregates; aggregates 
with an irregular outline and others having rounded appearance.
(b) H69V cells derived from H69 cells, grow as monolayer of epithelioid and 
spindle-shaped cells.
(c) H69VZ cells derived from H69 cells, grow as monolayer of spindle-shaped 
epithelioid cells similar to (b).
(x 10 objective, phase-contrast, bar=  200 /im) .
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nucleoli [Plate 3A.4 b & c]. These features were distinct from the NSCLC cell line 
WIL [see below, Plate 5.1 a], which had a pavement-like appearance.
Cytological Features
The parental cell line, H69, showed small rounded cells, with deeply staining 
nuclei, granular chromatin, nuclear moulding, clearer and scanty cytoplasm [Plate 
3A.5 a]. The NSCLC cell line, WIL, showed large cells with abundant cytoplasm 
[Plate 3A.5 b]. The sublines, H69V & H69VZ, showed large cells with moderate 
amount of palely staining cytoplasm, inconspicuous nucleoli and perinuclear clearing 
[Plate 3A.5 c & d].
3A.3.5 GROWTH CHARACTERIZATION IN VITRO 
Growth rate
The parental cell line grew slowly, with a population doubling time of around 
2 days [Table 3A.3], and a lag period of around 2 days [Figure 3A.3]. The 
population doubling times decreased in both sublines, to 34 hours. Both the 
derivative lines reached plateau after approximately 10-12 days, when plated at initial 
cell concentration of lxlO4 cells/well, in 24 well plates, however H69 cells with initial 
seeding concentration of lxlO5 cells/well did not reach plateau. The growth of 
adherent cells was faster than the parental line.
Plating Efficiency in Monolayer
The plating efficiencies (PE) of both derivative lines in monolayer culture 
were not significantly different, but lower than the NSCLC line WIL [Table 3A.3]. 
Both the derivative lines had similar values.
Colony Forming Efficiency in Soft Agar
Table 3A.3 shows the mean cloning efficiencies (CE) of the cell lines in 
suspension. These were significantly higher in NSCLC cell lines, than in the SCLC 
line and intermediate in both sublines. The CE of both sublines were approximately 
the same and both NSCLC lines had similar values. The H69 cell line formed 
diffuse colonies with irregular margins.
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Plate 3A.5:- Cytological characteristics of the cell lines.
(a) SCLC cell line, H69, shows small rounded cells, with clearer and 
scanty cytoplasm, deeply staining nuclei, granular chromatin, and one or two 
darkly staining nucleoli. Acetone fixation, Papanicolaou stain, X 900.
(b) NSCLC cell line, WIL, showing larger cells with polygonal outline, 
abundant cytoplasm, granular chromatin, and inconspicuous nucleoli. 
Acetone fixation, Papanicolaou stain, X 900.
(c) H69 derivative cell line, H69V, shows larger cells with abundant 
amount of palely staining cytoplasm, evenly distributed granular chromatin, 
perinuclear clearing, and inconspicuous nucleoli. Acetone fixation, 
Papanicolaou stain, X 900.
(d) H69 derivative cell line, H69VZ, shows features very similar to the 
H69V cell line (c). Both the derivative lines show cytological features similar 
to the NSCLC cell line, WIL. Acetone fixation, Papanicolaou stain, X 900.
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Figure 3A.3:- Growth curves of H69 and its derivative cell lines in vitro.
A semi-logarithmic plot for the cell lines, grown in 24-well plates. Cultures for the 
parental cells were set up at lxlO5 cells/cm2, while for the derivative lines were at 
lxlO4 cells /cm 2, on day 0. The cells were fed on alternate days during the first 5 
days, and daily thereafter. Cells from at least three replicate wells were trypsinised 
and counted daily. Each point represents the mean ± SEM (b a rs )  .
Table 3A.3:- In v itro  growth characteristics of cell  
l in e s .
Cell  l i n e Doubling t im e  
( h o u r s )
Cloning E f f i c i e n c y  (%) 
Monolayer Suspens ion
H69 55 .0 NA 7.5
H69V 3 4 .0 21 .5
4»
14.0
H69VZ 34 .5 22 .5 *14.5
WIL 35 .5 45 .5 *24.5
A549 34 .5 36 .5 *25.5
P l a t i n g  e f f i c i e n c y  (PE) was de te rm ined  by monolayer 
c l o n i n g .  C e l l s  (500)  were seeded in  50 mm p e t r i  d ish  
and i n  5 ml c u l t u r e  medium. Co lon ies  were f i x e d  a f t e r  
3 weeks .  C lon ing  e f f i c i e n c y  (CA) was de te rm ined  by 
p l a t i n g  104 c e l l s  p e r  ml 0.3% a g a r ,  ove r  1% agar  
u n d e r l a y e r .  Data  a r e  mean o f  a t  l e a s t  two s e p a r a t e  
e x p e r i m e n t s .  NA: n o n - a d h e r e n t .  The c lo n i n g  
e f f i c i e n c i e s  o f  bo th  t h e  d e r i v a t i v e  and NSCLC c e l l  
l i n e s  were s i g n i f i c a n t l y  h i g h e r  th a n  t h e  H69.
*P<0.001 ( a n a l y s i s  o f  v a r i a n c e ,  and Bonferoni 
a d j u s t m e n t ) .
Colony Morphology
The H69 cell line formed diffuse, asymmetrical, colonies with irregular 
margins, and bizarre morphology. Both derivative and NSCLC lines formed more 
spherical colonies of regular size.
Isolation and Expansion of H69 clones
Preliminary experiments showed that H69 clones can give rise to a 
heterogeneous cell population in culture, as found in the parental line. Clones were 
grown in 0.3% agar in RPMI 1640 medium with 10% FBS. After 6 weeks colonies 
were transferred to 24 well plates, and fed regularly. After another 3-4 weeks period 
cells were transferred to flasks and allowed to grow to confluence, which was 
reached in further 4-5 weeks. Adherent cells appeared in the confluent cultures of 
H69 clones, with morphology similar to H69V and H69VZ.
Growth Media and Serum Requirements
All cell lines showed growth in serum free conditions for up to 2 weeks. 
However, after this, cultures deteriorated with partial necrosis which was not 
complete by 4 weeks.
3A.3.6 NEUROENDOCRINE MARKER EXPRESSION 
Biochemical Analysis
Dopa decarboxylase (DDC) activity was measured during the late log phase 
of the cell growth cycle, where the activity has been shown to be steady [Murray, 
1989]. The numerical data are shown in Table 3A.4. The DDC levels were 
approximately 7-fold lower in both derivative lines, than in the parental line. The 
NSCLC lines were 10-fold lower than H69. There was no significant difference 
between H69V and H69VZ.
For CK analysis all experiments were carried out during late log phase of 
growth. The creatine kinase BB isoenzyme (CKBB) was the predominant form, and 
H69 cells were found to express the highest CKBB activity among all the lines 
investigated [Figure 3A.4, Table 3A.5]. The activity of the enzyme was below the 
level of detection both in NSCLC cell lines and in the derivative lines.
The BLI levels were significantly higher in the parental line compared to both 
the derivative lines and the NSCLC cell lines [Table 3A.6]. The activity was similar
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Table 3A.4:- Expression of L-DOPA Decarboxylase (DDC) 
a ct iv ity  in H69, i t s  derivative ce ll  l ines  H69V & 
H69VZ, and 2 NSCLC cell  l in es .
Cell  l i n e 1DDC a c t i v i t y  
[uIU/mg p r o t e i n ]
p .
c D i f f e r e n c e  
(%)
NCI-H69 2853 + 335 
(n=9)
100
H69V 4 0 8 + 1 1 5
(n=6)
14
H69VZ 333 + 61 
(n=6)
*12
WIL 276 + 68 
(n=6)
*10
A549 203 + 121 
(n=6)
*7
d h e  DDC a c t i v i t y  i s  e x p re s s e d  as  micro i n t e r n a t i o n a l  
u n i t s  (uIU) p e r  mg c e l l u l a r  p r o t e i n .  Where 1 ulll i s  
e q u i v a l e n t  t o  one u mole o f  p ro d u c t  formed pe r  m in u te .
d i f f e r e n c e  i n  p e r c e n t a g e  from c l a s s i c  SCLC c e l l  l i n e
mpt ucn + . 1™  oc 1 nn°/ na+a ppq mean + SEM o f  t h e  N C I-H 69 , . t a ke n  as ,100/o.  Data - -l qnumber ^ iv e n  i n  t h e  p a r e n t h e s e s ,  from air l e a s t  2
i n d e p e n d e n t  e x p e r i m e n t s .
*p<0.0001 ( a n a l y s i s  o f  v a r i a n c e ,  and Bonferoni  
a d j u s t m e n t )
■BBM M MB
b.
Figure 3A.4:- Electrophoretic scan of the human creatine kinase isoenzymes activity.
(a). The scan shows the result of electrophoretic separation of the three creatine 
kinase isoenzymes in the standard; the first peak represents the MM isoenzyme 
which is the slowest of all, followed by MB isoenzyme which is intermediate, and 
lastly the BB isoenzyme is fastest migrating fraction, (b). The human SCLC cell 
line NCI-H69 shows a significant increase in BB isoenzyme (arrows).
Table 3A.5:- Creatine kinase brain isoenzyme (CKBB) activ ity  of
the ce ll  l in e s .
Cell l i n e ^CKBB a c t i v i t y  Isoenzymes [%)  
[Il l/mg p r o t e i n ]  BB MM MB
NCI-H69 3 .0  + 0 .3 95 .2  + 0 .9 4 .9  + 1 .0 0
H69V 0 0 0 0
H69VZ 0 0 0 0
WIL 0 0 0 0
A549 0 0 0 0
1The CKBB a c t i v i t y  i s  e x p r e s s e d  as  i n t e r n a t i o n a l  u n i t s  (III) pe r  
mg c e l l u l a r  p r o t e i n .  Where 1 III i s  e q u i v a l e n t  t o  one umole o f  
NADH produced  p e r  m in u t e .  Data a r e  mean _+ SEM from 3 s e p a r a t e  
e x p e r i m e n t s .
Table 3A.6:- Expression of bombesin-like immunoreactivity (BLI) in
cell l in e s .
Cell l i n e BLI R e l a t i  ve Value
[pg/mg p r o t e i n ] (X)
C e l l u l a r S e c r e t e d Cel 1u l a r S e c r e t e d
NCI-H69 0 .4 8 0 + 0 .040 0.672  + 0.080 100 100
H69V 0 .0 3 7 + 0 .003 0.091 + 0 .0 .0 3 0 ★8 *13
H69VZ 0.036 + 0 .0 07 0.079  + 0.027 *7 *12
WIL 0 .006 +_ 0.001 0.001 _+ 0.000 *1 *0.1
A549 0 0 0 0
Data a r e  mean + SEM o f  a t  l e a s t  6 va lu e s  from a t  l e a s t  two indepe nde n t  
d e t e r m i n a t i o n s - r  The s e c r e t e d  a c i v i t y  was de te rmined  in  t h e  c o n d i t i o n e d  
medium f o l l o w i n g  48 hou r s  i n c u b a t i o n  w i th  t e s t  c e l l s .
*P<0.0001 ( a n a l y s i s  o f  v a r i a n c e ,  with Bonferoni  a d j u s t m e n t ) .
in both the derivative lines, with the secreted levels slightly higher than the cellular. 
The activity was very low in WIL, while there was no detectable activity in the A549 
cell line.
The H69 cell line expressed the highest levels of NSE activity [Table 3A.7], 
ranging from 689 to 818 ng/mg protein. The activity was significantly lower in the 
derivative lines, with an approximately 14-fold difference from the parental line. 
NSE expression in WIL was significantly lower, with a difference of approximately 
30-fold from H69, but only 2-fold from sublines of H69. The secreted NSE level in 
H69 was approximately 8-fold lower than the cellular level. The secreted fraction 
was collected after 48 hours cellular incubation. The overall secreted activity of the 
sublines was in the same range as the parental line, but there was no significant 
difference in the secreted and cellular enzyme activity between the sublines.
Immunohistochemistry
H69 cells showed intense granular positivity for BLI in over 70% of cells 
[Plate 3A.6 a] compared to the derivative lines which showed only occasional 
positive cells. There was no positive staining of NSCLC cell lines.
The H69 cells stained 80% positive with intense and uniform staining for NSE 
[Plate 3A.6 b]. Both the derivative lines stained only focally, while there was no 
specific staining in NSCLC lines.
Chromogranin staining was only focal with approximately 25% cells showing 
positive staining. This pattern was seen in parental line as well as in sublines. 
Staining was always more focal in derivative lines. There was no staining of NSCLC 
cell lines.
3A.3.7 Invasion Studies In Vitro
When the test cells (H69, H69V & H69VZ) were confronted with embryonic 
chick heart fragments, attachment between test cells and the heart fragment was 
observed in all the cell lines within 24 hours. However, there was no evidence of 
invasion, and cells were found at the periphery of the heart fragment [Plate 3A.7 a, 
Tl]. The parental cells had invaded the heart fragment by day 2, singly and at 
different sites. Invading cells could be observed in the centre of the fragment, in 
haematoxylin and eosin stained sections by day 4 [Plate 3A.7 a, T4]. A progressive 
growth and replacement of the heart fragment by the invading cells was observed by
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Plate 3A.6:- Immunostaining of the H69 cells for neuroendocrine 
markers.
(a) H 69 cells, stained for bombesin-like immunoreactivity, by the
indirect alkaline phosphatase method. The majority of cells are 
immunopositive (x 247, indirect AP).
(b) H69 cells, stained for NSE by PAP method. Most cells are
immunopositive (x 247, PAP).
(c) Control H69 cells, stained as (b) except that the primary 
antibody (anti-NSE) was replaced by preabsorbed normal rabbit 
serum, show no staining.
t-Wr'
Plate 3A.7:-ju vitro invasion assay.
(a). IK,y cells co-cultured with chick heart show invasion within 48 hours. Tumour 
cells (short arrows) are identified in the centre of the heart fragment (long arrows), 
by haematoxylin & eosin (HE) staining, and confirmed by immunoperoxid 
staining using anti-neuron specific enolase (A NSE), and anti chick ( 
antibodies. Samples at day 1 (Tl), 4 (T4), and 7 (TV), after co-culture are shown
(X 250, H&E and IP).
A Ch
(b). As (a) except that the H69V cells are identified by H&E and anti-chick (A 
Ch) antibody, at day 2 (T2), 4 (T4) and 7 (T7). The cells (arrows) grow outside the 
heart fragment, using it as substrate, but invasion of individual cells is not identified.
H E  A Ch
(c). As (a) except that the H69VZ cells are stained with H&E and anti-chick 
antibody, at day 1 (T l), 2 (T2), 4 (T4), and 7 (T7) after co-culture. The tumour 
cells (arrows) grow around the heart fragment as H69V cells, and single cell invasion 
is not identified.
day 7 [Plate 3A.7 a, T7]. Invasion was confirmed by both tumour cell specific 
antibody (anti-NSE), and anti-chick antibody. Cells did not completely replace the 
heart fragment by day 10. Tumour cell proliferation was only moderate inside the 
fragment.
H69V cells co-cultured with chick heart showed greater proliferation than 
H69 and engulfed the heart fragment with progressive destruction and replacement 
of heart tissue [Plate 3A.7 b]. In contrast to the parental line, single cell invasion 
was not found. H69VZ showed a similar growth pattern around the heart fragment 
to H69V [Plate 3A.7 c]. It appeared as if both the derivative lines used the heart 
fragment as a substrate; attached to it they grew fast, with consequent degradation 
of the confronting normal heart tissue.
3A.3.8 Effects of Stromal Interaction
H69 cells grown with fetal lung fibroblasts (EWLU) in a 50:50 ratio, showed 
formation of small colonies, both floating and attached, to the fibroblast layer. Cells 
could be seen growing out as a monolayer from the H69 colony and running parallel 
to the fibroblasts [Plate 3A.8].
3A.3.9 GROWTH STUDIES IN VIVO 
Tumorigenicity
The parental, as well as its derivative lines, produced tumours in nude mice 
with 100% take rate [Table 3A.8]. The growth curves of tumours are shown in 
Figure 3A.5. The parental lines grew moderately after a latent period of 
approximately three weeks, with a doubling time of around 4 days. Tumours 
reached a volume of 2 cm3 in 3 weeks. Derivative lines yielded exponentially 
growing tumours with a shorter latency period, and reached maximum size in a 
shorter time than the tumours produced by the parental line.
Morphological Features of Xenografts
Grossly, the parental tumour appeared as a small nodule, at the site of 
inoculation, and grew slowly with well defined edges, a smooth surface and 
prominent vasculature. There was no ulceration. The tumour was attached firmly 
to the surrounding host tissues, and was firm in consistency. On the cut surface 
there was no evidence of necrotic tissue. The tumour showed evidence of gross
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Plate 3A.8:-Effect of stromal interaction on the morphology of H69 cells.
H69 cells grown in 50:50 ratio with EW LU cells in 25 cm2 flasks, at 10 
cell/ml concentration, in RPMI1640 medium, at day 10 after subculture. The 
cells form small sized aggregates, firmly attached on top of the fibroblast 
layer. Cells can also be seen growing out from aggregates, apparently mixing 
with the fibroblasts (x 10 objective, phase-contrast, bar=  200 i/m).
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Figure 3A.5:- Growth curves of xenografts derived from H69 and its derivative lines 
in nude mice.
Each mouse received a s.c innoculation of lxlO7 cells in 0.5 ml PBS on day 0. Each
line represents tumour growth in an individual mouse.
infiltration into the surrounding tissues. Microscopically, the tumour was anaplastic 
[Plate 3A.9 a], with a high incidence of abnormal mitotic and apoptotic figures 
[Table 3A.9].
Tumours produced by the derivative lines appeared as small nodules at the 
site of inoculation, with a shorter latency period. Growth was gradual, and tumours 
showed circumscribed margins. They were not firmly attached to the surrounding 
host tissues. There was no ulceration, and vasculature was not as prominent as in 
the parental tumour. Tumours appeared as isolated nodules during dissection, and 
the cut surface did not show gross evidence of necrosis. Microscopically, tumours 
of both H69V and H69VZ [Plate 3A.9 b] were poorly differentiated, pleomorphic, 
and showed moderate numbers of mitotic and apoptotic bodies. Tumours also 
showed focal areas of large spindle shaped cells, and spaces filled with amorphous 
eosinophilic material that stained positive with PAS/alcian blue [Plate 3A.10]. These 
features were not found in the tumours of the parental cell line. These findings 
were confirmed by more than one pathologist, independantly in blind fashion.
3A.3.10 Invasion and Metastasis in Vivo
The parental cell line produced invasive tumours. Local tumour cell 
infiltration was found in skin and its appendages, subcutaneous fat, and deep into 
muscles [Plate 3A.11], Both the derivative lines showed no evidence of invasion into 
deep structures, although, occasional fat infiltration was found.
Metastases were found in lungs [Plate 3A. 12 a] and in liver [Plate 3A. 12 b] 
of all the animals, bearing H69 tumour. Metastases were not found either in lungs 
or livers of animals with tumours produced by the derivative lines.
3A.3.11 Ultrastructural Studies
While the parental line showed clusters of dense core granules of 
approximately the same size, in the cell cytoplasm [Plate 3A.13 a], they were absent 
from both the derivative lines [Plate 3A. 13 b] and the NSCLC cell line [see below, 
Plate 4.4]. Other ultrastructural features such as desmosomes, intermediate 
filaments, tonofilaments, were also found in all the cell lines, which were consistent 
with their epithelial origin.
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Plate 3A.9:-Histology of xenografts.
(a). H69, showing pleomorphic, anaplastic tumour with abundant 1™t°  
apoptotic (A) figures (X  247, H & E). (b). H69VZ, showing poorly differentia 
tumour, with a m ore spindle cell morphology than H69. There is ceUular and 
nuclear pleomorphism, bu t fewer mitoses and apoptotic figures (X 247,
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Plate 3A.10:- Demonstration of mucin in H69VZ tumours.
Tumour derived from H 69VZ cells shows positivity for both acid (blue) and neutral 
(pink) mucins. Staining is seen in spaces between cells (long arrows) an 
individual cells (short arrows) (x 280, PAS-diastase/Alcian blue)
Plate 3A.ll:-Local invasion in vivo by H69 tumour cells.
H69 xenografts showed local invasion of skin and its appendages (A), subcutaneous 
fat (F), and muscles (M), with evidence of tumour cell proliferation and destruction
of the invaded host tissues (X 247, H&E).
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Plate 3A. 12:-Metastases of H69 tumour. and liver (b).
Tumour derived from H69 cells shows metastases 
(X 247, H&E).
Plate 3A.13:- Electronmicrographs of the H69 and the H69YZ 
tumours.
(a) Clusters of dense core neurosecretory granules (long arrow) can 
be identified in the cytoplasm of the H69 cell. Cell-cell relationships 
and the presence of desmosomes (short arrows) are typical of 
epithelial differentiation (Uranyl acetate, and lead citrate stain; X 
24500).
(b) H69VZ cell line, showed no evidence of specific neurosecretory 
granules, as illustrated in these three adjacent cells. The cells showed 
features of epithelial differentiation as above (Uranyl acetate, and lead 
citrate stain; X 24500).
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3A.3.12 Xenograft Immunohistochemistry
Parental tumours stained positive for neuroendocrine markers, used in culture 
cell lines, however, the staining was not intense compared to culture cells. The 
derivative lines stained focally, as did their cells in culture (see above).
3A.3.13 Sensitivity to The Cytotoxic Drugs
The parental line showed approximately 4-fold higher IC50 values to 
adriamycin compared to its both derivative lines [Table 3A.10]. Both the derivative 
and NSCLC cell lines were more sensitive to the drug. The parental line showed 
around 3-fold lower IC ^  values for vincristine, compared to its sublines and NSCLC 
cell lines.
3A.3.14 Radiation Sensitivity
The parental cell line was significantly more sensitive (2-fold) compared to 
both its sublines [Figure 3A.6] and NSCLC cell lines [Table 3A.11].
3A.3.15 Mvc Oncogene Expression
The c-mvc expression was found in both H69 and the derivative cell lines and 
also the tumours produced by them, by immunohistochemical methods using 
monoclonal antibody 9E10. Staining was focal in parental line (5-10%), while the 
derivative lines showed more generalised and intense staining (25-30%), both 
cytoplasmic and nuclear [Plate 3A. 14].
3A.4 DISCUSSION
The objective of this study was to establish whether the parental cell line 
(SCLC) and its derivative cell lines could be a valid model for the phenotypic 
transition in SCLC, in vivo. These data have shown that while the parental line 
expressed features of a classic SCLC, both the derivative cell lines had features 
similar to NSCLC, suggesting this was a potentially interesting model of in vivo 
tumour progression.
There are a number of possibilities for the origin of adherent cells in the 
parental cell line: 1) Cross contamination. 2) Polyclonal carcinogenesis. 3)
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Table 3A.10:- Sen sit iv ity of the ce ll  lines  to
cytotoxic drugs •
Cell  l i n e Adriamycin V i n c r i s t i n e
i d 50 i—
i
a cn o
(X 10"8M) (X 10~1°M)
H69 * 1 4 .0  + 4 .0 1 .6  + 0 .7
H69V 1 .8  + 0 .3 5 .5  + 0.5
H69VZ 4 . 0  + 0 .8 3 .5  + 0.6
For  n o n - a d h e r e n t  c e l l s ,  10^ c e l l s  in  100 ill medium 
were p l a t e d  p e r  well  in  96 w e l l ,  round bot tom 
p l a t e s ,  w h i l e  5x108c e l l s  were p l a t e d  pe r  well  in  
200 ul medium f o r  a d h e r e n t  c e l l s .  Drug was added 
t o  n o n - a d h e r e n t  c e l l s  a f t e r  3 hours  i n c u b a t i o n  a t  
37 °C in  a volume o f  100 ul a t  2x f i n a l  
c o n c e n t r a t i o n .  In a d h e re n t  c u l t u r e s  drug was 
added a f t e r  24 hours  a t  f i n a l  c o n c e n t r a t i o n  in  
c u l t u r e  medium. C e l l s  were exposed t o  drug  f o r  48 
h o u r s ,  and f r e s h  drug was added a f t e r  24 h o u r s .  A 
r e c o v e r y  p e r i o d  o f  3 days was a l lowed  f o l l o w i n g  
drug  r e m o v a l .
R e s u l t s  a r e  Mean +_ SEM, from 4 e x p e r i m e n t s .
*P<0 .02 ,  **P<0.05 (Mann-Whitney t e s t ,  wi th
Bonferoni  a d j u s t m e n t ) .
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Figure 3A.6:- Radiation survival curves of the cell lines.
The cells were grown in 96 well plates. Exponentially growing cultures 
were exposed to increasing doses of radiation, and allowed to recover 
for at least three cell generations. Cell survival was determined by 
MTT assay. Results are from one experiment similar results were 
obtained in a second experiment. Each point represents mean ± SEM 
( b a r s ) .
Table 3A.11:- 
ce l l  l in e s .
Radiation sen sit iv ity  of the
Cell  l i n e i d 50
(cGy)
H69 96.3  + 2 .4
H69V *157.5 + 4 .8
H69VZ *198.8  + 4 .3
WIL *182.5 + 3 .3
C e l l s  were p l a t e d  as  in  drug s e n s i t i v i t y  
a s s a y s  ( s e e  above ,  Table  3 . 1 1 ) .  A r ec o v e r y  
p e r i o d  was a l low e d  f o r  t h e  e q u i v a l e n t  o f  2-3 
c e l l  d o u b l i n g s .  Data a r e  mean +_ SEM from two 
e x p e r i m e n t s .
*P<0.05 (Mann-Whitney t e s t ) .
Plate 3A.14:- The c-myc expression in H69VZ cell line.
Immunoperoxidase staining for c-myc protein product is present in 
many cells. While the majority show cytoplasmic staining, a few also 
show nuclear positivity (x 360, Avidin biotin method; 9E10 antibody 
(anti-c-myc protein).
Interconversion o f SCLC into NSCLC. 4) Existence of a pluripotent stem cell 
subpopulation in the parental cell line.
Since the parental cell line was established from a pleural effusion of a 
patient with SCLC, it could be argued that the line was contaminated with other 
cells such as those of mesothelial origin, during establishment of the line, or the 
established line could have been cross contaminated in the laboratory. It was 
possible to rule out accidental interspecies cross-contamination by LDH-isoenzyme 
and cytogenetic analysis. Both the parental and the derivative cell lines showed 
typical human specific LDH isoenzyme bands. The chromosome number showed 
that cell lines were aneuploid and heteroploid. The karyotypic analysis of derivative 
line (H69V) indicated that it was derived from H69 [personal communication, Dr 
Jeffery M. Trent, Arizona Cancer Centre, The University of Arizona via Dr Stephen 
Merry]. The presence of a Y chromosome in the derivative line H69V supported 
a common origin of both the parental and the derivative lines, since the parental cell 
line was established from a male patient [Carney et al., 1985].
H69 clones isolated and expanded to mass culture, showed the morphological 
heterogeneity found in the parental line suggesting the existence of a pluripotent 
stem cell subpopulation in the parental line, as shown by clonogenic assay (5-7% of 
total cell population). It was however not possible in the time to characterize these 
clones fully, or expand the adherent cell lines to examine whether they behaved like 
H69V and H69VZ. However, the preliminary observations indicated similar 
behaviour and therefore favoured a common origin of the parental and the 
derivative cell lines. In addition, all lines expressed cytokeratin intermediate 
filaments, and adhesion specialisations such as desmosomes, suggesting a link 
between parental and the derivative lines. From these data it can be concluded that 
both H69 and its derivative lines share a common origin, probably from a stem cell 
sub-population in the parental cell line. Further confirmation of a common origin 
of the lines could be carried out by fingerprinting, and isoenzyme analysis.
The presence of a heterogeneous stem cell population in established SCLC 
cell lines has been demonstrated by Olsson et al. [1984], with sublines varying in 
tumorigenicity in nude mice, colony forming efficiency, reactivity with monoclonal 
antibodies, and radiosensitivity. Others, however, did not find significant differences 
in these properties among sublines of established SCLC cell lines [Morstyn et al., 
1983; Gazdar et al., 1985]. In the present study characterization in vitro and in vivo
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of cell lines derived from a classic SCLC cell line has been described, with a view 
to establishing a model of phenotypic transition in SCLC, and its implications for in 
vivo tumour progression. The cell lines have been characterized morphologically, for 
growth characteristics, neuroendocrine marker expression, invasion and metastasis, 
clonogenicity in soft agar, tumorigenicity in nude mice, chemosensitivity and 
radiation sensitivity, and mvc oncogene expression.
Morphological differences between the parental and the derivative cell lines 
were apparent in living culture, cytology, and xenograft histology. Significant 
morphological differences have been found in culture between H69 and the 
derivative lines. While the parental line grew as densely packed free floating 
aggregates, the sublines grew as monolayers of epithelioid cells. Though not 
identical, morphologies of the derivative lines were similar to those of NSCLC cell 
lines. This morphological change was one of the most obvious differences between 
the parental and the derivative cell lines. As the culture conditions were identical, 
the differences must be intrinsic to the cells.
Altered cell surface configuration may lead to an altered interaction of cells 
with their microenvironment. Each cell is thought to have a particular combination 
of cell-surface molecules that enables it to bind in its own characteristic way to other 
cells and to the extracellular matrix. It is possible that H69 cells may have increased 
cell-cell adhesion molecules, while the derivative cells may have an increased 
number of extracellular matrix receptors e.g a decreased expression of N-CAM, and 
an increased expression of integrins. Gazdar et al. [1981] have shown a change in 
morphological appearance of cells from SCLC to large cell morphology. Similar 
changes have been found in SCLC cell lines in vitro by Goodwin and Baylin [1981]. 
The change in SCLC into large cell type was associated with an increase in growth 
rate and cloning efficiency. There was also an accompanying loss of some of the 
NE-cells properties, including L-dopa decarboxylase, and neurosecretary granules. 
In another study Goodwin and Baylin [1982] established a cell line OH-1 from a 
patient with SCLC. After 16 months in culture the cells changed into a large cell 
phenotype with loss of NSG, DDC, and emergence of radiation resistance, suggesting 
a link between loss of neuroendocrine markers, acquisition of a NSCLC type 
morphology, and the resistant phenotype as commonly found in clinical studies of 
SCLC. The phenomenon of transition from SCLC to other lung cancer types has 
also been observed by Watanabe et al. [1988]. They have established a cell line
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SCLC-MO, which expressed phenotypic features of transitional cell type, between a 
classic and variant, such as low levels of DDC, high levels of NSE and CKBB, and 
a classic SCLC morphology, and an intermediate cell type histology in xenograft. 
After 9 months in culture this cell line showed some adherent cells. A continuous 
monolayer was established from these adherent cells after about an additional 8 
months in culture, two sub-lines (MOA1, MOA2) were established from this 
monolayer with different antigenic properties. The MOA1 cell line was 
characteristic of variant SCLC, it lacked DDC but expressed NSE and CKBB, grew 
as a monolayer, with small cell type, and gave rise tumours with an intermediate cell 
type histology, while the MOA2 cell line expressed features characteristic of NSCLC 
as it expressed very low DDC activity, lacked NSE, CKBB, and grew as a monolayer 
with large cell type morphology, and formed tumours in nude mice with large cell 
type histology. The further characterisation of these lines for antigenic markers and 
chromosomal analysis confirmed the origin of clones from one parental cell type. 
Bepler et al. [1987] established two cell line (SCLC-H21, & SCLC-H22) from 
different metastatic sites of a patient with histopathologically proven SCLC of oat 
cell type. Following in vitro characterization of lines it was concluded that the cell 
lines showed a transition from pure SCLC to large cell phenotype, suggesting a link 
between SCLC and other lung cancer types.
The cytology of cytospin preparations of the cell lines in this study showed 
that both the derivative cell lines had large nuclei with evenly distributed granular 
chromatin, inconspicuous nucleoli, moderate amount of cytoplasm, and a lower 
nucleo-cytoplasmic ratio, features similar to NSCLC cells, while the parental line 
revealed small cell characteristics with scanty cytoplasm, and inconspicuous nucleoli. 
The tumours produced by both the derivative lines showed NSCLC type features e.g. 
mucin production, more spindle and large cell histology and lower mitotic figures. 
These features were absent from the parental tumour, suggesting a transformation 
from SCLC towards NSCLC morphology.
Morphological changes were also observed following co-culture of H69 with 
embryonic fibroblasts. The purpose was to investigate whether any change in H69 
cells could be induced by the stromal environment. It has been shown that stroma 
can exert its effects on tumour cells both by physical as well as by chemical 
interactions [Post & Smith, 1984]. Embryonic fibroblasts were used because of the 
potential relevance between tumour phenotype (undifferentiated or quasi-embryonic)
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and embryonic stroma. Secondly, although adult stroma may have some effects on 
the tumour cell phenotype and could have been worth pursuing, all tumours contain 
adult stroma which is apparently unable to control differentiation in the tumour. 
H69 cells co-cultured with fibroblasts showed a phenotypic shift, as they attained a 
more epithelioid and spindle morphology. It was not possible in the time, to take 
this work any further, however, it would be interesting to isolate the morphological 
variants following stromal interaction, to compare with H69V and H69VZ, and 
establish whether similar or different phenotypic changes are induced in H69 cells 
by the different microenvironment.
The growth of derivative cell lines in monolayer culture was fast compared 
to the parental line, with doubling times around 35 hours, similar to NSCLC lines. 
Similarly, lower serum requirements and higher cloning efficiencies of derivative 
lines and the NSCLC lines were in approximately the same range, compared to the 
parental line. While the growth of SCLC is rapid in patients compared to NSCLC, 
the reverse is true in culture. It is possible that this difference is due to alterations 
in expression or distribution of cell surface receptors. Adherent cells may have 
greater access to the medium compared to cells in tight aggregates, but it is also 
possible that a different type of autocrine control is expressed in the derivative lines 
such as an alteration in the production of autocrine growth factors; e.g a decrease 
in bombesin or an increase in TGF-ar or IGF-1. Furthermore with an altered 
surface morphology two cells may behave differently under similar growth conditions, 
where one cell can utilize a certain growth factor present in growth medium but 
another cell cannot due perhaps to the expression of, or access to, different 
receptors. Further investigations are required to analyze this difference, by looking 
at synthesis of growth factors and the expression and distribution of growth factor 
receptors.
The derivative lines expressed very low levels of NE-cell markers compared 
to the parental line. The DDC activity was 7-9 fold lower in the derivative lines 
while it was 10-14 fold lower in the NSCLC cell lines, compared to the H69 cell line. 
CK-BB activity was undetectable, in both derivative and NSCLC lines, while the 
parental line expressed high levels of enzyme. Previously it has been shown that 
morphological variants expressed CK-BB, though other features of APUD-cells were 
lost [Gazdar et al., 1985], but in present study the morphological changes were 
accompanied with gross reduction or loss of NE-cell markers, including total absence
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of CK-BB. This was a major difference in the present study compared to the 
previous observations. Continued expression of high levels of CK-BB after 
morphological change is the basis of classification of SCLC cell lines into classic and 
variant [Carney et al. 1985; Gazdar et al., 1985] indicating that H69V & H69VZ do 
not fit into the variant category. This phenotypic shift is more NSCLC-like rather 
than a variant type, in agreement with previous observation by Watanabe et al. 
[1988], they have isolated a cell line MOA2 from a variant SCLC cell line and 
MOA2 cell line had all features of NSCLC, it lacked NSE and CK-BB, expressed 
only minimal levels of DDC, grew as monolayer with large cell morphology, and 
formed tumours in nude mice with large cell histology. It could be that the 
phenotypic changes are gradual, from stem cell to differentiated tumour cell, and the 
studies so far have only dissected individual links of this continuous spectrum.
SCLC cell lines have been found to contain higher levels of BLI than other 
lung cancers [Moody et al., 1981]. While H69 expressed BLI, both the derivative 
lines and the non-small cell lines expressed only minimal activity. Carney et al. 
[1982] have shown that high levels of NSE are expressed by SCLC cell lines. While 
significant levels of NSE were found in the parental line in agreement with previous 
observations [Gazdar et al., 1985], the derivative lines had significantly lower levels 
with around 12-fold difference from the parental line. NSCLC cell lines had only 
minimal activity. Previously it has been shown that a change in SCLC from non­
adherent to adherent morphology was accompanied with a loss of neuroendocrine 
markers except CK-BB and NSE [Gazdar et al., 1985]. However, in contrast to the 
previous observations, it has been found in the present study that both CK-BB and 
NSE were either grossly reduced or lost in the derivative line.
The parental line stained positively for immunohistochemical markers 
including NSE, BLI, and chromogranin A. Both sublines and NSCLC cell lines 
stained only focally with NSE, and staining was absent for BLI and chromogranin A. 
Thus both derivative lines showed either reduced or complete loss of NE-cell 
markers as determined either by immunohistochemical or biochemical techniques.
Neurosecretory type dense core granules in SCLC cells have been shown by 
others [Bensch et al., 1968; Sidhu , 1982]. It has been suggested that they are the 
only criterion that can differentiate SCLC from NSCLC with certainty [Dingemans 
& Mooi, 1984; Mooi & Dingemans, 1986]. A good correlation was found in the 
present study for the expression of different markers biochemically,
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immunohistochemically and ultrastructurally. The parental line expressed all 
markers and also showed increased numbers of DCG, while the derivative lines 
either expressed only low levels of markers or did not express them at all and had 
only occasional single neurosecretory type DCG. NSCLC lines did not show any 
significant marker expression and had no DCG at all.
Marker studies indicated that both the derivative cell lines express features 
different from H69, but similar to NSCLC cell lines. Therefore, the change in 
phenotype of the derivative lines is not of variant type, but a NSCLC type. Though 
NE-cell marker data have shown that both the derivative lines had significantly 
reduced levels compared to the parental line, there is an indication that the loss is 
not as complete in some of the markers (DDC, BLI, NSE), as seen in NSCLC lines. 
This may be due to the fact that all or some of the cells are still in the process of 
transition and are not fully transformed to NSCLC, and are still expressing some of 
the properties of the parental line. Some heterogeneity has been found in 
immunocytochemical staining of the derivative cells. These data indicate that further 
studies are required to investigate whether, with continued culture, the derivative 
lines would lose the marker expression completely or keep expressing markers at a 
low level. It would also be interesting to see whether expression of markers could 
be modulated by experimental manipulation e.g chemical induction with 
differentiation inducing agents, as will be discussed with H69 alone in the following 
chapter.
Though in vitro invasion was found in all cells lines, the pattern and the 
degree was different between H69 and the sublines. While the parental line grew 
more slowly attached to heart fragments, it was significantly more invasive, and 
solitary invasion was found from different fronts as observed by histological and 
immunohistochemical staining of the invading cells. Both the derivative cell lines 
showed proliferation around the heart fragment and engulfed it from all sides. It 
seemed as if tumour cells used the heart fragment as a substrate, and proliferated 
attached to it, and the replacement of the heart fragment was secondary to their 
local growth. It is also consistent with the preferential growth of the derivative cells 
in monolayer. It may be that invasion is a selective or programmed event in SCLC, 
where an individual cell is capable of invading without any apparent degradation of 
the invaded tissue. These findings suggest that a single SCLC cell may have had all 
the necessary mechanisms involved in invasion and metastasis, whereas invasion and
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metastasis may be the events secondary to local degradation of tumour and host 
tissue in case of NSCLC. It may reflect the clinical behaviour of SCLC and NSCLC 
tumours, since most of the SCLC show early metastatic spread [Matthews et al., 
1973], compared to NSCLC.
The derivative lines were more proliferative in culture, but they were less 
invasive. Although tumour growth and cell proliferation are associated with invasion 
there is evidence that invasion is not dependent on cell proliferation in vitro [Mareel 
et al., 1982, Thorgeirsson et al., 1984] and in vivo [Disttelmans et al., 1985], Drugs 
such as 5-Flourouracil (5-FU) that completely inhibited cell proliferation did not 
block invasion [Bracke et al., 1984, Storme et al, 1985]. The present data tend to 
support these findings and suggest that invasion is not controlled by the rate of cell 
proliferation.
All lines were tumorigenic in nude mice. The parental tumours were more 
irregular in outline, had a higher mitotic rate and an increased single cell death, 
which might have been responsible for a slightly smaller final tumour volume in spite 
of a relatively high mitotic rate. There was macroscopic evidence of invasion in the 
parental line, but the sublines were better demarcated and had less infiltration into 
the surrounding tissues. H69 tumours invaded skin, subcutaneous tissues, and deep 
structures, e.g muscles, while tumour cell infiltration was only found in subcutaneous 
fat in the case of the derivative cell lines. These features were consistent with the 
metastatic behaviour of the cell lines, with the parental cell line tumours producing 
metastatic deposits both in liver and lungs, while metastasis was not found in these 
organs from animals bearing tumours of the derivative lines. These data suggest that 
the parental line is both invasive and metastatic, while the derivative lines are mildly 
invasive, but non-metastatic under these conditions.
It may be possible that tumours were removed earlier than their required 
period for metastasis, as NSCLC are metastatic, but at relatively later stages of 
disease, whereas SCLC is metastatic from early stage disease. The data from both 
in vitro and in vivo invasion showed good correlation.
It is possible that the interplay of matrix adhesion receptors and cell adhesion 
molecules suggested as having a role in the altered growth characteristics in culture, 
are also related to changes in metastatic behaviour. A SCLC cell may be 
programmed for reduced homotypic adhesions at the primary site, but increased in 
the circulation, and increased heterotypic adhesions at secondary site. This can be
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possible simply by expression and deletion of cell receptors or ligands for matrix 
receptors. Homotypic adhesion is necessary for tumour cells to break in lumps or 
aggregates and to survive the long journey in the blood or lymphatic channels, and 
also to help their arrest in a capillary embolism. Heterotypic adhesion is essential 
for tumour cell-stromal interactions at different levels of invasion and at metastatic 
sites. Homotypic adhesion may be reduced, but heterotypic adhesion may be 
increased in metastatic tumour cells.
The parental cells formed bizarre colonies in agar with irregular margins and 
a poor outline compared to the colonies of derivative lines which were evenly 
rounded. These cells also form irregular aggregates in culture. A correlation can 
be established between the bizarre colony morphology and the metastatic phenotype. 
The parental cell line formed irregular diffuse colonies in agar, and showed wide 
spread metastases, while both the derivative lines formed spherical colonies and did 
not show metastases. Cifone [1981] has shown that the frequency of irregular shaped 
colonies was increased in cell lines that developed from the cells of highly metastatic 
clones growing in agar, and these colonies rarely developed from cells of clones with 
a low metastatic frequency, and when tested for in vivo experimental metastasis, the 
cells from such colonies were highly metastatic. This finding has significant 
implications; the diagnosis of the metastatic phenotype takes a long time in existing 
in vivo tumorigenic assays, and it would be a useful alternative assay for in vitro 
evaluation of metastatic potential of a tumour cell in a relatively shorter time period. 
The mechanism of irregular colony formation is unknown, but is probably due to 
variations in homotypic cell adhesion. Another possibility could be that the irregular 
colony formation was a result of a heterogeneous cell population in the colony of 
stem cells capable of generating cells with different growth rates. Further studies, 
particularly of the expression of integrins and CAMs, are required to establish the 
role of these alterations in cell adhesion, invasion and metastasis. The 
characterization of this model would indicate that it would be a good one for further 
study. Clonogenicity in soft agar and metastases formation in nude mice may be 
compared using cell lines of both low and high metastatic and clonogenic potential 
e.g. SCLC and NSCLC cell line.
The parental line was more sensitive to vincristine compared to the derivative 
or the NSCLC cell lines. This is in keeping with the common observation that 
SCLC is more sensitive to chemotherapy, but this was not the case with adriamycin,
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where the parental line was more resistant. The possible explanation could be that 
the H69 was established from a relapsed tumour after chemotherapy including 
doxorubicin, vincristine, nitrosourea, and methotrexate, without any prior 
radiotherapy [Gazdar et al., 1980; 1985; Carney et al., 1985], and it may be that 
resistance to adriamycin is inherent, but why this should not have been the case for 
vincristine is not clear. It implies that the resistance mechanism for adriamycin 
operating in these cells is not MDR as this would have included vincristine. Mirski 
etal. [1987] have isolated adriamycin resistant variants without MDR phenotype and 
no P-glycoprotein expression, suggesting that other mechanisms of drug resistance 
(e.g. expression of glutathione-S-transferase, and DNA repair) may also be involved.
The radiation experiments showed that the parental line was more sensitive 
than either the derivative or the NSCLC cell lines, suggesting a clinical correlation. 
It has been shown by others [Goodwin and Baylin, 1981; Carney et al., 1983] that 
morphological variants of SCLC cell lines in vitro were more resistant to radiation 
compared to classic SCLC cell lines. It has been proposed that the morphological 
alterations with accompanied loss of neuroendocrine markers, and increased 
resistance to radiation may have clinical significance, since a poorer response to 
therapy has been reported in patients with relapse following chemotherapy or 
radiation treatment of primary tumours. It may be that neuroendocrine markers are 
expressed at a certain stage of tumour progression from stem cell to a more 
differentiated tumour. The coexpression of NE markers and radiation sensitivity 
may be coincidental. Alternatively, SCLC may represent a more undifferentiated 
phenotype, and therefore may be more vulnerable to radiation, and as the tumour 
progresses and its cells attain the NSCLC phenotype with differentiation, they 
acquire the capacity to become more resistant to radiation. A terminally 
differentiated cell is not capable of self renewal, and therefore less prone to 
potential risks of radiation compared to an undifferentiated, intermediate, highly 
proliferative cell.
Although the difference in chemosensitivity could have been due to variations 
in growth rates and growth fractions of the cell lines. This seems unlikely as 
vincristine and adriamycin sensitivities altered in different ways. Other factors such 
as variations in the assay systems may also be important. In this study the parental 
line grew in suspension, while both the derivative cell lines and the NSCLC cell lines 
grew as monolayer. It would have been possible to trypsinize the cells just before
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ir r a d ia t io n  or drug exposure, but i t  was not attempted because H69 cells do not grow 
w ell following trypsin treatment, suggesting some adverse effects on growth probably 
by surface changes caused by proteases. The differences in adriamycin sensitivity 
co u ld  also be due to the variations in penetration as the aggregate mode of culture 
may reduce access to the centre of a group of cells. However, this was apparently 
not true for vincristine, suggesting that the intake and distribution of two drugs may 
be under different types of control.
An increased expression of c-mvc was observed in both the derivative lines 
using immunohistochemical techniques, which correlated well with an increase in 
growth rate, loss of neuroendocrine markers, and an epithelioid morphology of the 
cells. However, further studies, perhaps using gene transfection or anti-sense 
oligonucleotides, are required to correlate oncogene expression with phenotypic 
alterations in SCLC cell lines. The mvc gene, its message and expression in the 
parental and the derivatives may also be investigated by southern, northern, and 
western blot analyses respectively. It has been suggested [Bepler et al., 1987; 
Watanabe et al., 1988] that mvc amplification in variant cell lines might be 
responsible for a more aggressive malignant behaviour of these cells in vivo where 
a change occurs in relapsed SCLC with an epithelioid morphology, rapid growth, loss 
of neuroendocrine properties, drug and/or radiation resistant phenotype, either 
spontaneously or following therapy. Johnson et al. [1986] have shown that the 
transfection of a classic SCLC cell line with c-mvc oncogene resulted in a change 
associated with large cell morphology, increased growth rate and high cloning 
efficiency. However, there was no significant difference in the expression of 
neuroendocrine markers including DDC, BLI, suggesting that c-mvc expression may 
not be associated with biochemical markers, but rather with general morphology and 
growth potential of cells. It has been shown [Khan et al., 1990 ] that c-myc 
oncogene transfection of an immortalised lung epithelial cell line MvlLu increased 
the growth of the transfectants both in vitro and in vivo. It has been shown that a 
down regulation of c-myc expression results upon induction of differentiation [Filmus 
& Buick, 1985], and a blocked of differentiation in the case of persistent c-myc 
expression [Prochownik & Kukowska, 1986].
There is now an emerging body of data suggesting a considerable overlap of 
various properties among different lung cancer types. Although lung cancer can be 
divided into SCLC and NSCLC with their characteristic biological and clinical 
behaviour, it is now evident that all lung cancers are derived from a common stem
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cell [Camey & de Leij, 1988]. According to this theory a stem cell undergoes 
progressive differentiation, through morphologically undifferentiated intermediate 
stages committed to specific pathways of differentiation. The fully differentiated 
cells are end stage cells, and therefore, incapable of further division. A pluripotent 
precursor cell may differentiate along more than one pathway depending on 
environmental conditions and this could be altered or determined by a carcinogenic 
stimulus. Cells may even switch from one pathway to another, probably due to 
genetic alterations (e.g oncogenic activation, suppression of anti-oncogenes). 
Pulmonary NE-cells with amine precursor uptake and decarboxylation (APUD) cell 
properties may be one type of differentiation. It is possible that APUD-cell 
properties develop in this cell with the onset of endocrine differentiation or else 
these properties develop in all intermediate cells, and are then selectively retained 
only in endocrine cells [Baylin and Mendelsohn, 1981]. Transforming events occur 
in undifferentiated cells, since fully differentiated cells are not capable of replication, 
the differentiation status of the transformant may depend on the level of 
differentiation at which transformation occurs or progresses. According to this 
concept SCLC are regarded as partly differentiated along the endocrine pathway. 
Large cell carcinoma may represent the stem cells or undifferentiated tumour. This 
explains the presence of tumours having more than one morphological component, 
and also the APUD-cell markers in NSCLC. These cell types may represent 
intermediate stages in the spectrum of lung cancer progression.
The tumour cell population is propagated by a core of undifferentiated stem 
cells capable of a large number or infinite divisions, some of the progeny 
differentiate, while others remain relatively undifferentiated, and maintain the stem 
cell pool. The stem cell fraction in a tumour may appear morphologically different. 
It has been demonstrated that most SCLC cultures contain a very small percentage 
of large cells [Gazdar et al., 1981] which may be stem cells. According to this 
theory, a changing tumour morphology can be explained by progressive failure of the 
stem cells to undergo differentiation. Depending on the severity of differentiation 
failure, a pure small cell or mixed small cell-large cell tumour or pure NSCLC may 
he found in an originally SCLC with a very small stem cell population. The stem 
cell theory also explain the co-existence of SCLC with other histological types of lung 
cancer such as squamous and adenocarcinoma. If all lung cancers arise from a 
^gle stem cell, conversion from one differentiated cell type to another can occur,
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by maturation down one particular pathway, resulting either a pure squamous, adeno 
or SCLC or even a mixed population of SCLC with any of other lung cancer types.
The stem cell concept of lung cancer has also been supported by data derived 
from clonogenic assays both in the present and previous studies which indicate that 
only a small percentage of SCLC is capable of giving rise to progressively growing 
colonies with heterogeneous cell population, but that many cells are capable of 
limited replication. Carney et al., [1980] have shown similar results in support of this 
concept. In addition, in mixed small cell-large cell tumours, cell kinetic studies 
indicate greater thymidine uptake by the large cell components, suggesting a greater 
replicating ability of the latter.
The present data have shown that the H69 cell line contains cells of both 
small and non-small cell like phenotypes. It is possible that a pluripotent stem cell 
sub-population may exist in the parental line capable of generating cells with 
different phenotypes, and some of them are selected according to the culture 
conditions. In light of the previous and the present data it can be concluded that 
all lung cancers develop from a common stem cell, capable of differentiating into 
various lung cancer types depending upon the stage of differentiation at which the 
genetic and epigenetic forces exert their influences. H69 and its derivative lines may 
provide a suitable model system for the study of phenotypic transition in lung cancer 
in vivo. In future studies H69 clones might be investigated for heterogeneity. 
Cloning of H69V and H69VZ cell lines and investigation for heterogeneity and signs 
of reversion to SCLC would determine whether the process is reversible. It is not 
known whether a stem cell population in a given clone of adherent cells would 
behave like a common stem cell capable of generating different lung cancer types. 
Further studies are also required to investigate whether some genetic changes e.g 
new oncogene expressions or deleted suppressors, are responsible for these 
phenotypic shifts in lung cancer both in vitro and in vivo. Therefore, it can be 
concluded from these data that the H69 and its derivative lines, H69V & H69VZ, 
may be used as a valid model for the study of phenotypic transitions in SCLC.
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CHAPTER THREE
(B)
INDUCTION OF PHENOTYPIC CHANGES IN 
HUMAN SMALL CELL LUNG CARCINOMA
Spontaneous phenotypic changes in a SCLC cell line (NCI-H69) have been described 
in the previous chapter. The phenotypic variations described above could be due 
to genetic selection, however, the expression of phenotype may be under regulatory 
control. This Chapter investigates the effects of various chemical agents on 
phenotypic expression of the cell line both in vitro and in vivo.
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3B.1 INTRODUCTION
Induction of the differentiated phenotype in malignant cells has been shown 
following treatment with differentiating agents [Spermulli & Dexter, 1984; Freshney,
1985]. Induction of the differentiated phenotype can be monitored by the expression 
of differentiation associated markers and suppression of malignancy related 
properties, e.g an increased haemoglobin production and suppression of 
tumorigenicity in erythroleukemia [Reuben et al., 1976; 1980], suppression of PA, 
clonogenicity in agar, and tumorigenicity and induction of surfactant production in 
human alveolar cell carcinoma cell line [Speirs & Freshney, 1990]. The mode of 
drug action differs considerably depending upon the nature of the agent used and 
the system it is employed in. A phenotypic inducer may act via a number of 
pathways, such as alteration of cell surface proteins by expression or deletion, by 
phosphorylation and glycosylation of membrane and cytoplasmic proteins, resulting 
in altered cellular pathways. They also act on nuclear targets such as DNA, 
histones, resulting in expression or suppression of a particular gene.
To investigate the effects of various phenotypic inducers on H69 cells the 
following markers were selected to represent SCLC phenotype: dopa decarboxylase 
(DDC), creatine kinase BB isoenzyme (CK-BB), bombesin-like immunoreactivity 
(BLI), neuron specific enolase (NSE), chromogranin-A. In addition to the 
neuroendocrine markers, a number of other parameters were selected for 
investigation to indicate a phenotypic shift in SCLC. These included: growth and 
morphological characteristics of cells in culture, cloning in soft agar, invasion in vitro 
using chick heart assay [Mareel et al., 1979], tumorigenicity, histology of xenografts, 
and invasion in vivo in athymic nude mice.
The key APUD enzyme L-dopa decarboxylase or DDC (E.C. 1.1.28) has been 
demonstrated in lung tumours, lung tumour cell lines in culture, and xenografts of 
SCLC in nude mice [Baylin et al., 1978; 1980]. The enzyme occurs free in the 
cytoplasmic fraction of the cell. It is found in many human tissues including kidneys, 
liver, neurons, and the tumours of neuroendocrine origin. The activity of this 
enzyme constitutes an important element of the NE-cell concept [Pearse, 1969].
Creatine kinase (CK), found normally in striated muscles, brain, bladder, and 
gastrointestinal tract [Gazdar et al., 1981] has three isoenzymes. Each isoenzyme is 
a dimer composed of a combination of two distinct subunits, M and B. Skeletal
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muscle contains isoenzyme MM, brain tissue contains isoenzyme BB, while the MB 
hybrid form is characteristic of myocardium. High concentrations of creatine kinase 
BB isoenzyme or CKBB (E.C. 2.132) has been found in serum, biopsy specimens, 
and cell lines in culture from patients with SCLC. CKBB activity in SCLC is 
quantitatively (10-100 fold higher) but not qualitatively different from that in normal 
lung and in other lung cancer types [Gazdar et al, 1981]. Although morphological 
variants of SCLC in culture show considerable loss of many of neuroendocrine 
features e.g DDC, BLI, high levels of CKBB are maintained [Abeloff et al, 1979]. 
The presence of this enzyme has also been widely used as a criterion for SCLC 
phenotype in lung tumours and tumour-derived cell lines.
Bombesin is a 14 amino acid peptide originally isolated from the skin of the 
frogBombina [Anastasi et a l, 1971]. It is found in large quantities in brain [Moody 
& Pert, 1979], stomach and intestine [McDonald et al, 1979] and fetal lung [Moody 
et al, 1981]. The mammalian equivalent of bombesin is believed to be gastrin 
releasing peptide [GRP], a 27 amino acid peptide. In human lungs bombesin-like 
immunoreactivity has been demonstrated in bronchial and bronchiolar epithelia both 
in solitary NE cells and in NEB [Wharton et al, 1978]. High levels of BLI have 
been found in full term fetal and neonatal lungs, but this is significantly reduced or 
even absent in adult lungs. A regulatory role for BLI in normal development of 
lung has been suggested on the basis of these findings [Ghatei et al, 1983].
Measurements of intracellular and secreted BLI in cell lines of lung cancer 
has shown that only lung cancer cell lines of SCLC origin expressed high levels, 
while it was not detectable in NSCLC cultures [Moody et al, 1981; 1983]. Bombesin 
receptors have also been found in SCLC [Moody et al, 1985], suggesting an 
autocrine growth effect of bombesin on SCLC, and Carney et a l [1985] showed that 
monoclonal antibodies to bombesin could inhibit the clonal growth of SCLC in vitro 
and in vivo. Exogenously added bombesin and GRP stimulated colony formation in 
SCLC in vitro but had no stimulatory effects on NSCLC [Carney et al., 1987].
Enolases are a group of glycolytic enzymes necessary for the anaerobic 
conversion of glucose to metabolites suitable for oxidation. The enzyme has three 
subunits designated a , p , and y , and occurs in five forms including three 
homodimers [aa, pp, y y ]  and two heterodimers [ap, ay] .  The alpha isoenzyme is 
Ihe predominant form occurring in most adult tissues, also termed non-neuronal 
snolase (NNE). The beta form is found in muscle. The gamma form was thought
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to occur only in neural tissues and was therefore termed neuron specific enolase 
(NSE) [Marangos et al, 1979]. However, NSE has also been detected in the NE- 
cells of gut, pancreas, lung and skin. [Marangos et al., 1979; Schmechel et a l , 1978], 
in tumours with neuroendocrine properties [Odelstad et a l , 1982], in neuroblastoma 
[Ishiguro et al., 1982], in small cell lung carcinoma [Carney et al, 1982; Esscher et 
al, 1985], and also at low levels in NSCLC [Baylin et al, 1980]. The levels of NSE 
in the continuous cell lines of SCLC are found to be much higher than in NSCLC 
cells.
The family of proteins called chromogranins [Carmichael and Winkler, 1985] 
has emerged as a potential universal marker for neuroendocrine tissues and tumours 
[Wilson and Loyd, 1984; Lauweryns et al, 1987]. It has also been found in the 
central and peripheral nervous system, in retinal photoreceptor cells, thymic 
epithelial cells, and cells lining sub-mandibular gland ducts [Nolan et a l, 1985]. The 
chromogranins have been divided into three classes, A, B, and C. They have similar 
properties, have overlapping but not co-localization in tissue, and are secreted with 
other biologically active peptides. Their major component, chromogranin A, was 
first discovered by Banks and Helle [1965] secreted by adrenal medulla chromaffin 
granules upon neural stimulation. It has been characterized and in chromaffin cells 
chromogranin A with a molecular weight of 75,000 daltons, is synthesized as a single 
precursor which is partly broken down by the action of proteases within chromaffin 
granules, and smaller proteins thus formed can be detected by antisera against 
chromogranin A [Falkensammer et al, 1985]. Elevated levels of serum 
chromogranin-A have also been demonstrated in patients with SCLC [Sobol et al,
1986]. Chromogranins may act by binding intravesicular calcium, and may have a 
role in growth control [O’Connor and Bernstein, 1984].
Though there are different treatment modalities for cancer, the treatment of 
choice in SCLC is chemotherapy alone or in combination with radiotherapy. 
However, generation of resistant variants in relapsed tumours is a major limitation 
of cytotoxic therapy. It is speculative whether resistance is inherent or acquired 
following treatment by the overgrowth of a mutant subpopulation derived from the 
initial clone. Different approaches are being used to circumvent this problem. 
Chemotherapuetic agents are used in combination either with other cytotoxic drugs 
or with an agent that will enhance drug uptake, inhibit drug efflux thereby increasing 
cytotoxicity. Other approaches are also under investigation that involve tumour
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killing by indirect means rather than by direct killing e.g inhibition of invasion and 
metastasis. Induction of differentiation and suppression of malignancy is a more 
novel approach that is target specific, non-cytotoxic, and applies the biological rules 
to modify the abnormal cell behaviour.
H69 cell line was selected because of its potential stem cell or precursor cell 
nature and therefore greater potential to alter the phenotype using phenotypic 
modulators. After the study of spontaneous phenotypic changes in H69 cell line in 
the previous chapter it was decided to examine whether similar changes could be 
induced by various chemical inducers known to induce phenotypic changes in other 
systems. It may be possible to induce NSCLC-like phenotype in H69 cells following 
treatment with these agents. Some phenotypic alteration has been shown in H69 
cells following a 72 hour treatment with phenotypic modifiers [Murray, 1989]. The 
present study was aimed at investigating the effects on the H69 cell phenotype of 
prolonged treatment with the phenotypic modulators as has been seen in other 
systems [Chun et al., 1986; Toscani et al., 1988].
The activities of chemical inducers used in this study (HMBA, Na-But, 
dbcAMP and Dex) have already been described in Chapter one. They have been 
used either alone or in various possible combinations in this study. Following drug 
treatment cell cultures were examined for any shift in the SCLC phenotype. Specific 
objectives were: 1) To investigate the effects of a more prolonged (7 days) treatment 
on H69 cells morphology and growth in culture, clonogenicity in soft agar, and 
expression of NE-cell markers by both biochemical and immunocytochemical 
methods. 2) To study the effects of chemical agents on invasion of H69 cells in 
vitro, using chick heart assay (Mareel et al., 1979). 3) In parallel studies, to
investigate the effects of 14 days treatment on growth, histology, invasion and NE- 
cell marker expression by immunohistochemical staining of H69 xenografts grown in 
athymic nude mice.
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3B.2 MATERIALS AND METHODS
3B.2.1 Cell Lines
A classic SCLC cell line (NCI-H69) was used in this study. The cell line was 
grown and maintained in culture as described in the previous chapter.
3B.2.2 Chemical Inducers
The chemical agents (see Chapter one) used as phenotypic modulators 
included N6-2-0-dibutyryl adenosine 3’:5’-cyclic monophosphate, sodium salt 
(dbcAMP) [Sigma], N,N’-Hexamethylene bisactamide (HMBA) [Sigma], N-butyric 
acid, sodium salt (Na-But) [Sigma], and dexamethasone sodium phosphate (Dex) 
[Decadron, Merk, Sharp & Dohme Ltd]. Dosage is shown in Table 3B.1. All drugs 
were dissolved in culture medium.
3B.2.3 In Vitro Assay
Cells were seeded in 24 well plates at a final cell concentration of 105 
cells/ml/well. Exponentially growing cells were exposed to the phenotypic inducers 
i.e. 1 mM cAMP, 0.25 /jM Dex, 5 mM HMBA, and 1 mM Na-but, individually, in 
culture medium, for 7 days. Cells were fed on alternate days with growth medium 
containing drug (test) or drug vehicle (control). The test group was further divided 
into two parts: 1) cells received drug treatment throughout the experiment, 2) cells 
received drug treatment for 7 days only, and after drug removal cells were either 
allowed to recover in drug free medium for further 9 days or processed immediately 
for study of growth, morphology and marker expression. Cell number was 
determined by electronic particle counter, following trypsinization of at least 3 wells. 
Culture morphologies of control and treated cells were also examined and compared 
at the end of experiment. Cell viability was tested by trypan blue exclusion.
3B.2.4 In Vivo Assay
Cells were harvested from exponentially growing cultures, washed and 
resuspended in PBS at 2xl07 cells/ml. An aliquot of 0.5 ml cell suspension was 
injected subcutaneously into the flanks of six to eight weeks old male or female nude 
niice. For passage a 2x2x1 mm tumour piece was transplanted subcutaneously into 
the flank of each animal. When the tumours reached a size of approximately 4x4 
Ann in two perpendicular diameters, animals were assigned randomly into control
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Table 3B.1:- Dosage of phenotypic inducers in vitro and 
in vivo.
DRUG DOSAGE
In V i t r o In Vivo
HMBA 5 .0  mM 1.5  mg/gm body wt .
Na-But 1 .0  mM 2ug/gm body wt .
dbcAMP 1 .0  mM 2ug/gm body wt .
Dex 0 .25  uM 2ug/gm body wt .
HMBA: hexamethy lene  b i s a c e t a m i d e ,  Na-But: sodium 
b u t y r a t e ,  dbcAMP: d i b u t y r y l  c y c l i c  adenos ine  
monophospha te ,  sodium s a l t ,  Dex: dexamethasone,  sodium 
p h o s p h a t e .
and treated groups, 4-6 animals per group. Each of the test animals received a daily 
i.p injection of drug [Table 3B.1] for two weeks, at dose adjusted to the body weight 
at the time of injection. The control animals received an equal volume of drug 
vehicle. Animals were examined twice weekly, tumour volumes were measured for 
each animal, and total body weight recorded, according to General Methods
3B.2.5 Other Methods
The details of primary antibodies used in this chapter for 
immunohistochemical methods have been shown in table 3A.2 (see above). Other 
methods employed in this Chapter have been described in General Methods.
3B.3 RESULTS 
3B.3.1 Growth In Vitro.
Cells treated with 1 mM sodium butyrate showed suppression of growth, but 
the cell number did not decrease when grown in the continuous presence of drug. 
When drug was removed cells reentered exponential growth after 3-4 days with a 
doubling time equal to that of control cells [Table 3B.2]. However treated cells did 
not reach the concentration of controls in plateau by day 19 [Figure 3B.1].
When cells were treated with 5 mM HMBA, growth suppression was noticed 
within 24 hours of drug addition compared with control. Treated cells showed a 
different growth pattern [Figure 3B.2]. There was no complete growth suppression 
as observed with sodium butyrate, rather cells continued to proliferate, though at a 
very low rate with a prolonged doubling time [Table 3B.2]. When drug was removed 
after 7 days exposure, cells showed a lag of 3 days before resuming exponential 
growth, when the normal growth rate was restored with a doubling time of around 
40 hours. However, cell number did not reach control levels even after 9 days in 
drug free conditions.
The growth pattern of cells treated with dbcAMP was similar to that seen in 
sodium butyrate treated cells. When cells were exposed to 1 mM dbcAMP growth 
was suppressed within 24 hours [Figure 3B.3] with only a minor rise in cell number. 
When drug was removed after 7 days exposure, cells reentered exponential growth
1 02
Ta
bl
e 
3B
.2
:-
 
E
ff
ec
ts
 
of 
ph
en
ot
yp
ic
 
in
du
ce
rs
 
on 
gr
ow
th
 
pr
op
er
ti
es
 
of 
H6
9 
ce
lls
 
in
 
vi
tr
o.
>-
O
CD Z
lu
•—i <—i
Z  CD .—» o IX CO CM
o  <-< fee o T--- , —
—I u_ -— - T---
t_> u_
X UJ
z : LO CO
• 11 T— CO CO 'S'
CO 'S- LO ^ —
>- cc +1 +  !S  LU + 1 + 1 +  | +  1
o  oc o CO
_ J Z cr "S' *0- CO ^ —
o  o (O CTs CO oo CM LO
CD S CD 'S' * *
5T~ *
IX to
LO CO O CM *
• • • • t—
O' o o O
-1
+  1 +1 +1 +  |
CO
LO LO •s- •
>- • • * • CMb- — CM in LO h—
*—1 1— cc T--- * * *
co EE
2  X
lu  to
o
ir—
O  QJ 'S' CM CM to
O  O ' LC O' o O' •
•-H i • • • • CM
h-LO o o o o
<C J +  1
QC o + i +  ! + 1 + 1
—•- H— LO
f— X •S' CO CM CO *
C h _ . • • • • —
to <c CM H---- o o ------
* * * *
LU CM rx rx co crs
* • • • •
*— ! CD CM H---- » — H— CM'
!—
CD ■— -
s :  c/s
*—• >
_J flO
QD X3---
o CM CO CO co *—
Q < * • # • *
CM CD CD CD CM
CC
LU O +-» Q_
03 3 3 z
Jp <C CQ <c
£2 o m 1 o Xzz o 21 (0 a os
CD 31 o TJ Q
CO
CD
3 3
o <D
SZ
-—»
(O
CD
> r—
3 o
3 3
O JP •
o —i
o O 'S' »
HP o • -—v
COJP
o  u - 3
3 o as CD
CD r— E
fee X> JP
X to to
CM f—3
"3
4-> • as -o
</J 3 a> (0
(0 o to
OS*•—I_ _ _ 1- i —
, — to 3
co 03 Q
-P a; > 3
3 o ©
O. jO Lt—
E Qlto 3o 3 o
3 to to CDu_ to
„D *3
as jp to 3
s_ f~ (0
tf©O o
3 *»—©
(0 CD Jp 3
Jp (0 3
£0 * *»»—1(0
Q CO > —
• 03 3
CD 3 (0
• jO >
..--s O'
*— • (103
m J/S O
> jp 3
a 3 03 to
EE0jas E 4P to
3 -f—o >5
s_ FT—
3^2 CIS
3 CL •
3 x  fee m
"3 as oo
3 jp ■w—
® c —
as so O '
(U_ ID (10 (l-~ J
<0 c 0H_ _ ^0J 3 OQ. fltf '✓
CD as lx cl.
-o to *
*■ 3  J P *
os w  ~  
3  Os O
"O c *—  o
^ S- * 
O  JP Q  
«—  3  
o  O  CL
o c
10000
•a  H69
+—  +Na-But
-Na-But
1000 :
100 -
1 0 -
1 - t — ---------------------------  1---------------------------------------------------   1----------------   i-------------------------------------------------------------------
0 5 10 15 20
Days
Figure 3B.1:- Effects of sodium butyrate on growth of H69 cell in vitro.
The cells were seeded in 24 weli plates al 1x10s cells/ml on day 0. Exponentially 
growing cells (day 3) were treated with 1.0 mM sodium butyrate, continuously for up 
to 19 days ( + Na-But) or allowed to recover in absence of drug after 1 week drug 
exposure (-Na-But). The drug treated cells showed growth inhibition, and following 
drug removal cells were able to reenter exponential growth again. Results are from 
one experiment, and similar results were obtained in a second experiment. Each 
point represents mean ± SEM (bars). Arrow, time at which the drug was removed 
from culture.
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Figure 3B.2:- Effects of HMBA on growth of H69 cells in vitro.
As [Figure 3B.1] except that the inducer used was HMBA (5.0 mM).
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Figure 3B.3:- Effects of dibutyryl cyclic AMP on growth of H69 cells in vitro.
As (Figure 3B.1) except that inducer used was dibutyryl cyclic AMP (1.0 mM).
Plate 3B.1:- Effects of phenotypic inducers on morphology of cells in culture, j
j
(a) H69 cells seeded in 25 cm2 flasks (105/ml), grew as irregular cellular aggregait 
Aggregates were collected together for photographs on day 10.
(x 20 objective, phase-contrast, bar = 100 ^m)
(b) H69 cells treated with sodium butyrate (1.0 mM) for 7 days in log phase 
growth formed larger aggregates, than the control, and with a more roui 
morphology. However, the number of aggregates was reduced compared to con! 
In addition there were more single cells in the medium and attached to the subsln 
compared to the untreated control.
(c) H69 cells treated with HMBA (5.0 mM) as in (b). These grew as sffll 
aggregates than the control with more rounded outline. However, the nuflito 
aggregates was reduced compared to control. Single cells were found in the dp 
but to a lesser extent than following sodium butyrate treatment.

Dexamethasone treated cells showed no significant morphological changes 
compared to control.
Cytology
There were no differences in the cytological appearances of treated and 
untreated cells, in Giemsa stained cytospin preparations.
3B.3.4 Neuroendocrine Marker Expression
Effects on Bombesin like immunoreactivity (BLI).
Table 3B.3 shows the effect of various phenotypic modulators on the 
expression of BLI of H69 cells, used either alone or in combination. Both cell 
associated and secreted levels were examined from each replicate sample, using 
RIA, and activity was expressed as pg/mg total cellular protein. The control showed 
slightly less cell associated than secreted BLI, but not significant. There was no 
significant effect of drug treatment on the cellular levels of BLI, used either alone 
or in different combinations, except an additive effect, following treatment with 
dbcAMP and Na-But in combination. However, there was a slight increase in the 
levels of secreted BLI, following treatment with single agent (HMBA) or a 
combinations of two agents (dbcAMP + HMBA; HMBA+Na-But).
Effects on DDC Expression
Table 3B.4 shows the effects of various drugs alone or in combination on 
expression of DDC in H69 cells. There was no significant effect of dbcAMP or dex, 
either alone or in combination. HMBA and Na-But alone and in different 
combinations (dbcAMP + HMBA; dbcAMP + Na-But; Dex + HMBA; Dex + Na- 
But; HMBA + Na-But) decreased significantly the DDC activity of the treated cells 
(by approximately 50%).
Effects on CKBB Expression
H69 cells expressed creatine kinase, predominantly, CKBB isoenzyme, a very 
small fraction of CKMM, but undetectable levels of CKMB [see above, Figure 3A.4] 
Treatment of cells with various phenotypic modulators did not have any significant 
effect on levels of either total enzyme activity or alteration of its relative isoenzyme 
expression [Table 3B.5].
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Table 3B.3:- Effects o f  phenotypic inducers on the expression of
bombesin l ik e  immuoreactivity (BLI).
BOMBESIN LIKE IMMUNOREACTIVITY ( p g /u g )
DRUG
CELLULAR SECRETED
Mean +_ SEM (%) Mean _+ SEM (X)
Control 0 .4 8  + 0 .04 100 0 .6 7  + 0 .08 100
dbcAMP 0 .4 7  + 0.01 99 0 .8 2  + 0 .1 0 122
Dex 0 .4 5  + 0 .02 95 0 .7 4  + 0 .0 8 110
HMBA 0 .4 4  + 0 .02 91 1.12  + 0 .3 0 167
Na-But 0 . 4 8 +  0 .03 101 0 .4 9  + 0 .09 73
dbcAMP+Dex 0 .4 5  + 0 .02 94 0.61 + 0 .0 8 91
dbcAMP+HMBA 0 .4 2  _+ 0 .0 3 87 1 .26  + 0 .22 188
dbcAMP+Na-But 0 .5 2  + 0 .0 5 109 1 .4 3  + 0 .14 213
Dex + HMBA 0.41 + 0.01 86 0 .688  + 0 .1 0 102
Dex + Na-But 0 .5 0  + 0 .04 105 0.61 + 0 .0 7 91
HMBA+Na-But 0 .4 7  + 0 .04 98 1.03  +_ 0 .14 153
10 c e l l s / m l  were s eeded  in  75 cm^ f l a s k s ,  l a t e  log  phase  c e l l s  
were t r e a t e d  c o n t i n u o u s l y  w i th  drug  f o r  7 days ( f r e s h  drug 
d a i l y ) .  Cel l  and s p e n t  media were a s sa y e d  f o r  BLI by RIA as  in  
methods. BLI was e x p r e s s e d  as  pg /ug  t o t a l  c e l l  p r o t e i n .  R e s u l t s  
are a t  l e a s t  f£om 5 r e p l i c a t e s  o f  a t  l e a s t  2 i n d e p e n d e n t  
exper im en ts .  *P<0.05 ( a n a l y s i s  o f  v a r i a n c e )
Table 3B .4:- E ffects  
expression.
o f phenotypic i nducers on DDC
INDUCER
DDC ACTIVITY
( uIU/mi n/mg) 
Mean _+ SEM % o f  c o n t r o l
Cont ro l 2853 + 355 100
dbcAMP 3389 + 74 122
Dex 3608 + 42 131
HMBA 1524 + 204 54
Na-But 1827 + 255 */- * 64
dbcAMP + Dex 2788 + 2 1 5 99
dbcAMP+ HMBA 1543 + 199 *57
dbcAMP+ Na-But 1887 + 97 *69
Dex + HMBA 1684 + 4 1 6 *58
Dex + Na-But 1607 + 275 *56
HMBA + Na-But 1408 + 108 *50
C e l l s  were se ed e d  i n  75 cm^ f l a s k s ,  exposed  t o  drug  i n  
l a t e  l o g  phase  f o r  7 d a y s , f r e s h  d rug  was added d a i l y .  
C e l l u l a r  DDC a c t i v i t y  was d e te r m in e d  and e x p r e s s e d  as  
ul l l /min/mg t o t a l  c e l l u l a r  p r o t e i n .  Values  a r e  f rom a t  
l e a s t  t h r e e  i n d e p e n d e n t  e x p e r i m e n t s .
P<0.05 ( a n a l y s i s  o f  v a r i a n c e ) .
Table 3B.5:— Effects o f  phenotypic inducers on creatine kinase (CK)
activity.
INDUCER TOTAL CK ACTIVITY 
(Il l/mg)
% OF CONTROL ISOENZYMES ANALYSIS 
CKBB CKMB CKMM
Control 3 .1 2  + 0 .36 100 95 0 5
dbcAMP 3 .8 8  + 0 .73 124 96 0 4
Dex 3 .2 0  + 0 .5 6 103 '95 0 5
HMBA 2 .7 8  + 0 .62 89 94 0 6
Na-But 3 .5 4  + 0 .94 113 96 0 4
dbcAMP + Dex 3 .3 8  + 0 .6 0 108 94 0 6
dbcAMP + HMBA 3.5 0  + 0,26 112 94 0 6
dbcAMP + Na-But  3.21 + 0 .53 103 95 0 5
Dex + HMBA 3.1 4  + 0 .70 101 90 0 10
Dex + Na-But 2 .9 3  _+ 0 .89 94 96 0 4
HMBA + Na-But 3 .6 4  + 0 .6 8 117 95 0 5
Cells were grown as fo r  DDC (see above Table 3 .15 ) .  The r e s u l t s  are  Mean + 
SEM of 3 independent exper iments.  Resul ts  are  a l so  shown as percentage o T  
control, where th e  control  value i s  taken as 100.
3B.3.5 Immunohistochemical Marker Expression
Expression of immunohistochemical markers by the H69 cell line was shown 
in the previous chapter. There was no detectable alteration in the expression of 
NSE; BLI; and chromogranin-A, following drug treatment either alone or in 
combinations.
3B.3.6 Invasiveness In Vitro
When combined in confronting culture with chick heart the H69 control cells 
showed invasion within the first 48 hours [Plate 3B.2 a], while invasion was found 
only by day 4 in HMBA or Na-but treated H69 cells. Following a 72 hours pre­
treatment with HMBA (2.5 mM) there was a delay of approximately 4 days in 
invasion compared to control cells [Plate 3B.2 bj. Invasion was also delayed for the 
similar period of time in treated cells following a 14 days recovery period in drug 
free medium before co-culture [Plate 3B.2 c]. Cells treated with 1 mM sodium 
butyrate for 72 hours before confrontation did not invade the fragment for at least 
5 days, and significant invasion was not observed until day 7 [Plate 3B.2 d]. Viability 
determined by dye exclusion, was found to be over 80-90% in treated non-invasive 
cells in co-culture assay.
3B.3.7 Growth of Xenografts
There was 100% tumour take following transplantation of 2x2x1 mm tumour 
pieces subcutaneously, after a latency period of around 17 days [Figure 3B.5]. 
Tumours grew with a doubling time of around 5 days. They attained an average 
maximum volume of approximately 2 cm3 in a period of around 5 weeks [Table 
3B.6]. Following HMBA treatment, there was a growth suppression compared to 
untreated controls [Figure 3B.5, Table 3B.6]. HMBA given i.p daily for 14 days 
increased the tumour doubling time 3-fold and reduced the final tumour volume 8- 
fold. Na-But [Figure 3B.5, Table 3B.6] increased the tumour doubling time by 5- 
fold, and reduced the final tumour volume by 13-fold. Treatment for 14 days with 
dbcAMP slightly increased the tumour doubling time (around 1-fold), and reduced 
the final tumour volume [Figure 3B.5, Table 3B.6]. The effects were less than those 
of HMBA or Na-But. There was no effect of dexamethasone treatment on tumour 
growth [Figure 3B.5, Table 3B.6].
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3B.2:- Effects of phenotypic modulators on invasion of H69 cells in vitro.
(a). H69 cells co-cultured with embryonic chick heart show invasion within 48 hours. 
Tumour cells (arrow) are identified in the centre of the heart fragment, by 
haematoxylin & eosin (HE) staining, and confirmed by immunoperoxidase staining 
using anti-neuron specific enolase (ANSE), and anti-chick (ACh) antibodies. 
Samples at day 1 (T l), 4 (T4) and 7 (T7), after co-culture are shown (x 250, H&E, 
and IP).
(b). Tumour cells (arrow) treated with HMBA (2.5 mM) for 3 days, then co­
cultured with pre-cultured heart fragment show invasion by day 4 (T4) compared to 
48 hours for untreated  H69 cells (see above, a). Cells remained alive outside the 
fragment during this period but did not invade. Invasion after day 4 was progressive. 
% day 7 (T7) tum our cells are seen throughout the heart fragment, but complete 
replacement was not seen (x 250, H&E, IP).
f— f—
L_J
c
(c) As (b), except that tum our cells (arrow) were allowed to recover for 14 days 
in drug free medium, before co-culture. Invasion is observed at day 4 (14), and 
more extensive at day 7 (T7) (x 250, H&E, IP).
(d) H69 cells (arrow) treated with sodium butyrate (1.0 mM) for 3 days, and co­
cultured with heart fragment. Evidence of invasion is not identified by day 4 (14). 
Cell are seen in the centre of the heart fragment at day 7 (T7). Cells were found 
alive around the heart fragment before that time (x 250, H&E, IP).
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Figure 3B.5:- Effects of phenotypic inducers on growth of H69 xenograft.
H69 xenografts were produced in athymic nude mice following s.c transplantation of 
2x2x1 mm tumour piece in each animal. Animal bearing tumours of approximately 
same size were randomly assigned to test and control groups. Each of the test 
animals received a daily i.p dose [see Table 3.2] of the phenotypic inducer for 14 
days, while controls received same dose of drug vehicle. Tumour size was measured 
twice a week in maximum and minimum cross diameters, and tumour volume was 
determined as described in General Methods. Each point represents mean ± SEM 
(bars) from at least 7 replicate observations, from at least two separate experiments.
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3B.3.8 Tumour Morphology.
Grossly, control tumours of H69 grew with an irregular nodular outline, the 
overlying skin showing prominent vasculature, with frequent ulceration, and 
macroscopic evidence of tumour infiltration into the surrounding host tissues. The 
cut surface showed evidence of necrosis and cavitation. The tumour was firmly 
attached to both skin and deep tissues.
Animals treated daily with HMBA, Na-But, or dbcAMP [see above, Table 
3B.1] for 14 days had smaller sized tumours, with well defined edges, smooth 
surface, and sparse blood vessels. Tumours were adherent to the skin, but 
attachment to the deep tissues was not firm. Cut section showed central areas of 
dead tissue with viable tissue around. Tumours were firm. Following treatment 
with dexamethasone tumour showed features similar to control, but with more 
necrotic tissues and central cavitation.
Histologically, the control tumours showed necrotic areas, with viable tumour 
tissues interposed, as small islands. The tumour appeared poorly differentiated with 
both cellular and nuclear pleomorphism and also showed high mitotic activity [Plate 
3B.3 a]. Local invasion into surrounding host tissue was found in all cases.
Tumours treated with dbcAMP showed moderate mitotic activity, and 
trabecular/alveolar-like morphology and less pleomorphism; however, overall 
features were not significantly different from the parental tumour [Plate 3B.3 b]. 
Tumours treated with HMBA [Plate 3B.3 c] and sodium butyrate [Plate 3B.3 d] had 
similar features to dbcAMP treated tumours. Dexamethasone treated tumours 
showed more central necrosis compared to control, but similar histology. All treated 
tumours showed less local invasion. These results were confirmed by more than one 
pathologist.
3B.3.9 Expression of SCLC Markers in Tumours.
Tumours were processed for immunohistochemical staining as outlined above. 
Control tumour stained positive for all markers i.e. BLI, NSE, and chromogranin- 
A, however, staining was less intense in tumours compared to monolayer. There 
was no significant difference in the pattern of staining caused by treatment with any 
of the inducers, either in cell culture or in tumours.
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Plate 3B.3:- Effects of in vivo adminstration of inducing agents on tumour 
morphology.
(a). H69 control tumour, shows undifferentiated pleomorphic tumour, with a higl 
mitotic rate (x 247, H&E).
(b). H69 tumour treated with dibutyryl cyclic AMP (2 /Jg/gm body wt) for 14 df 
showing a suggestion of alveolar/trabecular morphology. Subjective mitotic fig® 
are less frequent than in control (x 247, H&E).
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(c). H69 tumour treated in vivo with HMBA (1.5 mg/gm body wt) for 14 days 
shows features similar to (b), but the changes are less prominent compared to those 
induced by dibutyryl cyclic AMP (x 247, H&E).
(d). H69 tumours treated with sodium butyrate (2 ^g/gm body wt) for 14 days 
again shows similar features as above (b&c), with less mitotic activity (x 247, H&E).
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3B.4 DISCUSSION
While the phenotypic variation observed in the previous chapter may be due 
to genetic selection, similar behaviour of the derivative lines suggested that this may 
not be the case. This suggested that the expression of the phenotype may progress 
spontaneously to a more adherent NSCLC-type under regulatory control. To 
investigate this, SCLC H69 cells were exposed to various phenotypic modulators, 
known to have activity in other systems [Egorin et a l, 1988; Philippe et al., 1987; 
Guiffre et al., 1988], and any change in SCLC phenotype was measured. While it 
was relatively easier in other systems to show whether the effects were 
differentiation associated or otherwise, it is not straightforward in SCLC, because of 
the lack of appropriate markers of differentiation. SCLC may represent an 
intermediate progenitor tumour cell population, characterized by NE-cell markers 
expression, and sensitivity to cytotoxic agents. As the cell population progresses 
towards a more differentiated phenotype, they may change morphology, stop 
expressing NE-cell markers, become more resistant to therapy, and grow more slowly 
and start expressing new lineage specific markers. Previously, effects of the agents 
had been demonstrated in SCLC cell lines [Murray, 1989], where an alteration in 
marker expression was found following a 72 hours exposure. The changes in the 
phenotypic expression were not consistent among different SCLC cell lines, but were 
consistent within one cell line. The objectives of this study were to investigate the 
effects of prolonged treatment with the phenotypic inducers, within one cell line, 
alone and in different combinations, and both in vitro and in vivo. A period of 7 
days (in vitro) or 14 days (in vivo) was selected for the induction of phenotypic 
changes in the present study, because similar exposure times used in other studies 
have shown significant effects [Chun et al., 1986; Toscani et al., 1988].
Now the question arises, is the phenotypic shift in SCLC differentiation 
associated? H69 cells treated with the phenotypic inducers (HMBA, Na-But, and 
dbcAMP) showed suppression of malignancy associated properties and expression 
of differentiated phenotype, both in vitro and in vivo. The growth of cells in culture 
was stopped as long as cells remained in drug containing medium, however, 
following drug removal cells were able to regain exponential growth, suggesting a 
cytostatic effect. Treated cells formed only fewer and small rounded colonies, 
compared to more numerous and large irregular colonies of the control cells. This
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may imply increased cellular homogeneity in treated colonies possibly by effects of 
the inducer on the stem cells. It may be a differentiation associated effect; as 
tumour cells differentiate, they start receiving normal growth regulatory signals that 
prevent cellular diversification. Alternatively, phenotypic modulators could have 
prevented tumour cell diversification by inhibiting cell proliferation and thereby 
suppressing clonal expansion. It would be interesting to investigate this further by 
a comparative study of treated and untreated H69 colonies for cellular 
heterogeneity. Single viable cells in the treated cultures suggested that the effects 
were non-cytotoxic, and cytostatic. Similarly, the H69 xenografts treated with the 
inducers showed significant growth retardation. This in vitro and in vivo correlation 
suggests that the agents may have significant therapeutic potential.
The molecular mechanisms of growth arrest by these agents are only partly 
understood in other systems, where they appear to control the expression of specific 
genes, including both proto-oncogenes and oncogenes [Sporn et al., 1985]. They 
have been shown to prevent the progression of a premalignant cell to a malignant 
cell, or in certain cases they could arrest or reverse the process of malignant 
transformation [Sporn et al., 1985]. Polar planar compounds (e.g. HMBA) can 
induce differentiation of malignant cells, and the differentiated cells lose their ability 
to proliferate, to clone in suspension, and to propagate when transplanted into 
animals [Spermulli & Dexter, 1984]. HMBA induces a transient increase in 
intracellular level of cyclic adenosine 3’:5’-monophosphate, followed by a 
prolongation of G1 phase, during differentiation in murine erythroleukemia cells 
[Gazitt et al., 1978]. In the present report, HMBA had significant phenotypic effects 
on H69 cells in vitro. Further studies on cell kinetics are required to establish 
whether effects of HMBA on H69 cells are due to arrest in G l, by above 
mechanisms. This may involve investigating the effects of modulating agents by 
growth curve analysis, and analysis of cellular DNA synthesis, and growth associated 
genes (e.g c-mvc. c-fos).
Sodium butyrate has been shown to cause an inhibition of DNA synthesis by 
arresting the treated cells in the G l stage of the cell cycle [Wintersberger et al.,
1983]. It also modulates the expression of a variety of genes [Andrews & Adamson,
1987], and induces terminal differentiation in other systems [Philippe et al., 1987]. 
It appears to be an active process which either directly or indirectly represses the 
expression of some genes such as those involved in cell proliferation (e.g c-mvc)
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while inducing the expression of others such as those involved in cell differentiation 
e.g. c-mvc, c-fos [Toscani et al., 1988]. H69 cells treated with Na-But showed
complete growth arrest. It had the maximum cytostatic effect among the inducers 
used in this study. Na-But in the present study may have induced these phenotypic 
changes in H69 cells, by expression or suppression of specific genes related to 
growth and differentiation. Future studies may be carried out to find an answer to 
these possibilites by looking at the effects of, mvb or fos. transfection on H69 cell 
phenotype and also by antagonizing their effects by antisense oligonucleotides.
Dibutyryl cyclic AMP can exert its effects due to both released butyrate and 
cAMP. The activities of many genes are regulated by binding of ligands to cell 
surface receptor proteins. Transmission of the signal from the plasma membrane to 
the nucleus, where regulation of transcription occurs, is mediated by second 
messengers. Cyclic AMP acts in the signal transduction pathway for a number of 
different external stimuli [Alberts et al., 1889]. Cyclic AMP exerts its effects in 
animal cells by activating an enzyme called cAMP dependent protein kinase (A- 
Kinase). A-Kinase catalyses the transfer of the terminal phosphate group from ATP 
to specific serine or threonine residues of selected proteins in the target cell, 
resulting in activation or inactivation of a number of different enzymes. H69 cells 
treated with dbcAMP exhibited a growth suppression throughout drug exposure, 
similar to sodium butyrate. However, following drug removal, cells were able to 
regrow exponentially, implying reversibility. So cyclic AMP in these studies may 
have induced more differentiation related effects by the signal transduction 
mechanisms and this requires more investigations to elucidate the effects of cyclic 
AMP further. It may be that the effects of cyclic AMP observed in the present 
study were due to cleaved butyrate as seen above. Therefore, it would be interesting 
to analyse these finding further by specifically blocking the effects of one of the 
compounds at a time.
Production of neuroendocrine markers in SCLC may indicate an 
undifferentiated, intermediate cell phenotype in the spectrum of lung cancer 
progression or a tumour differentiated towards a more neuroendocrine phenotype, 
after originating from a stem cell compartment, under the influence of different 
microenvironmental factors. Some of these may be cell derived autocrine growth 
factors. Bombesin has been proposed as an autocrine growth factor in SCLC. The 
action of bombesin is believed to be mediated via a membrane receptor [Moody et
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al, 1985], which activates a post-receptor signal transduction mechanism resulting 
in mitogenic response. Other studies in vitro have demonstrated a role of bombesin 
as an autocrine growth factor in SCLC [Cuttitta et al., 1985; Woll & Rozengurt,
1988]. In the present study, there was no significant change in cellular BLI, 
however, a slight increase in secreted BLI was found after treatment with dbcAMP 
alone, and also in combination with HMBA or Na-But. As the increase in released 
BLI exceeded the fall in cellular BLI a total increase rather than simply secretion 
is implied. Preliminary data from the present study have suggested that bombesin 
may not have an autocrine growth effect on H69 cells, in contrast to the above 
hypothesis. Further studies could be carried out, to determine how the phenotypic 
inducers could modulate the cellular and secreted BLI in H69 cells, perhaps by 
labelling, and also by investigating the effects of inducers on BLI inhibitors. It could 
be that the increase in secreted BLI was due to inhibition of BLI inhibitors.
Treatment of H69 cells with HMBA either alone or in combination with 
other inducers significantly reduced DDC. Similarly, Na-But either alone or in 
combinations with other inducers also reduced DDC levels significantly, and the 
maximum effect was found in combination with HMBA. Cyclic AMP in 
combination with HMBA or Na-But decreased DDC expression, suggesting an 
additive cytostatic effect. These data are consistent with previous observations 
[Murray, 1989], where a 50% reduction in DDC was found following a 72 hours 
treatment with HMBA. More investigations are required to delineate the role of 
DDC in growth of SCLC. DDC has no direct role in cell growth, however it may 
alter cell growth by catacholamine regulation. The effects of catacholamine agonists 
(e.g noradrenaline) and antagonists (e.g phentolamine, propranalol) may be 
investigated in future studies. Selection of appropriate models from lung cancers, 
with relatively lower and higher levels of marker expression may show whether NE- 
cell markers have a definite role to play in the growth regulation of human lung 
cancer.
Morphological changes have been observed following treatment of H69 cells 
in vitro with HMBA and Na-But. HMBA treated H69 cells formed small regular 
aggregates in culture, while Na-But treated cells showed regular, but, larger sized 
aggregates, compared to the irregular type aggregates of the parental line. More 
cells were found sticking to the substrate, similar to the cells found spontaneously 
in H69 culture adhering to the substrate as described in the previous chapter,
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implying again, a cytostatic rather than cytotoxic event. The changes could be-due 
to alterations in cell surface molecules, either directly or via specific gene expression 
(e.g. glycosyl transferase activity, inhibition of proto-oncogenes). The modification 
in cell surface glycoproteins and proteoglycans by chemical agents like retinoids have 
been shown to induce cytostasis [Lotan et al., 1978]. Cell surface molecules may be 
altered in several different ways, following treatment with inducers. They may be 
deleted, truncated, or altered by sialation of carbohydrate moieties of cell membrane 
proteins. This could modify the receptors, cell adhesion molecules or matrix 
interactions. Alteration in aggregate size and substrate attachment implies an 
alteration in cell-cell adhesion and cell-matrix adhesion molecules. Morphological 
change may also be due to cytoskeletal alteration due to phosphorylation or 
dephosphorylation of vinculin and tubulin. Changes have also been found in H69 
tumours grown in nude mice. These changes, though not very prominent, may be 
significant. A trabecular or alveolar type pattern emerged in treated tumours, 
suggesting a shift towards a more differentiated phenotype. It would be interesting 
to see the effects of cytotoxic agents on these induced tumours in vivo. More 
differentiated cells may become resistant to cytotoxic drugs. It has been shown 
[Murray, 1989] that induction of SCLC cell lines with chemical agents (HM BA Na- 
But, dbcAMP, and Dex) for 72 hours did not have any significant effects on 
sensitivity of cells to cytotoxic drugs (i.e adriamycin, vincristine, and VP-16). It may 
be that 72 hours time was not enough to exert phenotypic effects that could have 
altered the drug sensitivity. Therefore, it may be appropriate to test sensitivity after 
7 days pretreatment with the inducers.
Pretreatment of H69 cells with HMBA or Na-But delayed invasion without 
affecting cell viability. The effects could be due to growth retardation as a result of 
cytostasis, although Storme et al. [1985] found inhibition of cell proliferation with 5- 
fluorouracil did not inhibit invasion in this assay. More important may be the 
possible cell surface changes. Changes in matrix receptor could result in an altered 
interaction between the cell and matrix components. Carbohydrates exposed at cell 
surface might be implicated in invasion of tumour cells [Smets et al., 1984]. 
However, both treated and untreated cells were able to attach to the heart fragment, 
and as invasion was delayed in treated cells compared to the control, this may 
implicate cytoskeletal interaction and cell motility rather than adhesiveness. The 
effects were reversible, once the drug was removed. This suggests a regulatory
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phenotypic effect, rather than an irreversible change in gene expression, and might 
be associated with terminal differentiation.
In treated animals, the tumour cells were found in subcutaneous fat only, 
whereas in untreated control tumours invasion was found in subcutaneous fat, skin, 
and deep into the muscles, with the evidence of the destruction of the invaded host 
tissues. Tumours treated with inducers were not processed for evidence of 
metastatic growth, in this study, because of the large number of samples and the 
shortage of time. However, this remains an interesting avenue of investigation that 
may well be worth pursuing in future studies. H69 is metastatic, and it may be that 
treated tumours could be induced to a non-metastatic phenotype, as there was only 
minimal invasion in treated tumours. An anti-metastatic phenotypic effect of a 
chemical agent may have significant therapeutic implications.
Therefore, it can be concluded from these data that the effects of phenotypic 
inducers on H69 cells are cytostatic, non-cytotoxic, and related to a more 
differentiated phenotype (morphologically, anti-invasive, anti-clonogenic, anti- 
tumorigenic), compared to the malignant phenotype of the H69 cells, both in vitro 
and in vivo.
The clonal nature of H69 cells implies that the malignancy begins with a 
single aneuploid cell whose progeny proliferate to produce clinical disease. It 
follows that in order to achieve clinical cure of malignant disease, the last aneuploid 
malignant cell must be eradicated. Reversibility and lack of any significant loss of 
viability of cells treated with the inducers in this study suggests that the effects were 
cytostatic and not cytotoxic. This could lead to the possible combination of cytotoxic 
and cytostatic agents in a coordinated schedule, as has been proposed by Lotan and 
Nicolson [1988], and has also been shown in a human colonic carcinoma cell line by 
combination of 5-Fluorouracil with N-methylformamide [Zupi et al., 1988], 
suggesting a possible role of this potential therapeutic approach in future. In 
contrast to the conventional cytotoxic therapy, whose objective is tumour cell 
destruction, the rationale for using cytotoxic therapy alternating with cytostatic 
therapy in the clinic would be to kill tumour cells using cytotoxic agents while to 
prevent the diversification and heterogeneity of surviving tumour cells. The 
cytostatic agents could be used to suppress tumour cell diversification during 
therapeutic recovery periods between cycles of cytotoxic therapy. This therapeutic 
regimen can hopefully improve the outcome of cancer treatment in future.
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CHAPTER FOUR
PHENOTYPIC REGULATION IN HUMAN NON-SCLC
This Chapter consists of three parts. The first part deals with the effects of stromal 
interaction on the tumour cell phenotype, and its relationship to chemosensitivity, 
the second part describes the possibility of induction of a differentiation associated 
phenotype in malignant cells, by allowing them to grow in a histotypic tissue culture 
model system, while the third part compares the phenotypic changes in histotypic 
culture with in vivo growth characteristics of the tumour cells.
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4,1 INTRODUCTION
The role of substratum in growth and differentiation of cells has been 
described [Kleinman et al., 1981]. Extracellular matrix (ECM) has been reported to 
be an important substratum for cultured cells. Normal epithelial cells generally 
attach, grow and maintain differentiated functions, when components of the 
basement membrane or stroma are used as the substratum instead of plastic 
[Emerman and Pitelka, 1977], although, the effects of an ECM on growth and 
differentiation appear to be different in different cell types [Gospodarowicz et al.,
1984], and it is still unclear which ECM components are related to such effects. 
Morphogenesis or three-dimensional development of epithelial tissue is brought 
about by its close association with the mesenchyme in vivo. This process can be 
partially simulated in vitro by growing epithelial cells cultures on type 1 collagen with 
the formation of multicellular structures [Emermann et al., 1979]. A specific role of 
collagen in the maintenance of the functional state of membrane structures 
associated with specific functions has been suggested for hepatocytes [Michalopoulos 
and Pitot, 1975], mammary cells [Emerman et al., 1979], and thyroid epithelium 
[Chambard et al., 1981; 1982].
It has been shown that normal respiratory epithelium expresses differentiated 
functions when grown in the proper micro-environment [Wu and Wu, 1984; Wu et 
al, 1985]. An alveolar cell carcinoma cell line A549 has been shown to produce the 
differentiated phenotype when grown on top of a filter near the air-liquid interphase 
in culture [Speirs & Freshney, 1990].
The work presented in this Chapter was an effort to investigate whether a cell 
line derived from a human lung carcinoma could be manipulated to express a 
differentiated phenotype when grown in optimal culture conditions.
The WIL cell line was selected among the different NSCLC cell lines 
available. It showed an intermediate response to the cytotoxic agents. It had the 
property of dome formation in culture implying a capacity to differentiate. It was 
originally derived from lung adenocarcinoma, and was mucin positive. Histologically, 
WIL has also been described as both a squamous and an adenocarcinoma, and may 
in fact be a stem cell which could become either with the appropriate inducer 
and/or micro-environment. Manipulation of its phenotype may influence its
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malignancy and/or differentiation associated properties. Hence, if WIL can be 
manipulated from a stem cell-like phenotype to a more mature normal or 
differentiated phenotype, then it might be a good model for the study of relationship 
between malignancy and differentiation and between differentiation and 
chemosensitivity. Previously, it has been shown that WIL cells treated with 
dexamethasone exhibited reduced malignancy associated properties [McLean et al., 
1986]
Assuming that tumour cells are primitive progenitor-like cells, which exhibit 
a more fetal type (quasi-fetal) phenotype, it was appropriate therefore to use a 
stromal cell line of fetal origin. The cell lines EWLU and LF113 were selected as 
they were derived from normal human fetal lung, and grew in culture with typical 
fibroblastic morphology.
Malignant tumours with a high proliferative rate are generally more sensitive 
to the effects of cytotoxic agents, while differentiated tumours or normal tissues are 
resistant. The second aim of the study was to assess the effects of phenotypic 
alterations on sensitivity of tumour cells to cytotoxic drugs. The specific aim was to 
compare the growth of tumour cells plated on plastic with and without stroma, on 
a filter well system, and on a collagen gel matrix and in the presence and absence 
of chemical inducers.
A third aim was to investigate whether a differentiated phenotype could be 
induced in the WIL cell line if a histotypic tissue culture environment was provided. 
The purpose was to develop a histotypic model, one which should represent in vivo 
conditions as closely as possible, and then to stimulate the tumour cells growing in 
such an environment with agents known to cause phenotypic changes in other 
systems.
Various chemical substances have been shown to induce differentiation 
associated functions in cells of respiratory epithelium. The agents used in the 
present study included: retinoic acid, TGF-/3, dexamethasone, HMBA, Na-But, and 
dibutyryl cyclic AMP (see Chapter one).
A number of different parameters were selected for the determination of a 
shift in tumour cell phenotype by stromal influences. These included morphological 
changes, effects on tumour cell growth, alterations in mucin secretion, and changes 
in expression of cytokeratins, vimentin, epithelial related membrane proteins (human
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milk fat globulins 1 & 2, HMFG 1 & 2) epithelial membrane antigen (EMA), and 
the oncofetal proteins, carcinoembryonic antigen (CEA), and sensitivity of cells to 
the cytotoxic drugs.
4.2 MATERIALS AND METHODS
4.2.1 Cell Lines
A panel of non-small cell lung carcinoma (NSCLC) cell lines was used [Table 
4.1], for cytotoxicity assays. All cell lines grew as adherent monolayer, in 
F10:DMEM.
Table 4.1:- Cell lines.
Cell line Origin Lineage Pathology Source
WIL human lung epithelial adeno ca Haddow, Suttoi
'WIL+b human lung epithelial adeno ca Medical Oncol
A549 human lung alveolar alv cell ca ATCC, MD
SKMES human lung epithelial sq cell ca ATCC, MD
NCI-H125 human lung epithelial adeno ca NCI, MD
2MOG-EWLU human lung fibroblast normal Med Oncol
2MOG-LFII3 human lung fibroblast normal Med Oncol
MOG-MLC mouse lung lung normal Med Oncol
1The cell line derived from WIL xenograft. 2Fetal. ATCC: American type culture 
collection
4.2.2 Cytotoxic Drugs
Vincristine was obtained from Sigma Co Ltd, and adriamycin (doxorubicin) 
was obtained from Farmitalia Co Ltd. The drugs were dissolved in PBS and diluted 
m culture medium in final concentration.
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4.2.3 Chemical Inducers
Retinoic acid, sodium n-butyrate, HMBA, cyclic AMP were obtained from 
Sigma Co Ltd, and TGF-/3 was kindly provided by Dr David Kerr. Retinoic acid was 
d is s o lv e d  in ethanol, other chemicals were dissolved in complete culture medium. 
The doses used in this study are shown in table 4.4 (see below).
4.2.4 Tumour-Stromal Interaction
The tumour cells were co-cultured with fibroblasts in conventional monolayer 
for different time periods, after which they were examined using phase-contrast 
microscopy of living cultures, or light microscopy of Giemsa stained preparations, 
immunohistochemical staining for expression of different markers, and histochemical 
detection of mucin synthesis. Cells were also treated with drugs in co-culture to 
observe any effects of stromal interaction on tumour cell sensitivity to cytotoxic drugs 
by clonogenic assay.
4.2.5 Development of Histotypic Tissue Culture Model
A three dimensional complete histotypic tissue culture model was constructed 
for induction of differentiated phenotype in malignant (WIL) cells [Figure 4.1]. It 
consisted of a polycarbonate filter [8 p, Nuclepore] suspended in a filter unit, which 
was used as a basic supporting structure, and secondly to keep cultures at an air- 
liquid inter-phase (respiratory epithelium) for maximum inductive effects. A 
complete fibroblast layer was grown on the filter, then a layer of collagen gel 
containing fetal lung fibroblasts was laid on the top of fibroblast layer, representing 
stroma in an in vivo environment. Then a thin layer of matrigel (collagen type IV 
+ laminin) represented the basement membrane in natural conditions. This was 
called a 3-D histotypic tissue culture model. Malignant cells were cultured in this 
inductive environment in presence of a known inducer of phenotypic changes. 
Culture medium was saved from filter well cultures and analyzed for mucin-like 
glycoproteins, the cells were processed for histology, immunohistochemistry and 
electron microscopy as shown in figure 4.2. Mucin was identified using the 
PAS/diastase-alcian blue stain. Cells were counterstained with haematoxylin for 1 
fflin. Stained slides were then examined by light microscopy using a x 100 objective 
(oil immersion). Blue (acid mucins) and red (neutral mucins) granules were seen.
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Figure 4.1:- Proposed model for induction of differentiated phenotype in NSCLC 
in vitro.
A schematic representation of sequences of steps leading towards a differentiated 
respiratory epithelium, in a three dimensional histotypic tissue culture model. 
The model provides optimum inductive microenvironment. Filter Well Assembly 
with malignant cells (A). Malignant cells (WIL) in histotypic tissue culture model 
grown at high cell density (B). An initial stage of polarity and orientation (C & 
D). Differentiated cells [E]. Normal epithelium (F), with basal (b), mucous (m), 
and ciliated columnar (c) cells.
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4.2.6 Biochemical Analysis of Mucin-like Glycoproteins.
Cells growing in histotypic culture were incubated with 10 i/m l 3H- 
glucosamine (29 Ci/mmol, NEN) in 2 ml of medium/well. Following incubation 
with precursor, medium was collected by simple pipetting followed by an additional 
wash with 1 ml of the fresh medium. The spent medium was centrifuged to remove 
cell debris, and the supernatant was lyophilized and then stored at -20 °C. The 
lyophilized material was dissolved in PBS containing 2% v/v 2-mercaptoethanol and 
applied to a Sepharose G-50 column (Nick Columns, Pharmacia, 2.5 cm x 10 mm) 
and eluted with the same buffer. The excluded fractions which contained high 
molecular weight glycoproteins were pooled and subjected to enzymatic digestion. 
Hyaluronidase treatment was performed at 37 °C for 16 hours with lOU/ml 
hyaluronidase (streptomyces, Miles). Fractions of 75 ij\ were collected, mixed with 
5 ml Ecoscint and radioactivity of the sample counted, in a scintillation counter 
(Packard). A sum of 5 void volume peak fractions was used as the amount of 
hyaluronic acid free mucin-like glycoprotein present in the sample. Results were 
expressed as percentage of total counts per sample.
4.3 RESULTS
4.3.1 TUMOUR-STROMAL INTERACTION IN CONVENTIONAL MONOLAYER
4.3.1.1 Tumour Cell Morphology
WIL grew in culture as a monolayer of two cell populations [Plate 4.1 a] a 
rounded small cell population and a large epitheloid cell population. The growth 
of cells in 24 well plates showed characteristic phases [Figure 4.3], a lag of around 
2 days, exponential phase of approximately 5 days, and a plateau after around 8 days 
of subculture. The fibroblasts alone grew in culture with characteristic morphology 
[Plate 4.1 b].
WIL cells growing in 50:50 (WIL:EWLU) co-culture showed morphological 
changes after a week, becoming more like cells of primary cultures from WIL 
xenografts or mouse lung growing in culture. Tumour cells grown on top of a
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Plate 4.1:- Morphology of tumour and stromal cells in culture.
Tumour (WIL) cells showing epithelial morphology (a), and stromal (EWLU) 
cells showing typical fibroblastic morphology (b). One week after subculture on 
the plastic substrate (x 10 objective, phase-contrast, bar=  200 pm) .
1000
Growth Curve: WIL
100
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Figure 4.3:- Growth curve of WIL cell line in vitro
A semi-logarithemic plot for WIL cells grown in 24-well plates. The cells were 
seeded at 5xl04 cells/cm2 on day 0. They were counted by trypsinization, of at 
least triplicate wells on alternate days and fed. Each data point represents mean 
value.
confluent dead fibroblast layer did not show any morphological change, implying that 
the effects were not just physical, but needed viable cell interaction. After 3 weeks 
circular ridges appeared which grew as a complex pattern [Plate 4.2] not found in 
pure cultures.
The histology of cells grown on the filter well did not show any gross change 
in co-culture compared to the cell lines alone.
4.3.12 Marker Expression
There was no significant change in the expression of intermediate filaments 
or membrane proteins as identified by immunohistochemical staining techniques, 
between co-cultures and tumour cells alone [Table 4.2].
4.3.1.3 Colony Forming Efficiency
There was a significant increase in the cloning efficiency of WIL cells 
following interaction with fibroblasts (297 ± 16), compared to WIL cells cloned alone 
(183 ± 18), the difference was consistent in 8 different observations (Mean ± SEM). 
Statistical analysis (P< 0.001) was carried out by analysis of variance and adjustment 
[see Figure 4.4],
4.3.1.4 Expression of Mucin-Like Glycoproteins
The histochemical staining showed that there were no significant differences 
in the expression of mucin-like substances by the tumour cells grown either alone or 
with fibroblasts.
4.3.1.5 Sensitivity of Tumour Cells to Cytotoxic Drugs.
The effects of vincristine and adriamycin on sensitivity of tumour cells alone 
or in co-culture are shown in table 4.3. The results are shown as ID50 values 
obtained from dose response curves of the WIL cells to adriamycin [Figure 4.4 a] 
and vincristine [Figure 4.4 b]. There were no significant differences in the sensitivity 
of tumour cells by increasing duration of interaction (3 days, 1 week, 3 weeks) 
duration of drug exposure (24 h, 48 h, and 72 h), or by varying the cell ratios 
(WIL:EWLU, 30:70; 50:50; 80:20). The results are shown from one representative
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Plate 4.2:- Morphology of tumour-stromal co-culture.
WIL and EW LU cells plated at lxlO5 cell/cm 2 in 50:50 ratio showed formation 
of circular patterns after 3 weeks, (a), (x 10 objective, phase-contrast, 
bar= 200 /im). (b). (x 20 objective, phase contrast, bar=  100 fjm).
Table 4.2:- Effects of microenvironment on malignant cell phenotype.
Phenotypic
Marker
Monolayer
Culture
Histotypic
Culture
Xenograft
(Vivo)
Morphology smooth
surface
microvilli
connections
adeno-squamous
differentiation
Mucin + + + + +
CEA + + + +
HCG + + + +
CAM5.2 + + + + + + + + +
Polykeratin + + +
Prekeratin + + +
EMA + + +
Vimentin + + + + + + +
CEA: Carcinoembryonic antigen. HCG: Human chronic gonadotrophin. EMA: 
Epithelial membrane antigen.
Table 4.3:- Sensitivity of WIL cells to cytotoxic drugs with or without stromal 
interaction by clonogenic survival assay.
Cell line aID 50
Vincristine 
(x 10’9 M)
Adriamycin 
(x  10'11 M)
WIL 4.4 ± 0.3 7.5 ±0.1
WIL + EWLU 4.0 ± 0.4 6.5 ± 0.9
aThe ID50 was defined as the drug concentration required to inhibit cell growth 
to 50% of that in untreated control. Values are arithmetic mean ± SEM from 
at least 3 experiments, carried out at different occasions.
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Figure 4.4:- Chemosensitivity of WIL cells to adriamycin and vincristine (24 hrs 
exposure) in presence or absence of fibroblasts.
The chemosensitivity was determined using clonogenic survival assay as outlined 
in the text. Each point represents mean ± SEM (bars) from 3 replicate values 
of one representative experiment. Similar results were obtained from more than 
3 other experiments.
set of data (50:50 ratio; 3 days interaction; and 24 hours drug exposure). A 
niitogenic effect was observed at lowest drug concentrations, in both tumour cells 
alone and following fibroblastic interaction.
4.3.2 INDUCTION OF PHENOTYPIC CHANGES IN MALIGNANT CELLS,
GROWN IN A HISTOTYPIC TISSUE CULTURE MODEL
4.3.2.1 Effects on Morphology
Histology of WIL cells grown on three dimensional (3-D) model showed that 
the cells were aligned in a single cell layer on top of the gel, with some evidence of 
polarity, however there was little evidence of cell-cell interactions and findings on 
light microscopic observations did not suggest any morphological change. There was 
no resemblance of the sections of histotypic culture to the histology of WIL 
xenografts [Plate 4.3, see Plates 4.1 a & 4.6]. However, differences were obvious 
compared to monolayer morphology in culture, as the cells formed more than one 
layer.
There was no difference in the morphological features of the cells grown in 
the presence or absence of different inducers; however, substrate had some effects 
on tumour cell morphology. While cells grown on plastic showed a spread 
morphology, and covered the substrate completely, on a collagen substrate the cells 
did not form a complete monolayer; rather individual cells or isolated small colonies 
were found on the gel, with a reduction in the total cell number compared to plastic 
substrate.
Transmission electron microscopy of the control WIL cells grown in the 
histotypic model was typical of epithelial interaction, with development of adhesion 
specialisations [Plate 4.4 a], cytoskeletal elements and formation of surface microvilli 
[Plate 4.4 b]. Some cells showed evidence of mucin production [Plate 4.4 cj. 
Desmosomes, intermediate filaments, and tonofilaments were also found in cells 
grown on plastic, but microvilli and surface specialisations were not well developed, 
compared to cells grown in 3D model.
Scanning electron microscopy showed two types of cells; cells growing on
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Plate 4.3:= Morphology of cells grown on histotypic model
(a). A single cell layer (C) is shown on top surface of Filter (F). The cells can 
also be seen crossing to the undersurface of the filter membrane (arrows).
(b). Culture from (a) 2 weeks later show approximately six cell layers. The filter 
membrane was separated from under surface (arrow) of the cell layer during 
histological processing (x 20, H&E, bar =100 /um).
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Plate 4.4:- Transmission electronmicrographs of WIL cells.
(a). The cells grown in histotypic culture show epithelial cell-cell relationships, 
and desmosome (D) (x 42500, Uranyl acetate and lead citrate stain), (b). Cell 
grown as (a) shows tonofilaments (T), and microvilli (V) (x 45000, Uranyl acetate 
and lead citrate stain).
m  *m
*
(c). Cell grown as (a) shows apoptosis (A) and fluffy intracellular 
inclusions (? mucin) (M) (x 42500, Uranyl acetate and lead citrate).
plastic substrate showed more smooth surfaced cells [Plate 4.5 a], while cells grown 
on collagen substrate showed more microvilli, and developed cell-matrix [Plate 4.5 
b] and cell-cell [Plate 4.5 c] connections.
There was no significant effect of phenotypic inducers on the morphology of 
the cells growing in the histotypic model by both transmission and scanning electron 
microscopy.
43.2.2 Expression of Mucin-Like Glycoproteins.
WIL cells grown on a collagen substrate did not show any significant increase 
in the expression of mucin by histochemical staining. Positive staining was observed 
in 5-10% cells [see below, Plate 4.7], irrespective of the inducer used.
The results of biochemical analysis are shown in table 4.4. Growth of cells 
on a collagen substrate showed a peak for secreted mucin/GAGS in the conditioned 
medium, however, no difference was found following induction with different 
inducers. The peak was very low or absent in medium conditioned with WIL cells 
alone, grown on plastic substrate.
4.3.2.3 Immunohistochemical Marker Expression
There was little difference in the expression of various antigenic markers 
expression on WIL cell grown in different micro-environments [Table 4.2].
4.3.3 EFFECTS OF IN VIVO GROWTH ON PHENOTYPE OF THE WIL
Histology of xenografts grown in athymic nude mice showed areas of mixed 
cellularity with both squamous and glandular differentiation [Plate 4.6]. Cell lines 
derived from xenografts (W IL+b) showed an increase in the expression of mucin­
like glycoproteins both histochemically [Plate 4.7] and by biochemical analysis [Table
4.4]. The expression of mucin-like glycoproteins decreased with increasing passage 
number in culture. There was no difference in expression of intermediate filaments 
or membrane proteins, compared to the WIL cells grown as monolayer in plastic or 
m histotypic culture, however, a slight decrease in the expression of CEA and HCG 
was observed [Table 4.2].
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Plate 4.5:- Scanning electronmicrographs of WIL cells.
(a). W IL cell grown on plastic substrate for 10 days, shows smooth 
surface.
(b). The W IL cell grown on collagen substrate (C) in histotypic 
culture shows form ation of surface microvilli and cell-matrix 
connections (arrows).
(c). The cells grown as (b) show cell-cell connection indicated by 
arrow (specimen was tilted for full view).
Table 4.4:- Effects of phenotypic inducers on expression of mucin-like
glycoproteins/GAGS in WIL cells.
CELL LINE/INDUCER GAGS (% OF TOTAL CPM)
WIL (plastic) 2.1 ± 0.1
WIL (histotypic culture) 6.3 ± 0.4
+ Cyclic AMP (1 mM) *6.0 ± 0.3
+ Dexamethasone (25 pM) *6.1 ± 0.2
+ HMBA (5 mM) *6.3 ± 0.1
+ Na-But (1 mM) *6.2 ± 0.4
+ Retinoic acid (0.5 iM ) *7.4 ± 0.1
+ TGF -0 (1 ng /ml ) *6.3 ± 0.4
WIL + b (WIL xenograft derived line) *7.0 ± 0.2
WIL cells in histotypic culture were treated with chemical inducers, conditioned 
medium was assayed for mucin-like glycoproteins/GAGS as described in 
Methods. Cells grown in histotypic culture showed induction of mucin-like 
glycoproteins/GAGS compared to WIL cells grown on conventional plastic 
substrate. Results are mean ± SEM from at least 3 experiments.
P<0.01 (Mann-Whitney test and Bonferoni adjustment).
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Plate 4.6:- Effects of in vivo growth on morphology of WIL cells.
WIL xenograft grown in nude mice shows poorly differentiated cells with some 
evidence of both squam ous (S) and glandular (G) differentiation. lxlO6 cells 
were inoculated s.c into the flank of nude mice and tumour removed after 5 
weeks (x 280, H & E).
Plate 4.7:- Expression of mucin in WIL xenograft derived cells in culture.
WIL xenograft derived cells (WIL + b) in second passage culture stained with 
PAS-diastase/Alcian blue show positive staining both for acidic (A) and neutral 
(N) mucins (x 210, PA S/D iastase/A lcian blue).
4,4 DISCUSSION
The purpose of this study was to investigate the effects of stromal interaction 
on the phenotype of NSCLC. The WIL adenocarcinoma cell line was co-cultured 
with normal human fetal lung fibroblasts for different time periods in the presence 
and absence of different differentiation inducers, and the effect on the tumour cell 
morphology, antigenic marker expression, and chemosensitivity were investigated.
Changes were observed in the morphology of co-cultures. A close similarity 
was observed in morphology of co-culture, mouse lung culture, and the WIL 
xenograft derived cell line. One explanation is that all of these culture models have 
similar composition; fibroblasts, and epithelial cells either normal or tumour derived. 
Therefore, it is conceivable that the morphological changes were due to fibroblastic 
influence. It seems that the effects were not just physical, but needed live and 
growing fibroblasts, suggesting a possibility of both physical and biochemical 
interactions. Similar morphological changes have been found in an alveolar cell 
carcinoma cell line A549 following fibroblastic interaction [Speirs & Freshney, 1990], 
where it was proposed that a diffusible growth factor might be responsible. Effects 
were less obvious on histological examination of co-cultures in filter wells.
Mitogenic effects were observed in tumour cells, following stromal interaction. 
The stimulation of tumour cell growth by fibroblastic interaction may be due to the 
release of growth factors from fibroblasts, or it might be that tumour cells stimulate 
fibroblasts, which in turn synthesize and secrete other substances which are 
mitogenic to the tumour cells. Proliferation of normal mammary epithelial cells in 
vitro has been shown to be associated with the presence of mammary fibroblasts 
[Haslam, 1986], suggesting a role of fibroblasts in epithelial cell proliferation. 
However, others [Delinassios, 1987] have shown negative growth effects in other 
systems, suggesting that the effects are selective, stimulatory in some cases and 
inhibitory in others.
There was no difference in the sensitivity of the cells to the cytotoxic drugs 
vincristine and adriamycin with or without stromal interaction . It is possible that 
the WIL cell line was not sensitive enough to show any significant differences in 
chemosensitivity. Stimulation of tumour cell colony formation was also found at very 
low drug concentrations. It may be a defensive response on the part of tumour cells,
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when they are challenged with non-toxic drug concentrations. The exposure to low 
drug concentration then may trigger a mitogenic response in cells probably via a 
receptor mechanism, which could be overridden by high drug concentrations, or high 
drug concentrations may have different mechanisms of cytotoxic effects.
There was no significant effect on the expression of any marker or on the 
sensitivity to cytotoxic drugs. There could be many reasons for this failure of tumour 
cells to respond to stromal interaction. Lack of specificity of the markers could be 
one reason. The WIL cell line was selected as the most suitable available model to 
represent NSCLC. The cell line had been shown to respond to dexamethasone 
treatment with a growth reduction both in vitro and in vivo, and a decrease in 
plasminogen activator production [McLean et aL, 1986], The other possibility could 
be the lack of proper inductive micro-environment.
Therefore, it was decided to develop a histotypic tissue culture model system, 
and then induce the tumour cells, growing under optimal conditions, with agents 
known to induce phenotypic changes in other systems. The geometry of the 
histotypic model used in this study has already been described [see above, Figure 4.1 
& Plate 4.3]. WIL cells grown in this system were allowed to develop cell-cell 
interactions of both homotypic (tumour-tumour) and heterotypic (tumour-stromal) 
nature, cell-matrix (collagen, laminin), and chemical (by chemical inducers) 
interactions. The cells were allowed to grow in three dimensional culture to recreate 
polarity and orientation, so that the cells should be receptive. It has been shown 
that this type of culture system optimises surfactant synthesis in A549 alveolar 
carcinoma cells [Speirs & Freshney, 1990]. The cultures in the raised position were 
able to receive nutrients from the basal surface through the filter and the collagen 
substrate, while the apical surface was exposed to the air-liquid interface, to simulate 
in vivo conditions of respiratory epithelium. Polarization of thyroid cells in similar 
conditions has been described by Chambard et al [1983]. They have demonstrated 
that thyroid cells growing in a filter well system were able to generate receptors for 
thyroid stimulating hormone on the basal surface, while the apical surface released 
thyroglobulin. It has been shown in different studies that the differentiated 
phenotype can be restored by growing the cells on collagen rather than on 
conventional plastic substrate. However, most of these studies have examined 
normal tissues such as tracheal epithelial cells [Wu et al., 1985] or hepatocytes [Ben-
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Z e ,e v  et al., 1988].
The tumour cells grown in histotypic culture showed morphological as well 
as biochemical changes. There was increased formation of cell surface microvilli 
compared to the cells grown in conventional monolayer which showed more smooth 
s u r fa c e d  cells. Intercellular and cell-matrix communications were more obvious in 
histotypic cultures. The cells formed connections with other cells as well as with 
collagen substrate, but only in histotypic cultures.
In addition there was stimulation of mucin-like glycoprotein synthesis in WIL 
cells grown in histotypic culture. The effects were significant compared to the 
monolayer cultures. Since microvillus formation and glycoprotein synthesis are seen 
in normal respiratory cells, this suggests that the histotypic model did alter 
differentiation. The chemical inducers caused no further changes, suggesting that a 
component of the model was effective. It is possible that the collagen substrate was 
responsible.
WIL cells grown as xenografts showed morphological and biochemical changes 
associated with the differentiated phenotype. There was an increase in synthesis of 
mucin-like glycoprotein, formation of glandular structures, microvilli, and 
ultrastructural evidence of mucin-like intracellular inclusions, and a slight decrease 
in expression of CEA, and HCG by immunohistochemistry. These features were 
similar to those observed in histotypic culture, suggesting that the model could be 
used to simulate in vivo conditions.
These data indicate that although further changes could not be induced in 
WIL in this system, it might prove useful in the study of other cell lines.
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CHAPTER FIVE
EFFECTS OF ONCOGENE TRANSFECTION ON PHENOTYPIC 
PROPERTIES OF MINK LUNG EPITHELIAL CELLS
This chapter describes the development and characterization of a model for the 
study of phenotypic alterations in relation to malignancy, following transfection 
of an epithelial cell line with human oncogenes.
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5,1 INTRODUCTION
The key events involved in conversion of normal human cells to malignant 
cells by biological and chemical carcinogens remain unclear. This is in part due 
to the fact that human cells, particularly of epithelial origin are more resistant to 
transformation by these agents in vitro [DiPaolo, 1983]. The reason for this 
resistance is as yet unknown. However, it has been proposed that host factors 
such as chromosomal stability, suppressor genes [Spandidos & Anderson, 1989] 
and efficient DNA repair system [Topal, 1988] may be responsible.
Cancer has a complex biology in vivo, and in vitro model systems are useful 
alternatives for the study of malignant process. Since malignancy cannot be 
demonstrated in vitro, it is useful to use a number of markers associated with 
malignant cells grown in culture, and which can be used to identify a malignant 
cell in vitro, though it may not imply a causal relationship between these 
characteristics in vitro and malignancy in vivo. The major advantage is that a 
number of malignancy associated parameters (e.g immortalization, lack of contact 
inhibition, high terminal density, loss of anchorage dependence and loss of serum 
dependence, altered morphology) can be studied in isolation under defined 
conditions, though each type of assumed transformed phenotype has to be 
carefully put into its proper biological setting and the criteria for the 
transformation have to be meticulously compared with the behaviour of 
histogenetically analogous normal cells; when this is done properly, it will be 
found that the phenotypes defined as transformations in laboratory model systems 
can be used as reliable indicators or marker of the acquisition of essential 
neoplastic cell features. Transformation in the experimental models deserves the 
same careful biological, functional, morphological, biochemical, and genetical 
analysis as tumours in vivo. Because of the vast experimental advantages of the 
laboratory model systems, this approach will probably be the best avenue towards 
the distant goal of understanding the biology of the malignant cell.
Transformation is a term applied to describe emergence of the malignant 
phenotype in vitro, however transformation and malignancy are not necessarily 
equivalent though the events occurring during transformation in vitro may be 
similar to those in carcinogenesis. While the term malignancy has a fairly clear 
meaning in vivo, it is difficult to translate into cell culture conditions. Malignant 
cells express a number of properties including proliferation, secretion of 
proteolytic substances, stimulation of angiogenesis, invasion, metastasis, glycolytic 
metabolism, all of which are also the properties of normal cells, with the only
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difference that expression of these properties in malignant cells is inappropriate 
in space and time. Therefore, it can be concluded that malignant cells are 
characterized by an inappropriate expression of normal cell properties, rather 
than de novo expression of tumour specific properties. The term neoplastic 
transformation, instead of malignancy, has been applied to cells in culture in 
order to describe the transition of a normal cell into a cell expressing properties 
associated with malignant cells. However the exact relationship between 
transformation in vitro and malignancy in vivo is not fully understood.
The malignancy associated phenotype has been studied, mainly by two 
approaches; a) the study of malignant cells in culture, following their isolation 
from tumours, and b) oncogenic transformation of normal cells in vitro e.g by 
transfection. An ideal approach may be the isolation of tumour cells and 
equivalent normal cells from the same patient and the same tissue, for 
comparative studies. However this has not been possible in the majority of cases, 
partly because the normal cells do not grow in culture easily, and secondly if they 
do, they may not belong to the same lineage, and their position in the lineage is 
not always clear. Therefore, such an approach though ideal, is not easily 
available and comparison not justified in all cases, especially, where the genetic 
background of such normal cells is not known in relation to expression or 
suppression of oncogenes.
Transformed cells exhibit an altered response to humoral growth 
controlling factors. The rate of proliferation of normal cells in routine media at 
low cell density may be as high as that of transformed cells [Buehring and 
Williams, 1976]. In order to reveal characteristic growth differences between 
normal and transformed cells they should be cultivated and tested at saturation 
density or under limiting concentrations of serum or growth factors.
With increasing knowledge of the role of oncogenes in carcinogenesis, a 
new approach has been based on the transfection of cells with oncogene 
sequences and this has been shown to induce malignant change in some cell lines.
Most of the previous studies involving the effects of oncogene transfection 
have been performed with non-epithelial cells, mainly NIH 3T3 fibroblasts. 
However, of great interest, complexity and clinical relevance are studies utilizing 
epithelial cells, from which most solid tumours arise, since carcinomas comprise 
over 80% of human malignancies. In these cells additional features such as cell 
lineage, differentiation status, and production of and response to endocrine 
growth factors may be involved in their progression towards autonomy and 
metastatic phenotype. Even in these limited studies so far investigators have
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focused mainly on growth and morphological alterations in vitro and 
tumorigenicity in vivo of the transfectants. Relatively little is known about the 
effects of oncogene transfection on tumour pathology, invasion, and metastasis.
Recently, however, some attempts have been made by Wyllie et al. [1987] 
to analyze pathological changes in tumours produced by c-mvc or Ha-ras 
transfected fibroblast cell lines. The effects of expression of human c-mvc and 
both mutated and normal human Ha-ras^ were studied in an aneuploid rat 
fibroblast line (208F), and activated ras alone in Chinese hamster lung fibroblasts 
(CHF). In contrast to the parental fibroblasts, cells expressing any of the human 
oncogenes formed rapidly growing tumours in nude mice. In general Ha-ras 
transfected cells were more aggressive than those expressing c-mvc oncogene. 
Metastases were found in all tumours expressing oncogenes. Activation of c- 
abl and c-fos was found in all transfected tumours. These findings have suggested 
that though transfection of Ha-ras. and c-mvc itself may be important for 
transformed phenotype, activation and co-transfection of other oncogenes may 
also contribute.
The objectives of this study were to investigate the effects of human 
oncogene transfection on a diploid epithelial cell line. The model system chosen 
was a cell line of mink lung origin (MvlLu) and three derivative lines transfected 
with normal c-mvc. normal Ha-ras and activated Ha-ms. (T24) oncogenes 
individually. This model was selected because of the potential relevance in the 
study of carcinomas, particularly the lung carcinoma systems studied in this thesis.
Oncogene transfection was assessed using southern blotting and 
immunocytochemistry. The cell lines were characterized with respect to lineage 
growth and invasive characteristics in vitro and in vivo, and response to cytotoxic 
drugs. The transfected lines were compared with the parental line. Such studies 
will provide a baseline for further studies on oncogene interaction and/or 
modulation of phenotype.
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5.2 MATERIALS AND METHODS
5.2.1 Cell Lines
The parental cell line MvlLu is available from the American Type Tissue 
Culture Collection (ATCC), Rockville, Md; where it is designated CCL64. For 
present studies the cell line was obtained from the European Collection of 
Animal Cell Cultures, Porton Down, Salisbury, Wilts.
The oncogene transfected cell strains used in this study were obtained 
from Dr Demetrios Spandidos at the Beatson Institute. The derivation of the 
plasmids used for transfection has been fully described elsewhere (Spandidos & 
Wilkie, 1984). From the parental MvlLu cell line three sublines were derived 
following insertion of mutated T(24) and normal human Ha-ras and human c- 
mvc genes in high expression vectors by calcium phosphate transfection technique 
[Graham & Van der Eb., 1973]. Each derivative line was expanded from a single 
clone. The plasmids used for the transfection were pH 0 6 T l, pH 06N l 
(Spandidos & Wilkie, 1984), and pM CGM l (Spandidos, 1985), containing the 
entire T(24) Ha-ras gene, the entire normal human Ha-ras proto-oncogene, and 
the entire human c-mvc proto-oncogene respectively. In p H 0 6 T l and pH 06N  1 
the Ha-ras genes are surrounded by both SV40 and Moloney virus LTR 
enhancers; whilst in pM CGM l the Moloney virus sequence is linked to the 
human c-mvc gene. All the plasmids contain the aminoglycoside 
phosphotransferase (aph) gene conferring resistance to geneticin (G418), which 
was used in the selection of the lines after transfection.
The cell lines were designated Mvl (parental), M l (c-mvc transfected). N1 
(Ha-ras transfected), and T1 (mutated Ha-ras transfected), as outlined in Table
[5.1].
FH05T1 cell line was derived by transfection of an early passage 
embryonic Chinese hamster lung fibroblast line (CHL), with the plasmids 
pH05Tl, which contained the mutationally activated human T24 Ha-ras 
oncogene ligated to viral LTR enhancing sequences. This cell line was selected 
as a positive control for ras immunostaining because it has been shown to express 
the ras specific membrane staining in previous studies [Going et al., 1988].
SCLC cell line H69 and its two derivative lines (see Chapter three-A) 
were used as positive control for c-mvc oncogene expression.
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5.2.2 Cytotoxic Drugs
Cytotoxic drugs; cytosine arabinoside and cis-platinum were purchased 
from Sigma Co. Ltd. Fresh drugs were prepared in culture medium each time.
5.2.3 Southern Blotting and Hybridization
Restriction enzyme cleaved DNA was electrophoresed on a 0.7% agarose 
gel at 1 volt/cm overnight, and transferred to Genescreen (NEN Research 
products) hybridization membrane by vacuum blotting using the Vacugene (LKB 
Pharmacia) vacuum blotting unit. DNA was first denatured by washing with 1.5% 
NaCl, 0.5M NaOH for 4 minutes, subsequently washed with neutralizing solution 
(1.0M Tris, 2.0M NaCl, pH 5.0) for 4 min and transferred to membrane in 
20xSSC under a vacuum of 40 cm H20  for 1 hour. Membranes were then baked 
at 80 °C for 2 hours prior to hybridization. Hybridizations were performed 
according to the methods of Maniatis et al. [1982], using random primed 
[Feinberg and Vogelstein, 1983] 32P-labelled probes at 42 °C in 5x Denhardts 
solution with 50% formamide, 10% dextran sulphate, 0.1% SDS and 100 /ig/ml 
denatured salmon sperm DNA. Membranes were washed at high stringency 
(O.lxSSC, 0.1% SDS at 65°C) for 1 hour with three changes of wash solution. 
(These techniques were performed by Dr Jas Lang at the Beatson Institute).
5.2.4 Cellular Localization of Ha-ras. Protein p21.
The immunohistochemical staining techniques as adapted by Going et al. 
[1988] were employed in this study, the steps are briefly outlined below.
Paraformaldehyde (BDH) stock solution (8%) was prepared in deionized 
distilled water (DDW) at 70 °C with the addition of 100 mg sodium hydroxide for 
each 100 ml of solution. The solution was stirred until cleared then filtered and 
stored at room temperature. Stock solution of 0.05M phosphate buffer pH 7.7 
contained 0.0367 M dibasic sodium phosphate (Na2HP04) and 0.0133 M 
monobasic sodium phosphate (NaH2P 0 4) in deionized distilled water (DDW). 
Fresh periodate lysine paraformaldehyde (PLP) solution was prepared in small 
batches of 200 ml before use by dissolving 2.74 gm of anhydrous sodium 
metaperiodate in a mixture of 50 ml of 8% paraformaldehyde and 150 ml of 
phosphate buffer pH 7.7. Subsequent periodate lysine paraformaldehyde 
bichromate (PLPD) was prepared by dissolving 2.5% w/v of potassium 
bichromate in PLP diluted with an equal volume of DDW.
Cell suspensions were prepared from monolayer cultures by trypsinization, 
cells were washed in PBS and spun at lOOg for 3 min. Approximately 5xl06 cells
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were fixed in PLPD for 15 min at 4 °C, washed in PBS and resuspended in 0.5 
ml of 2% low melting temperature agarose (Gibco Ltd, Paisley, Scotland) in PBS 
at 40 °C. The agarose cell pellet was post-fixed for up to 24 hours in PLPD 
washed in PBS and processed for paraffin embedding without raising the 
temperature higher than 56 0 C. Blocks (5x5x4 mm) from xenografts were placed 
immediately in PLPD and fixed at 4 °C for 24 to 36 hours. Subsequently tissues 
were washed overnight in running tap water and processed for paraffin sectioning. 
4 \im sections were cut and dried at 56 °C for at least 30 min before 
immunostaining.
An avidin-biotin complex (ABC) technique was employed as adapted by 
Going et al. [1988]. Briefly, the primary antibody Y13-259 (kindly provided by 
Dr D. Spandidos of Beatson Institute) was applied to sections overnight at 1:50 
dilution in tris-buffer isotonic saline (TBS), containing 10% normal goat serum 
(TBS/NGS). Biotinylated anti-rat antibody (Sigma Co Ltd.) 1/50 in TBS/NGS 
was applied for 30 min. These stages were each followed by two 5 min washes 
in tris saline (TS). Streptavidin biotin peroxidase complex (ABC) (Amersham 
International) 1/200 in TBS was applied for 30 min. After three 5 min TS 
washes sections were developed with diaminobenzidine-H20 2 in TBS. Negative 
controls included omission of Y13-259 from the first stage and its replacement 
with the same concentration of polyclonal rat immunoglobulin (Sigma Co Ltd.). 
The non-transfected parental cells and their tumours were included. FH05T1 
cells were used as positive controls to confirm specificity of staining.
5.2.5 Cellular Localization of c-mvc Protein p62
Mvl parental cell line was used as a negative control for M l the c-mvc 
transfected experimental test cell line. The lung carcinoma cell lines (H69; 
H69V, and H69VZ, see Chapter three-A), and their xenografts were included as 
positive controls.
Frozen sections, monolayer and cytospin preparations were stained by the 
alkaline phosphatase, and ABC staining techniques. Slides were incubated in 
0.1% triton x-100 in tris saline for 5 min before immunostaining. The primary 
antibody mvcl-9E10 (kindly provided by Dr Demitrius Spandidos of Beatson 
Institute) was applied at 1:20 dilution in tris-buffer saline for 2 hours at room 
temperature. Formalin fixed tissue were stained by the avidin-biotin complex 
peroxidase method. The primary antibody (mvcl 9E10) was used at 1:50 dilution 
in tris-buffer saline overnight at 4 °C.
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52.6 Autoradiography
Methods were adapted from Freshney [1987]. Cultured cells at saturation 
density were incubated with [3H]-thymidine to label the DNA, washed, fixed and 
dried. The preparations were coated with melted photosensitive emulsion in the 
dark and left to expose at 4 °C for 1 week, developed, and examined under the 
microscope to see the silver grains overlaying the areas where radioisotope was 
incorporated [see below, Plate 5.11].
Monolayer cultures of cell lines (Mvl, M l, N l, and T l)  were grown to 
saturation density monitored by daily counts in 24 well plates, and daily feeding. 
Routine medium was then changed to thymidine free medium (DMEM) for 24 
hours. 3H-thymidine was added to the culture at 5/iCi/ml (2Ci/mM) final 
concentration for 1 hour. They were washed in PBS, trypsinised, and 
resuspended in a few drops of PBS. The cells were fixed in ice-cold acetic- 
methanol (1:3) for 10 min, spun and resuspended in fixative at final dilution of 
lxlO5 cells/ml. Cytospin preparations were made on dry clean glass slides. They 
were washed in distilled water and finally in 10% cold trichloroacetic acid to 
extract the acid soluble precursors. They were washed again in distilled water 
then in methanol, and dried.
Slides were coated with melted photographic emulsion (Ilford L4 diluted 
1:1 v/v, with d/w) in dark room, and allowed to dry, then placed in a light-proof 
slide box with silica gel and sealed with dark vinyl tape, finally wrapped in a 
black bag and left at 4 °C for 7 days. After 7 days one slide was developed in 
D19 (Kodak) for 10 min, washed and fixed in photographic fixer (Ilfofix, Ilford) 
for 4 min, washed in distilled water and placed in hypoclearing agent (Kodak) 
for 2 min, and then washed with distilled water (5 changes over 5 min). The 
slides were dried, and examined under the microscope to check for the optimum 
grain formation. If satisfactory, remainder of the slides were then processed 
using the same protocol.
Slides were stained with Giemsa, washed, dried, and mounted. The 
preparations were examined under the microscope (x 10 eyepiece, x 100 oil 
immersion objective). The number of grains per cell was counted and the 
specific nuclear localization of grains was confirmed. Cells containing more than 
25-30 grains per nucleus were counted as positive. For labelling indices the 
labelled cells were counted as a proportion of the total cells per field, in 40-60 
fields, in total 2500-3000 cells.
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5.2.7 Bromodeoxyuridine Incorporation Assay
The assay was performed using a commercially available kit (Cell 
Proliferation Kit) and following the manufacturer’s (Amersham International Ltd, 
Bucks, England) instructions.
Coverslip cultures in 24 well plates were grown to saturation density. 
Routine medium was replaced by DMEM for 24 hours. Cells were then exposed 
to labelling reagent, bromodeoxyuridine (BrdUrd) at 1:1000 v/v final dilution in 
DMEM for 1 hour at 37 °C, washed in PBS three times, and fixed in acid- 
ethanol (1:3) for 30 min at room temperature, followed by another wash in PBS. 
Preparations were processed using the indirect immunoperoxidase method as 
described in the General Methods with following modifications. Non-specific 
binding sites were blocked with non-immune sheep-serum (1:5 in tris buffer) for 
20 min before application of each antibody. Pre-diluted mouse monoclonal 
primary antibody (anti-BrdUrd) was applied for 60 min at room temperature. 
Peroxidase linked secondary antibody (sheep anti-mouse-HRP) was applied for 
30 min at room temperature. Slides were washed in saline, and incubated with 
3’-3’-diaminobenzidine (DAB) solution containing nickel and cobalt as colour 
intensifier, for 10 min. Background nuclei were stained with neutral red. The 
coverslip preparations were then dehydrated and mounted. 2500-3000 cells from 
the representative areas of the replicate coverslips were counted in each assay 
(x 10 eyepiece, x 100 oil immersion objective). The labelling index (LI) was 
expressed as a percentage of total cells for each cell line.
5.2.8 Plasminogen Activator Assay
The chromogenic assay for measuring plasminogen activator (PA) activity 
adapted in this study was a modification of that developed by Whur et al. [1980].
The assay is essentially an amidolytic reaction which is a two step process, 
resulting in release of p-nitroanaline from a synthetic chromogenic substrate. In 
the first step, PA in the test sample (cell/medium, tissue/fluid) converts 
plasminogen into plasmin which in turn cleaves the chromogenic substrate S- 
2251 (H-D-Valyl-L-leucyl-L-lysine-p-nitroanilide dihydrochloride), releasing p- 
nitroanaline the absorbance of which is measured at 405 nm, which is used as a 
function of PA in the test sample [Figure 5.1].
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The cells were plated at lx l03/ml/well in 24 well plates, and grown to 
confluence at 37 °C, 2% COz and 98% air, in humid incubator. Routine culture 
medium was replaced with serum-free medium for 3 days followed by 24 hours 
incubation in serum free phenol red free medium, to remove possible absorbance 
of phenol red and also to reduce the inhibitory effects of serum factors on PA.
Conditioned medium was saved after 24 hours, centrifuged at lOOg for 5 
min and transferred into 24 well plates again to be assayed in the same way as 
cellular PA. The monolayer cells were washed 3 times with PBS. Test samples 
(cells/medium) were incubated with 500 ^ 1 of reaction mixture which consisted 
of 5 mM chromogenic substrate S-2251 (KabiVitrum) 5cu/ml of plasminogen 
(KabiVitrum), 1.5 mg/ml poly-D-lysine, in HBSS. The reaction was then allowed 
to run for up to 2 hours when the assay was terminated with the addition of 
500 fA of 5% acetic acid in each well. The absorbance was read at 405 nm using 
a spectrophotometer (Gilford 250), which gave a measure of p-nitroanaline 
produced as a function of PA released by cells. Cell number per well was 
determined by electronic counting of the single cell suspension following 
trypsinization. Protein content per well was also determined by the method of 
Lowry et al. [1951].
Each set of readings was blanked against the corresponding plasminogen 
free controls and the net change in absorbance attributable to the activation of 
plasminogen was calibrated against serial dilutions of a urokinase standard curve. 
A reagent blank was included, by excluding the source of PA (cells/or medium) 
from the reaction mixture. The enzyme activity was expressed as plough units 
(PU) per million cells or PU per mg protein, and also as PU per ml of medium 
in case of secreted PA.
52.9 Other Methods
All other methods used in this Chapter including tissue culture, 
chromosome analysis, LDH isoenzyme analysis, invasion in vitro, cytotoxicity 
assays, various animal experiments, invasion and metastasis in vivo, histological 
procedures, and immunohistochemical techniques were performed as described 
in General Methods, more specific details are provided with the figure legends, 
where appropriate.
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Plate 5.1:- Southern Blot Analysis of The Cell lines.
(a). Expression of Ha-ras in the cell lines N1 and T1
Southern blot analysis of Ha-ms. transfected cell lines hybridised with 32p 
labelled Ha-ms probe isolated by sma I/SST I cleavage of PT24C3 and 
spanning exons 1-4. The 6.6 Kd human specific Bam HI fragment 
encompassing the Ha-ms gene was observed in cell line N1 (track 2). An 
Ha-ras specific fragment of higher molecular weight was observed in cell line 
T1 resulting from a probable integration of Ha-ras sequence within the 6.6 
Kd Bam fragment with endogenous mink lung sequences (track 1). Parental 
cell line Mvl shows no hybridisation to the human Ha-ras. probe (track 3).
(b). Expression of c-mvc in cell line M l.
Southern blot analysis of c-mvc transfected cell line M l hybridised with 32p 
labelled human c-mvc probe isolated by PVU II/B gl II cleavage of PMC41 
and spanning exon 2. The 8 Kd human specific Hind III/EcoR I fragment 
encompassing the entire human c-mvc gene was observed in cell line M l 
(track 1) and was absent from parental cell line Mvl (track 2).
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Plate 5.2:- Ras p21 specific immunostaining
(a). FH05T1 cells showing membrane specific staining, using Y13-259 
antibody (X 360, avidin biotin technique).
(b). The Ha-ras transfected cells (T l) grown as tumour were stained as (a) 
showing focal membrane staining.
(c). Primary antibody replaced by non-immune rat immunoglobulin.

5.3.1.3 Cellular Localization of c-mvc Product
Both nuclear and cytoplasmic staining was observed in positive control 
lung carcinoma cell lines, H69V and H69VZ [Plate 5.3 a] when primary antibody 
9E10 was applied for 2 hours at room temperature with either of the methods 
used. Specific staining was not observed either in the parental cell line (Mvl) 
or in c-mvc transfectant (M l). However when antibody was applied overnight a 
few cells were stained positive, with both nuclear as well as cytoplasmic staining, 
but only at the expense of background staining [Plate 5.3 b]. Replacement of 
9E10 with non-immune mouse serum or monoclonal control at the same 
concentration abolished staining [Plate 5.3 c].
5.3.2 CHARACTERISATION IN VITRO
Following confirmation of the oncogene transfection, this section 
investigates the validity of selection system used in transfection assays, species 
and lineage identity of the cell lines, and the effects of oncogene transfection on 
morphology, and growth characteristics of transfectants in vitro.
Results of in vitro studies showed that oncogene transfections of mink lung 
epithelial cells had imparted a number of malignancy associated properties to the 
transfectants, which were absent in the non-transfected parental cell line, 
including morphological changes, enhanced growth rates, high labelling indices 
at saturation densities, acquisition of anchorage independent growth, less serum 
dependence, and invasiveness. Only minor differences were found in c-mvc 
transfectants compared with the Ha-ras oncogenes transfected cell lines.
5.3.2.1 Geneticin Sensitivity
Cells were grown in 25 cm2 flasks as well as cloned (monolayer cloning), 
in presence and absence of the drug. The drug sensitivity was tested both at 
early [Table 3.5 a] as well as at late [Table 3.5 b] passage levels following 
transfection. The parental line (Mvl) was sensitive while all the transfected lines 
were resistant to geneticin. 100% kill was observed in Mvl cells both at low 
(200 jig/ml) and at high (800/ug/ml) drug concentration. A few colonies seen in 
the parental line ( 200 /ig/ml) after 2 weeks were followed further but no growth 
was found after 4 weeks. On the other hand, all the transfected lines (M l, N l, 
and T l) exhibited resistance to geneticin, and no effect was observed when 
colonies were kept in the drug for up to 4 weeks, instead colonies grew and 
formed a monolayer culture in presence of drug. A significant increase in colony
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Plate 5.3:- The c-myc specific immunostaining
(a). H69V tumour tissue showing both nuclear and cytoplasmic staining for 
c-myc protein, using 9E10 antibody (X 360, avidin biotin technique).
(b). Tumours produced by M l processed as (a) showing occasional staining, 
both nuclear and cytoplasmic.
(c). Primary antibody replaced with monoclonal control or non-immune 
mouse serum.
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size was noticed in N1 cell line following drug exposure.
5,3.2.2 Species of Origin of The Cell Lines
(A) Chromosome Analysis
Chromosome analysis of cell lines showed a diploid chromosome number 
of 30 [Table 5.4, Figure 5.2].
Table 5.4:- Chromosome number of the lines.
*NO Mvl M l N1 T l
omII£ 70 67 60 77
N =30 30 33 40 23
*NO: Chromosome number. A Pearson chi-square test was not statistically 
significant (P = 0.15) indicating that the chromosome number of the four cell 
strains was the same.
A diploid chromosome number of around 30, a modal chromosome 
number of 30 and morphology of the chromosomes confirmed the mink origin of 
the cell lines. No obvious differences were observed among the strains in terms 
of their gross chromosomal morphologies, or chromosome number. Detailed 
karyotypic analysis of the cell strains by G-banding was attempted, but 
preliminary results did not show any differences (data not shown).
(B) Lactate Dehydrogenase Isoenzyme Analysis
LDH-isoenzymes revealed characteristic bands specific to the mink lung cell lines, 
which were absent from the cell lines of other species [see Plate 3.2, Figure 3.1].
5.3.2.3 Lineage Identification
(A) Morphological Properties
When grown in sparse culture there were no obvious differences among 
the lines. Both the parental as well as transformants showed multipolar flattened 
cells. When observed at confluence, Mvl cells grew as flattened cells exhibiting 
contact inhibition. M l appeared very similar to the parental line. However, N1 
and Tl showed distinct morphological changes, with cells attaining a bipolar or
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spindle shaped appearance. Their growth was also very fast and they reached 
confluence earlier than the parental line, started at the same cell density. The 
morphological phenotypes were strikingly different in the dense cultures, the 
parental line formed contact inhibited monolayer [Plate 5.4 a], while the 
transfected cells formed characteristic whorls [Plate 5.4 b, c, & d]. The 
differences were always more pronounced in mutated ras transformed cells 
compared with other transformed lines.
(B) Cytologjcal Studies
Examination of the centrifuged or whole mount preparations of monolayer 
cells stained with Giemsa showed an epithelial appearance in all the lines. Mvl 
[Plate 5.5] and M l cell lines were polygonal, with large central round nuclei, 
and prominent nucleoli, while T l [Plate 5.5] and N1 were spindle shaped.
(C) Loss of Contact Inhibition
The parental cell line, Mvl, grew as a typical contact-inhibited monolayer 
of cells [Plate 5.6], while all the transfected cell lines showed piling up of more 
spindle shaped fibroblastic type cells, as shown in T l [Plate 5.6].
5.32.4 Growth Characteristics of The Cell Lines
(A) Growth Rates
A growth curve was generated [Figure 5.3] for each cell line, by plating 
lxlO3 cells/well in 24 well plates and counting at 24 hours intervals. The cell 
number was significantly higher in the transformed than in the parental cells 
throughout the growth period, but the differences were most distinct at the 
saturation densities. The numerical data are shown in Table 5.5. Under routine 
culture conditions, all the cell lines grew rapidly with average doubling times of 
under 23 hours, a short lag period of around less than a day, and a relatively 
steeper log-phase of around 8 days duration. The plateau was reached after 
approximately 9 days in all cell lines under the culture conditions as described 
above. However, the population doubling time (DT) of the parental line was 
relatively longer than those of transfected lines. The doubling time was 
significantly reduced in transfected cell lines, especially in T l, compared to 
nontransfected line, and the saturation densities of the transfectants were 
increased relative to their nontransfected counterpart.
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Plate 5.4:- Morphology of the cell lines in culture.
Mvl grows with a typical epithelial morphology. M l also shows epithelioid 
morphology with some spindle cells. N1 and T l show a more marked 
spindle cell morphology, and the changes being most prominent in T l (X 
10 objective, phase-contrast, scale bar=  200 /an).
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Plate 5.5:- Effects of oncogene transfection on cytology of transfectant
Sub-confluent cultures fixed in methanol 48 hours after subculture, showing 
significant morphological differences. Compared to parental line Mvl (large, 
multipolar, epithelioid cells) the activated Ha-ras transfected line T l  shows a 
more marked spindle shaped morphology. M l cells were similar to Mvl and N1 
to T l  (X 20 objective, Giemsa stain, bar scale = 100 /2m)
Plate 5.6:- Effects of oncogene transfection on contact inhibition.
Post-confluent cultures of Mvl cells forming a contact inhibited monolayer, and 
the Ha-ras transfected line T l  showing evidence of multilayering with loss of 
contact inhibition (X 20 objective, phase-contrast, bar scale = 100jum)
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Figure 5.3:- Growth curves of cell lines in vitro.
5xl02 cells were plated per well in 24 well plates at day zero. Cells were 
trypsinised and counted from a minimum of 3 wells daily, and using an electrical 
particle counter. Medium was changed with fresh on alternate days in early 
growth period i.e from 1-5 days, and daily thereafter. Each point represents 
mean ± SEM of 4 replicates from one experiment similar results were obtained 
from three other experiments, repeated on different occasions.
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Table 5 .5 :- Growth characteristics in v itro , following oncogene 
transfection of mink lung cell lin e  Mv1.
Cel l  l i n e Oncogene
t r a n s f e c t i o n
P o p u l a t i o n  
Doubling t im e  
(Hours)
S a t u r a t i o n  
D e n s i ty  
( Cel l s / c r r r )  
x10‘ 5
Mv1 None 22 .8  + 1 .0 3 .9  + 0 .4
M1 c-myc 19.1 + 0 .7 6 .4  + 1 .0
N1 Ha-ra s 16 .9  + 1 .3 **9 .3  + 0 .7
T1 H a- ra s  (T24) *15 .7  + 1 .3 **9 .8  + 0 .5
C e l l s  were grown f o r  12 days in  F10:DMEM c o n t a i n i n g  10% FBS and 
i n  24 wel l  p l a t e s .  C e l l s  were c oun te d  from t h r e e  w e l l s  and f ed  
d a i l y .  Data  a r e  mean +_ SEM from a t  l e a s t  4 i n d e p e n d e n t  
e x p e r i m e n t s .
*P< 0 .02 ,  **P<0.004 (Mann-Whitney t e s t  w i th  Bonferoni
a d j u s t m e n t ) .
(B) Serum Dependence
Plating Efficiency in Monolayer Culture
The ras transfected cells always showed a relative increase in their ability 
to clone in monolayer in the absence of serum, compared with the non­
transfected line [Table 5.6]. However, all lines cloned poorly in the absence of 
serum, especially Mvl, and M l. The growth of transfected lines was not affected 
as much as that of the parental line when grown at high cell concentrations 
(lxl05/m l) in 25 cm2 flasks. However, the growth of all the cell lines was 
reduced significantly by increasing the passage number in serum free conditions. 
Increasing the serum concentration to 0.5% increased the cloning efficiency 
although the number was still higher in the transfected lines by over three fold. 
The plating efficiency of transfected lines showed only a modest increase when 
serum concentration was raised from 10% to 20%, an increase in the mean size 
of colony was noticed at 20% serum especially in N1 line [Plate 5.7].
Anchorage Dependence
While the plating efficiency in monolayer showed only a modest increase 
in the transfected lines, cloning in suspension with 10% serum gave a low 
efficiency in Mvl, and both N1 and T l showed a marked increase, 7-10 fold in 
N1 and 10-20 fold in T l [Table 5.7]. A more modest increase of 2-3 fold was 
also observed in M l. The small number of colonies formed in Mvl plates were 
of the same size as M l and T l, while N1 cell gave numerous smaller colonies 
[Plate 5.8]. Slight inhibition of colony formation was observed in N1 and T l in 
contrast to an apparent stimulation of colonies in Mvl and M l when serum 
concentration was raised from 10% to 20% [Table 5.7]. M l and T l gave larger 
sized colonies while N 1 gave numerous but smaller sized colonies. This finding 
was consistent, but in contrast to monolayer cloning. When cloned in medium 
containing 0.5% serum, Mvl cells died within 10 days of cloning. While the 
transfected cells did survive, though they could not form colonies, they were alive 
and non-dividing or quiescent, and were able to be stained with MTT dye even 
after 3 weeks in agar suspension. When cloned in serum free medium none of 
the cell lines was able to form colonies. The cells died completely both in Mvl 
and Ml, although a few single and non-dividing cells were still able to reduce the 
MTT, after 3-4 weeks in agar culture.
Saturation Densities
Cells were plated in 24 well plates at a density of 1x10s cells/well in 
routine culture medium (10% FBS). The cells were trypsinised and counted
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from at least 3 w ells/treatm ent on alternate days until the cell number reached 
the plateau usually at 10th. to 12th. day. The peak cell number for each cell was 
determined and compared with control. In parallel experiments, saturation 
densities were found in different serum concentrations (0%, 0.5%, 10%, and 
20%). Saturation densities in regular monolayer cultures were higher in the 
transfected lines than in non-transfected cells, and were maximum at 10% FBS, 
while the parental line still showed a further increase at 20% FBS [Figure 5.4]. 
All transfected lines showed a higher cell number in limiting serum 
concentrations (0.5%) with T l showing least dependence. Terminal cell numbers 
in the absence of serum were extremely low but were still highest in T l  and 
higher in N1 and M l than in Mvl.
5.32.5 Effects of Dexamethasone on Cloning Efficiencies of The Cell Lines.
The effect of dexamethasone (lxlO6 M) on monolayer cloning was 
stimulatory. Though the effect on the number of colonies was only modest 
[Table 5.8], a significant increase in size of colonies was noticed as seen with 20% 
serum, and striking finding was a marked increase in size of colony in N l, an 
effect opposite to that in agar [see above, Plate 5.7].
Dexamethasone also showed stimulatory effects on the growth of cells in 
agar [Plate 5.9; Table 5.8]. A marked increase in size of colonies was noticed in 
all lines [Plate 5.10], except N l which showed numerous, but still very small 
colonies, a feature opposite to that found in monolayer. Mvl and M l showed an 
intermediate response.
532.6 Labelling Indices of The Cell Lines
Labelling indices (LI) were determined at saturation densities both by 
conventional autoradiography and by BrdUrd incorporation assays. A  good 
correlation was found between the values determined by these two different 
techniques [Table 5.9]. There were consistent differences among the different 
cell lines [Plate 5.11]. The indices increased both in N l and T l cell lines by 
approximately 4 fold, but there was only slight increase in M l cell line. These 
differences were consistent with the growth of cell strains in culture [see Table
5.5], where T l  and N l showed a high growth rate compared with the parental 
line and the M l was intermediate relative to other lines.
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Table 5 .6 :- Effect of serum concentration on plating effic ien cy  in 
monolayer.
Cell l i n e Pla t ing  e f f i c i e ncy  (%)
0% FBSa 0.5% FBS 10% FBS 20% FBS
Mv1 0 . 0 2 . 8  + 1 . 4 b 59 .2  + 6.1 70 .6  + 10 .0
M1 0 . 0 9 .3  + 1 .4 67 .5  + 6 .8 81.1 + 10.1
*N1 0.1 + 0.1 7 .3  + 0 .9 75 .3  + 4 .5 8 9 .0  + 6 . 8
*T1 0.1 + 0.1 7 .7  + 3 .9 8 1 .9  + 7 .7 90.1 + 7 .2
a FBS F o e t a l  b o v in e  serum. ^Values  a r e  mean + SEM o f  t h r e e  i n d e p e n d e n t  
e x p e r i m e n t s ,  each  c o n t a i n i n g  a t  l e a s t  4 r e p l T c a t e s .
P<0.008 ( A n a l y s i s  o f  v a r i a n c e  and Bonferoni  a d j u s t m e n t ) .
10%FCS 20%FCS
Plate 5.7:- Effects of serum concentration on plating efficiency and colony size 
of the cell lines.
A single cell suspension in culture medium was seeded into 60 mm petri dishes 
with 500 cells per dish in 5 ml medium with varying serum concentration (0%, 
0.5%, 10%, and 20%), and colonies fixed after 2 weeks. Ml and N l showing an 
increase in colony number and size in 20% serum compared to 10% serum. Mvl 
and T l  were similar to M l. N l cells show an increase in size in 20% serum, in 
contrast to a small size colony formation in agar (see Plate 5.8). Similar effects 
were seen when the cells were grown in 10% serum containing 1 /^M 
dexamethasone.
Table 5 .7 :- Effect of serum concentration on the cloning 
efficiency o f mink lung c e lls  growing in semi sol id medium.
Cel 1 1 i ne Cloning  e f f i c i e n c y  (%)
0% FBS 0.5% FBS 10% FBS a 20% FBS
Mv1 0 .0 0 .0 0.1 + 0 .0 0 . 5  + 0 .3
*M1 0 .0 0 .0 0 . 7  + 0.1 5 .4  + 0 .5
*N1 0 .0 0 .0 15 .2  + 2 .2 10 .3  + 1 .3
*T1 0 .0 0 .0 22 .6  + 2 .0 1 0 .7  + 1 .8
FBS= F o e t a l  b o v in e  se rum. S i g n i f i c a n t  i n c r e a s e  i n  c o lo n y  s i z e .  
Data a r e  mean +_ SEM from a t  l e a s t  3 i n d e p e n d e n t  e x p e r i m e n t s ,  each  
e x p e r i m e n t  w i t h  a minimum o f  4 r e p l i c a t e s .
*P<0.050 (Mann-Whitney t e s t )
M1
N1
■1
Plate 5.8:- Clones of cells in soft agar.
lxlO4 cells were plated per dish in 0.3% agar on a 1% agar underlay in 
a 35 mm dish, and colonies stained with M IT  after 3 weeks. There is no 
colony formation in Mvl. All transfected cell lines show colony formation 
reaching a maximum with T l. N l formed numerous small sized colonies, 
while M l formed fewer but still large size colonies.
from at least 3 wells/treatment on alternate days until the cell number reached 
the plateau usually at 10th. to 12th. day. The peak cell number for each cell was 
determined and compared with control. In parallel experiments, saturation 
densities were found in different serum concentrations (0%, 0.5%, 10%, and 
20%). Saturation densities in regular monolayer cultures were higher in the 
transfected lines than in non-transfected cells, and were maximum at 10% FBS, 
while the parental line still showed a further increase at 20% FBS [Figure 5.4]. 
All transfected lines showed a higher cell number in limiting serum 
concentrations (0.5%) with T l showing least dependence. Terminal cell numbers 
in the absence of serum were extremely low but were still highest in T l and 
higher in N l and M l than in Mvl.
53.2.5 Effects of Dexamethasone on Cloning Efficiencies of The Cell Lines.
The effect of dexamethasone (lxlQ6 M) on monolayer cloning was 
stimulatory. Though the effect on the number of colonies was only modest 
[Table 5.8], a significant increase in size of colonies was noticed as seen with 20% 
serum, and striking finding was a marked increase in size of colony in N l, an 
effect opposite to that in agar [see above, Plate 5.7].
Dexamethasone also showed stimulatory effects on the growth of cells in 
agar [Plate 5.9; Table 5.8]. A marked increase in size of colonies was noticed in 
all lines [Plate 5.10], except N l which showed numerous, but still very small 
colonies, a feature opposite to that found in monolayer. Mvl and M l showed an 
intermediate response.
5.3.2.6 Labelling Indices of The Cell Lines
Labelling indices (LI) were determined at saturation densities both by 
conventional autoradiography and by BrdUrd incorporation assays. A good 
correlation was found between the values determined by these two different 
techniques [Table 5.9]. There were consistent differences among the different 
cell lines [Plate 5.11]. The indices increased both in N l and T l cell lines by 
approximately 4 fold, but there was only slight increase in M l cell line. These 
differences were consistent with the growth of cell strains in culture [see Table
5.5], where T l and N l showed a high growth rate compared with the parental 
line and the M l was intermediate relative to other lines.
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1500
■a—  Mvl 
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1000 -
500 -
0 10 20
Serum Concentration (%)
Figure 5.4:- Effects of serum concentration on terminal cell density.
103 cells were seeded per well in 24 well plates on day 0, with medium containing 
varying serum concentration (0%, 0.5%, 10%, and 20%). Cells counted daily 
from wells with 10% serum (see Figure 5.3), and cell number for each serum 
concentration determined at day 10-12. Each data point represents mean ± SEM 
(bars) from 3 experiments.
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Plate 5.9:- Effect of dexamethasone on colony number in agar.
M l cells 104/m l 0.3% agar plated with 10% serum without dexamethasone 
(CONT) or 10% serum containing 1 dexamethasone (DXM). Duplicate 
plates show increased number of colonies in the presence of dexamethasone. 
Colonies stained with MTT after 3 weeks. Similar results were observed in Mvl 
and T l  lines, while N l formed numerous but still small size colonies (see above, 
Plate 5.8)
Plate 5.10:- Effects of serum and/or dexamethasone on agar cloning.
T l colony size 2 weeks after cloning in 0.3% agar in 10% serum (a), 20% serum 
(b), and 10% serum with 1/jM dexamethasone (c). Both increasing serum 
concentration and the addition of 1 nM dexamethasone resulted in an increase 
in colony size. Similar results were seen in M l (see above, Plate 5.9) and to a 
lesser extent in Mvl. There was no effect on colony size in N l (see above, Plate 
5.9).
f

Table 5 .9 :- Labelling indices of the cell lin es at saturation 
density.
a LABELLlNG INDICES (%)
Cell  l i n e A u to rad iog raphy Bromodeoxyur id ine *P-Value
(^H -thym id ine) (Brdl lrd  a s s a y )
Mvl 6 .3  + 0 .6 4 . 7  + 0 .3
M1 6 .6  + 0 . 8 5 .5  + 0 .2 >0.05
N1 22 .3  + 0.1 15 .9  + 0 .7 <0.001
T1 24 .0  + 1.3 2 7 .0  + 1.4 <0.001
a C e l l s  were exposed  t o  t h e  l a b e l l i n g  r e a g e n t  (^H - thym id ine  o r  
Bromodeoxyur id ine)  f o r  1 hour  a t  37 °C.
^ S t a t i s t i c a l  a n a l y s i s  was c a r r i e d  o u t  u s in g  a n a l y s i s  o f  v a r i a n c e  
t e c h n i q u e  w i th  Bonferoni  a d j u s t m e n t .
Plate 5.11:- Autoradiogrphy
Cells labelled with 3H-thymidine (5.0 /iCi/ml) for 1 hour in DMEM medium, 
were fixed, and coated with radiosensitive emulsion, and incubated in the dark 
for 1 week before developing. Photomicrographs of labelled cells from 
representative fields of Mvl, M l, and T1 are shown. Labelled cells are more 
frequent in both M l and T1 than in the parental line (see Table 5.8), with T1 
showing greatest number, and N1 appeared as T l.
(X 40, Giemsa, scale bar=  50 ian).
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Plate 5.12:- Expression of cytokeratins in monolayer cultures
Positive staining for broad range basic cytokeratins is demonstrated in Mvl (a), 
M l (b), and T1 (c). N1 appeared as T l. Staining was abolished when primary 
antibody was excluded in Mvl (d). (X 225, AE3 antibody: indirect IP).
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Plate 5.13:- Expression of low molecular weight cytokeratin in cell lines.
Example of focal positivity for low molecular weight cytokeratin in Mvl, 
consistent with glandular differentiation. Similar results were observed in 
other cell lines (X 255, CAM5.2 antibody: indirect IP).
Plate 5.14:- Expression of vimentin in monolayer cultures.
Positive staining for vimentin is demonstrated in cell line Mvl (a), M l (b) 
and T1 (c). N1 appeared as T l. Staining was abolished when primary 
antibody was replaced with non-immune serum in Mvl (d).
(X 225, anti-vimentin antibody: indirect IP)).
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Plate 5.15:- Effects of stromal interaction on morphology of cell lines.
Morphology of fibroblast co-culture with Mvl (a), M l (b), N1 (c), and T l  (d) 
cells in 50:50 ratio, 3 weeks after seeding. 2xl04 cells/ml were plated in 25 cm2 
flasks, with 5 ml culture medium. Mvl shows no morphological effects in 
presence of fibroblasts, and M l shows only slight changes. In contrast N1 and 
11 show intermingling of the cells with fibroblasts giving different culture 
morphology compared to the cultures without fibroblasts (see above, Plate 5.4) 
(X 20 objective, phase-contrast, scale bar=  100 jzm).
532.1 Immunohistochemical Marker Expression
(A) Cytokeratin Intermediate Filament Proteins
All cell lines stained positively [Plate 5.12] with a broad spectrum anti- 
cytokeratin monoclonal antibody AE3, which recognizes almost all of the known 
basic, type-II cytokeratins (type 1-8 according to Moll’s catalogue, [Moll et al., 
1982].
Cell lines were negative when stained with AE1 another broadly specific 
monoclonal antibody against type-I or acidic cytokeratins of Moll’s catalogue 3, 
5, 12, and 19 [Moll et al., 1982].
Focal positivity (around 10%) was observed in cells stained with CAM5.2 
[Plate 5.13], which demonstrates low molecular weight (39kD, 42kD, and 45kD) 
cytokeratins [Moll et al., 1982).
Approximately, 40%-50% of all cell lines showed positive staining for 
vimentin, an intermediate filament protein more commonly expressed by the cells 
of non-epithelial origin. The pattern of staining was different from that of 
cytokeratin, with prominent positivity in cell processes [Plate 5.14].
(B) Membrane Specific Antigens
Positive staining with EMA was focal and observed in less than 5% of 
cells. There was no difference in the staining of different cell lines.
Staining was similar with HMFG 1 and 2.
Immunopositivity with a,and /3-HCG was demonstrated in less than 5% of
cells.
5.3.2.8 Ultra structural Features
The presence of intermediate filaments, poorly developed adhesion 
specializations, microvillus profiles, and general cell to cell relationships were 
indicative of epithelial differentiation. These findings were present in all cell 
lines. The ras transfected cells showed more lysosomes then the other lines, but 
this feature was not consistent, and other lines also occasionally showed similar 
features (see below).
5.3.2.9 Effects of Stromal Interaction
In preliminary studies co-culture with human fetal lung fibroblasts did not 
produce any significant differences, in terms of cellular morphology [plate 5.15 
a,b,c,d]. Cells growing in 50:50 co-culture grew normally first with fibroblasts 
intervening, but later on fibroblasts were invaded by epithelial cells, and growth 
of fibroblasts was reduced with time with their ultimate replacement by the test 
cells.
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5.3.3 RESPONSE OF THE TRANSFECTANTS TO THE CYTOTOXIC DRUGS
This section describes the potential effects of oncogene transfection on the 
response of mink epithelial cells to cytotoxic drugs; cisplatin and cytosine 
arabinoside. The specific aims were to investigate whether transfection of lung 
epithelial cells with human oncogene could alter the cellular response to cytotoxic 
drugs in vitro, either by altering growth rate or by genetic change conferring an 
altered cellular phenotype with different response to cytotoxic drugs. Studies 
undertaken in this section showed varying response of transfectants to cytotoxic 
drugs depending upon the type of oncogene involved.
5.3.3.1 Chemosensitivity Studies
Chemosensitivity data of cell lines are summarised in Table 5.10 and the 
dose response curves of different cell lines to cisplatin [Figure 5.5a] and ara-c 
[Figure 5.5b] are also shown. The normal ras transfected cell line was 
significantly more resistant to ara-c, compared with the parental cell line or other 
transfected lines. There were no significant differences in the sensitivities of the 
other transfected cell lines, relative to the parental cell line, to either ara-c or 
cisplatin.
5.3.4 INVASIYENESS IN VITRO AND PLASMINOGEN ACTIVATOR 
ACTIVITY OF THE TRANSFECTANTS
The proteolytic activity and invasion are malignancy associated properties. 
Plasminogen activator activity and invasive behaviour of the cells, before and 
after transfection were investigated in this section. In vitro invasion assays were 
performed using fragments of embryonic chick heart in confrontation with cells 
in tissue culture, while plasminogen activator activity of cells was determined 
using a chromogenic assay.
5.3.4.1 Invasiveness In Vitro
Loose adhesion of the cells to the chick heart fragments could be detected 
within first 6 hours in all of the cell lines used, and firm adhesions within 24 
hours.
Invading cells were readily identified in all sections because their nuclei 
were considerably larger and more intensively stained with haematoxylin than 
those of the host tissues. Only minor differences in the rate of attachment and 
adhesion between transformed and control cells were found. All the lines tested
145
Table 5 . 1 0 : -  S e n s i t i v i t y  o f  c e l l s  t o  c y t o t o x i c  
d rug s .
CELL LINE
a I D 50 VALUES (M) OF CYTOTOXIC DRUGS
CI SPLATI N 
( 1 x 1 0 “ 7 M )
CYTOSINE ARABI NOSI DE 
(1 x 1 0 “ 6 M )
Mv 1 4 . 1  + 0 . 5 3 . 3  + 0 . 1
M1 4 . 6  + 0 . 6 3 . 1  + 0 . 1
N1 3 . 3  + 0 . 3 * 5 . 4  + 0 . 3
T 1 5 . 0  + 0 . 2 2 .9  + 0 . 1
a Th e  I D50  v a l u e  i s  d e f i n e d  a s  t h e  c o n c e n t r a t i o n  o f  
d r u g  w h i c h  g i v e s  a 50% r e d u c t i o n  i n  a b s o r b a n c e  
c o m p a r e d  t o  t h a t  i n  d r u g  f r e e  c o n t r o l .  V a l u e s  
r e p r e s e n t  a r i t h m e t i c  me a n  _+ SEN f r o m  a t  l e a s t  3 
i n d e p e n d e n t  o b s e r v a t i o n s .
* P < 0 . 0 2  ( M a n n - W h i t n e y  t e s t )
Figure 5.5:- Cytotoxicity curves of cell lines exposed to cytosine 
arabinoside and cisplatin for 48 hour.
Curves show relative absorbance of Mvl, M l, N1 and T l cell lines, 
following a 48 hours exposure to increasing concentrations of 
cytosine arabinoside (A) and cisplatin (B), by MTT assay. Cells 
were allowed to recover in drug free medium for 3 days. Each 
point is the mean ± SEM (bars) of 3 replicate values, from one 
experiment, similar curves were obtained from three other 
experiments (see Table 5.9).
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were invasive with minor differences in the degree and the pattern of the process. 
Invasion was progressive in time from grade I through to IV [Table 5.11] with 
complete replacement of PHF after 7-10 days.
The unexpected invasive behaviour of the Mvl cell line (parental) was an 
interesting finding in this study. Though slightly slower in progression, these 
cells were equally invasive within the first week of confrontation. Following 24 
hours of incubation [Plate 5.16] cell aggregates were found lying at the edge of 
the PHF or forming a layer of cells on the rounded edge of heart fragment, this 
was scored as grade-I invasion. The cells showed grade-II invasion on day 2 and 
on day 4 grade-IIb when clumps or strips of cells were observed invading into 
PHF. After day 7 [Plate 5.17] they reached deep into heart fragment scoring 
grade-IV invasion. Most of the heart fragment was destroyed by day 10.
Under similar conditions, M l cells attached rapidly scoring grade-II on day 
1 [Plate 5.16], and showed a grade-III invasion on day 2. They exhibited an 
infiltrated pattern of growth and invasion through the outer fibroblastic layer. 
Histologically, whorls or clumps or strands of cells were seen advancing and 
invading PHF as continuous sheet of cells, maintaining the characteristic tissue 
culture pattern of growth and morphology. This was called massive or bulk 
invasion. As shown in plate 5.17, by day 7 the whole fragment was replaced 
almost by test cells.
N1 and T l invariably showed very rapid invasion, destruction and 
replacement of the cardiac cells. As shown in plate 5.16, within 24 hours of 
confrontation cells penetrated the outer fibroblastic layer (grade II). Thereafter 
replacement of the host tissue by the test cells took place rapidly (grade III by 
day 2), and grade IV by day 4. By day 7 the tissue fragment consisted mainly of 
the invading tumour cells [Plate 5.17]. The nuclei of the normal heart cells next 
to the advancing invading cells were smaller and more compact in appearance, 
and these disappeared rapidly leaving only a network of interstitial fibres.
Following complete or nearly complete replacement of the heart fragment 
by these cells central necrosis appeared after 7 to 10 days. Both N1 and T l 
were scored as the most aggressive in three successive experiments.
5.3.4.2 Cell Proliferation and Invasion
There was no correlation between invasiveness and the mitotic activity of 
the cells, in chick heart invasion assays. Though all lines were invasive, Mvl 
showed lower mitotic activity compared to the transfectants (data not shown).
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Table 5 .1 1 :- Grading o f the c e ll lin es  for i_n v itro  
invasiveness.
Cel l  l i n e 24 h r s
Grading A f t e r  
2 days 4 days 7 days 10 days
Mvl I II 11 b IV V
M1 II I I I IV V V
N1 II I I I IV V V
T1 II I I I IV V V
C onf ron ted  samples  were p r o c e s s e d  a t  day 1, 2 ,  4 ,  7 & 10 
a f t e r  c o - c u l t u r e  o f  t e s t  c e l l s  w i th  c h i c k  h e a r t  f r a g m e n t s ,  
f o r  e v a l u a t i o n  o f  i n v a s i o n  as  d e s c r i b e d  in  General  Methods.
Plate 5.16:- Invasion of chick heart fragments in vitro at day 1 after
co-culture.
Histological sections from confronting cultures of mink lung cell lines 
with pre-cultured heart fragments (PHF) set up as described in 
General Methods and grown for 10 days on a gyratory shaker. 
Samples were collected at day 1 and day 7 ( see below, Figure 5.17) 
fixed sectioned and stained with H&E and by immunoperoxidase for 
anti-chick heart antigen, with the avidin biotin technique. Mvl cells 
are on the surface of PHF but attached firmly (grade I), M l has 
partially replaced the heart fragment (grade II), Both N 1 and T l have 
shown similar effects to M l.
CELL
LINE H E
1 d a y  c o n f r o n t a t i o n
A n t i  c h i c k
Mv I
PHF PHF 7
M 1 PHF
PHF
T 1
ph f
> PHF.
Plate 5.17:- Invasion of chick heart fragment in vitro at day 7 after 
co-culture.
All four cell lines show significant invasion. Explanation as for Figure 
5.16.
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5.3.4.3 Plasminogen Activator Activity
A low PA activity was observed in all lines [Table 5.12]. There was no 
significant increase in transfected lines compared to the parental line. A 
significantly low activity was found in N1 line, while T l expressed only slightly 
increased activity. All lines had undetectable levels of secreted PA. A 
reasonable correlation was found for values obtained by both cell count and 
protein estimation.
5.3.5 CHARACTERISATION IN VIVO
As discussed in previous sections, cultured cells may acquire a number of 
transformed characters following oncogene transfection. One of these characters 
is tumorigenicity, that is the ability of the cells to grow as tumours when 
implanted into appropriate animals. The development of tumours implies that 
cells in vitro can undergo transformation similar to that occurring in course of 
carcinogenesis in vivo. Tumorigenicity is a manifestation of a series of changes 
which progress in one direction towards more malignant phenotype.
This section describes in vivo studies of the cell lines, and their comparison 
with in vitro growth properties as described in previous section. In vivo studies 
included: tumorigenicity of cell lines in nude mice, observation and evaluation of 
the tumour growth patterns, gross morphological properties during tumour 
development, tumour histology, immunohistochemistry, and ultrastructure 
features.
In present studies, the pattern of cell growth in vitro was nicely correlated 
with their growth as tumour in athymic nude mice, demonstrating that growth 
in vitro can be used as predictive test for in vivo growth of cell as tumours.
5.3.5.1 Tumorigenicity
The M vl cell line without oncogene transfection produced only 20% 
tumours. Negative cases were observed for over 16 weeks after injection, and 
showed no abnormality at autopsy. Tumours grew with a typical growth pattern 
[Figure 5.6 a]. An initial steep curve representing a rapid growth was followed 
by a steady phase showing a pause in growth, and then a slow but gradually rising 
growth rate. Doubling time was relatively shorter during the first phase 
compared to the second half of growth. Only one tumour could be assessed by 
histology and passage, because of either the death of the animal or necrosis of 
the tumour in the other two cases. The average latency period was around two
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Figure 5.6:- Growth curves of primary xenografts of cell lines in nude mice.
lxlO6 cells of each cell line (Mvl, M l, N l, & T l) were inoculated subcutaneously 
into the flank of each mouse at day zero. Tumour measurements were carried out 
twice weekly, starting, when tumours reached a volume around 14 to 19 mm3. 
Volume was calculated from two diameters by calliper measurements as outlined in 
General Methods.
months, and the tumour which could be assessed reached a maximum volume 
of less than 1 cm3 after 6 weeks [Table 5.13].
However, the single tumour when passaged grew with 100% take and a 
short latency period around three weeks. The growth pattern though not 
identical [Figure 5.7 a] was of the same type as described above but more steep 
with shorter doubling times. Transplants reached a significantly larger size within 
approximately 5 weeks. The growth was significantly enhanced in passaged 
tumours [Table 5.14]
The M l cells transfected with the c-mvc human proto-oncogene yielded 
rather slow growing tumours, though faster than Mvl, after an average latency 
period of six weeks and with 100% take rate. The pattern of tumour growth 
remained the same as in Mvl [Figure 5.6 b], with a shorter doubling time during 
the first half than during the second half of tumour growth [Table 5.13]. These 
tumours were relatively larger in size than parental, but smaller than the tumours 
produced by ras transfected cell lines.
All passaged tumours grew with 100% take rate, a shorter latency period, 
with doubling times and final tumour volumes similar to primary tumours [Table 
5.14]. The growth curves showed the same growth pattern as primary tumours 
[Figure 5.7 b]. The passaged tumours showed significantly more aggressive 
behaviour compared either to parental tumour or M l tumours during primary 
growth, but their growth was less aggressive than both of N1 and T l.
The N1 cell line expressing the normal human Ha-ras gene produced 
rapidly growing tumours in all animals with 100% take after an average latency 
period of around 5 weeks, tumours reached a larger size within a relatively 
shorter period, compared to the parental tumours (4-fold). The tumours showed 
a gradually increasing growth pattern [Figure 5.6 c]. Doubling time was shorter 
in the first than in the second half of the growth [Table 5.13].
After the first passage [Table 5.14] the tumours grew significantly more 
rapidly compared to parental or M l tumours, with a short latency period of 
around 1 week and 100% take rate. Doubling times were reduced significantly. 
Growth was faster in passaged than in primary tumours [Figure 5.7 c], and they 
reached a mean diameter significantly greater than the parental tumours.
The T l cells bearing the T24 Ha-ras human oncogene yielded rapidly 
growing tumours in all animals with 100% take rate and very short latent period. 
They grew with a sharp progression reaching a greater volume in relatively 
shorter time. Tumour doubling times were significantly shorter during primary 
growth [Table 5.13]. The growth was faster and progressive [Figure 5.6 d].
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Figure 5.7:- Growth curves of transplanted tumours after first passage.
A tumour fragment approximately 2x2x1 mm was transplanted subcutaneously into 
the flank of each mouse at day zero. Size was measured twice per week. Volume 
was calculated from two diameters by calliper measurements as out lined in General 
Methods.
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The latent period remained the same during first passage [Table 5.14] with 
a take rate of 100%, and shorter doubling, tumours gained significantly greater 
volume compared to the parental tumour, with over 20-fold difference. The 
growth pattern was sharper in the first than in second half of the tumour growth 
[Figure 5.7 d]. Growth of the T1 tumours was most aggressive in both primary 
and transplant tumours. The tumour showed irregular growth with macroscopic 
evidence of invasion [see Plate 5.23].
Statistical analysis of data during primary tumour growth showed that the 
latency period of T1 was significantly shorter than Mvl (P< 0.0001), M l 
(P< 0.008), N1 (P< 0.009). Doubling time during first half of growth in primary 
tumours of Mvl was significantly longer than M l (P< 0.008), N1 and T1 
(P<0.005). Doubling time of M l was significantly longer than either N1 or T1 
(P< 0.006). Doubling time during second half of the growth in Mvl was also 
significantly more longer than M l (P< 0.008), T1 (P< 0.001), and the tumour 
doubling time of T1 was significantly shorter than M l (P< 0.008) and N1 
(P< 0.006). Maximum tumour volume of Mvl was significantly smaller than 
either N1 or T1 tumours (P<0.04).
Statistical analysis of passaged tumours showed that the latent period of 
Mvl was significantly longer than T1 (P< 0.0001), N1 (P< 0.001) and M l 
(P<0.001). The latent period of T1 was also significantly shorter than M l 
(P< 0.0001) and N1 (P< 0.003). The doubling time of Mvl during the first half 
of growth was significantly longer than N1 and T1 (P< 0.008). T1 was shorter 
than M l (P < 0.0001). Doubling time of Mvl was longer than M l (P< 0.008), N1 
(0.004) and T1 (P< 0.005) during second half of growth. Maximum tumour 
volume of Mvl was less than N1 (P< 0.008), and T1 (P< 0.0001), and M l was 
significantly less than N1 (P< 0.008) and T1 (0.0001). [Mann-Whitney test with 
Bonferoni adjustment].
5,3.52 Morphological Features
Grossly the Mvl tumour showed circumscribed margins with a smooth 
surface [Plate 5.18 a]. The skin was attenuated over the tumour with sparse 
blood vessels passing from the skin into the tumour mass. It showed little 
attachment to underlying structures, and was enucleated easily during dissection. 
There was no evidence of necrosis, ulceration or inflammation. The tumour was 
firm in consistency. On section the tumour was firm and showed little attachment 
to the underlying structures. Skin attachment was relatively firm with small blood 
vessels and connective tissue attached to tumour. There was minimal evidence
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Plate 5.18:- Nude mice bearing primary tumours of different cell lines.
lxlQ6 cells were inoculated s.c in each mouse. Tum our sizes 30 days after the first 
appearance of tum our nodule at the site of cell inoculation.
of central necrosis. Histologically, the tumour was undifferentiated, with mild to 
moderate nuclear pleomorphism and a low mitotic rate [Plate 5.19 a]. Central 
necrosis was present. There was no evidence of local invasion in the single 
tumour during primary growth, and no lymph node or distant metastases were 
identified. Transplants showed similar features with undifferentiated cells 
forming sheets or plates in between necrotic material [see Plate 5.20].
Grossly, the M l tumours grew gradually with well circumscribed margins 
[plate 5.18 b] and firm attachment. Again the skin over the tumour was 
attenuated. Tumours were attached firmly to the underlying tissues, and could 
not be easily enucleated by dissection. Transplants grew faster than primary 
tumours, with irregular margins, frequent ulceration, and an increase in 
vasculature in the overlying skin. The cut surface of the tumour showed no 
evidence of gross cavitation. Tumours were also attached firmly to both the skin 
and underlying tissues, the margins were more irregular, and it was difficult to 
remove the tumour from its bed completely. Histologically all tumours were 
undifferentiated, with moderate nuclear pleomorphism [Plate 5.19 b]. Mitoses 
were moderately frequent. The transplanted tumours showed similar features, 
but with increased pleomorphism, and central necrosis with sheets of viable 
tumour cells in between the necrotic material.
Grossly the N1 tumours grew as irregular masses at the site of injection 
with a nodular surface, ill defined margins and prominent blood vessels [Plate 
5.18 c]. The skin over the tumour was firmly attached, giving a nodular 
appearance. Tumour was also firmly attached to underlying tissues. Early 
necrosis and ulceration was not observed in primary tumours. After the first 
passage tumours grew much faster to a relatively bigger size in a shorter time, 
with evidence of early necrosis of the central tumour tissue. The cut surface was 
firm with some evidence of central necrosis. Histology of N1 [Plate 5.19 c] 
revealed a pleomorphic, undifferentiated tumour with giant cells, many mitotic 
figures, apoptotic bodies and prominent vascular elements. Transplants also 
showed similar picture but with more necrosis.
Grossly growth of the T1 tumour was very irregular in outline with ill- 
defined margins and nodular surface appearance [Plate 5.18 d]. Overlying skin 
had prominent blood vessels passing across or into the tumour. There was 
macroscopic evidence of infiltration into both superficial and deep structures. 
Ulceration was often present [see Plate 5.24]. Transplanted tumours showed 
similar features, but they grew to a larger size in shorter time, with more 
ulceration. The cut surface of the tumour showed areas of necrosis. There was
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Plate 5.19:- Histology of xenografts.
All tumours were poorly differentiated, consisting of sheets of large nucleolated 
cells. Pleomorphism was more marked and mitoses more abundant in N 1 and T1 
(X 360, H& E).
firm attachment to skin and underlying tissues. Histologically, the tumour was 
again undifferentiated and showed significant pleomorphism [Plate 5.19 d]. 
Necrotic areas were frequent, lying between sheets of tumour cells [Plate 5.20]. 
Tumours had a high mitotic rate, and frequent abnormal mitoses. Transplanted 
tumours showed similar features, necrosis and pleomorphism being most marked.
5.3.5.3 Quantitative Study of Cell Turnover
Mitotic and apoptotic figures [Plate 5.21] were counted in each tumour. 
Numerical data are shown in table 5.15. There was no significant difference 
between primary and passaged tumours in all transfected tumours, and therefore, 
combined data are shown, except Mvl, which showed significant differences 
between primary and passaged tumours.
During primary growth, in Mvl a low level of mitotic activity was 
observed, and apoptoses were not frequent. However, in first passage (Mvl-P) 
the mitotic index was significantly higher, but the apoptotic index was of the 
same order as primary tumour.
M l tumours also had a moderately increased mitotic and apoptotic rate, 
in both primary and passaged tumours. The mitotic index was significantly higher 
compared to the parental line tumours, but there was no significant difference in 
their apoptotic indices.
N1 had significantly higher mitotic, and apoptotic indices compared to the 
parental line tumours. The mitotic and the apoptotic indices were also 
significantly higher than M l tumours.
T1 had the highest indices for both the mitotic and apoptotic figures. It 
had significantly increased number of mitoses and apoptoses compared to the 
parental line tumours. The mitotic index was significantly higher than M l, but 
not the N l. Apoptotic index was higher than all other tumours.
5.3.5.4 Antigenic Marker Expression
All tumours were immunopositive with cytokeratins [Plate 5.22 a,b ]. They 
also stained focally for EMA and HMFG1&2, and all tumours were positive for 
vimentin [Plate 5.22 c]. The intensity of the staining was not as strong as in 
monolayer cultures, but the cellular patterns or the staining were the same both 
in vitro and in vivo in all cell lines. There was no significant difference among 
the lines in terms of their staining characteristics.
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Plate 5.20:- Tumour necrosis
T1 tumour showing significant areas of necrosis (arrows) (X 144, H&E).
Plate 5.21:- Typical mitotic and apoptotic figures.
T1 tum our showing mitotic (M) and apoptotic (A) figures (X 360, H&E).
Table 5 .15 :- The m itotic (MI) and apoptotic (AP) 
indices o f  tumours, produced by the d ifferen t c e ll
l in e s .
Cell  l i n e  MI AI
Mvl 1 .2  + 0 . 2  3 . 0  + 0 . 3
Mvl-P * 2 .8  + 0 . 2  **3.1 + 0 . 2
<+ +4*
M1 2 . 5  + 0 .3  3 .3  + 0 .3
N1 *4 .0  + 0 .3  *4.1 + 0 . 2
T1 *4.1 + 0 .2  *7.1 + 0 .3
For each  tumour t h e  mean o f  m i t o t i c  and a p o p t o t i c  
f i g u r e s  i n  12 h ig h  power f i e l d s  (X 40) p e r  s l i d e  
were d e t e r m i n e d  from 3 s l i d e s  o f  t h e  s i n g l e  
p a r e n t a l  tumour ( Mvl ) ,  4 f rom Mvl tumours  i n  f i r s t  
p a s s a g e  i n  v ivo  (M vl-P) ,  and 6 s l i d e s  o f  M1, N1, 
and T1 from tumours  grown a t  d i f f e r e n t  t i m e s .
* P<0.0001 ,  ** P>0.05 ( a n a l y s i s  o f  v a r i a n c e  and
Bonferon i  a d j u s t m e n t ) .
Plate 5.22:- Expression of immunohistochemical markers in tumours.
(a). T1 tumour showing immunopositivity for broad spectrum basic cytokeratins (X 
360, antibody AE3: indirect IP).
(b). T1 tumours showing more focal positivity for simple glandular cytokeratins (X 
360, CAM5.2: indirect IP).
(c). T1 tumour cells also show immunopositive staining for vimentin (X 360, anti- 
vimentin, indirect IP).
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5.3.5.5 Ultrastructural Features of The Tumours
Tumours showed features similar to those found in their parental cell lines 
in culture, including microvillus profiles [Plate 5.23 a], intermediate filament like 
structures [Plate 5.32 b], poorly developed adhesion specializations [Plate 5.23 c], 
and epithelial type cell to cell relationships [Plate 5.23 d].
Only minor ultrastructural differences were observed in the transfected 
cell lines compared to the non-transfected line. T1 showed more lysosomal 
activity [Plate 5.23 e], and glycogen contents. However, these features were not 
consistent, and could be seen occasionally in the parental cells as well. There 
was a good correlation between in vitro and in vivo ultrastructural features of the 
cell lines and their tumours.
5.3.6 INVASION AND METASTASIS
In vivo studies were followed further to investigate the invasive and 
metastatic behaviour of the cell lines, as these are the most definitive markers of 
the advanced malignant phenotype, to determine whether oncogene transfection 
would result in increased expression of transformed phenotypes such as invasion, 
and metastasis. Although several assays have been described for the study of 
invasion and metastasis, none is without shortcomings [Mareel et al, 1983]. In the 
present study, invasion and metastasis in vivo were investigated by subcutaneous 
inoculation of cells in athymic nude mice.
5.3.6.1 Gross Morphological Analysis of Invasion
Tumours produced by all the transfected lines showed macroscopic 
evidence of invasion. However, the tumours engendered by T1 line exhibited 
more aggressive behaviour compared with those produced by other lines, 
especially in terms of growth pattern, being irregular and spreading into the 
surrounding tissue planes, intimate adherence to skin and underlying tissue, and 
frequency of skin ulceration [Plate 5.24]. The single tumour formed by the 
parental line did not show any obvious sign of macroscopic invasion, but only 
formed a small nodule attached to skin, fairly mobile over the underlying tissues. 
All lines showed aggressive behaviour during first passage in vivo. No enlarged 
lymph nodes were found in any of the tumour bearing animal.
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Plate 5.23:- Ultrastructural features of cell lines in vitro and in vivo.
(a). Electronmicrographs showing microvillus structures (arrows) in M vl both in 
vitro (above x 7500) and in vivo (below x 14750) (uranyl actate and lead citrate 
stain).
jk'Hp i
(b). Electronm icrograph demonstrating cytoplasmic interm ediate filaments 
(arrows) in M vl (x 18000, uranyl actate and lead citrate stain).
(c). Electronmicrographs of M vl (above) and M l (below) showing moderately 
developed adhesion specializations, the arrows indicating desmosome like structures 
[above x 55000, below x 24500, uranyl actate and lead citrate stain].
(d). Electronm icrograph of T1 tumour showing cell-cell relationship of epithelial 
nature. Five cells are in view showing their membrane attachments (x 18750, uranyl 
actate and lead citrate stain).
AT
(e). E lectron micrograph of T1 showing secondary lysosomal structures 
(arrows) (x 16875, uranyl acetate and lead citrate stain).
Plate 5.24:- Gross morphology of the T1 tumour
Nude mouse bearing T1 tumour, showing irregular outline, nodular 
surface, and early ulceration.
5.3.6.2 Histological Analyses of Invasion
Microscopically, the single tumour nodule formed by the parental line 
showed minimal infiltration of surrounding structures with well a defined edge 
during primary growth [Plate 5.25 a], but it was equally as invasive after first 
passage as the transfected tumours, showing invasion into all surrounding tissues 
as above. The tumours produced by all transfected cells showed invasion into 
surrounding host tissues including overlying skin and its appendages [Plate 5.25 
b], subcutaneous fat [Plate 5.25 c], and deep into muscles [Plate 5.25 d]. The 
tumours produced by M l showed evidence of local invasion into the surrounding 
structures, but were not as aggressive as ras transfectants. Both N1 and T1 
showed extensive infiltration into host tissues, but T1 was always more aggressive.
All transplanted tumours were more invasive than the primary tumours. 
Tumour cells were seen in blood vessels but without evidence of vessel wall 
damage or adherence which made any further interpretation difficult.
There was no evidence of metastatic spread to local lymph nodes or 
distant sites, including lung, liver, and brain, at either macroscopic or microscopic 
level.
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Plate 5.25:- Histology of tumour invasion into surrounding host tissues.
Primary tumours were sampled at the interface between tum our and surrounding 
host tissue, and processed as outlined in General Methods.
(a). Mvl tum our showing well defined edge with no sign of invasion into normal 
surrounding tissue (x 205, H&E).
(b). T1 tum our showing invasion and destruction of skin and appendages with 
penetration as far as epidermis (x 395, H&E).
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(c). Tum our cells are seen infiltrating adipose tissue (x 502, H&E).
(d). Tum our cells are seen infiltrating muscle, with obvious damage (x 439, H&E).
5.4 DISCUSSION
The objectives of studies carried out in this chapter were to establish a 
laboratory model for the study of the phenotypic effects of oncogenesis. Mink 
lung epithelial cells transfected with human c-mvc. normal Ha-ras, and activated 
Ha-ras oncogenes by individual transfections were investigated for different 
parameters associated with malignant transformation, both in vitro and in vivo. 
It was observed that the oncogene transfected cells had enhanced expression of 
malignancy related properties.
5.4.1 Confirmation of Transfection
The Southern blot analysis of normal Ha-ras transfected line showed a 6.6 
Kd human ms specific fragment with multiple copies of the gene incorporated 
into host DNA during transfection. The activated ms transfected line showed a 
higher molecular weight Ha-ras specific fragment, resulting from a probable 
integration of endogenous ras sequence, confirming that the transfection had been 
successful.
Detection of the Ha-ras. gene product by immunostaining techniques was 
not as evident as from the southern blotting. The positive staining was only focal, 
even after overnight incubation with primary antibody, and with some background 
staining. Different methods have been used for the optimal tissue fixation, 
preservation, and immunocytochemical localization of p21 Ha-ras oncogene 
product. Previously Ha-ras oncogene product has been demonstrated using 
cryostat sections fixed in acetone, but with poor morphological localization [Kerr 
et ai, 1985; Williams et al., 1985; Candlish et al., 1986]. Robinson et al., [1986] 
have shown that p21 was not optimally preserved when formalin fixed material 
was used for its immunohistochemical localization. However, more recently, 
specific immunostaining of p21 Ha-ras protein has been reported [Going et al,. 
1988], using Y13-259 on paraffin sections of tissue fixed in PLPD with good 
preservation of both intensity of staining as well as morphological details of 
staining. In the present study, this gave similar results to those in cryostat 
sections, but with a superior tissue morphology, cytoplasmic staining was noticed 
in controls accompanied by some loss of membrane staining. It is possible that 
a similar loss might have occurred in the present studies due to membrane 
destabilization during tissue processing and this loss could have been to the 
outside of the membrane; mild cytoplasmic staining was also observed. 
Therefore, poor ms staining might have resulted from its membrane association
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and its poor preservation.
A well characterized rat monoclonal pan-ras antibody Y13-259 [Furth et 
al., 1982; Lacal et al., 1986] was used. It reacts with an epitope most probably 
amino acid sequence 70 to 80 [Lacal and Aaronsen, 1986] shared by 21 kD 
protein product of mutationally activated and non-mutated Harvey (Ha), Kirsten 
(Ki), and N-ras. oncogene. Staining was not observed in the control cell line 
(Mvl), suggesting that either the antibody did not cross react with endogenous 
p21 or cells were not expressing the endogenous gene product. Therefore, this 
antibody has been used to confirm p21 localization at the membrane of Ha-ras 
oncogene transformed cells, as reported in other studies [Hsu et al., 1982]. The 
use of FH 05T1 activated Ha-ras.gene expressing cell line [Spandidos and Wilkie, 
1984] as a positive control has been reported by others [Williams et al., 1985; 
Going et al., 1988] when using the monoclonal antibody Y13-259 to demonstrate 
the ras gene product p21. It gives a membrane specific staining; however a faint 
cytoplasmic staining with a concomitant loss of membrane staining has also been 
reported [Going et al,. 1988].
The Southern blot analysis of the c-mvc transfected line showed a faint 
8 Kd human-specific c-mvc fragment which was absent from the parental line, 
confirming that transfection was successful.
The monoclonal anti-c-mvc protein antibody (mycl-9E10) was raised and 
described by Evan et al. [1985]. The antibody is a mouse IgG raised against a 
synthetic peptide immunogen (peptide G) corresponding to residue 408 through 
439, from the open reading frame sequence in exon 2 and 3 of human p62 
c-mvc. The antibody binds specifically to human p62 c-mvc and does not cross 
react with mouse p64.p66 c-mvc [Evan et al., 1985] or endogenous mink c-mvc as 
tested in control Mvl cells. The study of c-mvc expression by 
immunocytochemical methods using mvcl-9E10 showed focal positivity in the M l 
tumours or cell cultures. The positive staining increased when primary antibody 
was applied overnight at higher concentration, but only at the expense of 
background staining. Nevertheless, this observation lends further weight to the 
idea that c-mvc is not expressed in sufficient quantities to be detected by these 
two techniques.
5.4.2 Confirmation of Species and Lineage
Chromosome and isoenzyme analyses confirmed the origin of the lines as 
mink. Before morphological and in vitro growth characterization the oncogenic 
transfection was also confirmed using the geneticin (G418) selection system,
155
where the parental cell line was sensitive, while the transfectants having the aph 
gene remained stably resistant to the drug which was used for selection of these 
lines, implying that the selection system was intact and effective. The integrity 
of the selection system was tested at regular intervals to make sure that the 
population was homogeneous, since heterogeneity following transfection has been 
reported in other studies [Spandidos et al., 1985].
Having confirmed their species of origin, the cell lines were characterized 
also for their lineage. MvlLu cells have been described as normal and epithelial- 
like, in previous studies [Henderson et al., 1974; Barbacid et al., 1978] but they 
have never been characterized for their lineage or tissue of origin.
All cell lines stained positive for cytokeratin intermediate filament proteins 
(IFP) with the antibodies AE3, and CAM5.2. Cytokeratins have been used as 
lineage markers in other studies [Ramaeckers et al., 1983]. These are generally 
used to differentiate the epithelial origin of the cells, however, mesothelial cell 
derivatives will also stain positive for these proteins. Vimentin, another member 
of intermediate filament proteins is generally expressed by cells of mesodermal 
origin. In this study all cell lines also stained positive for vimentin. However, 
vimentin co-expression with cytokeratin is a common finding, especially in 
continuous cell lines in culture [Franke et al., 1978; Virtanen et al., 1981] as well 
as in many of malignant cells both in vivo and in vitro [Ramaeckers et al., 1983],
Both the parental as well as transfectants stained positively for membrane 
proteins or cell surface antigen e.g EMA, and HMFG1&2. These proteins, 
expressed by epithelia, have been used to differentiate epithelium from stroma. 
Specific antibodies have been used to elucidate these markers 
immunohistochemically such as anti-HMFGl&2 [Burchell et al., 1983], and anti- 
EMA [Heyderman et al., 1979].
In addition, ultrastructural study of the cell lines revealed moderately 
developed adhesion specializations such as desmosome-like structures, and 
intermediate filaments. Hence, culture morphology, expression of epithelial 
markers, together with ultrastructural evidence have suggested an epithelial origin 
of both the parental and oncogene transfected cell lines.
5.4.3 Morphological Characterization In Vitro
A number of morphological changes were observed in transfectants 
including a decreased spreading on the substrate in sparse cultures, deficient 
formation of monolayer epithelial sheets, and decreased attachment to the 
substrate, decreased spreading in the dense cultures, formation of various
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abnormal multicellular patterns and foci, and invasive behaviour in the mixed 
cultures with normal fibroblasts. Most of the transformation signs listed above 
are manifestations of decreased cell-cell and cell-substrate attachments in the 
transformed cell cultures, with high saturation density, and loss of density 
dependent growth inhibition. Similar results have been shown in previous studies. 
Spandidos and Wilkie [1984] demonstrated a morphologically transformed 
phenotype in early passage rodent cells transfected with activated Ha-ras 
oncogene. Cells transfected with activated ms oncogene showed spindle shaped 
cells in contrast to normal polygonal epithelial cells, suggesting an effect of 
oncogenic transfection on cell morphology, either due to alterations in 
cytoskeletal elements of the transfectants, or cell surface alterations secondary to 
receptors or ligands changes which are commonly the products of oncogenes.
Oncogenes can alter the cell morphology by a number of proposed 
mechanisms, such as production of growth factors, loss of or altered synthesis of 
surface receptors, or altered signal transduction. Genetic change in the cells, e.g 
oncogenic insertion into the host genome, may also lead to altered cell-cell 
interactions or loss of cell receptors necessary for its attachment to substrate, or 
interaction with stroma. Normal cells attach to substrate and stroma by receptor 
for fibronectin or laminin, therefore, loss or denaturation of these receptors or 
matrix proteins would lead to decreased cell-cell or cell-substrate interactions, 
which is characteristic of malignant cells. Morphological change can result from 
abnormal growth factor expression. It has been shown that EGF controls cell 
surface glycoproteins expression in normal cells [Chen et al., 1977].
5.4.4 Growth Characterization In Vitro
Serum had variable effects on cell growth properties depending upon its 
concentration, type of oncogene, and status of culture, and substrate. All cell 
lines were capable of growing, following serum removal, once the cells had 
entered into the exponential growth phase. However, they did not grow for more 
than a few passages once serum free, except the activated ras. transfected line 
which was able to grow in serum free conditions for 8-10 passages, when plated 
at relatively high seeding cell density. The parental cells, on the other hand, grew 
only for a few passages under similar conditions. The growth of c-mvc 
transfected cells remained intermediate in serum free conditions. Growth 
stimulation was noticed at 0.5%, 10%, and 20% serum in the parental line. 
There was no inhibition of growth, though growth stimulation was maximum 
between 10-20% serum concentration. The c-mvc transfected line also showed
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stimulation of growth in 0.5% and also at 10% serum concentration, but there 
was no significant stimulation of growth at 20% serum. Transfection with normal 
Ha-ras had similar effects as c-mvc. where 20% serum concentration was no 
more stimulatory than 10%. However, activated Ha-ras. transfection had slightly 
different effects, growth stimulation at 0.5% serum was evident but comparatively 
less than in other lines. Stimulation at 10% serum was slightly higher, but no 
further growth stimulation was observed in 20% serum.
The effects of serum concentration on the saturation density of the cell 
lines were also studied. Generally the saturation density of all the cell lines 
increased in a concentration dependent fashion, when the serum concentration 
was raised gradually up to 20%. The effects of serum on saturation density of 
different lines can be analyzed in two ways. Firstly the comparison of saturation 
density in relation to different serum concentrations for an individual cell line, 
and secondly, a comparison of saturation density among different cell lines.
Cell concentrations at saturation density were different for each cell line, 
however, consistently higher values for ms transfected cells were found, suggesting 
an increase in saturation density following ras transfection. High saturation 
density of the transformed cells could be due to a high rate of proliferation, and 
altered morphology of cells, where rounded and crowded piled up cells were 
found in ras transfectants, with loss of contact inhibition and multi-layering of the 
cells in a disordered manner. The cell number at saturation density was much 
less than expected from the morphology of the transformed cells, and perhaps 
this could be due to the loss of cells on the top layer, due to the rounded cell 
shape, resulting from both high mitotic activity and transformation, and poorer 
attachment to the substrate.
Plating efficiency of transfectants was significantly higher in all different 
serum concentrations compared with the parental cell line. A generalized 
increase in colony size was found in monolayer, in 20% serum, regardless of 
whether the colony number had increased or decreased. The same effect was 
found when cells were grown in medium with 10% serum, containing 1 nM 
dexamethasone, but the colony size was much larger in dexamethasone stimulated 
cells. It has been found that transfected cells were able to survive and grow in 
culture conditions with either low serum, and high seeding cell density or high 
serum concentration with low seeding density.
Agar cloning has been used in almost all transfection assays as a criterion 
for the transformed phenotype following oncogene insertion into the cells. The 
serum effects on cloning efficiencies in agar of the cell lines were also studied.
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The parental lines cloned poorly while transfected cells cloned efficiently in agar. 
There was no colony formation in serum free or 0.5% serum concentration. 
Significant differences were found in 10% serum where growth of parental cells 
was negligible compared with a very high cloning efficiency in activated ras 
transfected cells, normal ms transfected cells also showed high colony formation, 
but the size of colony was very small compared with other cell lines. The c-mvc 
transfectants had a sightly better cloning efficiency in agar compared with 
parental, but very low compared with the Ha-ras transfectants. The results were 
different in 20% serum concentration, where a stimulation was noticed in colony 
formation both in the parental and the c-mvc lines, but a decrease in colony 
formation was noticed in both the ras transfectants. An increase in colony size 
was observed in 20% serum, regardless of whether the colony number had 
increased or decreased. The transfected cells remained alive in agar in serum 
free and 0.5% serum, but there was no cell division or proliferation, while the 
parental cells died under similar conditions. Stimulation of parental, and the c- 
mvc transfected lines, and inhibition of the Ha-ras transfected cell lines at 20% 
serum suggests that the cell response to serum is not general, but specific in 
nature, dependent on the oncogene, substrate, and concentration of serum in the 
medium.
These results show that growth of the ras transfected cells was significantly 
higher in serum deficient conditions, compared to parental line, suggesting serum 
dependence of normal cells, and its independence in transformed cells, which is 
characteristic of the difference between malignant and normal cells. These 
properties have been attributed to an autocrine growth potential in transformed 
cells [Eagle et al.y 1970]. The growth rate of the parental line was as high as 
those of transfected cells, under optimal growth conditions, however differences 
in growth of transformed and non-transformed cells were evident under sub- 
optimal conditions, such as decreased serum concentration, growth in agar, 
saturation density, and decreased cell number etc [Buehring and Williams, 1976]. 
Transformed cells were able to grow in serum free conditions, and grew actively 
at 0.5% serum compared with parental line. Dulbecco, [1970] has reported 
similar results. Clarke et al. [1970] and Pitts, [1971], have also shown similar 
effects of cell transformation and serum response. These observations suggest 
that the threshold concentration of serum needed for initiation of proliferation 
may be decreased to zero in transformed cells compared to non-transformed 
counterparts.
It has been suggested that transformed cells produce their own growth
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factors. It has been shown that cells with decreased serum requirement have 
altered sensitivities to growth factors contained in the serum [Moses et al., 1978]. 
The insensitivity to the exogenous growth factors may be associated with the 
formation of endogenous growth factors by neoplastic cells, these factors may 
then block corresponding receptors on the cell surface. Thus a transformed cell 
may lose both the ability to stop proliferation without growth factors and also the 
ability to initiate proliferation in presence of them. Todaro and de Larco [1978] 
have demonstrated that one of the manifestations of the transformed phenotype 
is the alteration of the' cell’s reaction to various components of growth medium 
such as serum factors or growth factors. It is possible that transformation is 
accompanied by the acquisition of a decreased sensitivity not only to the growth 
inhibitory conditions, but also to certain growth stimulatory factors. 
Transformation of the normal cell phenotype by growth factors has been 
reported. Induction of anchorage-independent growth in NRK cells by TG F-a 
[Todaro & de Larco 1978], has suggested a possible role of growth factors in 
transformation of cells. These data have supported the autocrine hypothesis of 
growth transformation in transformed cells.
In previous studies it was shown that the activated ras. oncogene 
transfected cells did not respond to EGF or TGF-/3, while c-mvc transfected cells 
had a reduced inhibitory response to TGF-0 and an exaggerated response to 
EGF [Kerr et al., 1990]. Transforming growth factor-/3 (TGF-/3) has been shown 
to inhibit incorporation of 3H-thymidine by mink epithelial cells MvlLu, in a dose 
dependent manner [Kerr et al., 1990]. Epidermal growth factor (EGF) had the 
opposite effects with stimulation of 3H-thymidine incorporation. It was also 
demonstrated that 3H-thymidine incorporation depended upon the relative 
concentration of the growth factors, where TGF-/3 and EG F shifted each other’s 
dose response curves to the right, which is consistent with the phenomenon of 
antagonism between these growth factors. Similar results have been reported by 
others [Coffey et al., 1988]. An altered response to growth factors was found in 
oncogene transfected cells, mvc transfected cells had a reduced response to 
TGF-/3, and an exaggerated response to EGF. There was no significant effect of 
normal ras transfection on the response of mink epithelial cells to these growth 
factors. However, activated ras transfected cells were refractory to the effects of 
exogenous growth factors, both TGF-/3 and EGF.
Effects of growth factors can be mimicked by oncogenes in some instances 
such as abnormal production of PDGF, and expression of erb-B receptor. It has
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previously been shown that the endogenous production of growth factor is one 
of the cellular responses to viral transformation (Kaplan & Ozanne, 1982). Such 
studies were extended to include transfection of cells with various proto­
oncogenes and oncogenes. The ras transformed cells were shown to have lost 
their EG F requirement with increased growth factor production [Anzano et al., 
1985; Stern et al., 1986; Saloman et al., 1987; Leof et al., 1986]. It has been found 
that the cells transfected with ms oncogenes circumvent the EG F requirement for 
their monolayer growth in culture [Stern et al., 1986; Salomon et al., 1987; 
Kelekar and Cole, 1987] perhaps as a result of growth factor production.
While growth factor regulation seems to be the possible regulatory 
mechanism for these effects of serum, polarity of cells may also be important. 
In agar cells are exposed to environmental stimuli from all sides, while in 
monolayer only the top surface is exposed to growth medium and lower surface 
to the substrate. These two different configurations in the culture systems may 
be important in interpretation of results. The increase in colony size in 20% 
serum could be due to a clonal effect of serum on the cells capable of cell 
division, especially when a heterogenous cell population exists in the transfected 
lines due to growth transformations.
5.4.5 Transformation and Chemosensitivity
Chemosensitivity studies showed that the normal Ha-ms transfected cell 
line was resistant to ara-c, compared to the parental line. However, there was 
no effect of other drugs investigated on any of the transfected cell lines, relative 
to the non-transfected parental line. It has been shown in previous studies that 
the activated ras transfected cell line was significantly more resistant to 
adriamycin compared to the parental line [Kerr et a l, 1990]. Sklar [1988] have 
shown that Ha-ras transfected NIFI3T3 cells were more resistant to cisplatin 
compared to non-transfected control. The current data suggest that oncogene 
transfection can alter the sensitivity of mink lung epithelial cells to cytotoxic 
drugs, but only in selected cases, and the rate of proliferation does not always 
regulate the sensitivity to cytotoxic agents, following oncogene transfection. It has 
been shown by Kerr et al. [1990] that although TGF-/3 and EG F have significant 
effects on DNA synthesis of the parental, c-mvc. and normal Ha-ras transfected 
cells, their exposure did not alter the response of the lines to cytotoxic drugs 
adriamycin and vincristine. This also suggested that rapidly proliferating cells 
may not necessarily be more sensitive to cytotoxic drugs. Therefore, despite its 
higher rate of proliferation and shorter doubling time, the Ha-ms transfectants
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were resistant to the effects of the cytotoxic drugs.
It is possible that oncogene activation may confer resistance to tumours, 
and therefore, though the tumours are rapidly proliferating yet they are resistant 
to drugs, due the mechanisms outlined below. It has been commonly found in 
clinical practice that drug sensitive tumours following drug treatment and 
remission become resistant upon clinical relapse, and it might be that oncogenes 
are involved in this phenomenon. Therefore, it is essential to know oncogenic 
status of tumours both before and after drug treatment.
The emergence of the multidrug resistant phenotype following 
chemotherapy in initially sensitive tumours, such as small cell lung carcinoma 
[Little et al., 1983], and the expression of ras oncogene in inherently resistant 
tumours such as colorectal cancers [Thor et al., 1984] also raised the possibility 
of oncogene involvement in the underlying molecular mechanism of resistant the 
phenotype. A relationship has been proposed between transformation in vitro 
and the drug resistant phenotype, following chemical, viral, or oncogenic insult 
to a normal cell, suggesting a probable common mechanism underlying these 
processes.
The mechanisms by which experimentally induced tumours develop 
pleiotropic drug resistance include alterations in the levels of several enzyme 
systems involved in detoxifying xenobiotics e.g glutathione-S-transferase [Cowan 
et al., 1986] and membrane associated glycoproteins acting as active pumps to 
expel drug out of the cell e.g P-glycoprotein [Thorgeirsson et al., 1987]. Both p- 
glycoprotein [Moscow and Cowan, 1988], and glutathione-S transferase [Wolf et 
al., 1986] are thought to play an important role in the phenomenon of multidrug 
resistance (MDR) phenotype. Cellular resistance to adriamycin and vinblastine 
has been shown to be secondary to the increased levels of MDR gene [Moscow 
and Cowan, 1988] and glutathione-S-transferase [Doroshow et al., 1980]. Burt et 
al. [1988] in similar studies have shown that the transformation of rat liver 
epithelial cells with v-Ha ras was associated with expression of MDR-1, 
glutathione-S-transferase- tt and an increased resistance to cytotoxic drugs
including adriamycin and vinblastine.
How exactly oncogenes do induce resistance in the recipient cells is far 
from clear. The c-mvc and Ha-ras oncogene products are not directly responsible 
for the drug resistance phenotype. The Ha-ras p21 is a membrane G-protein 
associated with signal transduction pathways, and the c-mvc p62 is a nuclear 
protein and may be involved in the expression of other genes associated with 
drug resistant phenotype, but this is not known yet. W hether oncogenes can
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induce drug resistance by a direct mechanism by acting directly at the genetic 
level is unknown.
From these findings it can be concluded that either there were no effects 
of oncogene transfection on the sensitivity of the cells, or where some effects 
have been observed, they were only marginally significant. There can be many 
possible explanations to these findings. Firstly it could be that the cells exposed 
during exponential growth phase have comparatively little differences in their 
mitotic rates, as the growth rate differences could only be clearly observed when 
compared at saturation densities of the cell lines. Therefore it would be 
interesting to see the effects of cytotoxic drugs at saturation density. Although 
it depends on the type of drug and the cell cycle, generally drugs are known to 
be effective on cells during their exponential growth phase, and less so in the 
plateau phase. Secondly, it may be possible that the oncogenes did induce the 
resistant phenotype in the transfected cells, but the parental cell line was already 
resistant so that any effect of oncogene transfection was not detectable.
5.4.6 Growth Characterization In Vivo: Correlation With In Vitro Growth
Characteristics.
A significant correlation has been observed between growth properties of 
the cell lines in vitro and in vivo. A mild degree of spontaneous phenotypic 
transformation was observed in the parental non-transfected cells. The 
expression of the transformed phenotype was enhanced following tumour passage 
in vivo, and was amplified by oncogenic transfection. Mvl line is immortalized, 
Ml is moderately malignantly transformed, while both N1 and T1 are highly 
malignant, but T1 is always more aggressive where distinctions can be made. 
Land et al. [1983] have shown a correlation between expression of cellular 
oncogenes and multi-step carcinogenesis. Spandidos and Anderson [1987] have 
proposed that the process of oncogenesis is multi-step, and that each stage is 
probably regulated by one or a set of oncogenes.
In vitro growth patterns of the cell lines were reflected by tumour 
formation in vivo. Under standard culture conditions the parental cells were non- 
clonogenic in semi-solid medium, and were serum dependent. However, they 
were able to form colonies in soft agar as well as to grow in low serum 
conditions, but only, when a high cell concentration was seeded. The Mvl cell 
line did not produce tumours below a critical cell number. However, following 
inoculation of a high cell number, tumours were produced in only 20% of the
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cases, and with a relatively long latency period and prolonged doubling time, but 
these produced 100% tumours during their first passage in vivo with a shorter 
latency period and doubling times. These findings are in agreement with Stiles 
et al. [1975]. They could not obtain tumours from several human cell lines 
transfected with SV-40 viruses, but later several of these cell lines were found 
tumorigenic when large numbers of cell were inoculated into the animals 
subcutaneously [Koprowsky and Croce, 1977], suggesting a positive correlation 
between cell number, cloning in vitro, and incidence of tumour formation in vivo.
A number of separate, but interrelated, issues emerge following these 
observations. First, in the spontaneous acquisition of transformed or oncogenic 
properties by the parental cells, an increase in cell number was associated with 
a corresponding increase in expression of oncogenic properties.
The non-transfected cells did not express a transformed phenotype under 
standard experimental conditions, both in vivo and in vitro. However, a milder 
acquisition of transformed characters have been observed, but only at the expense 
of very high cell number. The same characteristics were enhanced by varying 
degrees following transfection of the cells, by different oncogenes individually. 
Spontaneous acquisition of transformed phenotypes including tumorigenicity and 
invasion have been found in normal mouse [Aaronson & Todaro, 1968] and rat 
[Van Roy et al., 1986] fibroblasts, suggesting that transformation can occur in 
apparently normal cells without transfection. Mareel et al. [1975] have shown 
spontaneous expression of tumorigenic phenotype in C3H/3T3 immortalized cells.
According to one theory, it is possible that some oncogenes, yet unknown 
are activated in the parental cells, either due to culture conditions, host 
influences, or spontaneously by some other yet unknown mechanisms. Another 
possibility is that perhaps a subpopulation with this genetic background is present 
in the original heterogeneous cell population. It has been reported that rat 
fibroblast cell line 208F transfected with a single human oncogene was expressing 
other oncogenes with both nuclear-(c-abl) and membrane- (c-fos) associated 
products [Wyllie et al., 1987].
Passage of cells in vitro and tumour passage in vivo seems to have a 
selective effect for a subpopulation of cells. The observations made under 
standard experimental conditions have shown a significant difference between the 
parental and the transfected cells as far as their growth properties are concerned 
in vitro and in vivo. Therefore, taken together, these data suggest that oncogenes 
are involved in the progression, if not initiation, of malignant transformation.
The second important finding is a significant enhancement in the
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malignancy associated properties by oncogenic transfection of parental cells, 
suggesting their role in the regulation of these phenotypes. In vivo growth 
potentials have been enhanced by separate transfections with human oncogenes. 
All transfectants produced tumours in 100% cases with shorter doubling times 
and latency periods. The growth of the activated Ha-ms transfectants was most 
aggressive followed by the normal ras, and the c-mvc in that order. No significant 
effects of oncogenic transfection on expression of markers and ultrastructural 
features have been observed. Either there are no effects or the methods were 
not sensitive enough to discriminate the minor alterations in phenotypic 
expression. This pattern of growth has already been shown in vitro studies.
An interrelationship has been demonstrated between in vivo and in vitro 
transformed phenotypes, e.g. a highly clonogenic cell line in agar in vitro was also 
highly tumorigenic in vivo and a poorly clonogenic cell line exhibited a very low 
tumorigenicity in vivo. The comparison is shown in the table below.
Table 5.16: Correlation of Growth Properties in Vitro and in Vivo .
Cell line 1Clonogenicity Tumorigenicity
(%) (%)
Mvl 0.5 20
Ml 5.4 100
N1 10.3 100
T1 10.7 100
' 20% FBS
When cultured cells implanted into an animal formed a progressively 
growing tumour nodule at the site of implantation, the assessment of 
tumorigenicity was considered positive. However, it may be that tumours can 
arise from the host tissue, e.g. stromal cells under the action of inducing agents 
(e.g. viruses, or oncogenes) contained in the implanted material. There are other 
possibilities as in some cases variants of implanted cells can be tumorigenic, 
which might have been present initially in the implanted population or might 
have been induced spontaneously, or by micro-environmental influences, after 
implantation. Additional studies were undertaken to exclude these possibilities,
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including histological examination of tumour, immunohistochemical marker 
expression, and ultrastructural studies. The histological examination was useful 
to distinguish an epithelial tumour from a reactive granuloma. Therefore these 
controls were taken into consideration to prove tumorigenicity of the 
transfectants. It is difficult to interpret a negative result of tumorigenicity, as it 
may be due to certain limitations of the assay methods e.g. antigenicity and 
immunological incompatibility of implanted cells with the host e.g by interactions 
with NK cells of the host [Mora et al., 1977]. However, the use of 
immunodeficient mice reduces the possibility of negative results due to the host 
immune system. One of the factors affecting results of tumorigenicity in this 
study was the number of implanted cells especially in the parental cell line. The 
critical number of cells leading to a positive take varies among species, cell lines, 
and in different experimental conditions. These findings are in agreement with 
various previous studies, where a high cell number (106-107 cells per inoculum per 
animal) has been used to get tumorigenicity [Winterbourne & Mora, 1977].
Why is a large cell number necessary to give rise to a tumour? There are 
many possibilities: 1) the cells may co-operatively form a favourable micro­
environment for themselves e.g. induce stromal growth, secrete growth factors, 
and form intercellular communications; 2) only a small number of tumorigenic 
cells were present in the total cell population.
5.4.7 Plasminogen Activator Activity.
There was no significant difference in PA activity of cells before and after 
transfection with human oncogenes, and no definite correlation has been found 
between oncogene transfection of epithelial cells and PA production. Many of 
the previous attempts to correlate PA activity and neoplasia in human tumours 
have been conflicting. Markus et al. [1980] have found no difference in PA 
activity of benign tissue and malignant tumour from human lung. Similarly, no 
relationship was found between PA activity and local invasion in breast cancer 
[Evers et al., 1982]. PA production by human normal tissues has also been 
reported. Schumacher and Schill [1972] demonstrated higher PA activity in 
normal cells of human fetal lung in early passage cultures, compared to adult 
lung, suggesting that PA production may be the property of tissues undergoing 
reconstruction as during fetal life, and cancer growth also involve destruction of 
tissues though repair is probably overridden.
In another study a number of clinical and histopathological variables were 
examined separately for their possible association with PA activity. Although a
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very weak association of PA activity was found with disease stage, invasion and 
nodal status, the vast majority of other variables did not influence PA level 
including histological grades, size of tumours, and metastasis. [Colombi et al., 
1984].
It has also been proposed that the production of an increased amount of 
PA is not an obligatory feature of transformed cells in culture, in particular the 
cell lines with long history in culture may lose this property without losing other 
malignancy associated phenotypes [Rifkin and Pollack, 1977], suggesting that PA 
production may be the property of early stage tumours, since a transient 
proteolytic activity is essential for invasion at primary tumour site.
Still another reason for these discrepancies could be the production of 
specific protease inhibitors, the net PA activity depending upon the interaction 
[Sprengers & Kluft, 1987].
5.4.8 Invasion and Metastasis
Invasion in vitro showed that all cell lines, including the parental, line co­
cultured with chick heart fragments, were invasive with only minor differences 
in the pattern and rate of invasion. All transfected lines were also invasive in 
vivo, however Ha-ras transfectants were always more aggressive. The parental 
line was non-invasive during primary growth. Virtually all transplanted tumours 
were found invasive including those engendered by the non-transfected cells. 
Spontaneous metastases were not found in any of the cell lines.
These data have demonstrated a significant correlation between invasion 
in vitro and in vivo, and in agreement with previous reports of Mareel et al. [1987] 
and de Ridder et al. [1987], who have been able to predict in most cases 
invasiveness in vivo on the basis of assay of invasion in vitro, using chick heart 
fragments. More recently it has been shown that invasion of glioma cells in this 
model was consistent with their invasive behaviour in vivo, suggesting a potential 
utility of the assay for predicting invasion in patients [de Ridder and Calliauw, 
1990],
The single tumour formed by the parental line at high cell number was 
minimally invasive in vivo during primary growth, transplants took with 100% 
efficiency, and were all locally invasive like the tumours of the transfected cell 
line.
All tumours produced by the mvc transfectants were locally invasive, with 
evidence of host tissue destruction and replacement by invading cells. Similarly
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transfection of Mvl cells with Ha-ras also enhanced tumour incidence to 100%. 
These tumours showed the most aggressive behaviour in terms of their invasive 
phenotype with macroscopic as well as microscopic evidence of host tissue 
infiltration and destruction of surrounding host tissue. Mareel et al. [1987] found 
similar results, cells transfected with Ha-ras oncogenes were invasive and 
metastatic, however, the non-transfected parental cell line also showed 
transformation associated characteristics, both in vitro and in vivo, including agar 
cloning, invasion and metastasis.
From these data it can be concluded that a subpopulation of cells in the 
parental cell line is capable of expressing the properties of a transformed cell and 
that the expression of these transformed properties has been enhanced by 
oncogenic transfection of the parental cell line.
Taken together these data suggest that tumours produced by mink lung 
epithelial cells, either before or after separate transfection with human oncogenes 
were locally invasive with exception of primary tumours of Mvl, and expression 
was enhanced after tumour passage in vivo, with only slight differences in their 
pattern and rate of invasion.
Invasive phenotypes can be obtained by transfection of normal or non- 
invasive primary or immortalized cells in culture with plasmid containing 
oncogene(s). However reports from other workers have seriously challenged a 
sole role of oncogene(s) in conversion of the non-invasive into the invasive cell 
phenotype [Mareel & Van Roy, 1986].
It has been suggested that invasion can arise in a cultured cell population 
in an apparently spontaneous way under different conditions such as: 1) Routine 
passage of cells in culture has been reported to cause conversion of non-invasive 
to invasive phenotype, with or without transformation of growth [Mareel et al., 
1988]. This has been found in a variety of cell types e.g. in mouse embryo cell 
lines [Mareel et al., 1975; Greig et al., 1985]. 2) Gene transfer procedures per 
se such as the calcium phosphate technique of Grahm and Van der Eb [1973]. 
Therefore it is essential to confirm oncogene incorporation into the host cells by 
southern blot analysis, to exclude the possibility that carrier DNA had an effect 
without oncogene. Usually this is confirmed using controls including parental cell 
line and parental cells treated as test cells (transfected) but without oncogene. 
3) Cloning cells in vitro has been found to cause invasive phenotype in an 
immortalized cell line [Mareel & Van Roy, 1986] spontaneously. This can be due 
to activation of an oncogene following growth in agar, but the most probable 
explanation is the selection of clones (transformed or stem cells) with the invasive
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phenotype, which were already present in the parental cell population but at a 
very low number. Our results are in agreement with these findings. Mvl formed 
very few colonies in agar, very low tumorigenicity, and invasion in vitro was 
possibly due to a selective process. 4) An increase in the level of the in vitro 
transformed phenotype and tumorigenicity in vivo have been reported in many 
studies following tumour passage in vivo. Invasion has been reported to be 
acquired quite frequently through a single in vivo passage of non-invasive 
tumours. Van Roy et al. [1986] showed that rat cells were non-invasive in vitro 
assays, but produced invasive tumours when injected into syngeneic Fischer rats 
through subcutaneous route. Subsequently a cell line derived from such a tumour 
was frankly invasive, suggesting selection of an existing subpopulation of cells with 
invasive properties. These findings are in agreement with present results.
There could be two possible explanations to the above observations. 1) 
Host factors may activate the genetic mechanisms for the transformed phenotype 
such as activation of oncogenes and suppression of anti-oncogene(s) resulting in 
a transformed phenotype. 2) Transformed cells are selected by growth in vivo. 
Apparently these observations do challenge an absolute role of oncogenes in the 
acquisition of the malignant phenotype, because the parental line is expressing 
the transformed properties as well. However, the expression of endogenous 
oncogenes in the parental line cannot be excluded.
Collard et al. [1985] have suggested a possible role of endogenous 
oncogene activation in tumour derived cell lines, following in vivo passage. Cells 
may acquire invasiveness or a malignant phenotype through interaction with host 
cells or the in vivo environment may select a subpopulation which is already 
present in the parental cell line, which in this case is heterogeneous but with a 
predominantly normal phenotype. This stem cell subpopulation is perhaps 
capable of expressing malignant properties, and may represent a similar cell type 
in vivo capable of causing tumours under various conditions of environmental 
changes.
Heterogeneous expression of oncogene products in a given tumour cell 
population has further supported the idea of heterogeneity of tumour cells both 
in vivo and vitro. Moreover, heterogeneous expression of oncogene products in 
an invasive cell population suggests that the malignant cells are dynamic both in 
function and structure. Perhaps all malignant phenotypes are transient, 
interchangeable, and may alter due to a high cell turn over and genetic changes 
taking place at relatively higher rate than in normal cells which are relatively 
static. These changes in tumour cells may go from bad to worse or vice versa,
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depending upon the circumstances resulting in expression of differentiation or 
malignancy associated characteristics. It represents a spectrum of intermediate 
phenotypes between a normal differentiated phenotype and undifferentiated 
malignant phenotype.
It has been shown that invasion results from selective growth of a 
subpopulation of cells with invasive potential, and heterogeneity may result from 
random genetic changes occurring in a transformed cell population [Talmadge 
and Fidler, 1982; Weiss & Ward, 1983]. It has been shown in the present study, 
where the parental cell line becomes as invasive as the transformed cells, 
suggesting a selective process, and heterogeneity in the Mvl cell line. It is 
possible that some invasive cells are present in the parental cell line population 
which are selected by in vivo passage. It may also be possible that these cells 
respond to oncogene transfection and expand to dominate the culture. 
Oncogenes may facilitate growth expansion, but do not make cells invasive per 
se.
Interestingly, despite the local invasiveness of the cell lines, there was no 
evidence of metastatic spread, either locally to regional lymph nodes or to distant 
sites, including liver, lungs, and brain under these assay conditions. There was 
no obvious correlation between metastatic and other malignancy associated 
phenotypes.
Although the ability of the tumour cells to cross the basement membrane 
is found in general to correlate with their metastatic ability in vivo [Liotta et al., 
1986], all invasive tumour cells are not necessarily metastatic. It has been 
proposed that invasion and metastasis are two distinct steps in tumour 
progression towards increasing malignancy [Mareel and Van Roy, 1986]. A gene 
for the invasive phenotype has been proposed [Sporn & Roberts, 1985]. Similarly 
specific gene(s) have been suggested in causation of metastatic phenotype 
[Mareel & van Roy, 1986], or the same gene acting at different levels of 
malignant progression may be involved. However there is no known example of 
such a genetic sequence responsible for metastatic conversion of a non- 
metastatic model either in vitro or in vivo.
In accordance with these results, it has been found that the Ha-ras 
transformed cells may be capable of experimental metastasis, but not spontaneous 
metastasis [Thorgeirsson et al., 1985]. They found that the Ha-ras transfected 
cells were metastatic when injected directly into the blood vessels, but the same 
cells were non-metastatic when injected subcutaneously, suggesting some specific 
effects of route of injection.
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A progressive reduction in metastatic ability of the cells maintained in 
culture has been reported [Ossowski and Reich, 1980], apparently in contrast to 
the increase in the invasive phenotype with passage number [Mareel et al., 1988], 
suggesting that metastasis may require some differentiated phenotype lost in 
vitro. Invasion on the other hand may be associated with proliferation, and a 
more undifferentiated phenotype.
It has been suggested that metastasis can be a transient change in growing 
cells either due to mutations or epigenetic changes [Weiss & Ward, 1983]. 
Similarly it has been observed that different cell lines transfected by the same 
virus, exhibited different metastatic abilities suggesting that an intrinsic cellular 
property may be responsible for the metastatic non-metastatic behaviour.
There could be the following possible reasons for the failure of the cells 
to metastasize in spite of invasion: 1) related to models and methods used, 2) and 
related to the process of invasion and metastasis itself.
In vivo metastasis is mostly studied using animal models usually syngeneic 
or immunodeficient mice, since no in vitro assay is capable of modelling all of 
the aspects of naturally occurring metastasis. Metastatic assay performed on 
heterogeneous cell populations such as those obtained following transfections with 
oncogenes introduces an extra requirement for an immunodeficient host e.g. 
athymic nude mice. There has always been some caution raised about the use 
of nude mice in the study of metastasis due to the non-metastatic behaviour of 
some malignant cell lines and the potential for the natural killer cell modulations 
of metastatic ability [Fidler, 1986; Chambers & Tuck, 1988], and the success of 
the nude mouse model for studies of cancer metastasis has been limited as most 
malignant neoplasms tested in this model were not metastatic. Using human 
melanoma cell lines in this system Tveit and Pihl, [1981] showed that human 
xenografts grown in nude mice retained the properties of the parental tumours. 
Although tumours grew extremely well in nude mice metastases were rare. 
Because of the reports that perhaps the NK-cell system is active in nude mice 
[Fidler, 1986]], and that oncogenes may increase cellular sensitivity to NK cell 
cytolysis [Johnson, et al., 1985; 1987], it may be possible that this mechanism was 
operating in this model. Naito et al. [1987] have used the NK-cell deficient beige 
mice model but they did not find a higher incidence of experimental lung 
metastasis than in the conventional nude mice model. In addition, a SCLC cell 
line, NCI-H69, was metastatic in the same model [see above, Chapter three-A]. 
Therefore, it is unlikely that NK cells or the nude mouse model were responsible 
lor the non-metastatic phenotype of the cells in this study.
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5.4.9 Are Oncogenes Involved in Phenotypic Transformation?
Tumour invasion, dissemination and metastases formation are considered 
as advanced characteristics of malignant transformation. The tumour cell 
population may employ different strategies to achieve the same end. Many 
investigators have sought to determine the phenotypic traits which distinguish 
metastatic cells, yet no specific characteristics have been unequivocally recognized 
as being constitutively required by all cells capable of metastasis [Mareel et al., 
1986].
All stages of the malignant processes including invasion and metastasis are 
now thought to be under genetic control. Specific genes are thought to be 
responsible for these individual steps. Normal cellular genes or proto-oncogenes 
control normal cell functions. Activation of the proto-oncogenes may contribute 
to neoplastic transformation and progression to the metastatic phenotype. 
Oncogenic expression has been correlated with invasion and metastasis in several 
different studies, both in vivo in human tumours [see above, Table 1.3], and in 
vitro experimental models. Little et al. [1983] found that expression of c-mvc 
gene was observed commonly in cells from a variant of small cell lung carcinoma 
with poor prognosis. These findings suggest that amplified or activated 
oncogenes may produce heterogeneity in tumour tissue by increased rate of cell 
proliferation, and once a diversification has occurred in the tumour cell 
population, the subsequent changes may not be critical for progression of the 
malignant process to achieve a final invasive or metastatic phenotype.
It is often difficult to determine whether oncogene expression is a primary, 
i.e causal, or secondary, i.e induced event, in a malignant cell. Many oncogenes 
including mvc and ras have been found during normal growth and development. 
This ambiguous expression of oncogenes both in normal and tumour tissues has 
suggested two possible explanations for these observations. It may be possible 
that oncogenes simply confer greater growth potentials on cells already possessing 
the necessary genetic elements required for metastasis. On the other hand 
activation or insertion of an oncogene in the host DNA may trigger a "pre­
programmed" cascade of events normally undertaken by migrating cells during 
embryogenesis or wound healing. Therefore, a single gene such as Ha-ras 
apparently can influence a complex multi-step sequence of events such as 
invasion and metastasis, by above mechanisms. An activated oncogene such as 
ras may cause invasion and metastasis by: 1) Mitogenic effect due to growth 
factors production e.g T G F -a  mitogenic for epithelial and stromal cells, and
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endothelia, TG F-0 mitogenic for stromal cells; these events may modify cellular 
adhesion and cause an increased release of cells from the tumour site. 2) 
Production of lytic enzymes; ras transfected cells are known to produce cathepsin 
L, this and collagenase type IV may be involved in the degradation of basement 
membrane. 3) An altered expression of cell surface receptors and antigens may 
alter cell interactions with growth factors, altered glycosylation with increased 
branching, decreased cell contacts, enhanced extravasation, and sensitivity to 
immune system and tumour cell survival in circulation.
Abnormal expression of ras. oncogene has also been described in human 
colonic carcinomas by different investigators. Immunohistochemical studies [Thor 
et al., 1984] using a monoclonal antibody broadly active against the ras group, 
raised against a synthetic peptide showing sequence homology to the human T24 
ras oncogene product, showed that the majority of the cells in colon carcinoma 
were positive for ras. but only less than 10% cells were positive in benign 
tumours, and less than 1% cells were positive in normal colon. However, about 
90% cells were positive in metastatic tumours. Moreover, a correlation was 
shown between the depth of invasion and ras p21 expression where only a very 
small number of positive cells was found in normal mucosa, an intermediate 
numbers of positive cells in superficial invasion, and a large numbers in deeply 
invasive carcinoma, suggesting a possible role of ras oncogenes products in 
invasion and metastatic processes. Spandidos & Kerr, [1984] have demonstrated 
higher transcripts of Ha-ras in adenomatous polyps of colon than in carcinoma. 
It can be concluded from these observations that ras p21 overexpression was not 
per se sufficient evidence for the generation of the invasive phenotype in human 
colonic tumours.
Cell surface changes due to oncogene products have been described in 
different studies. Collard et al [1987] have shown that ras p21 is located in the 
plasma membrane therefore suggesting that the mechanism of possible interaction 
between p21 and cell surface molecules like carbohydrates, proteins, or lipids etc., 
may well be involved in alteration of these structures at the cell surface, which 
has been proposed to be related to malignancy. Collard et al., [1987] have 
demonstrated p21 involvement in the metastatic phenotype of transfectants in 
nude mice model suggesting that the cell surface changes secondary to oncogene 
transfection might be due to presence of oncogene product(s) which may 
contribute to the invasive and metastatic changes in the cells.
A substantial number of oncogene related products have an effect on 
cellular functions that are implicated in invasion and metastasis, such as
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migration [Mareel and de Mets, 1984] and secretion of lytic enzymes [Jones and 
de Clerck, 1982]. Mareel et al. [1981] showed that stimulation of migration in a 
non-invasive cell was related to the development of the invasive phenotype, 
suggesting that the oncogene products may act by altering specific functions in the 
cell that may lead indirectly to the invasive phenotype. Similarly Bade and 
Nitzgen [1985] have found that EGF could cause migration of liver epithelial cells 
on a tissue culture substrate, while EGF-stimulated migration of human foreskin 
fibroblasts has been shown by Westermark and Blomquist [1980]. They proposed 
a possible role of such factors in invasion in vivo of tumour cells during invasion 
and metastasis.
Many research groups have found that abnormal expression of members 
of the ras oncogene family can contribute to metastasis, using either nude mice 
or chick embryo models and NIH 3T3 cells. Spandidos & Wilkie [1984] 
demonstrated transformed phenotype in ras transfected fibroblasts, suggesting that 
a single oncogene can induce the malignant phenotype, probably by acting at 
different stages of the carcinogenic and metastatic processes. Similar results have 
been shown by a number of other studies using fibroblasts with ras. transfection 
[Wyllie et al., 1987; Chambers & Tuck, 1988]. Working with normal human 
bronchial epithelial (NHBE) cells Yoakum et al. [1985] have shown that following 
transfection with v-Ha-ras these cells acquired carcinogenic potential such as 
tumorigenicity, invasion, and formation of colonies in soft agar. Using mouse 
mammary cell lines a metastatic subclone was obtained after transfection with c- 
Ha-ras oncogene, and after co-transfection with PSV2 neu plus c-Ha-ras oncogene 
a higher metastatic frequency was observed, suggesting that ras transfection alone 
in some cases may not be sufficient to induce metastatic potentials. Greig et a 
/., [1985] have shown that immortalized cells may express both tumorigenic, 
invasive and metastatic phenotypes, and the exact role of ras in such cases is not 
clear. He further suggested that the majority of immortalized cell lines are far 
from normal and need special caution in the interpretation of transfection data.
In summary, the data presented in this chapter have shown that the 
transfection of mink lung epithelial cells, with human mvc normal Ha-ras, and 
activated Ha-ras has imparted malignancy associated characteristics to the 
transfected lines, by varying degrees of severity, both in vitro, and in vivo, in a 
pattern consistent with the multi-step theory of carcinogenesis.
The parental line was already immortalized, but serum dependent, with 
mild growth transformation, very low clonogenicity in soft agar, and 
tumorigenicity in nude mice, invasion in vitro assay and mildly so in vivo. On the
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other hand, transfection with activated Ha-ras exerted the most aggressive and 
malignant transformation to the transfectants, while the normal Ha-ras and the 
mvc transfectants expressed properties intermediate between the parental and 
activated Ha-ras transfected cells.
These data therefore suggest a role of oncogenes in progressive malignant 
transformation of epithelial cells. While the mvc may have carcinogenic 
potential, the role of activated Ha-ras seems to be more crucial. This model, 
therefore, may be useful for the study of oncogenesis in epithelial tumours in 
general, and lung carcinomas in particular, with special reference to oncogenic 
involvement.
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CHAPTER SIX
GENERAL DISCUSSION
As the results have already been discussed in detail in each chapter, the purpose 
of this chapter is to bring together the main findings of different chapters, with 
more general conclusions, possible implications, and the future prospects.
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6.1. The Objective And Achievements.
The purpose of the studies performed in this thesis was to investigate and 
establish, whether induced or spontaneously arising alterations in the phenotypes 
of lung cancer cells affected their malignancy and chemosensitivity. Phenotypic 
alterations have been shown to arise spontaneously in the H69 small cell lung 
carcinoma cell line and to be inducible by differentiating agents. In both cases 
the changes in phenotype resulted in decreased malignancy, but had no consistent 
effect on chemosensitivity. Genetic manipulation of mink lung epithelial cells, 
by transfection with human oncogenes, resulted in increased malignancy but 
again with only minor effects on chemosensitivity. Attempts to modify the 
phenotype of non-small cell lung cancer cells met with only limited success.
While attempts to manipulate the phenotype to alter chemosensitivity have 
been unrewarding, it is clear that the expression of phenotypic characteristics 
associated with malignancy can be manipulated in a manner which can regulate 
tumour growth in vivo.
Spontaneous phenotypic changes have been observed in H69 cells in 
culture. The cells changed from typical SCLC morphology to NSCLC type 
morphology, accompanied by biological and biochemical changes. While the 
parental line expressed markers of neuroendocrine differentiation both the 
derivative lines either did not express or expressed only small quantities. The 
parental cells were invasive in vitro, while derivative lines were not. H69 cells 
were also invasive in vivo, and showed widespread metastases, but the derivative 
lines were neither invasive nor metastatic. These, with a number of other 
parameters studied in the present report [Chapter three-A], suggested that the 
derivative lines were of H69 origin, but had transformed to NSCLC phenotype, 
spontaneously.
Further studies [Chapter three-B] showed that the H69 cell phenotype 
could also be altered by experimental manipulation. The cells exposed to various 
potential phenotypic inducers (cyclic AMP, HMBA, Na-But) also showed 
morphological and biochemical changes, suggesting that the H69 cell phenotype 
can be altered by external influences, in addition to the changes arising 
spontaneously.
The effects of microenvironmental changes on a NSCLC cell line were 
also investigated [Chapter four]. WIL cells (lung adenocarcinoma derived cell 
line) grown in histotypic culture exhibited a more differentiated phenotype.
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There was an increase in mucin production, accompanied by morphological 
change. The cells grown in the histotypic model were able to form surface 
microvilli, compared to smooth surfaced cells grown without histotypic culture in 
a conventional plastic monolayer. These changes again suggested that the cell 
phenotype can be modulated by microenvironmental manipulations.
In addition to microenvironmental manipulations, the effects of genetic 
alterations on cell phenotype have also been investigated [Chapter five]. An 
immortalized lung epithelial cell line transfected with human Ha-ras. and c-mvc 
oncogenes individually showed significant phenotypic changes in cell phenotype. 
Transfectants acquired changes in morphology and growth both in vitro and in 
vivo, suggesting that a small genomic change can have extensive effects on 
phenotypic expression. To summarize, it has been demonstrated in different 
models in these studies that the tumour cell phenotype can alter spontaneously, 
or can be altered following microenvironmental changes, and by genetic 
manipulation.
Phenotypic changes either spontaneous or induced by genetic alterations 
were stable. Both the derivative lines of H69, H69V & H69VZ [Chapter three- 
A], and oncogene transfected lung epithelial cell lines [Chapter five] showed 
phenotypic stability. However, changes induced by chemical inducers were mostly 
reversible [Chapter three-B]. Cells exposed to chemical agents showed growth 
arrest, and loss of invasive capacity, but following drug removal cells were able 
to grow again, and regained invasiveness. These findings have demonstrated that 
phenotypic change once induced may become stable or revert back to the 
parental phenotype, once the inducer is removed, suggesting that the phenotypic 
changes following genetic alterations are more stable than the changes due to 
microenvironmental influences. This suggests that H69 cells may have changed 
their genotype to give rise to H69V and H69VZ [Chapter three-A], in an 
analogous fashion to the transfection of lung epithelial cells with human 
oncogenes [Chapter five], although with opposite effect.
6.2 Phenotypic Transition In SCLC: Implications For Lung Cancer
Classification.
In vitro conversion from classic SCLC to NSCLC accompanied by the 
coordinate shifts in morphology, growth and neuroendocrine phenotype has been
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shown in the present study [Chapter three-A]. This in vitro model could be useful 
for the study of phenotypic conversions in lung cancer in vivo. It may also be a 
useful model for studying response of SCLC to radiation and chemotherapy. This 
model can also be used to investigate the interrelationship of chemosensitivity 
and neuroendocrine differentiation and its potential therapeutic implications. 
Heterogeneity has been found in lung cancer both in clinical and in experimental 
studies, and may be the cause of treatment failure due to emergence of resistant 
variants in the original tumour. These mixed histology tumours have a 
significantly lower complete response rate to cytotoxic therapy and worse 
prognosis [Radice et al., 1982]. Generally a change in the SCLC phenotype 
toward a NSCLC phenotype is noticed [Goodwin et al., 1983]. It has been found 
difficult to quantitate tumour progression in precise terms by conventional 
histopathological studies of the tumour, and a lack of this knowledge hampers 
tumour treatment and ultimate outcome. Although, not immediately identified 
by conventional histopathological examination, lung cancers may show a profound 
heterogeneity when examined by ultrastructural or immunohistochemical 
techniques. It has been shown that only 34% of lung carcinomas were 
homogeneous, even on simple histological examination [Roggli et al., 1985]. 
Significant heterogeneity has also been found in cytological specimens of lung 
cancer [Hess et al., 1981] and on ultrastructural examination [Trump et al., 1982]. 
A so called tripartite differentiation within the same tumour cell has been 
reported [McDowell et al., 1981], who showed squamous, adenomatous and small 
cell differentiation in a small cell lung carcinoma at ultrastructural level, 
suggesting a link between these three tumour types, possibly by a common 
differentiation pathways originating from a stem cell. In another study, Broers 
et al. [1987] have examined 218 cases of human lung cancer, and found combined 
phenotype only in 6% on routine histology, however, after immunohistochemical 
examination heterogeneous staining for epithelial and neural antigens was 
observed in about 66% cases. These reports have suggested that lung cancer 
diagnosis, and hence treatment and prognosis may be significantly improved, by 
immunohistochemical and ultrastructural investigations of not only the borderline 
cases, but all suspected cases that may show any sign of heterogeneous cell types 
on histological examination. The present report confirms the heterogeneity of 
some lung tumours and shown that alterations in phenotype can influence 
outcome.
Changes in histological features are usually associated with the biological,
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biochemical and pathological behaviour, and with changes in the sensitivity of 
the tumour to radiation and chemotherapy. It is unknown whether this change 
represents the evolution of two separate lung cancers present from the outset, 
transformation of SCLC to other lung cancer types, development of a second 
tumour following cytotoxic therapy, or in fact it reflects a common origin for all 
lung cancers with different levels and pathways of differentiation. The present 
study favours the last of these.
It is possible that multiple oncogenic events may simultaneously transform 
different cells in close proximity to each other. The transformed cells of more 
than one histological type then grow together to form a composite tumour, but 
this concept has not been supported by enough evidence. On the contrary, it has 
been shown that the lung cancer tumours and tumour derived cell lines had a 
single aneuploid peak [Gazdar et al. [1981], suggesting that the concept of 
multiple oncogenic events occurring in normal cells to give transformed cells 
within a heterogeneous tumour may be unlikely. Another explanation could be 
that a single transforming event may give rise to morphologically different cell 
types. Tumours of one morphology may then convert to tumours having different 
morphologies. There is evidence that SCLC may undergo squamous metaplasia, 
and both SCLC and squamous cell carcinoma have a common etiology, and are 
commonly found in clinical specimens as mixed SCLC-squamous histology [Sidhu, 
1979], suggesting some common features between small cell and squamous cell 
carcinomas of lung. Similarly, in vivo studies have shown that nitrosamine 
induced pulmonary neoplasia in the hamster is preceded by bronchial endocrine 
cell hyperplasia and subsequent squamous metaplasia, suggesting a link between 
NE-cell related tumours and squamous cell carcinoma.
The development of a second tumour following therapy is an other 
possibility, perhaps by the overgrowth of a mutant subpopulation derived from 
the initial clone [Abeloff et al., 1979]. However, most of the morphological, 
biochemical, and biological data now clearly suggest that SCLC has the 
pluripotential ability to differentiate along more than one pathway of 
differentiation [McDowell et al., 1981; Nomori et al., 1986; Bepler et al., 1987; 
Gazdar et al., 1987], thus it seems more than likely that a stem cell population 
may exist in the H69 cells, which is capable of generating cells with SCLC and 
NSCLC phenotype, suggesting a common origin at least for these two types of 
lung cancer. One could argue that a heterogeneous cell population existed in the 
parental cell line H69, because the sublines were not derived from clones of H69.
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However, this seems unlikely as preliminary' studies on H69 clones showed 
morphological heterogeneity similar to the parental line, suggesting a stem cell 
nature of H69 clones. Furthermore, karyotypic investigation confirmed a 
common origin of both H69 and the derivative cell lines H69V & H69VZ, 
suggesting that the transition from H69 to H69V & H69VZ was an in vitro 
conversion. These data in agreement with previous observations imply that lung 
tumours may change slowly their whole biological behaviour in vivo from one 
characteristic of the classic cell types to another characteristic of the variant cell 
type, and ultimately to NSCLC, and that this is also reflected in vitro, where a 
link can be established between SCLC and NSCLC through various transitional 
types, having characteristics of both cell types.
In light of these observations, it appears that the existing lung cancer 
classification should be revised, in line with histogenetic, biological, histological 
and clinical data. The first official WHO lung cancer classification [Kreyberg, 
1967] included four subtypes of SCLC based on the original morphologic 
description of Barnard [1926]; fusiform, polygonal, lymphocyte-like and others 
(SCLC containing small foci of squamous cell nests, tubules, or giant cells). The 
WHO lung cancer classification was subsequently revised and published in 1981. 
The lymphocyte-like subtype was segregated and the term oat cell replaced the 
lymphocyte-like designation. The remaining three subtypes of the WHO 
classification were included in an intermediate category, implying a continuum 
between small and non-small cell lung carcinoma. However, no attention was 
paid to these morphological variants i.e by separating them into a subgroup, 
however, it could be justified, because at that time data were not available to 
demonstrate whether patients with large cell features behaved in a clinically 
similar way to patients with pure SCLC.
The morphological subclassification of the WHO subtypes of SCLC into 
the oat cell and intermediate cell were subjected to intense clinical and 
experimental studies to evaluate clinical course, ultrastructure, 
immunocytochemical and biological characteristics. Clinical studies have shown 
that SCLC tumours whether viewed as oat cell or intermediate in subtype, did 
not have any significant clinical applications, as no correlation was shown 
between the subtypes and the clinical course reflected by survival, response rate, 
sensitivity to chemotherapy and radiotherapy [Hansen et al., 1978; Burdon et al., 
1979; Carney et a l, 1981; Gazdar & Linnoila, 1988]. Others [Radice et al., 1982; 
Hirsch et al., 1983] have shown that patients with mixed small cell-large cell
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tumours have a poorer response to chemotherapy and a decreased median 
survival compared to pure SCLC, suggesting a lack of correlation between the 
WHO subclassification and clinical behaviour of SCLC.
With respect to the biology of the disease, some significant advances have 
been made in the understanding of human lung cancer that may have clinical 
implications. Most of the experimental work has been done on tumour cell lines. 
These cell lines are usually able to retain the histological and biochemical 
properties of the parental tumours in culture. Carney et al. [1985] and Gazdar 
et al. [1985] have proposed a new subclassification of SCLC based on extensive 
morphological and biochemical analyses of more than 50 cultured SCLC cell 
lines. In this classification, SCLC cell lines have been divided into two major 
groups, classic (approximately 70% of cell lines) and variant (approximately 30% 
of cell lines) cell lines. Classic cell lines express high levels of NE-cell markers 
(DDC, BLI, NSE, CK-BB & DCG), have a characteristic culture morphology, 
relatively long doubling time, low cloning efficiency, higher radiation sensitivity, 
and an intermediate cell type of SCLC [see above, Table 1.1]. Variant SCLC 
lines have a low or undetectable levels of DDC and BLI, but continue to express 
elevated levels of NSE and CK-BB, have a looser morphology in culture, a higher 
cloning efficiency, and faster doubling time and are radiation resistant in vitro 
[Goodwin & Baylin, 1982; Carney et al., 1983]. In addition these variant lines 
have up to 60 fold DNA amplification of c-mvc. and also show an increased 
expression of the gene [Little et al., 1982; Gazdar et al., 1985], suggesting a more 
malignant behaviour for the variant SCLC lines, which may in part be related to 
c-mvc amplification and expression in these lines. In many of their features the 
variant cell lines correspond to and in fact may represent mixed small cell-large 
cell carcinomas in vivo. In addition to classic and variant lines of SCLC, the 
multipotent cell lines capable of growing towards both SCLC and NSCLC lines 
have been observed [Carney et al., unpublished data]. D ata from this thesis 
[Table 6.1] suggest that these multipotent cell lines may correspond to, or at least 
contain, the stem cell population in vivo, and provide evidence for a common 
origin of all bronchial carcinomas.
The original lung cancer classification was entirely based on histological 
criteria. This type of classification takes into account the morphological 
similarities between the tumour cells and their assumed progenitor or normal 
counterparts in the particular site in which the tumour arises. In identifying an 
unknown tumour, one is actually looking for morphological features which bear
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Table 6.1:- Properties of the parental and its derivative cell lines.
Characteristics H69 H69V H69VZ
Morphology Aggregates epithelioid epithelioid
Doubling time long short short
CFE low high high
NE properties present abs/dec abs/dec
Karyotype SCLC SCLC unknown
Tumorigenicity present present present
Invasion present absent absent
Metastasis present absent absent
c-mvc expression low high high
FFA: free floating aggregates. CSF: colony forming efficiency. NE: 
neuroendocrine. SCLC: small cell lung carcinoma, abs/dec: absent and/or 
decreased.
resemblance to the appearance of the putative cell of origin and in this way 
placing the tumour in a particular category. This approach is based on the 
histotypic hypothesis that tumour cells retain at least some of the characteristic 
features of the normal cells. This histogenetic approach is not entirely justified 
for lung tumours in which the morphology is not a reliable criterion of the origin 
of the tumour [Bolen & Thorning, 1982], and in which multidirectional 
differentiation is often reported [Gould et al., 1981] and shown also in the present 
studies, suggesting a pluripotent stem cell subpopulation in the tumour capable 
of generating tumours cells with different phenotypes.
However, with the accumulation of more information both from clinics and 
laboratory research, a number of facts have emerged. First, there are no 
significant clinical or biological differences between the subtypes of SCLC (the 
oat cell and intermediate cell). Second, there are significant clinical, diagnostic 
and therapeutic differences between classic SCLC and SCLC combined with other 
lung cancer types, as patients with mixed histology have significantly worse 
prognosis. Third, a significant proportion (approximately 20%) of NSCLC 
express neuroendocrine, and cytogenetic characteristics of SCLC, suggesting a link 
between two types of lung cancer, and therefore a need for common histogenetic 
classification. Finally, NSCLC with NE-cell marker expression are sensitive to 
cytotoxic therapy, unlike other NSCLC which are resistant to radiation and 
chemotherapy, suggesting that NE-cell phenotype is more sensitive to cytotoxic 
therapy like SCLC and these NSCLC should be treated as SCLC.
On the basis of in vitro SCLC studies, a new histological classification of 
SCLC was proposed by the Second Workshop of the International Association for 
the Study of Lung Cancer at Gleneagles in 1984. It has been proposed that 
SCLC should include tumours with no NSCLC element, and it has been shown 
that more than 90% of untreated SCLC fall within this category [Hirsch et al., 
1988]. Small cell-large cell carcinoma should be grouped separately. It is 
estimated that 4% to 6% of untreated SCLC fall into this category, and these 
tumours have significantly worse prognosis compared to pure SCLC [Radice et 
al., 1982; Hirsch et al., 1983]. Combined small cell carcinoma is SCLC with 
squamous or glandular neoplastic components, and it is estimated to be less than 
1% of untreated SCLC. However, once again no proper attention was paid to 
the growing concept of a common origin of different lung cancer types. It is very 
important to consider the biological aspects of the disease in its classification. 
This will make histopathological classification of lung cancer simpler and
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reproducible among pathologists, and therefore better biological, clinical, and 
therapeutic comparisons would be made to understand changing clinico- 
pathological behaviour of the disease.
6.3 Signification Of Phenotypic Changes In Lung Cancer.
A number of phenotypic changes can be found in lung cancer during 
differentiation in vitro and in vivo. Although, induction of a differentiation 
associated marker in lung cancer cells may not necessarily imply a reduction in 
malignancy, there is growing evidence in other systems that induction of the 
differentiated phenotype is inversely correlated with malignancy associated 
properties [Roblin & Young, 1980; Freshney, 1985; 1987]. It has been shown 
[Sidell, 1981] that when a human neuroblastoma cell line, LA-N-1, was induced 
with retinoic acid to form neurite extension this was accompanied with a decrease 
in colony forming capacity in soft agar. Others [Rudland et al., 1982] have shown 
that rat mammary carcinoma, RAMA 25 cells, synthesised casein, and formed 
domes, had reduced DNA synthesis and were less tumorigenic in nude mice 
following induction with prostaglandin-E and DMSO. Induction of differentiation 
with suppression of malignancy in leukaemia has also been shown [Sachs, 1978; 
Lotem & Sachs, 1984]. An inverse relationship has also been shown in human 
glioma cells treated with dexamethasone [Frame et al., 1984], and glia maturation 
factor. Induction of differentiation associated properties was accompanied by a 
reduction in PA activity and endothelial cell mitogenesis. Similarly, it has been 
shown that B16 mouse melanoma cells treated with anthracycline antibiotics 
showed morphological differentiation with simultaneous inhibition of proliferation 
and tumorigenicity [Raz, 1982]. These are the few of the examples where an 
inverse correlation between differentiation and malignancy could be established.
This type of interrelationship between malignancy and differentiation has 
significant therapeutic implications. This means that the malignant cells could 
be treated not only with cytotoxic agents, but also with agents that may modify 
the biological behaviour of the tumour cells, e.g. differentiation inducers. 
Differentiation therapy can be used to inhibit malignancy phenotype. Inhibition 
of cell proliferation or invasion by chemical agents (e.g. HMBA) would provide 
an alternative treatment of cancer cells, by reversal of abnormal phenotypic 
expression.
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An inverse correlation between differentiation and malignancy has been 
demonstrated in some lung cancer models. Tralka & Robson, [1976] have 
demonstrated cilia formation and reduced tumorigenicity of human lung 
carcinoma cell line ChaGo treated with DMSO, suggesting that the malignant 
phenotype was reduced with induction of differentiation. It has been shown that 
normal human bronchial epithelial cells transfected with v-Ha-ras oncogene had 
decreased sensitivity to differentiation inducing agents as TGF-/3, TPA and serum 
[Yoakum et al., 1985; Masui et al., 1986] suggesting an inverse relationship 
between differentiation and malignancy in this model. A549, an alveolar cell 
carcinoma derived cell line, expressed surfactant production when grown in a 
filter well system in the presence of dexamethasone and embryonic fibroblasts 
[Speirs & Freshney, 1990], and induction of surfactant was correlated with 
suppression of the malignancy associated phenotype e.g., PA production, 
tumorigenicity in nude mice and cloning in agar. It has been demonstrated in 
these studies that a phenotype can be represented by a change in expression of 
either some specific markers of differentiation (e.g., mucin in adenocarcinoma, 
surfactant synthesis in alveolar cell carcinoma) or by changes in non-specific 
cellular activities (e.g., morphology, growth or cytostasis, anchorage dependence, 
serum dependence, contact inhibition, density limitation of growth, proteolytic 
activity, angiogenesis, apoptosis, invasion, and metastasis).
An inverse correlation between malignancy and differentiation has been 
demonstrated in the studies presented in this thesis. Apart from specific markers 
of differentiation, various other functional properties of cells have also be used 
to determine whether the shift in cell phenotype is towards a differentiated 
phenotype or towards a more malignant phenotype.
It is difficult to establish an inverse relationship between malignancy and 
differentiation in H69 and its two derivative cell lines [Chapter ihree-A], because 
of lack of differentiation markers in SCLC. However, it could be easier in 
NSCLC, where specific markers can be used to represent change in malignancy 
and differentiation e.g. mucin in adenocarcinoma, surfactant in alveolar cell 
carcinoma. However, it has been shown in this study that both the derivative 
lines exhibited benign properties, compared to the parental line. These data 
have suggested that SCLC cell line H69 was more malignant, while both NSCLC- 
like derivative lines were relatively benign. It implies that NSCLC in fact may 
represent a more differentiated phenotype, characterised by expression of specific 
differentiation markers (e.g. mucin in adenocarcinoma), loss of neuroendocrine
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properties, loss of invasive and metastatic potential, induction of resistance to 
radiation and chemotherapy, perhaps due to genetic alterations e.g. 
overexpression of c-mvc oncogene. More studies are required to establish 
whether NSCLC are differentiated compared to SCLC, by establishing and 
investigating more lung cancer models, for specific markers, oncogene expression 
and response to therapy.
Generally, malignant cells are highly proliferative, and arrest of cell 
proliferation is usually associated with differentiation in malignant cells, following 
treatment with differentiating agents. H69 cells treated with phenotypic inducers 
showed arrested growth of cells as long as the cells were in the drug. Most of 
the previous studies have shown G1 arrest following treatment with phenotypic 
inducers [Terada et al., 1977; Wintersberger et al., 1983], but this remains to be 
investigated with HMBA, Na-But, or dibutyryl cyclic AMP treated H69 cells. 
Loss of invasiveness in tumour cells following induction with differentiating agents 
is also a good criterion to indicate loss of malignant phenotype. Invasion was 
delayed in H69 following treatment with the phenotypic inducers, HMBA, Na- 
But and cyclic AMP, and this was correlated well with decrease in tumour size 
in vivo, when H69 tumour bearing mice were treated with these agents for 14 
days. W hether the effect was due to cytostasis or differentiation is not known, 
and it would be worth pursuing in future studies, by treating H69 cells with 
inducers and testing for tumorigenicity, invasion and metastasis in nude mice and 
clonogenicity in agar. However, there is no specific marker of differentiation in 
SCLC, and it may be that other cell lines such as A549 with surfactant production 
may be used. In this study it has been observed that treatment of SCLC with 
differentiation inducers was associated with suppression of malignancy, but 
whether it was related to induction of differentiation in vivo remains to be 
investigated. Preliminary results have suggested induction of morphological 
features of differentiation in treated tumours, and this could be pursued with 
other markers, and an attempt made to determine the effects on metastasis.
Mucin induction was also observed in WIL cells grown in histotypic culture 
in filter wells, with morphological evidence of differentiation e.g., formation of 
surface microvilli [Chapter four]. Mucin expression being a property of normal 
cells of the respiratory epithelium, has been used in previous studies as a marker 
of differentiation in normal and malignant lung tissues in vitro and in vivo [Spicer 
et al., 1980; Hall et al., 1980; Boat, 1982]. Although no attempt was made to 
analyze malignancy associated properties of WIL in these experiments, this
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remains a potential model for investigating the relationship of differentiation and 
malignancy as invasion could be measured in the filter well system. Whether 
mucin expression and formation of surface microvilli was related to reduced 
malignancy associated properties remains to be tested. It would be also 
interesting to test the cells following induction in histotypic culture, for cloning 
in soft agar and tumorigenicity, invasion, and metastasis in nude mice.
Mink lung epithelial cells transfected with human oncogenes also 
demonstrated an inverse correlation between malignancy and differentiation 
[Chapter five]. Changes in cellular morphology are the important criteria to 
differentiate a normal from transformed cell in vitro following oncogene 
transfection. Transfection of Ha-ras oncogene changed the flat morphology of 
mink lung epithelial cells to a spindle cell type, and this was the most significant 
effect of transfection that could be identified as an early sign of successful 
transfection. The transfected cells also showed an increase in the rate of cell 
proliferation, and increased clonogenicity in soft agar, loss of contact inhibition, 
serum independence, high labelling indices at saturation density and 
tumorigenicity in nude mice, all properties of the malignant phenotype. There 
was a good correlation between oncogene transfection and increased in 
malignancy-related characteristics of the transfected cells, with the exception of 
invasion. The parental line was found to be invasive in the in vitro invasion 
assay, leaving some doubts on validity of the assay with this cell line. It is 
possible, however, that a subpopulation of the parental line was transformed, as 
the line was mildly tumorigenic as well. This could be examined by 
characterization of clones of the parental cell line.
So far, phenotypic changes in lung cancer have been studied, for the most 
part, only at the extreme ends of cancer development. An ideal experimental 
strategy would be to identify specific markers (morphological, biochemical or 
functional) at various stages in the development of the differentiated or malignant 
phenotype in the respiratory epithelium. Then a phenotypic shift may be 
detected in its early phase, allowing stage-specific correlation between malignancy 
and differentiation. This may involve in vitro experimental models of both organ 
cultures and cell cultures, and in vivo experimental systems of both normal and 
malignant cells. Such an ideal model would be useful for the study of 
differentiation and carcinogenesis. So far only one model has been developed on 
these lines by Harris et al. [1985], using normal respiratory epithelium from both 
animal and human tissues for the study of differentiation and malignancy. It
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would be interesting to grow normal epithelial cells in histotypic tissue culture, 
to see whether differentiation could be induced, and then progressively more 
malignant cells from lung or other systems could be examined as discussed in 
Chapters three & four i.e. by regulation of the microenvironment and use of 
chemical inducers.
6.4 Phenotypic Changes In Lung Cancer: Effects On Radiation &
Chemotherapy.
It has been suggested that the cellular phenotype may be correlated with 
sensitivity to therapy and this would clearly be important in any attempt to 
combine differentiating agents and cytotoxic drugs. It is a common notion that 
more rapidly proliferating cells are generally more sensitive to radiation or 
chemosensitivity, compared to normal differentiated cells. To evaluate this 
further, the sensitivity of cells representing different degrees of differentiation 
and malignancy to cytotoxic drugs and radiation was tested. It was asked whether 
phenotypic change could influence chemosensitivity and what could be the 
implications? Do drug resistant mechanisms correlate with phenotypic change 
and how could they be modulated?
A SCLC cell line H69 and two of its NSCLC-like derivative lines were 
tested for radiation sensitivity in vitro. In this study, the parental H69 cell line 
was significantly more sensitive to radiation treatment compared to both the 
derivative lines and a NSCLC cell line WIL. This was in agreement with the 
previous clinical [Salazar et al., 1776; Owens & Abeloff, 1985] and experimental 
[Carney et al., 1983; Duchesne et al., 1986] studies on classic SCLC. H69V & 
H69VZ cell lines showed significant change in phenotype from classic SCLC to 
NSCLC-like phenotype, morphologically, biochemically and for growth properties 
in vitro and in vivo, and it correlated well with resistance to radiation. These data 
correlate with clinical response to radiotherapy, where SCLC is generally sensitive 
while many of these tumours on relapse are unresponsive. Cell lines derived 
from these relapsed tumours often exhibit the so called variant phenotype, which 
is associated with loss of neuroendocrine differentiation, more rapid growth in 
vitro, and increased expression of certain cellular oncogenes [Gazdar et al., 1985; 
Carney et a l, 1985]. Carmichael et al. [1989] have reported radiation sensitivity 
of a panel of lung cancer cell lines from both SCLC and NSCLC origin. It was
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found in their studies that SCLC cell lines were generally more sensitive, except 
the variant lines, and most of the NSCLC cell lines were resistant, except the cell 
lines that express neuroendocrine markers, suggesting that changes in lung cancer 
phenotype may alter response to radiation therapy, and this may have significant 
clinical implications. Therefore, in vitro predictive testing may be of clinical value 
for the detection of lung cancer patients with sensitive tumours.
The SCLC H69 cell line and the derivative lines, H69V & H69VZ, were 
investigated for their sensitivity to cytotoxic drugs vincristine and adriamycin in 
vitro. In this study H69 was more sensitive to vincristine, but resistant to 
adriamycin, while both the derivative lines were significantly more resistant to 
vincristine, but sensitive to adriamycin [Chapter three-A]. Vincristine sensitivity 
of the cell lines was consistent with previous observations [Carney et al., 1983; 
Duchesne et al., 1986]. However, resistance of SCLC and sensitivity of NSCLC 
to adriamycin was inconsistent with other phenotypic changes observed in this 
model. It was expected that the adriamycin sensitivity pattern should be similar 
to that of vincristine in this model, because resistance to these drugs have been 
shown to implicate the MDR-phenotype. However, this does not seems to be the 
case with adriamycin in this model at least. It was not entirely surprising, since 
adriamycin may act through a number of different mechanisms. In addition to 
inhibition of DNA synthesis, it can also form free radicels which can combine and 
inactivate or denature protein, carbohydrate, or lipid molecules resulting in wide 
spread effects on cellular functions. It can also have damaging effects on cell 
membrane. Though adriamycin has different mechanisms of action, it does not 
however explain different effects seen in H69 and its derivative lines. Whether 
it is related to penetration, neuroendocrine differentiation or alterations in 
growth control due to activation of some oncogenes, may be investigated in 
future studies.
It has been shown previously that H69 cells treated with different 
phenotypic inducers reduced some of the neuroendocrine markers (e.g. DDC), 
but this change did not influence the sensitivity of the cells to cytotoxic agents 
[Murray, 1989], suggesting that modifying the neuroendocrine phenotype may not 
always be associated with a change in chemosensitivity of the cells in vitro. It 
may be that the sensitivity of the cells may only change with induction of 
terminal, and irreversible differentiation. Hence, changes in H69V & H69VZ 
may be due to a stable phenotypic shift, while phenotypic change in H69 
following treatment with inducers was adaptive, since the effects were reversible,
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following removal of the inducer from the cell culture. It would be interesting 
to investigate phenotypic changes following more prolonged treatment with 
inducers, to determine whether more permanent changes could occur and 
chemosensitivity is altered.
The NSCLC cell line, WIL, co-cultured with fetal fibroblasts showed some 
changes in culture morphology [Chapter four], but there was no significant effect 
on sensitivity of the WIL cells to adriamycin and/or vincristine, suggesting that 
stromal interaction may not be important for the sensitivity of tumour cells in 
vitro. Similarly when the NSCLC cell line A549 was induced to differentiate in 
a filter well system in stromal co-culture, significant changes were observed in cell 
phenotype following stromal interaction including increased secretion of 
surfactant, reduced PA production and increased anchorage dependence, but 
there was no effect on chemosensitivity [Speirs & Freshney, 1990]. Again it may 
be that the phenotypic changes were reversible with the cells regaining original 
tumour phenotype once out of the inductive microenvironment. Further studies 
are required to compare these findings in models with stable phenotypic changes 
as shown in H69 and its derivative lines; this may then answer whether 
permanent changes in cell phenotype can alter sensitivity to cytotoxic agents.
Sensitivity of mink lung epithelial cells transfected with Ha-ras oncogene 
showed significant resistance in vitro to cytosine arabinoside compared with the 
non-transfected cell line [Chapter five], suggesting a role of Ha-ms. oncogene in 
drug resistance, at least in some cases. Similarly in an other study, activated H a­
ras transfected cells of mink lung epithelium showed significant resistance to 
adriamycin, compared to the untransfected cells [Kerr et al., 1990], suggesting 
again that oncogene expression may be related to drug resistance. Mink lung 
epithelial cells transfected with H-ras, activated Ha-ms or c-mvc oncogene did not 
have any significant effects on the sensitivity of transfectants to vincristine [Kerr 
et al., 1989; 1990], or cis-platin [Chapter five], suggesting that the effects of 
oncogene transfection may be specific to certain drugs. Further studies could 
examine whether drug resistance is correlated with oncogene transfection.
The multidrug resistant phenotype (MDR) in human cancer cell lines has 
been associated with overexpression of a plasma membrane glycoprotein (P- 
glycoprotein) of approximately 170,000 dalton [Kartner et al., 1983; Riordan & 
Ling, 1985; Gerlach et al., 1986]. The level of P-glycoprotein expression 
correlates with the degree of drug resistance, in many cell lines increased 
expression is accompanied by MDR-gene amplification [Riordan et al., 1985].
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However, in other studies MDR was not correlated with P-glycoprotein 
overexpression [Mirski et al., 1987], These data have suggested that there may 
be factors other than P-glycoprotein which may account for the development of 
MDR-phenotype in lung cancer.
However, ara-C does not fall within the MDR group, and adriamycin and 
vincristine which changed their sensitivities in opposite directions, do. This 
suggests MDR was not the significant mechanism in these studies, although it has 
previously been shown to have increased expression in differentiated cells 
[Meyers, 1990; Biedler et al., 1990].
Increased phosphorylation of a 20 kD protein has also been correlated 
with drug resistant phenotype in SCLC [Fine et al., 1985]. A possible role of 
detoxification enzymes in drug resistance has also been suggested [Doroshow et 
al., 1980; Cowan et al., 1986]. Elevated glutathione-S-transferase enzyme has 
been found in resistant cell lines [Wolf et al., 1986]. However, no significant 
difference were found in the levels of a number of detoxification enzymes 
including glutathione-S-transferase, between drug sensitive classic SCLC and drug 
resistant variant cell line in vitro [Carmichael et al., 1988]. Drug resistance may 
also be related to efficient damage repair mechanisms in cells. It has been shown 
by Zijlstra [1987] that increasing intracellular drug concentration did not alter the 
sensitivity of adriamycin resistant human SCLC cell line GLC4/ADR, suggesting 
that resistance may be multifactorial. These potential mechanisms of drug 
resistance could be investigated in H69 and the derivative cell lines.
The development of drug resistance has also been associated with specific 
chromosomal alterations such as homogeneously staining regions (HSRs) and 
double minute chromosomes [Robertson et al., 1984]. A number of resistant lung 
cancer cell lines have increased expression of one or more oncogenes [Gazdar et 
al., 1985; Johnson et al., 1987]. The c-mvc oncogene overexpression has been 
found in radiation and drug resistant variant cell line of SCLC in vitro [Gazdar 
et al., 1985]. In preliminary studies using immunohistochemical staining 
techniques it has been found in these studies [Chapter three-A] that both the 
derivative lines H69V & H69VZ had increased expression of c-mvc oncogene, 
compared to the parental line. An increased oncogene expression in the 
derivative lines may be responsible for resistance to radiation and some of the 
cytotoxic drugs. It may also be related to changes in growth rate and 
clonogenicity of the lines. However, there seems to be no direct causal 
relationship between c-mvc oncogene expression to radiation or chemosensitivity,
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either between classic and variant lines of SCLC or between SCLC and NSCLC.
Further studies are needed to investigate this in more detail, perhaps by 
oncogene transfection studies. It may be reasonable to assess radiation and 
chemosensitivity of different lung cancer cell lines with and without 
overexpression of an oncogene to answer whether oncogenes have a role in 
sensitivities of cells to therapy. Effects of oncogene transfection on phenotypic 
expressions, radiation and chemosensitivity of H69 and its derivative adherent cell 
lines is a potential model for future studies. Working on a similar approach it 
has been shown in this thesis [Chapter five] that transfection of immortalized 
mink lung epithelial cells with H-ras oncogene has increased resistance of the 
transfectants to cytosine arabinoside, and in an other study activated Ha-ras 
oncogene transfection in same cell line imparted resistance to adriamycin [Kerr 
et al., 1990] and cis-platin [Sklar, 1988], suggesting that oncogene may have a 
role to play in drug resistant phenotype, and it may have clinical implications, as 
a significant proportion of human tumours have been found overexpressing 
oncogenes [Field & Spandidos, 1990]. Sklar [1988] has shown that Ha-ras 
transfection in NIH 3T3 cells was associated with radiation resistance. However, 
others have found no correlation between in vitro radiation sensitivity testing and 
clinical responsiveness to radiation [Deacon et al., 1984; Malaisse et al., 1986]. 
Radiation sensitivity of the oncogene transfected cell lines (M l, N l, & T l)  was 
not investigated in present study, however, it remains an interesting area to 
investigate the effects of radiation on oncogene transfected lines relative to the 
untransfected parental line.
As more and more efforts are being put into various aspects of lung cancer 
research to elucidate biology of the disease, at the same time a number of 
potential therapeutic strategies are developing, taking advantage of these 
phenomena. The use of drug resistance modulators such as verapamil which 
overcome multidrug resistance associated with P-glycoprotein expression in some 
lung cancer cell lines in vitro is an attractive area of future research, however, it 
shows no success in vivo, mainly because the concentrations required are not 
achievable in patients [Rogan et al., 1984]. Furthermore, there was no indication 
of MDR involvement in the present studies.
It has been suggested that differentiating agents may be more effective as 
an adjuvant therapy after debulking of the main tumour mass with surgery or 
radiotherapy, or in combination with cytoreductive drugs. Significant effects of 
retinoids [Lotan et al, 1981], and NMF [Gescher & Gibson, 1982] have been
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seen in small tumours grown in mice. Combination of cytotoxic drugs and 
cytostatic agents have also been suggested as a potentially useful therapy. 
Retinoids have been shown to exert additive antitumour effects in combination 
with tamoxifen [Wetherall & Taylor, 1986] and synergistic effects in combination 
with cytosine arabinoside [Findley et al., 1985], or dexamethasone [Bregman et 
al., 1983]. In vivo studies with experimental animals have shown that retinoids 
can enhance the antitumour effects of cyclophosphamide [Cohn & Carbone, 
1972], or 5-fluorouracil [Tomita et al., 1982]. Similarly a combination of retinoid 
with tamoxifen was effective against mammary cancer [McCormick & Moon, 
1986]. It has been shown that cytotoxic effects of 5-fluorouracil were modulated 
by N-methylformamide on a human colon carcinoma cell line [Zupi et al., 1988]. 
In the present studies [Chapter three-B] HMBA has shown significant cytostatic 
effects on growth of H69 cells both in vitro and in vivo. A combination of 
cytotoxic drug such as cis-platin with HMBA could be worth investigating in H69 
cell line. These observations have suggested a future role of differentiation 
therapy in cancer treatment in conjunction with conventional cytotoxic 
chemotherapy. However, more studies are required to identify new agents with 
higher specific activity, more effective combinations, and to design appropriate 
experimental models for evaluation of these agents. Inducer agents which are 
effective in vitro and in vivo in experimental models could then be presented, with 
appropriate recommendations for scheduling with cytotoxic drugs, for clinical 
trials.
6.5 Model Of Cancer Cell Invasiveness In Vitro: Chick Heart Invasion Assay.
A large variety of heterologous model systems of in vitro invasion have 
been employed, using different natural substrates. These include: 1) Complete 
mono- or multilayers of normal cells e.g. endothelial cells [Nicolson, 1982; Yee 
& Shiu, 1986], fibroblasts [Benke et al., 1984]. 2) Biological membranes such as 
chick chorioallantoic membrane (CAM) [Hart & Fidler, 1978; Poste et al., 1980; 
Poste, 1982], human amniotic membrane [Liotta et al., 1980] and reconstituted 
acellular membranes [Terranova et al., 1986]. The biological membranes have 
often been used, because of their simpler structure, consisting of two layers of 
epithelium with an intervening layer of mesenchyme. Penetration and crossing 
of membrane by tumour cells constitutes invasion in this system. 3) Whole
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organ pieces e.g. from aorta, veins, bladder and thyroid [De Ridder, 1979; Poste 
et al., 1980]; fragments of organs from various tissues e.g. lung [Lohmann et al., 
1980; heart [Mareel et al., 1979], cartilage [Pauli et al., 1980] and brain [Wang 
et al., 1983]. 4) A filter well system currently in use in this laboratory was 
described in Chapter four. In this system a synthetic membrane covered with a 
complete monolayer of normal cells is used as a barrier for invasive cells. 
Penetration of the normal cell layer by tumour cells, and recovery of tumour cells 
from the under surface of the filter membrane and the bottom of the well 
confirms invasion. Though potentially useful, the efficacy of this system is yet to 
be proven.
The measurement and investigation of tumour cell invasion in vitro has 
been the subject of many research studies as discussed above, all of them aiming 
to fulfil two main criteria, namely, the in vitro invasion assay must resemble as 
closely as possible the situation in vivo, and at the same time must be 
reproducible, quantifiable, and amenable to experimental manipulation. 
However, despite the plethora of in vitro model systems, few of them actually 
satisfy the above criteria.
In the present studies, a three dimensional histotypic in vitro invasion 
model [Mareel et al., 1979] has been used to quantitate the ability of 
malignant/transformed cells to invade PHF. The assay is both qualitative and 
semi-quantitative. This, in vitro invasion model, mimics the natural situation 
more closely than other available systems, as no artificial substrates are involved 
and the geometry is closer to the in vivo situation. It has been demonstrated 
from the studies presented in this thesis that this three dimensional model system 
does provide a standard method to evaluate the invasive behaviour of 
transformed cells in vitro. The three-dimensional confrontations can be analyzed 
by the same methods as natural tumours. The test cells can readily be identified 
in the heart fragment on simple H & E staining because of their characteristic 
histological appearance in the background of chick fibroblasts and myoblasts. 
Immunohistochemistry can be used for identification of tumour cells in the heart 
fragment or heart tissue can be identified using specific chick mesodermal 
antibodies. Electronmicroscopy can also be performed for ultrastructural analysis 
of the invasion process [Mareel, 1982]. The assay can also be used for metabolic 
and biochemical investigations [Nicolson, 1982: Laug et al., 1983; Starkey et al., 
1984], and to quantify radiolabelled cells in the heart fragment [Waller et al., 
1986]. Computer-assisted image analysis can be used for quantitative analysis of
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invasion of tumour cells in the chick heart assay [De Neve et al., 1985], The 
staging of natural tumours can be performed for prognostic and therapeutic 
purposes, and the grading system used in this assay [Bracke et al., 1984] may be 
useful for various other purposes such as search for oncogenes involved in 
invasion [Mareel & Van Roy, 1986; Van Roy et al., 1986], and the development 
of anti-invasive means of cancer therapy [Mareel & De Mets, 1984]. The assay 
allows scoring and comparison of different variations of invasiveness between 
cells of different systems [Mareel et al., 1987], and the possibility of manipulating 
the process of invasion [Bracke et al., 1986]. The assay has a number of technical 
advantages over the other available invasion assays. It is reproducible, and 
consistent results have been obtained in the present and previous reports. It 
provides a three-dimensional tissue structure comparable to in vivo tumour-host 
relationship, but has an extra advantage that the host immune influences are no 
longer effective. The culture conditions can be monitored by morphological 
appearance and the beating property of the heart fragment.
Although, a good correlation between invasiveness in vitro and invasive 
behaviour of tumours in vivo has been demonstrated in this assay system in 
various studies [Mareel et al., 1987; De Ridder & Calliauw, 1990], there are 
some basic differences between in vitro and in vivo invasion in natural tumours 
that are also found in this system. The assay does not model the pre-invasive 
(carcinoma in situ) state of tumour cells, and may be more relevant to secondary 
invasion rather than primary invasion in vivo. Some of the important components 
of invasion in vivo are missing e.g. functional blood vessels and lymphatics 
(intravasation/extravasation), and the basement membrane with epithelium. 
Cellular reactions (e.g. inflammation) are not present during invasion in vitro. 
The host tissue used in vitro assay is not ideal, as heart is rarely seen as a site of 
invasion. It may be worth trying in future studies to use normal lung tissue 
instead of heart tissue for the study of invasion in lung cancer models.
Different patterns of invasion, colonization, and degradation of normal 
heart tissue have been observed in the studies presented in this thesis. The 
SCLC cell line H69 was invasive in the present assay system [Chapter three-A]. 
The pattern of invasion was very interesting, the tumour cells invaded the heart 
fragment singly at several fronts, and were able to reach the centre of the heart 
fragment. This type of invasion is not what is generally reported in the standard 
grading system [Bracke et al., 1984; Mareel et al., 1987]. Solitary invasion may 
reflect early metastasis in SCLC in vivo, as single cells could invade and colonize
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different organs in the body.
The derivative cell lines expressed NSCLC-like properties, and were non- 
invasive, compared to the parental SCLC cell line which expressed classic small 
cell properties and was invasive. This correlated well with in vivo invasion and 
metastatic studies [see below, section 6.6], suggesting that the model may be valid 
and reflect in vivo characteristics of invasion. This could have significant clinical 
implications, where the assay system could be used to predict tumour invasiveness 
and metastatic potential in SCLC. Furthermore, H69 with its sublines may be a 
useful in vitro model to study cellular properties associated with early metastatic 
spread in small cell lung cancer.
The invasive capacity of the H69 cells treated with HMBA or Na-But was 
significantly retarded [Chapter three-B]. This was in agreement with the other 
effects of the phenotypic inducers found in the present study. A decreased 
invasion was correlated with suppression of growth in vitro, a reduced colony 
forming efficiency in soft agar and reduced tumorigenicity in nude mice, following 
treatment with phenotypic modulators. It has been shown previously that 
invasion may be stopped by certain chemical agents such as catechin [Bracke et 
al., 1986], suggesting that the in vitro chick heart invasion assay may be used to 
identify anti-invasive agents. The correlation between in vitro and in vivo activity 
of HMBA & Na-But in these studies further validates the assay in its capacity to 
identify anti-invasive activity. This may have significant clinical implications as 
the possibility of manipulating the process of invasion can be used as a potential 
mode of cancer treatment in future. More investigations could be carried out to 
screen chemical agents with anti-invasive activity using this assay, and with 
parallel in vivo studies, to determine the potential use of anti-invasive treatment 
in clinical situations, such as in tumours with high invasive potential e.g. SCLC.
The chick heart invasion assay was also employed to investigate the effects 
of human oncogene transfection on invasiveness in vitro of mink lung epithelial 
cells [Chapter five]. It was interesting to find that all the transfected cell lines 
were highly invasive, but, it was surprising to find that the parental non­
transfected cell line was also invasive. Spontaneous acquisition of transformed 
phenotypic characteristics (tumorigenicity, invasion, metastasis) have also been 
observed previously in non-transfected 3T3 cells [Mareel et al., 1975; 1986] and 
also in various other cell lines [Van Roy et al., 1986; Mareel et al., 1988], in 
agreement with the present report. It was concluded from further studies of the 
parental line, that perhaps an invasive subpopulation of cells may exist in the
197
parental line, as it was also found to be mildly tumorigenic. The invasive cells 
could be retrieved from the heart fragment and characterised to establish whether 
all cells or only tumorigenic subpopulation of the parental line was invasive. The 
mechanism of spontaneous transformation in these cell lines could be investigated 
by genetic analysis for oncogenic sequences in cell DNA e.g. mvc and ras 
overexpression or loss of suppressor genes and also by cell surface expressions 
e.g. N-CAM.
The molecular mechanisms of invasion in vitro models are being explored. 
Different steps of invasion in the chick heart assay have been described such as 
adhesion, motility, penetration, degradation and progressive replacement of host 
tissue by tumour cells in time and space [Mareel et al., 1979; Mareel, 1983; 
Mandeville et al., 1987]. Adhesion was found in H69 and its derivative lines, but 
only the H69 cells were invasive, suggesting that although adhesion is a step 
towards successful invasion, adhesiveness per se may not be sufficient to cause 
invasion, therefore, all adhesive cells may not be invasive, though all invasive cells 
must adhere with the host tissue first before invasion. H69 cells treated with the 
chemical inducers (HMBA Na-But) showed reduced adhesion, and therefore 
delayed invasion, again suggesting that although adhesion is not a guarantee for 
invasiveness, yet it is important step for invasion to take place. It has been 
shown that homotypic adhesion is decreased in malignant cells, compared to their 
normal counterpart [Coman & Anderson, 1955: Coman, 1961]. Others have 
shown that both spontaneously transformed cells and cells transformed by viruses 
had greater heterotypic adhesiveness compared to the normal cells [Dorsey & 
Roth, 1973]. The present studies have shown that all invasive (H69, mink lung 
lines) or non-invasive (H68V & H69VZ) cell lines investigated did attach to the 
heart fragment, irrespective of their invasive and neoplastic potential, but invasion 
was found only in some of them, implying that adhesion may not be used as a 
criterion of invasiveness.
Penetration of normal host tissue by tumour cells is the next step for 
progressive invasion in this assay. It involves motility of invading cells [Strauli, 
1979] and may be accompanied by destruction of host tissue, and its progressive 
replacement by the invading cells [Mareel, 1983]. In the present studies, the 
pattern of penetration, and progression of invasion differed considerably between 
the cell lines. In the H69 cells [Chapter three] invasion was focal or solitary 
where single cells were found in the heart fragment at different areas, usually 
embedded in, and surrounded by, apparently healthy normal host tissue in which
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the histological structure of myoblasts was well preserved, and no traces of the 
path of infiltration could be detected. This behaviour was in sharp contrast to 
that of mink lung epithelial cell lines [Chapter five], both non-transfected (Mvl) 
and transfected with human oncogene (M l, N l, & T l). These lines showed 
aggressive behaviour, with rapid invasion of PHF, forming a continuous sheet of 
invading cells, and replacing the whole front of the invaded heart fragment. This 
was accompanied by rapid proliferation of invaders at the expense of normal 
heart tissue, resulting in disintegration of PHF, within 10 days after co-culture.
The precise mechanism of these differences in the pattern of invasion of 
malignant or transformed cells in heart fragment is yet to be investigated. One 
might suppose that different growth rates of cell lines may be responsible for 
their different invasive potential, and patterns. However, it has been shown that 
proliferation is not an absolute requirement for invasion to occur [Thorgeirsson,
1984]. Mandeville et al. [1987] have shown that the invasive capacity of the cells 
was independent of cell proliferation as determined by their relative mitotic index 
and invasive potential. In the present studies, it has been shown that though the 
derivative lines, H69V & H69VZ, had a more rapid growth rate, yet they were 
non-invasive, compared to the parental H69 cell line which had a slow growth 
rate in vitro, but was invasive [Chapter three-A], suggesting that the cell 
proliferation and invasion are not correlated. In agreement with above 
observations, it has been shown that the human oncogene transfected lines (M l, 
N l & T l)  were highly proliferative and invasive, but the parental line (Mvl) 
though it had a low mitotic index, was almost equally invasive [Chapter five]. 
These data are in agreement with previous studies suggesting that cell 
proliferation and invasion may be related but not interdependent.
It might be useful in future studies to investigate cell surface glycoprotein 
expression and correlate it with invasiveness, in H69 and its non-invasive sublines 
(H69V & H69VZ), and in the mink lung epithelial cell line (Mvl) and its 
transfected and non-transfected clones. This may give insight into the properties 
of the invasive phenotype and experiments could then be designed to target these 
properties specifically.
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6.6 Model Of Cancer Cell Invasion And Metastasis In Vivo: Nude Mouse Assay.
Clinical and experimental studies of lung cancer have shown that SCLC 
has an early metastatic potential, whereas NSCLC may become metastatic, but 
during later stages [Matthews et al., 1973; Hansen et al., 1978]. The present data 
suggest that the H69 and its derivative cell lines may reflect clinical behaviour of 
lung cancer, and may be used as a valid model system for studying metastasis. 
A number of phenotypic changes in vitro have already suggested a NSCLC-like 
phenotype of both H69V & H69VZ. What makes an invasive and metastatic cell 
(H69) become non-invasive, and non-metastatic (H69V & H69VZ)? To answer 
this question further studies are required, first to establish and confirm the 
validity of the nude mouse model, and by growing tumours for relatively long 
periods. In the present study tumours were removed after approximately six 
weeks, and it may be possible that they could form metastases, if grown for a 
longer period, as NSCLC do metastasize, but in late stages. Common sites of 
metastases formation other than lungs and liver such as brain, and kidney could 
also be examined. Once established it would be interesting to manipulate this 
model, both genetically, and microenvironmentally in conjunction with the in vitro 
assay, to delineate the biological mechanisms responsible for these changes in cell 
behaviour.
The phenotypic inducers showed significant reduction in H69 tumour 
growth in nude mice [Chapter three-B], but whether they had an anti-metastatic 
effect was not determined, so it may be useful in future studies to see effects of 
inducers on metastasis of H69 in this model. It may be worth investigating the 
cell surface expressions of the parental and the derivative lines for glycoproteins 
involved in cellular adhesion and locomotion such as N-CAM and integrins. Also 
the expression or deletion of certain oncogenic sequences may be responsible for 
these phenotypic differences between the parental and the derivative lines. The 
cell lines may be screened for the differences in oncogene expression e.g. mvc 
family, and cross-transfections attempted. In preliminary studies differences in 
c-mvc expression in the parental and the derivative lines have been observed in 
this model, and a role of mvc oncogene family in lung cancer has been reported 
in different studies [Little et al., 1982; Carney et al., 1985; Gazdar et al., 1985; 
Field & Spandidos, 1990].
The studies of human oncogene transfected cell lines of mink lung origin 
have shown that they were non-metastatic, either to regional lymph nodes or
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distant organs including brain, lungs, and liver, in spite of their invasive behaviour 
both in vitro and in vivo [Chapter five], suggesting that there is no apparent 
correlation between invasiveness and metastasis, or oncogenes and metastasis, 
at least in this model.
The results of transfection studies, on the role of oncogenes in metastasis 
are still controversial. The present study agrees with some of the previous results 
where oncogene transfection and invasiveness were not interrelated. Waller et 
al. [1986] have shown that a mouse lymphoma cell line was highly invasive in 
vitro, but had very low metastatic potential, suggesting that invasion and 
metastasis are two separate phenotypes. Thorgeirsson et al. [1985] showed that 
ras transfected cells were non-metastatic when implanted subcutaneously into 
the nude mouse, in agreement with the present results, but that the cells were 
able to form metastases when injected directly into the circulation, suggesting that 
the lack of invasive capacity at the primary tumour site may be important. 
However, this may not be the case in the present study, because the cells were 
invasive locally, suggesting that lack of metastatic growth was not due to the lack 
of invasiveness at the primary tumour site, in the present case. It has been 
suggested that though the ability of tumour cells to cross basement membrane in 
vivo may correlate with their metastatic ability, but all invasive tumour cells are 
not necessarily metastatic [Liotta et al., 1986]. It has been proposed that invasion 
and metastasis may be two distinct phenotypes in tumour progression [Mareel & 
Van Roy, 1986]. Others have suggested that tumour cell invasion and metastasis 
may be under separate genetic control mechanisms [Mareel et al., 1988]. It has 
been reported that rapid growth in tumours may also be responsible for a lack 
of metastasis in experimental tumours [Mareel et al. [1987], suggesting that it may 
be the case in the present study, as all the transfected cell lines were highly 
tumorigenic with rapid growth rate. H69 tumours grew relatively slower than the 
tumours of mink lung lines and were able to metastasize, but under the similar 
conditions, tumours of both the derivative lines were non-metastatic, making it 
more difficult to interpret the results.
In some reports it has been cautioned that failure of metastatic growth in 
nude mice model could be due to activity of natural killer (NK) cells [Fidler, 
1986], and others have proposed that oncogene transfection may stimulate 
cellular sensitivity to NK-cell cytolysis [Johnson et al., 1985; 1987]. However, it 
is not definite whether NK-cells are active in nude mice. Naito et al. [1987] have 
shown, using NK-cell deficient beige nude mice model, that there was no
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difference in metastatic behaviour of tumours grown either in nude mice or in 
beige nude mice, suggesting that NK-cells apparently had no effects on metastatic 
behaviour of tumours. In agreement with these observations, in the present 
study, H69 cells were metastatic in the same nude mice model under similar 
experimental conditions, where mink lines or the derivative lines of H69 were 
non-metastatic, suggesting that NK-cells may not be the cause of non-metastatic 
behaviour, rather it may be a cell specific property. H69 was metastatic, while 
its NSCLC-like cell lines and the parental and human oncogene transfected mink 
lung cell lines were non-metastatic, suggesting that there may be some common 
phenotypic characteristics in all non-metastatic lines, different from the metastatic 
H69 cell line. Whether, metastatic phenotype is under specific genetic control 
remains to be investigated.
The apparent differences between metastatic and invasive phenotypes are 
consistent with previous observations, suggesting that the two are separate, but, 
closely related phenotypes. The differences between metastatic and non­
metastatic cells should be investigated in future studies, as suggested above, at 
both cell surface and genetic level, and this may have significant clinical 
implications in the future. Therefore, it is concluded from these observations that 
the nude mouse model is a suitable model for the study of invasion and 
metastatic behaviour of human lung cancer in vivo.
6,1 Clinical Significance Of Mvc And Ras Oncogenes Expression In Human 
Lung Cancer.
The majority of previous investigations have been carried out on SCLC 
[Little et al., 1983; Nau et al., 1986; Johnson et al., 1987]. It has been shown that 
expression of L-mvc and c-mvc is coordinately regulated [Alt et al., 1986; 
W atanabe et al., 1988], and may be related to the biological behaviour of the 
lung cancer. A panel of SCLC cell lines has been established from treated and 
untreated patients, and investigated for c-mvc oncogene amplification [Johnson 
et al., 1987]. C-mvc amplification was seen only in cell lines established from 
treated cases, and the patients with c-mvc amplification have significantly shorter 
survival times, compared to the patients without c-mvc amplification. More 
recently [Field & Spandidos, 1990], it has been observed that c-mvc is 
overexpressed in various NSCLC specimens, by immunohistochemical staining
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with c-mvc specific monoclonal antibody (1-9E10). Elevated c-mvc expression 
was found in 43% (16/37) squamous carcinomas, 29% (4/10) adenocarcinomas, 
42% (3/7) large cell carcinomas,' and 19% (4/21) in SCLC. In the present 
studies, the c-mvc overexpression in H69V & H69VZ was in agreement with 
these observations, suggesting that c-mvc may be involved in tumour progression 
from SCLC to NSCLC-like phenotype, and hence with altered response to 
therapy.
Amplification and overexpression of the c-mvc oncogene has been reported 
in NSCLC-like morphological variant SCLC cell lines while L-mvc was 
overexpressed in classic SCLC cell line [Gazdar et al., 1985]. Similarly, Johnson 
et al. [1986] have demonstrated that transfection of the c-mvc oncogene into a 
classic SCLC cell line resulted in altered morphology and growth of SCLC 
towards a variant phenotype, suggesting a role of c-mvc in phenotypic conversions 
in SCLC towards NSCLC-like phenotype. In the present study, it has been shown 
that the derivative lines stained more uniformly for the c-mvc oncogene 
expression, compared to the parental line, again suggesting that phenotypic 
alterations in the derivative lines may be due to overexpression of c-mvc 
oncogene.
It has been shown in the studies presented in this thesis [Chapter five] that 
the transfection of an immortalized mink lung epithelial cell line MvlLu with 
human c-mvc oncogene increased growth and tumorigenic potential in the 
transfected cells (M l cell line), suggesting that enhanced growth stimulation by 
c-mvc oncogene overexpression may contribute to abnormal growth regulation 
leading to neoplastic transformation. It has been proposed that the regulation 
of c-mvc oncogene is involved in the control of proliferation and differentiation 
of cells [Klein & Klein, 1985], and the overexpression of c-mvc in E169V and 
H69VZ may be related to the differentiated, NSCLC-like phenotype, suggesting 
that the modulation in mvc gene expression may be the underlying cause of 
phenotypic shifts in human lung cancer. Therefore, the c-mvc overexpression may 
affect the histopathological diagnosis, and therapy of lung cancer. It would be 
interesting to investigate the expression of L-mvc and c-mvc in both the derivative 
and the parental cell lines, and the effects of transfection of L-mvc gene into the 
H69V and H69VZ, and c-mvc into SCLC H69. It may be possible that H69 
would change to H69V & H69VZ-like phenotype, while the derivative lines may 
revert to parental cells.
Kiefer et al. [1987] have investigated 12 SCLC cell lines for mvc
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and ras. family oncogenes. The c-mvc amplification was found in 7/12, N-mvc 
amplification in 3/12, and both c-mvc and N-mvc amplification in 1/12 cell lines. 
All lines has similar expression of Ha-ras* K-ras, and N-nis, there was no 
overexpression of these genes, suggesting that mvc rather than ras overexpression 
may be more crucial in SCLC. Co-expression of c-mvc amplification and Ka­
ras point mutation has been found in a large giant cell lung carcinoma [Taya et 
a l 1984], suggesting that oncogene co-operation may be essential for this type 
of tumour phenotype. Ka-ras mutation and overexpression has been 
demonstrated in NSCLC. Rodenhuis et al. [1988] have shown that 9/35 
adenocarcinomas of lung had K-ras mutation, and were able to establish a 
correlation between smoking and Ka-ras mutation in these cases, suggesting that 
mutational events in Ka-ras. may be related to the carcinogenic agents in tobacco 
smoke. In another study ms p21 overexpression was found in the majority of 
squamous cell carcinoma (9/12) compared to 1 out of 12 non-squamous cell 
carcinomas [Kurzrock et al., 1986], suggesting that ras oncogene overexpression 
may be involved in the evolution of squamous cell carcinoma.
Overlap in features of different main lung cancer subtypes have been well 
documented in previous [Gazdar et al., 1987; Bepler et al., 1987; W atanabe et al., 
1988] and in the present studies [Chapter three-A], suggesting that the tumours 
in transitional stages may coexpress features of more than one histological cell 
types. The c-mvc overexpression was observed both in H69 and its derivative 
lines, though the expression in latter was quantitatively more than the former, 
suggesting that H69V & H69VZ may represent transient phenotype between 
SCLC and NSCLC, however, ras expression has not been investigated in these 
lines in the present study. It may be interesting to screen these lines for all 
members of the mvc and ras oncogene families, to establish whether any 
correlation could be made, between oncogene overexpression and phenotypic 
shifts, and resistance to therapy. Transfection of mink lung epithelial cell line 
with human normal Ha-ras and activated Ha-ras oncogenes, individually, induced 
malignancy related properties, in agreement with the previous observations. The 
transfectants showed increased growth in vitro, anchorage independence, and 
tumorigenicity in nude mice [Chapter five], suggesting that ras oncogene 
activation may be important in lung cancer. The fact that the effects of activated 
ras were more pronounced compared to normal ras suggested that activation of 
ras oncogene may be more crucial in malignant progression. However, although 
these preliminary observations have suggested a role of mvc and ras oncogenes
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in lung cancer, no clear pattern has yet emerged. The c-mvc oncogene family has 
a role in the genesis or progression of SCLC, but there is no general consensus 
on which member is important. A significant involvement of the ras gene family 
has also been implicated in lung cancer. It may well be that ras oncogene 
activation is related to the lung cancer development and progression. Clearly, 
more studies are required to establish the role of oncogenes in lung cancer, by 
correlating their overexpression with phenotypic changes, both in clinical 
specimens and in lung cancer cell line. Once established it may have significant 
implication in human lung cancer in future. Oncogenes may be used as 
molecular probes for diagnostic and eventually, prognostic purposes. Oncogenes 
and their products may prove ideal candidates for novel therapeutic targets 
selective against cancer cells, and tumour progression may be prevented by 
antagonizing their functions. Effects of oncogene transfection in SCLC and in 
NSCLC may provide an opportunity to correlate oncogene overexpression and 
phenotypic changes in future studies.
6.8 Model Of Carcinogenesis In Vitro: Mink Lung Epithelium.
Developing a model of truly equivalent cultures of normal and malignant 
cells from the same lineage is often difficult [DiPaolo et al., 1983] and in vitro 
transformation has often been used as an alternative. Since the discovery that 
transfection with oncogenes can induce a malignant change in some cell lines, 
many investigators have tried to develop in vitro model systems of normal and 
transformed cells from the same lineage. In the present study [Chapter five], 
successful transfection of a normal (immortalized) mink lung epithelial cell line 
MvlLu with human c-mvc. Ha-ras. and activated Ha-ras. oncogene, individually, 
presented the possibility of investigating transformed lung epithelium and 
comparing it with a normal (immotalised) equivalent.
Transfection with each oncogene increased growth both in vitro and in 
vivo. A progressive rise in expression of malignancy associated phenotypes was 
observed, where c-mvc exhibited slight differences from the parental line, while 
transfection with Ha-ras. and activated Ha-ras. produced more pronounced 
differences from the parental line, and was found generally more aggressive. 
These data in agreement with previous studies [Yoakum et al., 1985; Spandidos 
& Anderson, 1987; Barbacid, 1986], suggest that c-mvc and Ha-ras human
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oncogenes can induce malignancy associated properties in the transfected cells, 
implying their possible role in human lung carcinogenesis.
W hether these differences represent intrinsic differences in transfection 
capacity or a lower frequency of transfection to lower copy number of c-mvc is 
not clear from these results. It may be possible that during expansion of the M l 
clone, some other mutational events took place and caused the alterations in 
growth characteristics. However, there is no evidence of this and staining with 
the anti-c-mvc antibody did demonstrate a significant difference from the parental 
line. The effects of normal Ha-ras transfection were, in most cases, similar to 
transfection with activated Ha-ras^ but, where the differences were apparent, 
activated Ha-ras was always the more aggressive phenotype. This is more likely 
to be an intrinsic difference in the mutated ras gene as the transfected normal 
ras gene appeared to be present at a higher copy number. The c-mvc 
immunostaining was patchy, in agreement with the possibility that the gene is not 
uniformly distributed in the population, while the ras immunostaining was 
uniformly distributed to the plasma membranes.
Though the overexpression of endogenous genes cannot be ruled out, it 
seems more likely that this is exogenous gene product, particularly in view of 
minor, but distinct differences between the normal and mutated Ha-ras 
transfection. Furthermore, no staining was observed for either ras or mvc gene 
products in the untransfected controls, suggesting some degree of species 
specificity in the antibodies used. The antibody to c-mvc protein. p62 (9E10) has 
been shown to be human specific in previous studies [Evan et al., 1985], so 
interaction with endogenous mink p62 is unlikely, in agreement with negative 
staining of the untransfected controls. However, it seems likely from the 
southern blot results that only a proportion of the M l cells actually contains the 
exogenous mvc gene. Hence the phenotypic effect may have become less than 
would be expected from more uniform distribution of the transfected genes.
It may be argued that the calcium phosphate transfection technique 
[Graham & Van der Eb., 1973] itself may contribute in the transformation of 
cells by carrier DNA, but this possibility was ruled out by using appropriate 
controls. Clones of the parental cell line, MvlLu, selected by G418 selection and 
although not characterized extensively, showed similar growth factor response, 
and morphological properties, suggesting that the altered phenotypic expressions 
in the transfected lines were not coincidental. Also the parental cells transfected 
with plasmid containing aph gene, but without oncogene, showed no sign of
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transformation, suggesting that the phenotypic transformations in the oncogene 
transfected clones were due to the oncogenes and not the plasmids, or carrier 
DNA in transfection technique.
Although the oncogene transfection produced malignancy changes in the 
transfectants, the parental line itself was found mildly transformed, as it was 
invasive in chick heart invasion assay and tumorigenic (albeit at a very low level) 
in athymic nude mice. It would have been useful to include at least one 
randomly selected clone of the parental line in order to determine whether the 
altered growth properties of the clone are due to the selection in vitro from 
heterogeneous cell population rather than oncogene transfection. However, it 
can be justified in presence of other controls (i.e. presence of oncogene in the 
transfected cells and its absence in the parental non-transfected cells by southern 
blot analysis, gene expression in the transfected lines as detected by 
immunocytochemical techniques, no effects of transfection without plasmid or aph 
gene on growth or morphology of transfectants, and significant phenotypic 
changes seen in the transfected cells, compared to the non-transfected parental 
line) that the altered phenotypic effects in the transfectants were due to the 
transfected oncogenes, though it can not be ruled out that the parental line was 
heterogeneous, perhaps containing a subpopulation of transformed cells. 
Therefore, the validity of the parental line as a model of normal epithelium may 
be controversial, but this does not invalidate the effects of oncogene transfection 
investigated in the present studies.
Though, the parental cell line was immortalized, it maintained the growth 
control and physiological properties of normal epithelial cells in vitro. It 
maintained relatively flat morphology in culture suitable for transfection. It 
exhibited the same stringent requirements of serum factors for growth in culture 
as primary epithelial cells. The cell line did not spontaneously produce 
transformed foci at a detectable frequency, and did not produce tumours in 
animals at a significant frequency. The parental line was density limited in 
culture, and anchorage dependent for growth in vitro. It showed normal 
response to growth factor stimuli in vitro. The cell line has been used in a 
number of transfection studies, because of its relatively flat morphology, and 
many of the properties of normal cells as described in previous studies 
[Henderson et al., 1974; Barbacid et al., 1978; Evans & Cloyd, 1984; Kerr et al., 
1990].
It would have been ideal to use normal lung epithelial cells for
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transfection studies. However, as mentioned earlier, such attempts have not been 
successful in previous studies [DiPaolo, 1983] and most of the transfection studies 
have been performed on non-epithelial cells, such as NIH 3T3 and other 
fibroblast cell lines [Spandidos & Wilkie, 1984; Barbacid, 1985; 1987; Spandidos, 
1985; Kelekar et al., 1986; Wyllie et al., 1987]. The mechanism of this resistance 
in human cells, particularly of epithelial origin, is not clear. However, it has been 
proposed that host factors such as chromosomal stability [Harris, 1987], 
suppressor genes [Anderson & Spandidos, 1988; Spandidos & Anderson, 1989], 
and efficient DNA repair system [Topal, 1988] may be responsible.
A  more appropriate, in vitro model of normal human bronchial epithelial 
(NHBE) cells has been developed by Harris et al. [1985]. NHBE cells have 
been transfected by v-Ha-ras oncogene by protoplast fusion [Yoakum, 1984] and 
selected for loss of differentiation control in presence of serum, based on 
hypothesis that malignant cells have defects in their differentiation pathways, and 
that they can grow in conditions that induce terminal differentiation of the 
normal parent epithelial cells. It has been shown that v-Ha-ras transfected 
NHBE cells expressed malignancy related properties such an immortalization, 
aneuploidy, and tumorigenicity in nude mice, suggesting that v-Ha-ras oncogene 
may be involved in multistep carcinogenesis [Harris et al., 1985; Yoakum et al.,
1985]. However, it has not been reported which cell types of the normal 
bronchial epithelium have been selected in culture or used in transfection studies. 
Terminally differentiated cells do not divide, and are incapable of self renewal. 
Stem cells (basal cells) might have been selected in these studies, but the 
possibilities of other cells being selected has not been ruled out. As it has been 
shown that basal, intermediate and mucus cells are capable of proliferation and 
self renewal [McDowell et al., 1978]. It would be interesting to determine 
whether different lung cancer phenotypes can be induced in the basal cells, using 
different carcinogenic agents and whether basal cells can be induced to 
differentiate to various cells of normal respiratory epithelium.
This may prove an ideal model for the study of differentiation and 
carcinogenesis in human lung epithelial cells. Preliminary studies have shown 
that Ha-ras p21 blocks differentiation in NHBE cells [Yoakum et al., 1985], 
possibly by regulating adenyl cyclase activity [Gilman, 1984; Toda et al., 1985; 
Manne et al., 1985]. It has also been shown that transfected NHBE cells express 
a decrease sensitivity to differentiation inducing stimuli, such as serum, TP A, and 
TBF-/3 [Yoakum et al., 1985; Masui et al., 1986], suggesting an inverse
208
relationship between differentiation and malignancy. These studies suggest that 
Ha-ras p21 induced transformation can be linked to GTP-binding protein 
pathways, where p21 may have a role to deregulate the differentiation pathways. 
It would be interesting to investigate the effects of human mvc and ras oncogene 
transfection on NHBE cells phenotype, and how this may be reversed by using 
appropriate inducer of differentiation, such as HMBA, Na-But, cyclic AMP etc. 
These studies would delineate the mechanisms of normal differentiation control, 
and how these mechanisms become aberrant in carcinoma cells. The role of 
oncogenes in human lung epithelial carcinogenesis, and reversal by different 
induction methods may have significant clinical implications, both in diagnosis 
and therapy of lung cancer in future.
6.9 Further Experiments And Future Prospects.
1). Adherent lines of H69 clones could be established and characterized 
in vitro and in vivo for growth, neuroendocrine phenotype, cytogenetic analysis 
for chromosomal markers, ploidy by flow cytometry, activation of oncogenes or 
loss of suppressor genes, invasion and metastasis. The results could be compared 
with the H69 and its derivative lines in the present study, to determine whether 
the adherent lines represent mono- or polyclonal origin.
2). H69 and its derivative lines (H69V & H69VZ) may be used as a 
model of phenotypic changes in lung cancer. These lines could be further 
characterized for karyotypic analyses to see any differences between the parental 
and the derivative lines. The lines could also be screened for oncogene 
expression such as c-mvc and Ha-ras, Transfection of lines with these oncogenes 
may be interesting, as there is some evidence that different members of the mvc 
family may be associated with phenotypic conversions in lung cancer; SCLC 
overexpress L-mvc. while variant lines with NSCLC-like phenotype overexpress 
c-mvc. Therefore, transfection of H69 with c-mvc and transfection of the the 
derivative lines, H69V & H69VZ, with L-mvc may change the phenotypic 
expression of the transfectants, as reflected by altered morphology, 
neuroendocrine marker expression, resistance to radiation and cytotoxic drugs. 
These studies may have significant clinical implication, in both diagnosis, and 
therapy of lung cancer.
3). Phenotypic conversion in human SCLC cell line H69 was due to a
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common stem cell subpopulation in the parental line, however, it is not known 
whether transformation of one malignant cell phenotype into another malignant 
cell phenotype is possible. Cloning a homogeneous cell population such as H69V 
or H69VZ may provide a good model to answer this question. Heterogeneity, 
or appearance of cells with H69 phenotype in the clones of the derivative lines 
would confirm whether inter-conversions between different lung cancer types is 
reversible i.e. can NSCLC clones give rise to SCLC phenotype?
4). Cytostatic effects of phenotypic inducers have been observed on 
H69 cells both in vitro and in vivo, in the present study, this study may be 
followed further to establish whether anti-tumour activity of HMBA or Na-But 
could inhibits metastatic growth in H69 xenografts. This may have significant 
therapeutic implications in SCLC. The cytostatic effects of inducers were 
reversible in vitro, but apparently the effects were not reversible within 16 days 
in vivo. This needs further experiments to see reversibility in vivo after a 
prolonged recovery period, following induction therapy of the tumour bearing 
animal. As the cloning efficiency of H69 in soft agar was significantly reduced, 
by induction treatment, it would be interesting to determine whether pre­
treatment of H69 cells with inducers, in culture, before inoculation, shows a 
correlation between clonogenicity in soft agar and tumorigenicity in nude mice.
5). As it has been shown in previous studies that short term (72 hours) 
induction of H69 cells with the inducers did not significantly alter 
chemosensitivity, it may be worth trying a combination of cytostatic and cytotoxic 
agents. Alternatively, the H69 cells may be induced for 7 days before cytotoxic 
drug exposure, because maximum cytostatic effects have been observed after 
prolonged treatment with these inducers in the present studies, and preliminary 
data from this laboratory and others [Zupi et al., 1988] suggest that sensitivity to 
some drugs may be enhanced by prior exposure to differentiating agents. This 
may have significant clinical implications, the cytostatic agent may turn a 
heterogeneous cell population into a homogeneous one, and the use of a specific 
cytotoxic agent may be able to eradicate the tumour cells altogether.
6). The histotypic tissue culture model described in Chapter four may be 
useful to establish the differentiated growth of normal respiratory epithelial cells 
in culture for the study of differentiation and carcinogenesis. It may also provide 
with the opportunity to carry out the comparative studies of normal and 
transformed cells, and to investigate whether microenvironmental changes could 
induce similar phenotypic expression in normal and transformed cells. This may
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have both biological and clinical significance. There was only mild effect of 
histotypic culture on WIL cells, but this model of histotypic culture may prove 
useful in malignant cells from other systems e.g. thyroid, breast, and gut etc.
7). It has been shown that the parental mink lung epithelial cell line Mvl 
was mildly transformed, as it formed colonies in agar (0.1%), tumours in nude 
mice (20%), and showed spontaneous invasion in chick heart fragment, suggesting 
heterogeneity in the parental line. It would be interesting to isolate the 
clonogenic cells from clones in agar, invasive cells from the invaded heart 
fragments and tumorigenic cells from xenografts in nude mice, and compare these 
with Mvl cell clones, to determine whether all cells or only one or perhaps more 
than one cell subpopulations exist in the parental line with different transformed 
phenotypes. The clones and other lines (clonogenic, invasive & tumorigenic) 
would provide the opportunity to characterize these cell lines, originating from 
one parental line, for a wide range of phenotypic properties. Heterogeneity in 
clones would indicate the stem cell nature of the parental line, as has been shown 
in H69 cell line.
8). Transfection studies could be performed using normal human 
bronchial epithelial model as established by Harris and coworkers [Harris et al., 
1985; Yoakum et al., 1985]. Transfection of normal human bronchial epithelium 
with human oncogenes, and induction of differentiation in the transformed cells 
could be the ideal model for the study of differentiation and carcinogenesis in 
human lung.
9). Future prospects of lung cancer treatment will be improved by using 
probes for specific DNA sequences that would help early recognition of lesions 
at the molecular level, in limited disease. As malignant phenotypic properties are 
due to alterations in gene expression, these genes and their protein products 
could be eradicated or reversed or blocked by differentiation inducers. Manifest 
disease with complete expression of the malignant phenotype might require 
synergistic cytoreductive therapy, consisting of cytotoxic and differentiation 
chemotherapy.
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